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Abstract: Genome instability is a characteristic of almost all human cancers and is a prerequisite for
acquisition of further hallmarks of cancer. While in hereditary cancers it arises due to mutations in
DNA repair genes, in sporadic cancers it appears that oncogene-induced replication stress is the main
cause for genomic instability. Hence, faithful DNA replication and repair are crucial to preserve genome
integrity, thus contributing to cancer prevention, and to properly transmit genetic information across
generations. Dna2 is an essential enzyme that is conserved from yeast to humans and is involved in
the maintenance of genome stability at multiple levels. It plays a role in unperturbed DNA replication
as well as under conditions of replication stress. In addition, Dna2 functions together with Sgs1 (in
yeast; Bloom or Werner in humans) in the repair of genotoxic double-strand DNA breaks, specifically
in DNA end resection, which is the commitment step to mostly error-free homologous recombination
pathway. Furthermore, Dna2 was described to be part of telomeric and mitochondrial DNA maintenance
systems, and to mediate checkpoint activation in yeast. During my PhD I was investigating the functions
of Dna2 in Saccaromyces cerevisiae and was mainly working with purified yeast proteins. First, we
expressed and purified yeast Dna2 and were able to show that it possesses not only a nuclease, but also
a vigorous helicase activity. Then we set out to analyze the regulation of the two activities within the
Dna2 protein. Using in vitro and in vivo approaches we show that yeast Dna2 is regulated by a post-
translational modification termed sumoylation. On the biochemical level, sumoylation of the N-terminus
of Dna2 selectively attenuated its nuclease activity, thus changing the balance between the helicase and
the nuclease within the protein. In vivo, we show that sumoylation of Dna2 is increased in the late
S/G2 phases of the cell cycle and appears to be involved in regulation of Dna2 upon treatment with
alkylating agents. Next, we addressed the essential function of Dna2 in lagging strand DNA replication,
where it acts together with Fen1 (Flap endonuclease I) in the processing of long DNA flap structures
arising during the maturation of Okazaki fragments. The nucleolytic cleavage of these flaps is required
for removal of the potentially mutagenic RNA/DNA primer initially used for the synthesis of the Okazaki
fragment and allows ligation of the neighboring fragments. While short flaps are processed by Fen1, long
flaps that are bound by replication protein A (RPA) need sequential cleavage by both Dna2 and Fen1
enzymes. Using in vitro reconstitution assays, we show that Dna2 is capable of processing the long flaps
to products that can be subsequently ligated by DNA ligase I and that Dna2 is highly efficient as a sole
nuclease in Okazaki fragment maturation in concert with replication, without the requirement of a second
nucleolytic activity of Fen1. We suggest that Fen1 processes most of the flaps in S phase, where it is
mainly expressed, and Dna2 is responsible for the cleavage of DNA flaps at later replication time points or
possibly also during post-replicative repair processes. Furthermore, we examined the role of Dna2 motor
activity in the context of DNA end resection, which initiates homologous recombination. Employing
biochemical approaches we show that on long stretches of ssDNA the motor activity of Dna2 acts as a
ssDNA translocase, especially in presence of RPA, and highly stimulates efficient DNA degradation, an
effect that we also see when it acts together with Sgs1. We propose that in resection the motor activity
of Dna2 functions as a ssDNA translocase, rather than a helicase, and is thus allowing Dna2 to keep up
with Sgs1 and promoting efficient DNA degradation. Moreover, in collaborative projects we were able to
show that Dna2 is also involved in the processing of replication forks that reversed upon replication stress
and provide further evidence that human DNA2 cooperates with BLM and WRN to promote long-range
resection. Additionally, another collaboration yielded proof that the helicase activity of Dna2 is required
for the response to replication stress and for the completion of replication. Lastly, single-molecule analysis
of RPA association to forked DNA substrates done by our collaborators sheds light on its mechanistic
role during DNA replication.
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ZUSAMMENFASSUNG	  
	  
Genomische	   Instabilität	   ist	   ein	   Merkmal	   von	   fast	   allen	   Krebsarten	   und	   ist	   die	  
Voraussetzung	   für	  das	  Erlangen	  weiterer	  Krebskennzeichen.	   In	  erblichen	  bedingten	  
Krebstypen	  entsteht	  genomische	  Instabilität	  aufgrund	  von	  Mutationen	  in	  Genen,	  die	  
an	  der	  DNS	  Reparatur	  beteiligt	   sind.	  Dies	  unterscheidet	   sich	  von	  den	   sporadischen	  
Krebsarten,	  bei	  welchen	  der	  Onkogen-­‐induzierte	  Replikationsstress	  als	  Hauptursache	  
für	   genomische	   Intsabilität	   gehandelt	  wird.	   Daher	   sind	   fehlerfreie	   DNS	   Replikation	  
und	   Reparatur	   ausschlaggebend	   für	   die	   Erhaltung	   der	   Integrität	   des	   Genoms	   und	  
somit	   auch	   für	   die	   Krebsvorbeugung,	   sowie	   für	   die	   korrekte	   Übermittlung	  
genetischer	  Informationen	  an	  nachkommende	  Generationen.	  	  
Dna2	   ist	   ein	   essentielles	   Enzym,	   das	   in	   der	   Evolution	   zwischen	   Hefe	   und	  Mensch	  
konserviert	   ist.	   Es	   ist	   auf	   mehreren	   Ebenen	   in	   die	   Aufrechterhaltung	   der	  
genomischen	   Stabilität	   involviert.	   Dna2	   erfüllt	   mehrere	   Funktionen	   in	   der	   DNS	  
Replikation	   und	   während	   erhöhtem	   Replikationsstress.	   Zusätzlich	   ist	   Dna2	  
zusammen	   mit	   Sgs1	   (in	   Hefe;	   Bloom	   oder	   Werner	   Proteine	   im	   Menschen)	   in	   die	  
Reparatur	   der	   genotoxischen	   DNS	   Doppelstrang-­‐Brüche	   eingebunden,	   genauer	  
gesagt	   in	   die	   Resektion	   der	   DNS	   Enden,	   welche	   den	   verbindlichen	   Schritt	   für	   die	  
Reparatur	   durch	   mehrheitlich	   fehlerfreien	   Weg	   der	   homologen	   Rekombination	  
darstellt.	   Außerdem	   wurde	   Dna2	   sowohl	   als	   Teil	   der	   telomerischen	   und	  
mitochondrialen	   DNS	   Aufrechterhaltungssysteme	   beschrieben,	   als	   auch	   ist	   es	  
bekannt,	   dass	   Dna2	   für	   die	   Aktivierung	   des	   Checkpoints	   für	   DNS	   Schäden	   in	   Hefe	  
verantwortlich	  ist.	  
Während	   meiner	   Doktorarbeit	   habe	   ich	   die	   Funktionen	   von	   Dna2	   in	   der	   Hefe	  
Saccharomyces	   cerevisiae	   untersucht	   und	   dabei	   hauptsächlich	   mit	   aufgereinigten	  
Proteinen	  gearbeitet.	  Zunächst	  haben	  wir	  das	  Dna2	  Protein	   in	  Hefe	  exprimiert	  und	  
aufgereinigt.	  Wir	   konnten	   zeigen,	   dass	   das	   Enzym	   zusätzlich	   zur	  Nuklease-­‐Aktivität	  
auch	   eine	   starke	   Helikase-­‐Aktivität	   besitzt.	   Dann	   begannen	  wir	   die	   Regulation	   der	  
beiden	  Aktivitäten	   innerhalb	  des	  Dna2	  Proteins	   zu	  analysieren.	  Wir	   zeigen	  mithilfe	  
von	   in	   vitro	   und	   in	   vivo	  Methoden,	   dass	  Hefe	  Dna2	   durch	   eine	   post-­‐translationale	  
Modifikaton,	  die	  als	  Sumoylierung	  bezeichnet	  wid,	  reguliert	  wird.	  Sumoylierung	  des	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N-­‐Terminus	   des	   Dna2	   Proteins	   verminderte	   selektiv	   die	   Nuklease-­‐Aktivität	   auf	   der	  
biochemischen	   Ebene	   und	   veränderte	   damit	   die	   Balance	   zwischen	   Nuklease	   und	  
Helikase	  innerhalb	  von	  Dna2.	  Zudem	  fanden	  wir	  in	  vivo	  eine	  verstärkte	  Sumoylierung	  
von	   Dna2	   in	   der	   späten	   S-­‐Phase/frühen	   G2-­‐Phase	   des	   Zellzyklus.	   Weiterhin	   ist	  
Modifikation	   von	   Dna2	   durch	   SUMO	   an	   der	   Regulation	   des	   Proteins	   infolge	   der	  
Behandlung	  mit	  alkylierenden	  Substanzen	  beteiligt.	  	  
Als	   Nächstes	   haben	  wir	   uns	  mit	   der	   essentiellen	   Funktion	   von	   Dna2	  während	   der	  
Replikation	  des	  DNS	  Folgestrangs	  beschäftigt.	  Dabei	  verarbeitet	  Dna2	  zusammen	  mit	  
der	   Flap	   Endonuklease	   I	   (Fen1)	   lange	   Einzelstrang-­‐DNS	   Strukturen	   ('flaps'),	   die	  
während	  der	  Synthese	  der	  DNS-­‐Einzelfragmente	  (Okazaki-­‐Fragmente)	  entstehen.	  Die	  
nukleolytische	   Abspaltung	   dieser	   'flaps'	   ist	   notwendig	   für	   das	   Entfernen	   der	  
möglicherweise	   genverändernden	   RNS/DNS	   Primer,	   die	   für	   die	   ursprüngliche	  
Synthese	   der	   Okazaki-­‐Fragmente	   benötigt	   wurden,	   und	   erlaubt	   die	   Ligation	  
benachbarter	  Fragmente.	  Während	  kurze	  DNS	  'flaps'	  von	  Fen1	  abgespalten	  werden,	  
benötigen	   lange	   DNS	   'flap'	   Strukturen,	   die	   von	   dem	   Replikationsprotein	   A	   (RPA)	  
gebunden	  werden,	  eine	  sequenzielle	  Verarbeitung	  durch	  sowohl	  Dna2,	  als	  auch	  Fen1	  
Enzyme.	  Mittels	  in	  vitro	  Rekonstitutions-­‐Experimente	  konnten	  wir	  zeigen,	  dass	  Dna2	  
allein	   zu	   der	   Verarbeitung	   der	   langen	   DNS	   'flaps'	   fähig	   ist	   und	   die	   Produkte	  
anschließend	   durch	   DNS	   Ligase	   I	   ligiert	   werden	   können.	   Zudem	   war	   Dna2	   sehr	  
effizient	  als	  alleinige	  Nuklease	  während	  der	  Verarbeitung	  der	  Okazaki-­‐Fragmente	  in	  
Zusammenarbeit	  mit	  der	  DNS	  Replikation,	  ohne	  dass	  die	  nukleolytische	  Aktivität	  von	  
Fen1	   benötigt	   wurde.	   Aufgrund	   dieser	   Erkenntnisse	   glauben	   wir,	   dass	   Fen1	   die	  
meisten	   DNS	   'flaps'	   in	   der	   S-­‐Phase	   des	   Zellzyklus,	   in	   der	   Fen1	   hauptsächlich	  
exprimiert	  wird,	   verarbeiten	   kann,	  während	  Dna2	   für	   die	  Abspaltung	  der	   'flaps'	   zu	  
späteren	  Zeitpunkten	  der	  Replikation,	  oder	  auch	  möglicherweise	  während	  der	  post-­‐
replikativen	  DNS	  Reparatur,	  verantwortlich	  ist.	  	  
Desweiteren	  haben	  wir	  die	  Rolle	  der	  Motoraktivität	  von	  Dna2	  im	  Zusammenhang	  mit	  
der	   Resektion	   der	   DNS	   Enden,	   die	   die	   homologe	   Rekombination	   einleitet,	  
untersucht.	  Unter	  Gebrauch	  biochemischer	  Methoden	  konnten	  wir	  aufdecken,	  dass	  
die	   Motoraktivität	   von	   Dna2	   auf	   langen	   Einzelstrang-­‐DNS	   Passagen	   vor	   Allem	   in	  
Anwesenheit	   von	   RPA	   als	   Einzelstrang-­‐DNS	   Translokase	   agiert	   und	   effizienten	  DNS	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Abbau	  stark	   stimuliert;	  ein	  Effekt,	  den	  wir	  auch	  beobachteten	  als	  Dna2	   zusammen	  
mit	   Sgs1	   gehandelt	   hat.	  Daher	   schlagen	  wir	   vor,	   dass	   die	  Motoraktivität	   von	  Dna2	  
während	   der	   DNS	   Resektion	   nicht	   als	   DNS	   Helikase,	   sondern	   als	   Einzelstrang-­‐DNS	  
Translokase	   funktioniert,	   und	   somit	   erlaubt	   sie	   Dna2	   mit	   Sgs1	   mitzuhalten	   und	  
schnellen	  DNS	  Abbau	  zu	  fördern.	  	  
Vielmehr	   zeigen	   wir	   in	   einem	   kollaborativen	   Projekt,	   dass	   Dna2	   auch	   in	   das	  
Verarbeiten	   der	   DNS	   Replikationsgabeln,	   die	   sich	   nach	   dem	   Replikationsstress	  
umgedreht	   haben,	   invololviert	   ist.	   Außerdem	   liefern	   wir	   weiteren	   Beweis	   für	   das	  
Mitwirken	   des	   menschlichen	   DNA2	   Proteins	   bei	   der	   Langstrecken-­‐Resektion	  
zusammen	  mit	  Bloom	  und	  Werner	  Proteinen.	  Zusätzlich	  konnten	  wir	  während	  einer	  
anderen	   Kollaboration	   aufzeigen,	   dass	   die	   Helikase-­‐Aktivität	   von	   Dna2	   für	   die	  
zelluläre	   Antwort	   auf	   den	   Replikationsstress	   und	   für	   die	   Vervollständigung	   der	  
Replikation	  benötigt	  wird.	  Zuletzt	  haben	  unsere	  Kollaborateure	  eine	  Einzelmolekül-­‐
Analyse	   von	   der	   Assoziation	   des	   RPA	   Proteins	   zu	   Gabel-­‐DNS	   Substraten	  
durchgeführt,	   die	   über	   die	   mechanistische	   Rolle	   von	   RPA	   während	   der	   DNS	  
Replikation	  Aufschluss	  gegeben	  hat.	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Genome	   instability	   is	   a	   characteristic	   of	   almost	   all	   human	   cancers	   and	   is	   a	  
prerequisite	   for	   acquisition	   of	   further	   hallmarks	   of	   cancer.	   While	   in	   hereditary	  
cancers	  it	  arises	  due	  to	  mutations	  in	  DNA	  repair	  genes,	  in	  sporadic	  cancers	  it	  appears	  
that	  oncogene-­‐induced	   replication	   stress	   is	   the	  main	   cause	   for	   genomic	   instability.	  
Hence,	  faithful	  DNA	  replication	  and	  repair	  are	  crucial	  to	  preserve	  genome	  integrity,	  
thus	  contributing	  to	  cancer	  prevention,	  and	  to	  properly	  transmit	  genetic	  information	  
across	  generations.	  
Dna2	  is	  an	  essential	  enzyme	  that	  is	  conserved	  from	  yeast	  to	  humans	  and	  is	  involved	  
in	   the	   maintenance	   of	   genome	   stability	   at	   multiple	   levels.	   It	   plays	   a	   role	   in	  
unperturbed	   DNA	   replication	   as	   well	   as	   under	   conditions	   of	   replication	   stress.	   In	  
addition,	  Dna2	  functions	  together	  with	  Sgs1	  (in	  yeast;	  Bloom	  or	  Werner	  in	  humans)	  
in	   the	   repair	   of	   genotoxic	   double-­‐strand	   DNA	   breaks,	   specifically	   in	   DNA	   end	  
resection,	   which	   is	   the	   commitment	   step	   to	   mostly	   error-­‐free	   homologous	  
recombination	  pathway.	   Furthermore,	  Dna2	  was	  described	   to	  be	  part	  of	   telomeric	  
and	  mitochondrial	  DNA	  maintenance	  systems,	  and	  to	  mediate	  checkpoint	  activation	  
in	  yeast.	  	  	  	  
During	  my	  PhD	  I	  was	  investigating	  the	  functions	  of	  Dna2	  in	  Saccaromyces	  cerevisiae	  
and	   was	   mainly	   working	   with	   purified	   yeast	   proteins.	   First,	   we	   expressed	   and	  
purified	  yeast	  Dna2	  and	  were	  able	  to	  show	  that	  it	  possesses	  not	  only	  a	  nuclease,	  but	  
also	  a	  vigorous	  helicase	  activity.	  Then	  we	  set	  out	  to	  analyze	  the	  regulation	  of	  the	  two	  
activities	  within	   the	   Dna2	   protein.	   Using	   in	   vitro	   and	   in	   vivo	   approaches	  we	   show	  
that	   yeast	   Dna2	   is	   regulated	   by	   a	   post-­‐translational	   modification	   termed	  
sumoylation.	   On	   the	   biochemical	   level,	   sumoylation	   of	   the	   N-­‐terminus	   of	   Dna2	  
selectively	  attenuated	   its	  nuclease	  activity,	   thus	  changing	  the	  balance	  between	  the	  
helicase	  and	  the	  nuclease	  within	  the	  protein.	   In	  vivo,	  we	  show	  that	  sumoylation	  of	  
Dna2	  is	  increased	  in	  the	  late	  S/G2	  phases	  of	  the	  cell	  cycle	  and	  appears	  to	  be	  involved	  
in	  regulation	  of	  Dna2	  upon	  treatment	  with	  alkylating	  agents.	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Next,	  we	  addressed	  the	  essential	  function	  of	  Dna2	  in	  lagging	  strand	  DNA	  replication,	  
where	  it	  acts	  together	  with	  Fen1	  (Flap	  endonuclease	  I)	  in	  the	  processing	  of	  long	  DNA	  
flap	   structures	  arising	  during	   the	  maturation	  of	  Okazaki	   fragments.	  The	  nucleolytic	  
cleavage	   of	   these	   flaps	   is	   required	   for	   removal	   of	   the	   potentially	   mutagenic	  
RNA/DNA	  primer	  initially	  used	  for	  the	  synthesis	  of	  the	  Okazaki	  fragment	  and	  allows	  
ligation	  of	  the	  neighboring	  fragments.	  While	  short	  flaps	  are	  processed	  by	  Fen1,	  long	  
flaps	  that	  are	  bound	  by	  replication	  protein	  A	  (RPA)	  need	  sequential	  cleavage	  by	  both	  
Dna2	  and	  Fen1	  enzymes.	  Using	   in	  vitro	  reconstitution	  assays,	  we	  show	  that	  Dna2	  is	  
capable	  of	  processing	  the	  long	  flaps	  to	  products	  that	  can	  be	  subsequently	  ligated	  by	  
DNA	  ligase	  I	  and	  that	  Dna2	  is	  highly	  efficient	  as	  a	  sole	  nuclease	  in	  Okazaki	  fragment	  
maturation	   in	   concert	   with	   replication,	   without	   the	   requirement	   of	   a	   second	  
nucleolytic	  activity	  of	  Fen1.	  We	  suggest	   that	  Fen1	  processes	  most	  of	   the	   flaps	   in	  S	  
phase,	  where	  it	  is	  mainly	  expressed,	  and	  Dna2	  is	  responsible	  for	  the	  cleavage	  of	  DNA	  
flaps	   at	   later	   replication	   time	   points	   or	   possibly	   also	   during	   post-­‐replicative	   repair	  
processes.	  
Furthermore,	  we	   examined	   the	   role	   of	  Dna2	  motor	   activity	   in	   the	   context	   of	  DNA	  
end	   resection,	   which	   initiates	   homologous	   recombination.	   Employing	   biochemical	  
approaches	  we	  show	  that	  on	  long	  stretches	  of	  ssDNA	  the	  motor	  activity	  of	  Dna2	  acts	  
as	  a	  ssDNA	  translocase,	  especially	  in	  presence	  of	  RPA,	  and	  highly	  stimulates	  efficient	  
DNA	  degradation,	   an	   effect	   that	  we	   also	   see	  when	   it	   acts	   together	  with	   Sgs1.	  We	  
propose	   that	   in	   resection	   the	   motor	   activity	   of	   Dna2	   functions	   as	   a	   ssDNA	  
translocase,	  rather	  than	  a	  helicase,	  and	  is	  thus	  allowing	  Dna2	  to	  keep	  up	  with	  Sgs1	  
and	  promoting	  efficient	  DNA	  degradation.	  	  
Moreover,	  in	  collaborative	  projects	  we	  were	  able	  to	  show	  that	  Dna2	  is	  also	  involved	  
in	   the	   processing	   of	   replication	   forks	   that	   reversed	   upon	   replication	   stress	   and	  
provide	   further	   evidence	   that	   human	   DNA2	   cooperates	   with	   BLM	   and	   WRN	   to	  
promote	  long-­‐range	  resection.	  Additionally,	  another	  collaboration	  yielded	  proof	  that	  
the	  helicase	  activity	  of	  Dna2	  is	  required	  for	  the	  response	  to	  replication	  stress	  and	  for	  
the	  completion	  of	  replication.	  Lastly,	  single-­‐molecule	  analysis	  of	  RPA	  association	  to	  
forked	  DNA	  substrates	  done	  by	  our	  collaborators	  sheds	  light	  on	  its	  mechanistic	  role	  
during	  DNA	  replication.	  
	  10	  
	   INTRODUCTION	   	  	   	  
1.	  INTRODUCTION	  
	  
1.1	  Genome	  instability	  as	  a	  hallmark	  of	  cancer	  	  	  
Cancer	   is	   a	   very	   complex	  disease	  and	   is	   according	   to	   the	  WHO	  the	   second	   leading	  
cause	  of	  death	  in	  Europe.	  In	  2000,	  Douglas	  Hanahan	  and	  Robert	  Weinberg	  suggested	  
six	   main	   capabilities	   that	   are	   acquired	   during	   multistep	   tumor	   development:	  
sustaining	   proliferative	   signaling,	   evading	   growth	   suppressors,	   activating	   invasion	  
and	  metastasis,	  enabling	  replicative	  immortality,	  inducing	  angiogenesis,	  and	  resisting	  
cell	  death	   (Figure	  1,	   left	  part,	   and	   (1)).	   Eleven	  years	   later	   the	   same	  authors	  added	  
deregulating	   cellular	   energetics	   and	   avoiding	   immune	  destruction	   to	   the	   emerging	  
hallmarks,	   as	  well	   as	   two	   enabling	   characteristics:	   tumor-­‐promoting	   inflammation,	  
and	  genome	  instability	  and	  mutation	  (Figure	  1,	  right	  part,	  and	  (2)).	  	  	  
	  
Figure	  1.	  The	  hallmarks	  of	  cancer.	  Left:	  original	  six	  hallmark	  capabilities	  proposed	  by	  D.	  Hanahan	  and	  
R.	  A.	  Weinberg	  in	  2000.	  Right:	  four	  additional	  hallmarks	  were	  suggested	  by	  the	  same	  authors	  in	  2011,	  
among	   them	   genome	   instability	   as	   an	   enabling	   characteristic	   driving	   tumor	   progression.	   Modified	  
from	  (2).	  	  	  
Genome	   instability	   is	   the	   main	   reason	   for	   the	   acquisition	   of	   multiple	   hallmarks	  
described	  above.	  Cancers	   carry	   a	   variety	  of	  mutations	   and	  genetic	   alterations	   that	  
drive	   tumor	   progression,	   e.g.	   mutations	   inactivating	   tumor	   suppressors	   (2).	   The	  
genome	  maintenance	  systems	  of	  our	  cells	  are	  usually	  very	  effective	  in	  repairing	  DNA	  
defects	   that	   arise	   from	   endogenous	   and	   exogenous	   sources,	   like	   inaccurate	   DNA	  
replication	  and	  reactive	  oxygen	  species	  (endogenous),	  or	  ionizing	  radiation,	  UV	  light	  
and	   genotoxic	   chemicals	   used	   in	   chemotherapy	   (exogenous)	   (3,4).	   Each	   cell	   in	   the	  
human	  body	  is	  subjected	  to	  104-­‐106	  DNA	  lesions	  per	  day	  which	  are	  removed	  by	  the	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highly	   conserved	   DNA	   repair	   systems,	   specialized	   for	   the	   particular	   DNA	   damage	  
(Figure	  2	  and	  (5,6)).	  	  
replication downstream of the blocking injury. The resulting gap is
filled in by recombinational replication, using the newly synthesized
complementary strand as a template and ignoring the original
lesion-containing one (Fig. 2, follow lower strand). Yeast proteins
implicated in this process, such as the Ubc13/Mms2 complex, are
conserved all the way to mammals. Thus, this largely unexplored 
system undoubtedly exists in humans and may be important in 
carcinogenesis. The endpoint of both of these pathways is that dam-
age persists and — when unrepaired — will cause similar problems in
subsequent rounds of replication. This is particularly relevant for
damage that is not efficiently recognized by any mammalian repair
process, such as cyclobutane pyrimidine dimers. 
Double-strand DNA breaks (DSBs) induced by X-rays, chemicals
or during replication of single-strand breaks (SSBs) and presumably
during repair of interstrand crosslinks are particularly relevant for
the recombination machinery. Cells with specialized DNA recombi-
nation activities, such as B- and T-cells, may be very sensitive to DSBs
when they are rearranging their immunoglobin or T-cell-receptor
genes. This explains the frequent involvement of these genetic loci in
oncogenic translocations in leukaemia and lymphomas and the 
preferential induction of these cancers by ionizing irradiation. DSBs
also pose problems during mitosis, as intact chromosomes are a 
prerequisite for proper chromosome segregation during cell 
division. Thus, these lesions frequently induce various sorts of 
chromosomal aberrations, including aneuploidy, deletions (loss of
heterozygosity) and chromosomal translocations — events which
are all intimately associated with carcinogenesis. 
The cell-cycle machinery somehow senses genome injury and
arrests at specific checkpoints in G1, S, G2 and M to allow repair of
lesions before they are converted into permanent mutations
(reviewed in ref. 11). Lesion detection may occur by blocked 
transcription, replication or specialized sensors. When damage is too
significant, a cell may opt for the ultimate mode of rescue by initiating
apoptosis at the expense of a whole cell (see review by Evan and 
Vousden, pages 342–348).
DNA damage repair systems 
In view of the plethora of types of lesions, no single repair process can
cope with all kinds of damage. Instead, evolution has moulded a
tapestry of sophisticated, interwoven DNA repair systems that as a
whole cover most (but not all) of the insults inflicted on a cell’s vital
genetic information. Inherited defects in any of these pathways in
general predisposes to malignancy (Table 1). Because the problem of
DNA damage has existed ab initio, DNA repair systems must have
arisen early in evolution. This explains why all known repair 
pathways are highly conserved (usually across the pro/eukaryotic
evolutionary border). At least four main, partly overlapping damage
repair pathways operate in mammals — nucleotide-excision repair
(NER), base-excision repair (BER), homologous recombination and
end joining12,13. The division of tasks between them can be roughly
defined as follows (see also Fig. 1a). 
NER deals with the wide class of helix-distorting lesions that
interfere with base pairing and generally obstruct transcription and
normal replication. Small chemical alterations of bases are targeted
by BER. These lesions may or may not impede transcription and
replication, although they frequently miscode. BER is therefore par-
ticularly relevant for preventing mutagenesis. Most NER lesions arise
from exogenous sources (except for some oxidative lesions), whereas
BER is mostly, but not exclusively, concerned with damage of
endogenous origin. Lesions for these two repair processes affect only
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Figure	  2.	  The	  vari ty	  of	  DNA	  damage,	  repair	  mechanisms	  and	  conseque ces.	  Various	  DNA	   amaging	  
agents	  lead	  to	  different	  DNA	  lesions	  that	  are	  removed	  by	  the	  corresponding	  DNA	  repair	  mechanism.	  
Consequences	  of	  DNA	  damage	  is	  cell-­‐cycle	  arrest,	  changes	   in	  DNA	  metabolism	  and	  mutations	  (long-­‐
t rm).	   Abbreviations:	   cis-­‐ t,	   cisplatin;	   MMC,	   mitomycin	   C;	   (6-­‐4)PP,	   6-­‐4	   photoproduct;	   CPD,	  
cyclobutane	   pyrimidine	   di er;	   BER,	   base-­‐excision	   repair;	   NER,	   nucleotide-­‐excision	   repair;	   HR,	  
homologous	  recombination;	  EJ,	  end	  joining.	  Modified	  from	  (5).	  
	  
Small	  chemical	  alterations	  of	  DNA	  like	  oxidative	   lesions	  are	  removed	  via	   incision	  of	  
the	  damaged	  b se	  by	  base	  excisio 	   repair	   (BER),	  while	  helix-­‐distorting	   lesions	   that	  
interfere	  with	  transcription	  and	  replication	  are	  targeted	  by	  nucleotide	  excision	  repair	  
(NER)	   that	   removes	   a	   short	   oligonucleotide	   sequence	   containing	   the	   injury	   (7,8).	  
Mismatch	   repair	   (MMR)	   pathway	   is	   responsible	   for	   correction	   of	   insertions,	  
deletions	  and	  mismatched	  base	  pairs	   incorporated	  during	  DNA	  replication	  (9).	  DNA	  
double-­‐st d	  br aks	  (DSBs)	  belong	  to	   he	  most	   oxic	  DNA	  lesions	  and	  are	  repa red	  
either	  by	  homologous	  recombination	  (HR)	  in	  S	  and	  G2	  phases	  of	  the	  cell	  cycle,	  or	  by	  
non-­‐homol gous	   end	   joinin 	   (NHEJ)	   pr dominantly	   in	   G1	   (10).	   In	   addi ion,	   lesions	  
that	   block	   DNA	   replication	   fork	   progression	   can	   also	   be	   bypassed	   by	   translesion	  
synthesis	   (TLS)	   polymerases	   without	   being	   repaired	   (11).	   Fanconi	   anemia	   (FA)	  
pathway	   together	  with	  proteins	   from	  HR,	  NER	  and	  TLS	  pathways	   is	   r sponsible	   for	  
the	  removal	  of	  interstrand	  crosslinks	  (ICLs),	  bridging	  two	  opposite	  DNA	  strands	  (12).	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Despite	   the	   existence	   of	   such	   a	   plethora	   of	   sophisticated	   DNA	   repair	   systems,	  
genome	   instability	   is	  present	   in	  all	   stages	  of	   cancer	   (13).	   In	  hereditary	   cancers	   the	  
presence	  of	  the	  genomic	  instability	  was	  clearly	  linked	  to	  the	  mutations	  in	  DNA	  repair	  
genes,	   also	   called	   caretaker	   genes,	   that	   further	   drive	   tumorigenesis	   (mutator	  
hypothesis,	   (14)).	   However,	   for	   sporadic	   cancers	   the	   molecular	   mechanism	  
responsible	   for	   genome	   instability	   is	   not	   yet	   clear	   but	   there	   are	   two	  main	  models	  
existing	   that	   could	   explain	   it.	   One	   model	   is	   supporting	   the	   mutator	   hypothesis,	  
although	  the	  mutation	  frequency	  in	  caretaker	  genes	  in	  sporadic	  tumors	  is	  rather	  low	  
and	  seems	  to	  increase	  only	  in	  late	  cancer	  development	  or	  even	  during	  therapy	  (13).	  
The	   second	   one	   suggests	   oncogene-­‐induced	   DNA	   replication	   stress	   as	   the	   main	  
reason	   for	   genome	   instability	   (15).	   It	   is	   supported	   by	   high-­‐throughput	   sequencing	  
studies	  showing	  that	  in	  sporadic	  cancers	  only	  very	  few	  genes	  are	  mutated	  with	  high	  
frequency,	   coding	   either	   for	   growth	   signaling	   proteins	   (oncogenes	   or	   anti-­‐
oncogenes)	  or	   for	  DNA	  checkpoint	  proteins	   like	   the	  tumor	  suppressor	  protein	  p53.	  
Those	   mutations	   might	   be	   the	   initiating	   event	   in	   cancer	   development,	   further	  
leading	  to	  DNA	  damage	  and	  replication	  stress,	  genome	   instability,	   followed	  by	  p53	  
inactivation	   and	   the	   establishment	   of	   the	   other	   hallmarks	   (13).	   Therefore,	   DNA	  
repair	  processes	  as	  well	  as	  DNA	  replication	  have	  to	  be	  precisely	  regulated	  to	  prevent	  
cancer	  development.	  
	  
1.2	  Dna2	  	  
1.2.1	  Domain	  structure	  and	  activities	  	  
Dna2	  is	  an	  essential	  protein	  that	  was	  found	  to	  be	  required	  for	  DNA	  replication	  in	  vivo	  
(16-­‐18).	  The	  S.	  cerevisiae	  Dna2	  has	  a	  size	  of	  172	  kDa	  and	  contains	  an	  unstructured	  N-­‐
terminal	   regulatory	   domain,	   a	   RecB	   family	   nuclease	   domain	   and	   a	   superfamily	   I	  
helicase	   domain	   (Figure	   3).	   Four	   cysteine	   residues	   (519,	   768,	   771,	   777)	  within	   the	  
nuclease	  domain	  coordinate	  an	  iron-­‐sulfur	  cluster	  that	  most	  likely	  plays	  a	  structural	  
role	   and	   thus	   affects	   the	   stability	   of	   the	   protein	   (19,20).	   Dna2	   is	   evolutionarily	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conserved	  from	  yeast	  to	  human,	  although	  the	  conservation	  is	  usually	  limited	  to	  the	  
nuclease	  and	  helicase	  domains,	  while	  the	  N-­‐terminus	  remains	  variable	  (21-­‐23).	  
	  
	  
Figure	   3.	   Domain	   structure	   of	   S.	   cerevisiae	   and	   human	   Dna2	   proteins.	   Both	   proteins	   contain	   a	  
nuclease	  and	  a	  helicase	  domain,	  yeast	  protein	  additionally	  possesses	  a	  regulatory	  N-­‐terminal	  domain.	  
[4Fe-­‐4S],	  iron-­‐sulfur	  cluster.	  Modified	  from	  (24).	  
	  
S.	  cerevisiae	  Dna2	  possesses	  both	  nuclease	  and	  helicase	  activities	  that	  require	  a	  free	  
ssDNA	   end	   for	   loading	   (16,25-­‐28).	   The	   nuclease	   activity	   has	   a	   5'	   to	   3'	   polarity	   in	  
presence	  of	  replication	  protein	  A	  (RPA)	  and	  is	  essential	  (27-­‐29).	  In	  contrast,	  the	  ATP-­‐
dependent	   helicase	   activity,	   that	   has	   the	   same	   polarity	   as	   the	   nuclease,	   was	  
described	   to	   be	   weak	   and	   helicase-­‐dead	   mutants	   were	   shown	   to	   be	   viable	   but	  
exhibited	   growth	   defects	   and	   sensitivity	   to	   methyl	   methanesulfonate	   (MMS)	   and	  
ionizing	   radiation	   (IR)	   (16,17,30,31).	   The	   human	   protein	   was	   found	   to	   have	   a	  
nuclease	   activity	   as	   well,	   while	   the	   presence	   of	   a	   helicase	   activity	   has	   been	  
questioned	  (32-­‐34).	  	  
The	  N-­‐terminal	   domain	   (NTD)	   of	   yeast	  Dna2	  was	   shown	   to	  be	  dispensable	   for	   the	  
nuclease	  and	  helicase	  activities	  of	  the	  protein,	  but	  it	  was	  required	  for	  normal	  growth	  
as	  deletion	  of	   the	   first	  405	  amino	  acids	   rendered	  yeast	  cells	   temperature-­‐sensitive	  
(35).	  This	  can	  be	  explained	  by	  three	  functions	  of	  the	  NTD	  that	  have	  been	  found	  so	  
far.	   First,	   the	   NTD	   was	   shown	   to	   mediate	   Dna2	   binding	   to	   DNA	   flaps	   containing	  
secondary	   structures	   and	   Fen1	   (flap	   endonuclease	   1,	   also	   Rad27)	   overexpression	  
rescued	  the	  temperature-­‐sensitivity	  of	  dna2delta405N	  mutants	  (35,36).	  Second,	  the	  
NTD	   of	   Dna2	   was	   found	   to	   mediate	   checkpoint	   activation	   through	   Trp128	   and	  
Tyr130	   residues	   (37).	   Interestingly,	   two	   overlapping	   bipartite	   NLS	   (nuclear	  
localization	  signals)	  exist	  within	  the	  first	  48	  amino	  acids	  of	  yeast	  Dna2	  protein	  (38),	  
and	  there	  is	  a	  third	  NLS	  within	  the	  C-­‐terminus,	  which	  alone	  is	  sufficient	  for	  nuclear	  
transport	   as	   dna2delta405N	   cells	   are	   viable	   (35).	   Third,	   NTD	   was	   shown	   to	   be	  
involved	  in	  RPA	  binding	  by	  Dna2	  (39).	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Human	   DNA2	   does	   not	   possess	   an	   unstructured	   N-­‐terminal	   domain,	   although	   the	  
exact	   translation	   start	   is	   not	   clear	   and	   longer	   variants	   (e.g.	   1146	   amino	   acids)	  
containing	  an	  N-­‐terminal	  tail	  might	  exist	  (32,40).	  The	  human	  protein	  does	  not	  have	  
any	  NLS	  but	  is	  still	  important	  for	  nuclear	  functions	  despite	  also	  being	  localized	  to	  the	  
mitochondria	  (40,41).	  	  
1.2.2	  Dna2	  and	  replication:	  Okazaki	  fragment	  maturation	  	  
DNA	   replication	   is	   an	   essential	   event	   in	   living	   cells	   and	   the	   main	   mechanism	   to	  
maintain	  genome	  integrity.	  It	  occurs	  in	  the	  S	  phase	  of	  the	  cell	  cycle	  before	  each	  cell	  
division.	   The	   fidelity	   of	   replication	   is	   safeguarded	  by	  many	   regulatory	  mechanisms	  
ensuring	   that	   all	   the	   chromosomes	   are	   replicated	   on	   time	   and	   in	   an	   error-­‐free	  
manner	   before	   subsequent	   distribution	   to	   the	   daughter	   cells	   (42).	   Checkpoints	  
within	  the	  cell	  cycle	  control	  the	  cell	  cycle	  progression	  and	  intervene	  in	  case	  of	  DNA	  
damage	  or	  perturbations	  of	  DNA	  synthesis	  (43).	  Replication	  is	  initiated	  from	  specific	  
sites	  called	  origins	   (ARS,	  autonomously	   replicating	  sequences	   in	  budding	  yeast),	  by	  
the	  pre-­‐replicative	  complex	  composed	  of	  ORC	  (origin-­‐recognition	  complex),	  MCM2-­‐7	  
(minichromosome	   maintenance	   proteins)	   helicase	   complex,	   Cdc6	   and	   Cdt1.	   The	  
activation	   of	   replication	   requires	   CDK	   (cyclin-­‐dependent	   kinase)	   and	   DDK	   (Dbf4-­‐
dependent	   kinase)	   activity	   as	   well	   as	   further	   proteins;	   among	   them	   are	   Cdc45,	  
Mcm10	  and	  the	  essential	  DNA	  replication	  complex	  GINS	  (44).	  Upon	  unwinding	  of	  the	  
dsDNA	  at	  the	  origin	  by	  the	  MCM	  helicase	  both	  strands	  are	  primed	  by	  the	  polymerase	  
(pol)	   α-­‐primase	   (Stillman	   2008).	   Importantly,	   unwinding	   of	   the	   DNA	   results	   in	  
topological	   stress	   due	   to	   supercoiling	   that	   is	   then	   resolved	   either	   by	   transiently	  
breaking	   one	   DNA	   strand	   and	   passing	   the	   other	   strand	   through	   the	   break	   (type	   I	  
topoisomerases),	  or	  by	  breaking	  both	  complementary	  strands	  and	  passing	  a	  dsDNA	  
segment	  (type	  II	  topoisomerases)	  (45).	  While	  the	  leading	  strand	  DNA	  is	  synthesized	  
continuously	  by	  pol	  ε,	  the	   lagging	  strand	  DNA	  is	  replicated	  discontinuously	   in	  short	  
fragments	   called	   Okazaki	   fragments	   due	   to	   5'	   to	   3'	   polarity	   of	   eukaryotic	   DNA	  
polymerases.	  The	  lagging	  strand	  DNA	  replication	  starts	  with	  the	  action	  of	  the	  error-­‐
prone	   pol	   α	   that	   synthesizes	   a	  ~30	   nucleotides-­‐long	   RNA-­‐DNA	   primer	   (Figure	   4).	  
Proliferating	   cell	   nuclear	   antigen	   (PCNA)	   is	   then	   recruited	   by	   replication	   factor	   C	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(RFC)	   and	   mediates	   the	   polymerase	   switch	   to	   pol	   δ,	   which	   further	   extends	   the	  
synthesized	   DNA	   fragment	   until	   it	   reaches	   the	   5'	   end	   of	   the	   downstream	  Okazaki	  
fragment	  (~200	  nucleotides;	  (46,47)).	  The	  RNA-­‐DNA	  primer	  is	  then	  displaced	  leading	  
to	  the	  formation	  of	  5'	  flap	  structures	  that	  have	  to	  be	  cleaved	  before	  ligation	  by	  DNA	  
ligase	  I	  can	  occur.	  This	  process	  is	  very	  important	  for	  genomic	  integrity	  as	  it	  ensures	  
the	  removal	  of	  RNA	  (if	  not	  yet	  removed	  by	  RNase	  HI,	  (48-­‐50))	  and	  DNA	  synthesized	  
by	  the	  error-­‐prone	  pol	  α	  (51,52).	  Short	  5'	  flaps	  displaced	  by	  pol	  δ	  are	  removed	  by	  the	  
nucleolytic	   activity	   of	   flap	   endonuclease	   1	   (Fen1).	   However,	   if	   flaps	   become	   long	  
enough	   to	   bind	   RPA,	   Fen1	   is	   not	   able	   anymore	   to	   process	   them	   (53,54).	   Current	  
model	  of	  long	  flap	  processing	  assumes	  a	  sequential	  action	  of	  Dna2	  and	  Fen1	  (Figure	  
4).	  First,	  RPA-­‐covered	  flaps	  become	  substrate	  for	  Dna2	  that	  shortens	  them	  up	  to	  5-­‐8	  
nucleotides.	   Only	   after	   this	   initial	   processing	   Fen1	   can	   cleave	   the	   remaining	   flap	  
structure	  that	  does	  not	  support	  stable	  RPA	  binding	  anymore	  (25,53-­‐55).	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Figure	  4.	  Okazaki	  fragment	  processing	  by	  sequential	  action	  of	  Dna2	  and	  Fen1.	  The	  initial	  RNA/DNA	  
primer	   is	   synthesized	   by	   the	   error-­‐prone	   polymerase	   α	   (pol	   α)	   followed	   by	   a	   PCNA-­‐mediated	  
polymerase	  switch	  to	  polymerase	  δ	  (pol	  δ),	  which	  performs	  the	  synthesis	  of	  150-­‐200	  nucleotides.	  Pol	  
δ	  displaces	  the	  5'	  end	  of	  the	  downstream	  primer	  leading	  to	  the	  formation	  of	  a	  flap	  structure	  that	  can	  
bind	  RPA.	  The	   flap	  DNA	  remaining	  after	  Dna2-­‐catalyzed	  cleavage	  varies	  between	  5-­‐8	  nucleotides	   in	  
length,	  so	  that	  stable	  association	  of	  RPA	  is	  not	  supported	  and	  Fen1	  can	  process	  the	  flap	  structure	  to	  a	  
ligatable	  substrate	  for	  DNA	  ligase	  I.	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However,	  dna2Δ	  mutation	   is	   lethal,	  while	   rad27Δ	  cells	  are	  viable	   (16,56,57),	  which	  
contradicts	  the	  notion	  of	  Dna2	  acting	  upstream	  of	  Fen1.	  	  	  
Further	   genetic	   studies	   showed	   that	   mutations	   promoting	   the	   generation	   of	   long	  
flaps	  such	  as	  increased	  strand	  displacement	  by	  exonuclease-­‐deficient	  pol	  δ	  are	  very	  
sensitive	  to	  Dna2	  dysfunction.	  In	  contrast,	  limited	  displacement	  synthesis	  resulting	  in	  
shorter	  flaps,	  e.g.	  by	  deletion	  of	  either	  Pif1	  helicase	  or	  POL32	  subunit	  of	  pol	  δ,	  or	  by	  
the	  overexpression	  of	  Fen1,	  can	  suppress	  lethality	  of	  dna2Δ	  (58-­‐61).	  	  
Despite	  being	  considered	  as	  the	  most	  important	  and	  essential	  physiological	  function	  
of	   Dna2,	   Dna2-­‐mediated	   Okazaki	   fragment	   processing	   was	   never	   shown	   in	   vivo.	  
Moreover,	  there	  is	  no	   in	  vitro	  data	  so	  far	  about	  the	  role	  of	  human	  DNA2	  in	  lagging	  
strand	  replication.	  In	  vivo,	  human	  DNA2	  was	  found	  to	  have	  a	  role	  in	  replication,	  but	  
likely	  independently	  of	  Okazaki	  fragment	  processing	  (62).	  
1.2.3	  Dna2	  and	  replication	  fork	  reversal	  	  
DNA	   replication	   fork	   reversal	   is	   now	   recognized	   as	   a	   global	   and	   evolutionary	  
conserved	   response	   to	   replication	   stress	   caused	   by	   a	   variety	   of	   means,	   from	  
exogenously	   induced	   DNA	   lesions	   to	   endogenous	   replication	   perturbations	   arising	  
from	  DNA	  regions	  that	  are	  difficult	  to	  replicate	  (63-­‐65).	  	  
First	  proposed	  in	  1976	  (66),	  fork	  reversal	  is	  defined	  as	  a	  remodeling	  of	  a	  replication	  
fork	   into	   a	   four-­‐way	   junction	   by	   unwinding	   the	   nascent	   DNA	   strands	   followed	   by	  
annealing	  of	  parental	  strands	  as	  well	  as	  the	  newly	  synthesized	  daughter	  strands	  that	  
then	   form	   the	   regressed	   arm	   (Figure	   5).	   A	   number	   of	   proteins	   are	   involved	   in	   the	  
replication	   fork	  remodeling	  process.	  The	   fork	  reversal	  was	  shown	  to	  be	  dependent	  
on	   the	   recombinase	  Rad51	   as	  well	   as	   on	   the	   F-­‐box	  DNA	  helicase	  protein	   1	   (FBH1)	  
(65,67).	  The	  restart	  of	  the	  forks	  is	  then	  driven	  by	  the	  DNA	  helicase	  RECQ1,	  which	  is	  in	  
its	  turn	  inhibited	  by	  PARP1-­‐mediated	  ADP	  ribosylation	  (68).	  However,	  forks	  reversed	  
in	  response	  to	  nucleotide	  depletion	  or	  oncogene-­‐induced	  replication	  stress	  can	  also	  
be	  processed	  nucleolytically	  by	  MUS81	  and	  SLX4	  nucleases	  possibly	  resulting	  in	  fork	  
breakage	   and	   genome	   instability	   (69,70).	   Interestingly,	   cells	   suffering	   from	  
oncogene-­‐induced	   replication	   stress	   showed	   MUS81-­‐dependent	   DSBs	   upon	   WRN-­‐
depletion	  (71).	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Figure	  5:	  The	  process	  of	  replication	  fork	  reversal.	  First,	  newly	  synthesized	  strands	  are	  unwound	  (top	  
panel),	   followed	   by	   reannealing	   of	   parental	   (middle	   panel)	   and	   nascent	   strands	   (bottom	   panel).	  
Modified	  from	  (64).	  	  
	  
A	   recent	   study	   in	   fission	   yeast	   suggests	   that	   also	   Dna2	   is	   involved	   in	   the	   fork	  
remodeling	  process,	  namely	  by	  stabilizing	  stalled	  forks	  upon	  induction	  of	  the	  intra-­‐S	  
phase	   checkpoint	   by	   hydroxyurea	   (HU)	   or	   MMS	   (72).	   Checkpoint-­‐mediated	  
phosphorylation	  of	  Dna2	  was	  necessary	  to	  promote	  its	  association	  with	  stalled	  DNA	  
replication	  forks	  (72).	  Surprisingly,	  in	  human	  cells,	  depletion	  of	  DNA2	  resulted	  in	  cell	  
cycle	  arrest	  in	  S/G2	  phases	  accompanied	  by	  internuclear	  chromatin	  bridges	  and	  this	  
phenotype	  was	   not	   rescued	   by	   FEN1	   overexpression	   (41,62).	   This	   finding	   suggests	  
that	   the	   Okazaki-­‐fragment	   processing	   independent	   role	   of	   human	   DNA2	   in	  
unperturbed	  replication	  might	  be	  during	   the	   fork	   remodeling	   that	   is	  also	  occurring	  
under	  unperturbed	  conditions	  (63,65,73).	  	  	  	  
While	  replication	  fork	  reversal	   is	  regarded	  to	  be	  beneficial	  upon	  DNA	  damage,	  as	  it	  
protects	  the	  fork	  and	  gives	  more	  time	  for	  repair	  of	  the	  lesions,	  in	  some	  cases	  it	  can	  
also	  promote	  disease	  development	  by	  e.g.	   leading	   to	  expansion	  of	  DNA	   repeats	   in	  
neurodegenerative	   syndroms	   (63,74);	   or	   by	   contributing	   to	   genomic	   instability	   in	  
cancers	  in	  case	  the	  reversed	  forks	  are	  subjected	  to	  unscheduled	  cleavage	  (70).	  Thus,	  
studying	  the	  mechanisms	  of	  replication	  fork	  remodeling	  is	  crucial	  for	  understanding	  
its	   physiological	   and	   pathological	   roles,	   and	   possibly	   for	   finding	   applications	   for	  
cancer	  therapy.	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1.2.4	  Role	  of	  Dna2	  in	  double-­‐strand	  break	  repair	  	  
DSB	  repair	  is	  composed	  of	  four	  different	  pathways:	  homologous	  recombination	  (HR),	  
single-­‐strand	   annealing	   (SSA),	   non-­‐homologous	   end-­‐joining	   (NHEJ)	   and	   alternative	  
NHEJ	  (alt-­‐NHEJ	  or	  also	  microhomology-­‐mediated	  NHEJ,	  MMEJ)	  (Figure	  6).	  NHEJ	  (also	  
called	   classical	   or	   canonical	  NHEJ)	   occurs	   during	   all	   phases	   of	   the	   cell	   cycle	   and	   is	  
initiated	   by	   binding	   of	   Ku70-­‐Ku80	   to	   broken	   DNA	   ends,	   followed	   by	   DNA-­‐PKCs	  
induced	  end	  processing	  by	  Artemis	  and	  finally	  ligation	  by	  DNA	  ligase	  IV	  (75).	  NHEJ	  is	  
error-­‐prone,	   so	  e.g.	   B	   cells	  make	  use	  of	   it	   for	   generating	   antibody	  diversity	  during	  
V(D)J	  recombination	  (76).	  
	  
Figure	   6:	   Pathways	   of	   double-­‐strand	   break	   repair.	  Abbreviations:	  HR,	   homologous	   recombination;	  
SSA,	   single-­‐strand	   annealing;	   NHEJ,	   non-­‐homologous	   end	   joining;	   alt-­‐NHEJ,	   alternative-­‐NHEJ;	  
microhomology-­‐mediated	  NHEJ	  (MMEJ).	  Modified	  from	  (77).	  
	  	  	  
The	   other	   three	   DSB	   repair	   pathways	   require	   resection	   of	   the	   broken	   ends	   prior	  
repair.	  Alt-­‐NHEJ	  needs	  only	  minimal	  end	  processing	  to	  uncover	  microhomologies	  (5-­‐
25	   bp)	   between	   the	   two	   strands	   allowing	   annealing	   (78).	   SSA	   is	   characterized	   by	  
annealing	   of	   longer	   tandemly	   repeated	  DNA	   sequences	   flanking	   broken	  DNA	   ends	  
and	  is	  mediated	  by	  Rad52	  that	  reanneals	  RPA-­‐covered	  ssDNA.	  Both	  pathways	  lead	  to	  
deletions	  and	  are	  therefore	  error-­‐prone	  (77-­‐79).	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HR	   is	   mainly	   active	   in	   S	   and	   G2	   phases	   of	   the	   cell	   cycle	   as	   it	   needs	   the	   sister	  
chromatid	   as	   a	   template	   and	   is	   the	   mostly	   error-­‐free	   pathway	   for	   the	   repair	   or	  
tolerance	   of	   DNA	   damage	   (80,81).	   The	   DNA	   lesions	   repaired	   by	   HR	   can	   be	   DSBs	  
induced	  by	   exogenous	   and	   endogenous	   sources	   (e.g.	   ionizing	   radiation	   or	   reactive	  
oxygen	  species),	  as	  well	  as	  programmed	  DSBs	  during	  meiosis	  (82).	  In	  addition,	  HR	  is	  
involved	   in	  repair	  of	   ICLs	  and	  DNA	  gaps,	  as	  well	  as	   in	  recovery	  of	  stalled	  or	  broken	  
replication	  forks	  (79).	  The	  latter	  is	  associated	  with	  post-­‐replication	  repair	  (PRR)	  also	  
termed	   DNA	   damage	   tolerance	   (DDT),	   processes	   that	   allow	   cells	   to	   survive	  
replication-­‐blocking	   lesions.	   Two	   main	   pathways	   have	   evolved	   in	   DDT,	   both	  
governed	  by	  Rad6	  family	  proteins	  and	  distinct	  modifications	  of	  PCNA:	  one	   is	  error-­‐
prone	   and	   involves	   TLS	   polymerases,	   while	   the	   second	   pathway	   is	   error-­‐free	   and	  
assumes	   transient	   template	   switch	   to	   the	   undamaged	   strand	   presumably	   by	   fork	  
regression	   (already	   discussed	   above)	   and/or	   post-­‐replicative	   gap	   repair	   by	   HR	  
(64,79,83,84).	  
Mechanistically,	  HR	  is	  a	  very	  complex	  process	  and	  can	  result	  in	  both	  crossovers	  and	  
non-­‐crossovers	  (Figure	  7).	  Resection	  leads	  to	  the	  formation	  of	  3'	  ssDNA	  tails	  that	  are	  
covered	   by	   RPA.	   Various	   recombination	  mediators	   (e.g.	   Rad51	   paralogs,	   Rad52	   in	  
yeast	   or	   BRCA2	   in	   humans)	   allow	   Rad51	   filament	   formation	   on	   the	   ssDNA;	   the	  
filament	   then	   performs	   homology	   search	   through	   DNA-­‐strand	   invasion,	   thus	  
generating	   a	   displacement	   loop	   (D-­‐loop)	   structure.	   The	   D-­‐loop	   formation	   is	   the	  
branching	   point	   for	   the	   three	   HR	   sub-­‐pathways:	   break-­‐induced	   replication	   (BIR),	  
synthesis-­‐dependent	   strand	   annealing	   (SDSA)	   and	   double	   Holliday	   junction	   (dHJ)	  
pathway.	   BIR	   occurs	   in	   the	   absence	   of	   a	   second	   DNA	   end	   and	   leads	   to	   a	   half-­‐
crossover	   often	   associated	   with	   the	   loss-­‐of-­‐heterozygocity.	   SDSA	   produces	  
exclusively	  non-­‐crossovers	  and	  requires	  the	  presence	  of	  the	  second	  DNA	  end	  that	  is	  
then	   annealed	   to	   the	   newly	   synthesized	   strand	   after	   D-­‐loop	   disruption.	   The	   dHJ	  
pathway	   is	   responsible	   for	   the	   generation	   of	   crossovers	   in	  meiotic	   recombination,	  
while	  in	  vegetative	  cells	  mainly	  non-­‐crossovers	  are	  produced	  (79).	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Figure	  7.	  Mechanisms	  of	  homologous	  recombination.	  Abbreviations:	  BIR,	  break-­‐induced	  replication;	  
dHJ,	   double	   Holliday	   junction;	   LOH,	   loss	   of	   heterozygosity;	   SDSA,	   synthesis-­‐dependent	   strand	  
annealing.	  Modified	  from	  (79).	  
	  
Dissolution	   and	   resolution	   are	   the	   two	   mechanisms	   of	   dHJ	   processing.	   In	   the	  
dissolution	   pathway	   Sgs-­‐Top3-­‐Rmi1	   (STR)	   complex	   in	   yeast	   (BLM-­‐TopoIIIα-­‐RMI1-­‐
RMI2,	  BTR,	  in	  humans)	  drives	  the	  convergent	  branch	  migration	  of	  dHJ	  resulting	  in	  a	  
hemicatenane	  structure;	  Top3	  action	  is	  required	  during	  branch	  migration	  and	  for	  the	  
dissociation	  of	  the	  hemicatenane	  (85-­‐87).	  
The	   resolution	   of	   a	   dHJ	   junction	   can	   be	   performed	   by	   three	   different	   structure-­‐
specific	   nucleases:	   Mus81-­‐Mms4,	   Slx1-­‐Slx4	   and	   Yen1	   (in	   humans:	   MUS81-­‐EME1,	  
SLX1-­‐SLX4	   and	   GEN1).	   While	   Mus81-­‐Mms4	   and	   Slx1-­‐Slx4	   cleave	   the	   dHJ	  
asymmetrically,	  Yen1	  was	  found	  to	  introduce	  symmetrical	  nicks	  across	  the	  junction.	  
The	  resolution	  pathway	  yields	  crossover	  as	  well	  as	  non-­‐crossover	  products	  (87).	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DNA	  end	  resection	  is	  the	  commitment	  step	  for	  alt-­‐NHEJ,	  SSA	  and	  HR	  (Figure	  6).	  The	  
term	  is	  defined	  as	  nucleolytic	  degradation	  of	  5'-­‐terminated	  DNA	  strands	  that	  results	  
in	  3'	  ssDNA	  tails	  required	  for	  recombination.	  Resection	  is	  initiated	  by	  the	  binding	  of	  
the	  Mre11-­‐Rad50-­‐Xrs2	  complex	   (MRX;	  MRE11-­‐RAD50-­‐NBS1,	  MRN,	   in	  humans)	   that	  
possesses	  a	  3'	  to	  5'	  exonuclease	  activity,	  which	  is	  the	  opposite	  polarity	  than	  needed	  
for	  HR	  (Figure	  8).	  Only	  recently	  it	  was	  shown	  that	  in	  the	  vicinity	  of	  a	  protein	  block	  at	  
the	   dsDNA	   end	   budding	   yeast	   Sae2	   (human	   CtIP)	   stimulates	   the	   endonuclease	  
activity	  within	   the	  Mre11	   to	   incise	   the	  5'	   terminated	  dsDNA	   strand	   (88).	   Then	   the	  
strand	  can	  be	  degraded	  by	  MRX	  in	  3'-­‐5	  direction,	  while	  the	  long-­‐range	  resection	  with	  
5'	   to	   3'	   polarity	   is	   performed	  either	  by	   Exo1	   (human	  EXO1)	  or	   by	   the	   STR	   (human	  
BTR)	  complex	  in	  conjunction	  with	  RPA	  and	  Dna2	  (Figure	  8,	  (89,90)).	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Supplementary Figure Legends 
Supplementary Figure 1. Model for resection of a DNA double-strand break by 
Dna2, Sgs1, Top3, Rmi1, Mre11, Rad50, Xrs2, and RPA.  
See text for details.  
Supplementary Figure 2. The nuclease, but not the helicase activity of Dna2 is 
required for DNA end resection.  The linear pUC19 DNA was incubated with 50 nM of 
either wild type Dna2, helicase-GHDG'QD.(RUQXFOHDVH-GHDG'QD.5LQ
the presencHRI53$(3 PM). All three proteins used in this experiment were purified 
from yeast cells using an identical procedure (see SI Material and Methods). The specific 
activity of the wt Dna2 was about 3-fold lower than that of the helicase-dead Dna2 
.(PXWDQWDVMXGJHGEDVHGRQthe nuclease activity on a Y-structure 
ROLJRQXFOHRWLGHEDVHGVXEVWUDWH7DNLQJLQWRDFFRXQWWKHGLIIHUHQFHLQVSHFLILFDFWLYLW\ZW
Dna2 is about 4-fold more efficient in DNA end resection than helicase-dead Dna2 
.(7KHQXFOHDVHDFWLYLW\RI'QDZDVDEVROXWHO\UHTXLUHGfor resection (lane 5). 
The extent of resection (in per cent) that is indicated below the lanes is the average from 
2 independent experiments. 
Supplementary Figure 3. Dna2 strictly requires a free end to degrade DNA.  
a, DNA containing 450 nt of unpaired ssDNA (“bubble DNA”) was incubated with Sgs1 
Q0DQGRU'QDQ0DVLQGLFDWHGDQG53$PM). The reaction products were 
VHSDUDWHGRQDJDURVHJHOLQWKHSUHVHQFHRIȝJPOHWKLGLXPEURPLGH'QDGRHV
not degrade bubble DNA, irrespectively of the presence of Sgs1. A fraction of the DNA 
VXEVWUDWHLVQLFNHGZLWKLQWKHVV'1$UHJLRQOLPLWHGGHJUDGDWLRQRIWKHQLFNHGEXEEOH
substrates by Dna2 is observed. b5HOD[HGGXSOH['NA was incubated with Sgs1 (70 
Q0DQGRU'QDQ0DVLQGLFDWHGDQG53$3 PM). The reaction products were 
VHSDUDWHGE\HOHFWURSKRUHVLVLQDJDURVHDQGVWDLQHGDIWHUZDUGVZLWKȝJPO
ethidium bromide. Sgs1 can unwind dsDNA without a free end (P&HMND-/3ODQNDQG
6&.RZDOF]\NRZVNLLQSUHSDUDWLRQ, as reveled by the change in superhelicity in the 
coupled reaction with Topo I (lane 4)5. Dna2 does not cleave the circular ssDNA 
produced by the Sgs1-catalyzed unwinding of the covalently closed dsDNA. 
	  
Figure	  8.	  Model	  for	  resection	  of	  DNA	  double-­‐strand	  breaks	  by	  Mre11-­‐Rad50-­‐Xrs2,	  Sgs1-­‐Top3-­‐Rmi1,	  
Dna2	  and	  RPA.	  Modified	  from	  (28).	  	  
Sgs1	  as	  well	   as	  BLM	  are	   embers	  of	   the	  RecQ	   family	  of	  helicases	   that	  possess	   an	  
ATP-­‐dependent	   3'-­‐5	   translocase	   activity	   (91).	   In	   resection,	   Sgs1	   unwinds	   the	   DNA	  
while	  Dna2	  degrades	   the	  5'	   termi ated	   strand.	   This	   reaction	   is	   fully	  dependent	  on	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RPA	   and	   requires	   Top3-­‐Rmi1	   in	   vivo	   (28,92,93).	   The	   nuclease	   activity	   of	   Dna2	   is	  
essential	   for	   DNA	   end	   resection,	   while	   the	   helicase	   was	   shown	   to	   be	   dispensable	  
(28,93).	  The	  long-­‐range	  resection	  can	  generate	  2-­‐4	  kb	  of	  ssDNA	  with	  a	  speed	  of	  4	  kb	  
per	  hour	   in	  budding	  yeast,	  ensuring	  efficiency	  and	   fidelity	  of	  HR	   (94).	  Additionally,	  
hDNA2	   was	   shown	   to	   function	   with	   FANCD2	   (Fanconi	   anemia	   complementation	  
group	  D2)	   in	   ICL	   repair.	  Depletion	  of	  DNA2	   led	   to	   increase	  sensitivity	   to	   ICL	  agents	  
and	  reduced	  HR	  frequency	  (95).	  	  	  
1.2.5	  Dna2	  as	  checkpoint	  activator	  	  
The	  cellular	  response	  to	  DNA	  damage	  and	  replication	  stress,	  which	  is	  part	  of	  the	  cell	  
cycle	   checkpoint	   response,	   is	   triggered	   by	   two	   protein	   kinases	   of	   the	  
phosphatidylinositol	  3-­‐kinase-­‐related	  protein	  kinase	  (PIKK)	  family:	  Mec1	  (homolog	  of	  
human	   ATR)	   that	   is	   activated	   by	   the	   presence	   of	   RPA-­‐coated	   ssDNA,	   and	   Tel1	  
(human	   ATM)	   that	   recognizes	   DSBs.	   Activation	   of	   the	   checkpoint	   results	   in	   the	  
stabilization	   of	   stalled	   replication	   forks,	   increased	   repair	   and	   dNTP	   synthesis,	  
inhibition	   of	   late	   origin	   firing	   and	   changes	   in	   gene	   expression	   allowing	   the	   cell	   to	  
overcome	  DNA	  damage;	  or	  in	  case	  of	  severe	  damage	  it	  initiates	  apoptosis	  in	  higher	  
eukaryotes	  (96).	  Tel1	  (ATM)	  is	  recruited	  to	  DSBs	  via	  its	  interaction	  with	  MRX	  (MRN)	  
and	   phosphorylates	   histone	   H2AX	   as	   well	   as	   Rad53	   (human	   Chk2)	   in	   some	   cases,	  
leading	  to	  the	  activation	  of	  further	  downstream	  mediator	  and	  effector	  proteins,	  and	  
cell	  cycle	  arrest.	  UV	   light	  and	  oxidative	  damage	  that	  are	  repaired	  by	  BER	  and	  NER,	  
respectively,	  activate	  Mec1	  due	  to	  ssDNA	  gaps	  appearing	  in	  course	  of	  the	  repair	  (96).	  
Moreover,	   DSBs	   that	   become	   subject	   of	   resection	   are	   serving	   as	   Mec1	   activator	  
upon	  exposure	  of	  the	  3'	  terminated	  ssDNA	  tails	  (97).	  Mec1	  is	  associated	  with	  Ddc2	  
(human	  ATRIP)	  and	  acts	  only	  as	  a	  heterodimer	  (98).	  Although	  Mec1-­‐Ddc2	  is	  recruited	  
to	   ssDNA	  via	   the	   interaction	  with	  RPA70	   subunit,	   it	   still	   needs	   further	   interactions	  
with	  sensor	  proteins	   to	  stimulate	   its	  kinase	  activity	   (99,100).	  Three	  of	   these	  Mec1-­‐
activator	  proteins	  were	  found	  in	  S.	  cerevisiae	   (Figure	  9).	  Their	  activity	  is	  dependent	  
on	  the	  cell	  cycle	  and	  show	  partial	  redundancy	  for	  checkpoint	  activation	  (24).	  The	  first	  
activator	   is	   the	   9-­‐1-­‐1	   checkpoint	   clamp	   (yeast	   Ddc1-­‐Rad17-­‐Mec3;	   human	   RAD9-­‐
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RAD1-­‐HUS1)	  that	  is	  the	  sole	  activator	  of	  Mec1	  in	  G1	  in	  S.	  cerevisiae.	  The	  stimulatory	  
function	  is	  carried	  out	  by	  the	  Ddc1	  protein	  (101).	  
	  
Figure	  9.	  Activation	  of	  Mec1ATR	  during	  the	  cell	  cycle.	  While	  in	  G1	  9-­‐1-­‐1	  protein	  (RAD9-­‐RAD1-­‐HUS1	  in	  
humans;	  Ddc1-­‐Rad17-­‐Mec3	  in	  S.	  cerevisiae)	  is	  the	  sole	  activator	  of	  Mec1,	  in	  G2	  Dpb11	  can	  carry	  out	  
this	   function	  as	  well.	  However,	   in	  S	  phase	  Dna2	  can	  serve	  as	  a	  Mec1	  activator	   in	  a	   third	   redundant	  
pathway,	  upon	  replication	  stalling	  induced	  by	  hydroxyurea.	  Modified	  from	  (24).	  	  
In	   G2	   phase,	   however,	   the	   9-­‐1-­‐1	   protein	   is	   additionally	   responsible	   for	   the	  
recruitment	  of	  the	  second	  activator,	  Dpb11	  (human	  TOPBP1),	  and	  both	  proteins	  are	  
required	  for	  full	  G2	  checkpoint	  signaling	  (102).	  In	  metazoans	  Dpb11	  (TOPBP1)	  is	  the	  
sole	  activator	  of	  Mec1	  (ATR),	  although	  9-­‐1-­‐1	   is	  still	  required	  for	  Dpb11	  recruitment	  
(103).	   The	   S-­‐phase	   checkpoint	   is	   quite	   complex	   and	   demonstrates	   a	   high	   level	   of	  
redundancy.	   In	   budding	   yeast,	   in	   addition	   to	   the	   activation	   by	   Ddc1	   and	   Dpb11,	  
Mec1	  can	  also	  be	  activated	  by	  Dna2	  in	  S-­‐phase,	  requiring	  its	  two	  aromatic	  residues	  
within	   the	   N-­‐terminal	   domain	   −	   Trp128	   and	   Tyr130	   (37).	   To	   abrogate	   Mec1	  
activation	  in	  S-­‐phase	  all	  three	  of	  these	  proteins	  have	  to	  be	  inactivated.	  However,	  to	  
completely	  abolish	  the	  S-­‐phase	  checkpoint	  also	  Tel1	  has	  to	  be	  inactivated	  and	  these	  
checkpoint-­‐deficient	   cells	   are	   very	   sick,	   grow	   slowly	   and	   fail	   to	   complete	   DNA	  
replication	   even	   in	   the	   absence	   of	   DNA	   damaging	   agents	   (37).	   These	   findings	  
underline	   the	   importance	   of	   the	   checkpoint	   function	   even	   in	   unperturbed	   DNA	  
replication.	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1.2.6	   Additional	   tasks	   for	   Dna2:	   telomere	   and	   mitochondrial	   DNA	  
maintenance	  	  
Chromosomal	   ends	   or	   telomeres	   resemble	   in	   many	   ways	   a	   DSB.	   However,	   it	   is	  
pivotal	   for	   the	  cells	   that	  the	  DSB	  repair	  pathways	  do	  not	   initiate	  on	  a	  telomere,	  as	  
this	  would	   result	   in	   fusion	  or	   loss	   of	   the	   telomeres,	  which	   actually	   can	  be	   seen	   in	  
most	   cancers	   and	   largely	   contributes	   to	   the	   genome	   instability	   (104).	   Telomeres	  
consist	   of	   long	   non-­‐protein	   coding	   repeats	   synthesized	   by	   the	   telomerase,	   a	  
telomere-­‐specific	   reverse	   transcriptase.	   At	   the	   end	   of	   the	   telomere	   there	   is	   a	   3'	  
ssDNA	  overhang	  (50-­‐300	  nucleotides)	  that	  pairs	  with	  the	  repeats	  in	  the	  dsDNA,	  thus	  
generating	  a	  protective	  t-­‐loop	  in	  human	  cells	  (105).	  This	  structure	  together	  with	  the	  
mammalian	   telomere-­‐specific	   shelterin	   complex	   protects	   the	   telomere	   end	   from	  
DNA	  repair	  enzymes	  and	  DNA	  damage	  signaling	   (104).	   In	  budding	  yeast,	   the	  3'	   tail	  
that	   is	   also	   called	   G-­‐tail	   at	   the	   end	   of	   the	   telomere	   is	   much	   shorter	   (12-­‐15	  
nucleotides)	  and	  serves	  as	  the	  binding	  platform	  for	  the	  CST	  capping	  complex	  (Cdc3-­‐
Stn1-­‐Ten1).	  Furthermore,	  dsDNA	  repeats	  are	  bound	  by	  Rif1/2	  and	  Rap1	  proteins	  that	  
together	   with	   CST	   protect	   telomeres	   from	   repair	   and	   checkpoint	   activation	   (106).	  
Surprisingly,	  many	  DNA	  repair	  proteins	  are	  found	  at	  the	  telomeres:	  e.g.	  Ku70-­‐Ku80	  
that	   contributes	   to	   capping,	   or	   Sgs1	   and	   Sae2	   that	   are	   responsible	   for	   C-­‐strand	  
resection	  after	  replication	  to	  generate	  the	  3'	  G-­‐tails	  (107,108).	  Also	  Dna2	  was	  shown	  
to	   localize	   to	   telomeres	  during	  G1	  and	   late	  S/G2	  phases	   (109).	   In	  mammals,	  DNA2	  
was	  found	  at	  telomeres	  as	  well	  and	  deletion	  of	  DNA2	  in	  mouse	  cells	  led	  to	  telomere	  
replication	  defects,	  fragile	  telomeres	  and	  sister	  telomere	  associations.	  Furthermore,	  
heterozygous	   DNA2	   knockout	   mice	   developed	   aneuplody-­‐associated	   cancers	   with	  
dysfunctional	  telomeres	  (110).	  Telomeric	  repeats	  are	  G-­‐rich	  and	  were	  shown	  to	  fold	  
in	  G-­‐quadruplex	  (G4)	  structures	  that	  might	  block	  replication	  (111,112).	  Both	  human	  
and	  yeast	  Dna2	  were	  described	  to	  unwind/cleave	  the	  G4	  structures	  which	  might	  be	  
one	  of	  the	  functions	  of	  Dna2	  at	  telomeres	  and	  would	  explain	  the	  phenotype	  of	  DNA2	  
knockout	  mice	  (110,113).	  	  	  
The	   finding	   that	   dna2Δ	   cells	   containing	   a	   pif1-­‐m2	   variant	   (necessary	   for	   their	  
viability),	   which	   still	   localized	   to	   mitochondria	   and	   showed	   full	   function,	   failed	   to	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grow	  on	   glycerol	  media	   suggested	   a	  mitochondrial	   function	   for	  Dna2	   as	  well	   (58).	  
Also	   human	   DNA2	   was	   reported	   to	   be	   mainly	   found	   in	   mitochondria	   where	   it	  
colocalized	   with	   the	   helicase	   Twinkle	   (40,41).	   Moreover,	   human	   DNA2	   interacted	  
and	  stimulated	  pol	  γ	  and	  is	  thought	  to	  participate	  together	  with	  FEN1	  in	  long-­‐patch	  
base	   excision	   repair	   of	   oxidative	   lesions	   in	  mtDNA	   (40).	   Finally,	   patients	   suffering	  
from	  progressive	  myopathy	  were	  found	  to	  carry	  DNA2	  mutations	  inferring	  that	  this	  
protein	   is	   not	   only	   important	   for	   nuclear	   but	   also	   for	   mitochondrial	   DNA	  
maintenance	  (114).	  	  
1.2.7	  Dna2	  as	  a	  potential	  therapeutic	  target	  	  
Cancer	  research	  of	  more	  than	  three	  decades	  allowed	  developing	  a	  steadily	  growing	  
number	  of	  cancer	  therapies	  that	  target	  one	  of	  the	  hallmarks	  of	  cancer	  (Figure	  10).	  	  	  
	  
Figure	   10.	   Therapeutic	   targeting	   of	   the	   hallmarks	   of	   cancer.	   Schematics	   showing	   compounds	  
interfering	  with	  the	  single	  acquired	  capabilities	  required	  for	  tumor	  growth	  and	  progression.	  Modified	  
from	  (2).	  	  	  	  
Also,	  the	  targeting	  of	  genome	  instability	  became	  an	  attractive	  therapy.	  So	  far,	  only	  
the	   inhibitors	   of	   PARP1	   enzyme	  made	   it	   to	   the	   clinics	   as	   a	   so-­‐called	   personalized	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medicine	   for	   treatment	   of	   BRCA1/BRCA2	   deficient	   tumors	   (115).	   Their	   efficacy	   is	  
based	  on	  the	  concept	  of	  synthetic	  lethality:	  PARP1	  inhibitors	  selectively	  kill	  cells	  that	  
are	   HR	   deficient	   due	   to	   BRCA1/BRCA2	   mutation	   (116).	   It	   is	   obvious	   that	   more	  
therapies	  are	  required	  that	  target	  the	  hallmark	  of	  genome	  instability.	  	  
There	  is	  a	  growing	  amount	  of	  evidence	  that	  DNA2	  is	  involved	  in	  cancer	  development	  
and	  progression,	  although	  the	  exact	  contribution	  is	  far	  from	  being	  clear.	  DNA2	  was	  
found	   to	   be	   overexpressed	   in	   a	   variety	   of	   human	   cancers	   and	   the	   expression	  
correlated	  with	   the	  disease	  outcome,	  suggesting	  a	   tumor-­‐promoting	  role	   for	  DNA2	  
(117).	  Conversely,	  a	  recent	  study	  uncovered	  activity-­‐impairing	  mutations	  of	  DNA2	  in	  
estrogen-­‐dependent	   cancers,	   although	   depletion	   of	   DNA2	   inhibited	   xenograft	  
growth	  in	  mice	  (118).	  The	  authors	  suggested	  that	  impairment	  of	  DNA2	  activity	  might	  
trigger	   cancer	   development,	  while	   an	   elevated	  DNA2	  activity	   is	   possibly	   important	  
for	   cancer	   progression	   and	   allows	   the	   tumor	   to	   cope	  with	   replication	   stress,	   thus	  
providing	   a	   growth	   advantage	   to	   the	   cancer	   cells	   (118).	   This	   hypothesis	   is	   further	  
supported	   by	   the	   phenotype	   of	   DNA2	   knockout	   mice	   that	   develop	   aneuplody-­‐
associated	  cancers	  (110).	  Taken	  together,	  these	  findings	  suggest	  that	  cancer	  patients	  
might	  benefit	   from	  therapies	   targeting	  DNA2:	   tumors	  with	  high	  DNA2	   levels	  might	  
thus	  loose	  their	  proliferative	  capacity,	  while	  cancers	  with	  mutated	  DNA2	  form	  could	  
be	   treated	   with	   additional	   inhibitors	   of	   DNA	   repair/replication	   proteins	   to	   induce	  
synthetic	  lethality	  (118).	  	  
Despite	   the	   tremendous	   progress	   in	   targeted	   cancer	   therapies,	   chemo-­‐	   and	  
radiotherapy	  are	  still	  very	  often	  used	  as	  treatments	  for	  many	  types	  of	  tumors.	  Both	  
therapies	   are	  based	  on	   the	   induction	  of	   a	   large	  amount	  of	  DNA	  damage	   in	   cancer	  
cells,	  thus	  leading	  to	  cell	  death	  (119).	  Caffeine	  was	  shown	  to	  sensitize	  cancer	  cells	  to	  
radio-­‐	  and	  chemotherapy	  (120,121).	  On	  the	  molecular	  level,	  caffeine	  was	  suggested	  
to	   inhibit	   p53,	   ATM	   and	   ATR	   proteins	   (122).	   However,	   caffeine-­‐induced	  
radiosensitivity	  was	  additionally	  proposed	  to	  result	  from	  HR-­‐inhibition	  (123).	  A	  very	  
recent	   study	   by	   the	   group	   of	   James	   Haber	   provided	   a	   possible	   explanation	   how	  
caffeine	   affects	   HR:	   they	   show	   that	   caffeine	   treatment	   leads	   to	   proteosomal	  
degradation	  of	  both	  Sae2	  and	  Dna2	   in	  budding	  yeast,	   thus	  compromising	  DNA	  end	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resection	   pathway	   (124).	   This	   underlines	   the	   potential	   of	   DNA2	   not	   only	   in	   a	  
targeted	  cancer	  therapy,	  but	  also	  in	  classical	  chemo-­‐	  and/or	  radiotherapy.	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2.	  RESULTS	  
2.1	  Summary	  of	  results	  	  
My	  PhD	  project	  started	  with	  the	  expression	  and	  purification	  of	  S.	  cerevisiae	  Dna2	  protein	  
followed	  by	   biochemical	   characterization	  of	   its	   helicase	   activity.	  Dna2	   is	   an	   iron-­‐sulfur	  
cluster	   protein	   and	   is	   thus	   very	   sensitive	   to	   oxidation	   and	   long	   dialysis	   procedures.	  
Therefore,	  we	  shortened	  and	  optimized	  the	  protein	  purification	  protocol,	  and	  obtained	  a	  
highly	   active	   Dna2	   protein	   preparation.	   We	   were	   able	   to	   show	   that	   our	   Dna2	  
preparation	   exhibits	   a	   vigorous	   but	   cryptic	   helicase	   activity,	   in	   contrast	   to	   previous	  
reports	   from	   other	   groups,	   and	   that	   the	   helicase	   activity	   of	   Dna2	   is	   masked	   by	   its	  
nuclease	  (Levikova	  et	  al.,	  PNAS	  2013;	  see	  2.2.1).	  	  
Next,	  we	  wanted	  to	  investigate	  how	  both	  helicase	  and	  nuclease	  activities	  are	  regulated	  
within	  the	  Dna2	  protein.	  We	  found	  out	  that	  Dna2	  is	  modified	  by	  sumoylation	  in	  vitro	  and	  
in	  vivo.	  Sumoylation	  of	  Dna2	  attenuated	  the	  nuclease	  activity	  of	  Dna2	  without	  affecting	  
its	   helicase.	   Moreover,	   sumoylation	   levels	   of	   Dna2	   varied	   during	   the	   cell	   cycle	   being	  
highest	   in	   late	  S/G2	  phases.	  Dna2	  protein	   levels	  differed	  as	  well	  depending	  on	  the	  cell	  
cycle	  stage	  and	  also	  decreased	  upon	  treatments	  with	  MMS	  and	  bleomycin,	  representing	  
an	  additional	  level	  of	  regulation	  of	  Dna2	  (Levikova	  et	  al.,	  manuscript	  in	  preparation,	  see	  
2.2.2).	  	  
Dna2	  was	  shown	  to	  function	  together	  with	  Fen1	  in	  Okazaki	  fragment	  processing	  during	  
lagging	  strand	  DNA	  replication.	  Having	  a	  preparation	  of	  S.	  cerevisiae	  Dna2	  protein	  that	  
displayed	  a	  higher	  and	  also	   somewhat	  different	  activity,	  we	   set	  out	   to	   revisit	   its	  exact	  
role	   in	  Okazaki	   fragment	  maturation.	  Previous	   studies	  postulated	  a	  model	   stating	   that	  
Dna2	  shortens	  long	  DNA	  flaps	  arising	  during	  lagging	  strand	  DNA	  synthesis	  up	  to	  5-­‐8	  nt,	  
thus	  requiring	  a	  second	  nuclease	  activity	  of	  Fen1,	  before	  adjacent	  Okazaki	  fragments	  can	  
be	  ligated.	  We	  demonstrated	  that	  Dna2	  is	  able	  to	  cleave	  DNA	  flaps	  at	  or	  near	  their	  base,	  
and	  is	  very	  efficient	  in	  Okazaki	  fragment	  maturation	  without	  Fen1,	  which	  is	  supported	  by	  
genetic	   data.	   We	   suggest	   a	   Fen1-­‐independent	   role	   for	   Dna2	   in	   lagging	   strand	   DNA	  
synthesis,	   probably	   in	   late	   replication	   for	   processing	   of	   DNA	   flaps	   that	   escaped	   Fen1	  
cleavage	  (Levikova	  and	  Cejka,	  NAR	  2015,	  in	  press,	  see	  2.2.3)	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Further,	  we	  analyzed	   the	  potent	  helicase	  activity	  within	   the	  wild	   type	  Dna2	  protein	   in	  
more	   detail	   with	   regard	   to	   its	   role	   in	   DNA	   end	   resection.	  We	   demonstrated	   that	   the	  
motor	   activity	   of	   Dna2	   can	   act	   as	   a	   ssDNA	   translocase,	   rather	   than	   a	   helicase,	   to	  
stimulate	   fast	  and	  efficient	  ssDNA	  degradation	  particularly	   in	  the	  presence	  of	  RPA.	  We	  
propose	  that	  in	  DNA	  end	  resection,	  where	  Dna2	  acts	  with	  Sgs1	  to	  degrade	  5'-­‐terminated	  
DNA	  strands,	  the	  translocase	  activity	  of	  Dna2	  helps	  it	  to	  keep	  up	  with	  the	  lead	  helicase	  
Sgs1	  and	  to	  rapidly	  cleave	  the	  unwound	  5'-­‐terminated	  DNA	  strand	  (Levikova	  and	  Cejka,	  
manuscript	  in	  preparation,	  see	  2.2.4).	  	  
In	   collaboration	   with	   the	   laboratory	   of	   Prof.	   Alessandro	   Vindigni	   (St	   Louis	   University	  
School	  of	  Medicine,	  MO,	  USA)	  we	  set	  out	   to	  define	   the	  role	  of	  Dna2	   in	   the	  processing	  
and	  restart	  of	  reversed	  DNA	  replication	  forks.	  We	  showed	  by	  employing	  biochemical	  and	  
cell	  biological	  methods	   that	  human	  DNA2	  cooperates	  with	  WRN	   (and	  yeast	  Dna2	  with	  
Sgs1)	   to	  process	   replication	   forks	  upon	  replication	  stress-­‐induced	  reversal,	   thus	  driving	  
their	  restart	  (Thangavel	  et	  al.,	  JCB	  2015,	  see	  2.3.1).	  
In	   another	   collaborative	   project	   with	   the	   laboratory	   of	   Prof.	   Ulrich	   Rass	   (FMI	   Basel,	  
Switzerland)	  we	  elucidated	   the	   role	  of	  Dna2	  helicase	   in	   completion	  of	  DNA	   replication	  
and	   its	   interplay	   with	   the	   Holliday-­‐junction	   resolvase	   Yen1	   in	   budding	   yeast.	   We	  
provided	  biochemical	   data	  with	   the	  helicase-­‐dead	  Dna2	   variant	   (Ölmezer	  et	   al.,	   under	  
revision	  in	  Nat.	  Com.,	  see	  2.3.2)	  
In	   a	   further	   collaboration	   with	   the	   laboratory	   of	   PD	   Dr.	   Pavel	   Janscak	   (University	   of	  
Zurich,	   Switzerland)	   we	   expressed	   and	   purified	   human	   DNA2	   protein	   that	   is	   similarly	  
difficult	   to	  purify	  as	   its	  yeast	  homolog.	  We	  showed	  that	  human	  DNA2	  cooperates	  with	  
WRN	  and	  BLM	  helicases	  in	  long-­‐range	  DNA	  end	  resection	  (Sturzenegger	  et	  al.,	  JBC	  2014,	  
see	  2.3.3).	  	  
RPA	  was	  shown	  to	  specifically	  interact	  with	  Dna2	  and	  stimulate	  its	  activity.	  The	  detailed	  
properties	   of	   yeast	   and	   human	   RPA	   were	   analyzed	   in	   single	   molecule	   experiments	  
performed	   in	   the	   laboratory	   of	   Prof.	   Ralf	   Seidel	   (University	   of	   Leipzig,	   Germany).	  We	  
provided	   the	   purified	   proteins	   for	   this	   study	   (Kemmerich	   et	   al.,	   manuscript	   in	  
preparation,	  see	  2.2.4).	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2.2	  Primary	  results	  	  
2.2.1	  Nuclease	  activity	  of	  Saccharomyces	  cerevisiae	  Dna2	  inhibits	  its	  potent	  
helicase	  activity	  	  
Maryna	  Levikova,	  Daniel	  Klaue,	  Ralf	  Seidel	  and	  Petr	  Cejka.	  	  
	  
	  
Article	  published	  in	  PNAS,	  2013.	  
	  
	  
I	   designed	   the	   research	   together	   with	   R.S.	   and	   P.C.	   and	   performed	   most	   of	   the	  
experiments	   with	   the	   help	   of	   P.C.	   The	   single	   molecule	   experiments	   in	   Figure	   3	   and	  
Supplementary	   Figure	   S6	  were	   carried	  out	  by	  D.K.	  All	   authors	   analyzed	   the	  data	  and	   I	  
wrote	  the	  manuscript	  together	  with	  R.S	  and	  P.C.	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Nuclease activity of Saccharomyces cerevisiae Dna2
inhibits its potent DNA helicase activity
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Dna2 is a nuclease-helicase involved in several key pathways of
eukaryotic DNA metabolism. The potent nuclease activity of Saccha-
romyces cerevisiae Dna2 was reported to be required for all its in
vivo functions tested to date. In contrast, its helicase activity was
shown to be weak, and its inactivation affected only a subset of
Dna2 functions. We describe here a complex interplay of the two
enzymatic activities. We show that the nuclease of Dna2 inhibits its
helicase by cleaving 5′ ﬂaps that are required by the helicase do-
main for loading onto its substrate. Mutational inactivation of Dna2
nuclease unleashes unexpectedly vigorous DNA unwinding activity,
comparable with that of the most potent eukaryotic helicases. Thus,
the ssDNA-speciﬁc nuclease activity of Dna2 limits and controls the
enzyme’s capacity to unwind dsDNA. We postulate that regulation
of this interplay could modulate the biochemical properties of Dna2
and thus license it to carry out its distinct cellular functions.
DNA nuclease | replication protein-A | Sgs1
The Dna2 enzyme functions at the crossroads of key DNAmetabolic processes. It was initially identiﬁed in screens for
Saccharomyces cerevisiae mutants deﬁcient in DNA replication (1,
2), and its importance was underscored by the ﬁnding that dna2Δ
mutants are not viable (3). When the DNA2 gene was cloned, it
was shown to be conserved in evolution from yeast to humans
and found to contain conserved nuclease and helicase motifs (4).
Further work identiﬁed a number of genetic and physical inter-
actions of Dna2 with factors required for the synthesis and matu-
ration of the lagging strand during DNA replication, including
Rad27 [homolog of human Flap endonuclease 1, FEN1 (5)].
Overexpression of Rad27 rescued growth defects of some dna2
point mutants, and, conversely, overexpression of Dna2 suppressed
rad27Δ defects (5). Subsequent work established that Dna2 func-
tions together with Rad27 in the removal of single-stranded (ss)
ﬂaps generated at the 5′ termini of Okazaki fragments by poly-
merase δ-catalyzed strand displacement. Although Rad27 seems to
have a more general role in ﬂap processing, Dna2 is required to
cleave only a subset of longer ﬂaps bound by Replication Protein A
(RPA), which stimulates its nuclease activity while inhibiting
cleavage by Rad27. In this process, Dna2 and Rad27 were proposed
to function in a sequential manner, with Dna2 loading ﬁrst onto the
ﬂap termini and shortening them with its 5′–3′ nuclease. Rad27 was
then proposed to further cleave the shortened ﬂaps at the ss/
dsDNA junctions, creating thus ligatable substrates for Cdc9 (DNA
ligase 1), which completes Okazaki fragment maturation (6–8).
The role of Dna2 in Okazaki fragment processing is now gen-
erally accepted although it still remains somewhat puzzling why
dna2Δ cells are inviable whereas rad27Δ mutants are not.
More recently, it has been shown that Dna2 has an independent
and conserved function in dsDNA break repair (9). Speciﬁcally,
Dna2 belongs to one of the pathways that resect 5′ ends of dsDNA
breaks to initiate homologous recombination. This process leads
to the formation of long 3′ overhangs, which become coated by the
strand exchange protein Rad51, and which also prime DNA syn-
thesis during the downstream steps in homologous recombination.
Genetic and later biochemical work established that Dna2 func-
tions together with the vigorous Sgs1 helicase (Bloom in human
cells) downstream of the Mre11-Rad50-Xrs2 (MRX) complex (9–
14). MRX ﬁrst recognizes dsDNA breaks and is likely involved in
their initial processing, and subsequently helps recruit Sgs1 and
Dna2. Sgs1 helicase then unwinds the DNA from the break and
the ssDNA is coated by RPA, which stimulates the 5′–3′ nuclease
activity of Dna2. The speciﬁc degradation of the 5′ end of the
unwound DNA ensures the correct polarity of resection, which is
required for homologous recombination (12, 13). However, the
roles of Dna2 are not limited to Okazaki fragment and dsDNA
break processing. Dna2 was also shown to function in telomere
maintenance (15), aging (16), long-patch base excision repair (17),
and prevention of reversal of stalled replication forks (18). The
expression of human DNA2 was increased in human cancers and
negatively correlated with disease outcome, indicating that DNA2
function is relevant for human health (19). However, the role of
Dna2/DNA2 in these latter processes remains poorly deﬁned.
The potent nuclease activity of Dna2 seems to be critical for all
of its functions, including replication and recombination. Point
mutants lacking the nuclease activity are inviable as a dna2Δ
strain (20). The nuclease activity of Dna2 is ssDNA-speciﬁc, and
shows both 5′–3′ and 3′–5′ polarities. Because RPA stimulates the
5′–3′ nuclease and inhibits the 3′–5′ activity, it is likely that only
the 5′–3′ directionality is important in vivo (12, 13). It has been
shown that the Dna2 nuclease can load only on a free ssDNA tail,
and that it subsequently cleaves DNA endonucleolytically into
short oligonucleotides (21, 22).
Much less is known about the function of the helicase activity
of Dna2. To date, very weak 5′–3′ unwinding capacity has been
demonstrated for the yeast enzyme (4, 7, 23). Interestingly,
similarly to the Dna2 nuclease, also the helicase domain requires
a free DNA end (22). In contrast, no unwinding activity could be
detected in the Xenopus laevis Dna2. Whether human DNA2
possesses helicase activity remains controversial (24–27). Yeast
point mutants lacking helicase activity show impaired growth but
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are viable under most conditions (23). Overexpression of Rad27
partially rescues dna2 helicase-deﬁcient mutants, suggesting that
the helicase activity might play a supportive but nonessential role in
DNA replication (28). The helicase-deﬁcient mutants show a dra-
matic sensitivity to the DNA alkylating drug methylmethanesulfo-
nate (MMS), pointing to an as-yet uncharacterized role of Dna2
helicase in the repair of DNA damage (29). In contrast, Dna2
helicase activity had no detectable effect on DNA end resection (9).
Due to the limited unwinding capacity of Dna2 observed in vitro,
the motor was proposed to function as an ssDNA translocase to aid
positioning of the nuclease domain on ssDNA and to remove
secondary structures from ssDNA, rather than as a DNA helicase
to unwind dsDNA (23).
In this work, we expressed S. cerevisiaeDna2 and its variants and
optimized the puriﬁcation of these polypeptides. We now show
that Dna2 is a potent but cryptic DNA helicase. It functionally
interacts with RPA, which enables it to unwind tens of kilobases of
dsDNA. Surprisingly, the nuclease of wild-type Dna2 interferes
with this remarkable helicase capacity by cleaving ssDNA tails that
the helicase requires for loading onto DNA to initiate unwinding.
The interplay between the two main biochemical activities of Dna2
might ﬁne-tune its behavior to suit its distinct cellular roles.
Results
Expression and Puriﬁcation of Wild-Type Dna2 and Nuclease- and
Helicase-Dead Variants. S. cerevisiae Dna2 is a large protein
(172 kDa) consisting of 1,522 amino acids (Fig. 1A). We no-
ticed previously that recombinant Dna2 was rather unstable,
rapidly losing activity during extended dialysis procedures used in
earlier preparation protocols (12). Furthermore, it was sensitive
to the omission of reducing agents, possibly due to the presence
of an oxidation-prone iron–sulfur cluster (30, 31). Modiﬁcation of
the puriﬁcation procedure allowed us to obtain Dna2 with a high
speciﬁc nuclease activity (12). In this work, we further optimized
and shortened the puriﬁcation process (Materials and Methods)
and obtained nearly homogenous wild-type Dna2 and nuclease-
dead Dna2 E675A, as well as helicase-dead Dna2 K1080E var-
iants (Fig. 1 A and B and Fig. S1 A and B).
Dna2 Possesses a Vigorous DNA Helicase Activity. The ssDNA-speciﬁc
nuclease activity of Dna2 was proposed to obscure the detection of
its limited unwinding property (22). Therefore, the nuclease-dead
Dna2 variants were used to characterize its helicase activity. One of
these mutants is Dna2 E675A, which had been designed based on
the homology betweenEscherichia coliRecB and S. cerevisiaeDna2
nuclease sites (20). Indeed, mutation of the conserved glutamate at
position 675 to alanine largely inactivated the nuclease activity of
Dna2, and Dna2 E675A has been shown to exhibit a weak helicase
activity (22, 23). Here, having used the optimized preparation
procedure, we set out to examine the helicase activity of this variant.
Dna2 E675A could readily unwind a synthetic Y-structure oligo-
nucleotide-based substrate containing 31 base pairs of dsDNA (Fig.
1C). To our great surprise, the helicase was active at subnanomolar
concentrations (Fig. 1C). Previously, ∼20 nM enzyme was needed
to unwind a similar length of dsDNA (22, 23), indicating that our
preparation possesses >20-fold higher speciﬁc DNA unwinding
activity. In agreement with previous data (23), supplementing the
reaction with S. cerevisiae replication protein A (RPA) did not
further stimulate its unwinding capacity whereas E. coli Single
Strand DNA Binding protein (SSB) strongly inhibited DNA un-
winding (Fig. 1 C and D). We show that a 5′-tailed DNA is a pre-
ferred structure for Dna2 E675A unwinding, with ∼0.05 nM Dna2
E675A required to unwind 50% of the DNA substrate, which was
used at 1 nMconcentration (Fig. 1E andFig. S2). The unwinding of
the 5′-tailed DNA substrate was therefore clearly catalytic, with
one enzyme molecule being capable of unwinding at least ∼10
DNA substrate molecules during the time course of the reaction.
The vigorous activity stands in contrast with previous studies
where ∼15- to 100-fold excess enzyme over DNA substrate was
required to detect DNA unwinding (22, 23). We further show that
∼0.3 nM Dna2 E675A was required to unwind 50% of the Y-struc-
ture DNA substrate; thus, the presence of an additional 3′ ssDNA
arm (Y-structure vs. 5′ overhang) inhibitedDNAunwinding∼sixfold
(Fig. 1E and Fig. S2). As anticipated for a 5′–3′ DNA helicase, the
unwinding of 3′-tailed or fully dsDNA substrates was inefﬁcient
(Fig. 1E and Fig. S2). The difference between the speciﬁc DNA
Fig. 1. The nuclease-inactive Dna2 E675A variant possesses a vigorous DNA
helicase activity. (A) A schematic representation of the recombinant Dna2 pro-
tein used in this study. The polypeptide contains an N-terminal FLAG and HA
tags, and a C-terminal 6xHis tag. Positions of mutations inactivating the nuclease
activity (E675A) or helicase activity (K1080E) are indicated. (B) Puriﬁed Dna2
wild-type (wt), E675A, and K1080E variant proteins (550 ng each) used in this
study were stained with Coomassie blue. (C) Representative polyacrylamide gels
(10%) showing the DNA helicase activity of Dna2 E675A on a 32P-labeled Y-
structure DNA substrate (1 nM). The length of both ssDNA arms was 19 nt. As
indicated, the reactions were supplemented with either S. cerevisiae RPA or
E. coli SSB (both 22 nM). *, position of the 32P label. (D) Quantitation of the
helicase assays such as shown in C. Error bars, SE, n = 3. (E) Quantitation of the
helicase assays such as shown in Fig. S2. Error bars, SE, n = 3. (F) Quantitation of
electrophoretic mobility shift assays showing the binding of Dna2 E675A to
various 32P-labeled DNA substrates (1 nM). Error bars, SE, n = 3.
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unwinding activity presented here and in earlier reports (22, 23) is
likely due to the optimized enzyme preparation procedure used
in this work (Materials and Methods and Discussion).
Next, we used electrophoretic mobility shift assays to assess the
binding of Dna2 E675A to DNA. We saw that Dna2 E675A binds
rather indiscriminately (Kd ∼5 nM) to structures that contain
ssDNA. A 5′ ssDNA overhang was bound equally well as a 3′
ssDNA overhang, despite the fact that the former structure is an
excellent substrate for the Dna2 E675A helicase whereas the
latter is not (Fig. 1F and Fig. S3A). Similar results were obtained
in the presence of competitor DNA in the electrophoretic mo-
bility shift assays (Fig. S3B). These results show that Dna2
E675A is a vigorous DNA helicase with high afﬁnity for DNA.
RPA Stimulates Dna2 E675A to Unwind Long Stretches of DNA. Dna2
nuclease-deﬁcient variants were previously shown to be only ca-
pable of unwinding short, oligonucleotide-based DNA structures.
The fraction of unwound substrate decreased dramatically with the
length of the duplex DNA; the unwinding of a 91-bp duplex was
∼15-fold less efﬁcient than the unwinding of a 30-bp duplex (23).
Is has been proposed that Dna2 is a weak and nonprocessive DNA
helicase (23). We have decided to analyze unwinding of long-
length DNA with our preparation of Dna2 E675A. Surprisingly,
the enzyme could readily unwind plasmid-based 2.7-kbp dsDNA
containing a 3-nt-long 5′ ssDNA tail (Fig. 2A). Half of the DNA
substrate was unwound by only 200 pM Dna2 E675A, a concen-
tration similar to that required for the unwinding of oligonucleo-
tide-based DNA substrates (Fig. 1 C and E). However, unlike in
the case of the oligonucleotide-based substrates, the unwinding of
the 2.7-kbp dsDNA was absolutely dependent on RPA, as no
DNA unwinding was observed when RPA was omitted (Fig. 2A,
lane 12). E. coli SSB could not replace RPA (Fig. 2A, lane 13),
indicating that species-speciﬁc interaction between yeast Dna2 and
yeast RPA plays an essential role in promoting long-length DNA
unwinding by the Dna2 helicase.
Sgs1 is the most vigorous DNA helicase characterized to date in
eukaryotes (32). Given that it functions in DNA end resection to-
gether with Dna2 (9, 12, 13), we set out to compare the unwinding
capacities of Sgs1 andDna2E675A. Sgs1 helicase can initiateDNA
unwinding of blunt-ended, 3′− or 5′-tailed DNA with similar efﬁ-
ciency (32). To compare the relative activities of both enzymes, we
selected 5′-tailed DNA, which is required for unwinding by Dna2
E675A. Remarkably, we show that Sgs1 was only slightly (∼30%)
better in unwinding of the 2.7-kbp-long dsDNA than Dna2 E675A
(Fig. 2 A and B), and similar results were obtained in kinetic
experiments (Fig. 2C and Fig. S4). We thus conclude that Dna2
E675A is almost as vigorous a DNA helicase as Sgs1.
To further characterize the unwinding capacity of Dna2 E675A,
we tested its ability to unwind long stretches of dsDNA. We have
digested bacteriophage λ DNA with HindIII and 32P-labeled the
restriction fragments. This procedure created linear DNA mole-
cules of up to 23 kbp in length with 3-nt-long 5′ overhangs. Dna2
E675A could efﬁciently unwind DNA fragments of all lengths and
produced a pattern of ssDNA molecules that comigrated with the
heat-denatured substrate (Fig. 2 D and E). The reaction was re-
markably efﬁcient; 1.2 nM Dna2 E675A unwound ∼50% of the
DNA substrate, which was present at a concentration corre-
sponding to 2.4 nMDNA ends. Furthermore, the 23-kbp fragment
was unwound only ∼twofold less efﬁciently than the 2.0-kbp frag-
ment, showing that the length of duplex DNA only marginally
affects the unwinding efﬁciency in the presence of S. cerevisiae
RPA. Unlike E. coli SSB, human RPA could substitute cognate S.
cerevisiae RPA, and, as expected, the reaction was completely
dependent on ATP (Fig. S5). We conclude that S. cerevisiaeDna2
E675A is a very vigorous DNA helicase, capable of unwinding tens
of kilobases of dsDNA in length in a reaction dependent on RPA
and ATP.
Single Molecule Experiments Reveal High DNA Unwinding Processivity
of Dna2 E675A. To gain insight into the processivity and the rate of
DNA unwinding by Dna2 E675A, we carried out single-molecule
magnetic tweezers experiments (Fig. 3 A and B). As substrate we
used a 6.6-kbp-long dsDNA fragment that contained 0.6-kbp
dsDNA tails with multiple digoxigenin or biotin modiﬁcations at
either end to allow its binding to the surface of an anti-digox-
igenin–coated ﬂuidic cell and to streptavidin-coated magnetic
beads. The construct contained a 40-nt 5′-terminated ssDNA ﬂap
to allow the loading of Dna2. A pair of magnets above the ﬂuidic
cell was used to stretch single bead-tetheredDNA constructs, and
video microscopy was used to read out the DNA end-to-end
distance in real time (33).
When adding Dna2 E675A in the presence of RPA and ATP,
rapid DNA unwinding was observed that resulted in an apparent
increase in the DNA length (Fig. 3 B and C). This increase is due
to the larger extension of RPA-coated ssDNA in comparison
with dsDNA (34, 35). No signiﬁcant DNA lengthening (>100 bp)
Fig. 2. Dna2 E675A can unwind long lengths of dsDNA in the presence of
RPA. (A) Representative agarose gels (0.8%) showing the helicase activity of
Dna2 E675A or Sgs1 on a 32P-labeled 2.7-kbp-long dsDNA substrate with
a 3-nt 5′ ssDNA overhang (1 nM). The reactions were supplemented with S.
cerevisiae RPA (0.4 μM) except lane 12 (RPA omitted) and lane 13 (RPA
replaced with E. coli SSB). Heat, heat-denatured DNA substrate; *, position
of the 32P label. (B) Quantitation of the helicase assays as in A. Error bars, SE,
n = 3. (C) Kinetics of DNA unwinding of 5′-tailed 2.7-kbp-long dsDNA (1 nM)
by either Dna2 E675A (1 nM) or Sgs1 (1 nM) in the presence of RPA (0.4 μM).
Error bars, SE, n = 3. (D) λ phage DNA was digested with HindIII to produce
dsDNA fragments ranging from 125 bp to 23 kbp in length, and 32P-labeled
with Klenow fragment of DNA polymerase I. The resulting DNA fragments
had 5′ ssDNA tails of 3 nt in length at their ends. Various concentrations of
Dna2 E675A were incubated with the restricted DNA (2.4 nM of DNA ends)
in the presence of RPA (1.08 μM). Heat, heat-denatured substrate. The panel
shows a representative agarose gel (1%). (E) Quantitation of the helicase
assays such as shown in D. Error bars, SE, n = 3.
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was observed in the absence of either RPA, ATP, or the 5′-ter-
minated ﬂap (but in presence of Dna2), in agreement with our
previous data showing that RPA, ATP, and a 5′ ssDNA tail were
required for the unwinding of long lengths of DNA by the Dna2
helicase. As expected, no DNA lengthening was found when
RPA was added in the absence of the helicase at the applied
forces. The observed DNA lengthening is thus due to DNA un-
winding by Dna2 E675A.
Unwinding rates were found to be highly variable (Fig. 3 C and
D) as found also for other DNA translocases (36). Although some
events displayed a rather constant unwinding rate of up to 120
bp·s−1 over distances of several kbp, also much slower events
(down to 15 bp·s−1) were observed with similar frequency. The
average unwinding rate over 500 bp of DNA was found to be 38 ±
4 bp·s−1 (SE) at a force of 25 pN (Fig. 3D). Slow events often
displayed multiple unwinding rate changes or stalls, with periods of
fast DNA unwinding in between. However, rate changes and stalls
were characteristic of fast unwinding events as well (Fig. S6A).
Because we measured DNA unwinding under an external tension,
we also investigated how the unwinding process is inﬂuenced by
different forces. Because the unwinding rates were variable from
molecule to molecule, we applied different forces during a single
unwinding run of a molecule (Fig. S6B). The unwinding rate was
found to decrease ∼ﬁvefold when lowering the force from 30 to 10
pN. Nonetheless DNA unwinding of several kbp was found also at
the lower forces.
An average unwinding distance of 4.2 ± 0.5 kbp (SE, n = 25)
was obtained (Fig. 3C). Activity was terminated after unwinding
several kbp or the complete 6.1-kbp DNA substrate (F= 25 pN).
Partially also the loss of the magnetic bead was observed. DNA
unwinding activity commenced after highly variable lag times
ranging from 0 to 800 s with a mean of 85 ± 31 s (SE, n = 25)
(Fig. 3C). Variable lag times and the abrupt termination of
helicase reactions before unwinding of the full-length substrate,
suggested that, in most cases, the reaction was catalyzed by
a single Dna2 E675A complex. Thus, Dna2 E675A could be
a processive DNA helicase. To investigate processivity in further
detail, we repeatedly ﬂushed out Dna2 E675A (by adding buffer
containing ATP and RPA only) just after an unwinding event
had been initiated. Each ﬂush corresponded to ∼1.7 ﬂow cell
volumes. DNA unwinding was not affected by removing free
Dna2 E675A from the solution either during or after the ﬂush
(Fig. 3E). Adding Dna2 E675A back in after the unwinding
stopped did not initiate further unwinding. Our results strongly
suggest that a single enzyme complex drives the observed long-
range DNA unwinding. In summary, these measurements show
that Dna2 E675A is a highly processive helicase capable of un-
winding kbp-sized DNA fragments in a single run.
Dna2 E675A Possesses Vigorous DNA-Dependent Atpase Activity That
Is Stimulated by RPA. The unexpected DNA helicase activity of
Dna2 E675A prompted us to characterize its capacity to hydrolyze
ATP. To this point, we used a spectrophotometric assay, which
measures ATPase activity based on a reaction coupled to the
oxidation of NADH (37, 38). To obtain kinetic parameters for
ATP hydrolysis, we ﬁrst varied ATP concentration in the presence
of Y-structure DNA as a cofactor (Fig. S7). The curve showing
the dependence of the ATPase activity on ATP concentration was
hyperbolic, and a ﬁt to the Michaelis–Menten equation yielded
Vmax = 21 ± 2 μM·min−1 and Km = 130 ± 24 μM. The ATPase
was stimulated by RPA, with Vmax = 24 ± 2 μM·min−1 and Km =
56 ± 10 μM (Fig. S7). Next, we used poly(dT) as cofactor, which is
ssDNA devoid of secondary structure, and varied its concentra-
tion (Fig. 4A). The ﬁt to the data yielded Vmax = 9.6 ± 1 μM·min−1
and Km = 164 ± 44 nM. Supplementing the reactions with RPA
promoted the rate of ATP hydrolysis and resulted in Vmax = 22 ±
2 μM·min−1 and Km = 181 ± 33 nM.
Next, we compared the ATPase activity in the presence of
various DNA cofactors. The greatest ATPase activity was ob-
served in the presence of 5′-tailed DNA (Fig. 4B). The apparent
kcat, which is the apparent ATP turnover number, was ∼85 s−1,
which is comparable with the kcat of Sgs1 ∼82 s−1 on the same
DNA structure (32). Nearly as effective was the Y-structure
dsDNA, with kcat ∼79 s−1. Other DNA substrates were substantially
Fig. 3. Single molecule experiments reveal highly processive DNA unwinding by Dna2 E675A. (A) Sketch of the DNA construct and (B) the magnetic tweezers
assay. (C) Representative DNA unwinding events by Dna2 E675A (F = 25 ± 2 pN, SD). DNA lengthening was observed only after addition of the enzyme, RPA,
and ATP in the reaction buffer (gray box). (D) Histogram of rates for unwinding 500 bp of DNA (F = 25 ± 2 pN, SD). Unwinding trajectories (n = 14) were split
into successive 500-bp segments, and the mean unwinding rate was determined from the slope of a linear ﬁt to each segment. The mean unwinding rate was
38 ± 4 bp·s−1 (SE). (E) Removal of free Dna2 E675A from solution during a DNA unwinding reaction. The reaction was initiated by adding the enzyme in the
presence of RPA and ATP (left gray box). After several hundred unwound bps, ∼50 μl of ATP and RPA in reaction buffer were ﬂushed through the ﬂuidic cell
(cell volume 30 μl) (blue boxes). The procedure was repeated four times during one unwinding event.
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less effective; ssDNA stimulated about 2.6-fold less than 5′-tailed
DNA, and 3′-tailedDNAand dsDNA stimulated 3.5- or 6.1-fold less
efﬁciently, respectively (Fig. 4B). The capacity of theDNAstructures
to promote ATP hydrolysis by Dna2 E675A corresponded to the
unwinding preference. The 5′-tailed and Y-structure DNA sub-
strates were the preferred substrates for DNA unwinding by Dna2
E675A (Fig. 1E), and they were also the most efﬁcient in stimulating
its ATPase activity (Fig. 4B). Almost no ATPase activity was ob-
served in the absence ofDNA, showing that the ATPase activity of
Dna2 E675A is DNA-dependent (Fig. 4B). As expected, the
ATPase-deﬁcient Dna2 K1080E variant showed no ATPase ac-
tivity (Fig. 4B). In summary, these parameters establish that
Dna2 E675A is a strong ATPase that has a high afﬁnity for both
ATP and DNA.
Nuclease Activity Within Dna2 Limits Its Unwinding Capacity. Having
established that Dna2 E675A variant lacking the nuclease activity
is a vigorous DNA helicase, we next wanted to study the interplay
of the nuclease with the helicase within the wild-type protein. The
nuclease of Dna2 is ssDNA-speciﬁc but may act on dsDNA upon
spontaneous denaturation/melting of dsDNA ends (39). We show
in Fig. 5A that, whereas 1 nM Dna2 E675A was sufﬁcient to
completely unwind a 2.7-kbp dsDNA substrate (lane 2), the same
concentration of wild-type Dna2 had no detectable activity (lane
3). When we used 10- to 50-fold higher wild-type Dna2 concen-
tration (10 and 50 nM), only limited DNA degradation was ob-
served, as indicated by the release of the radioactive label (Fig. 5A,
lanes 4 and 5), or mobility shift of unlabeled DNA stained with
ethidium bromide (Fig. 5B). DNA degradation by wild-type Dna2
was largely restricted to the vicinity of the DNA ends (compare
panels A and B in Fig. 5). Thus, wild-type Dna2 apparently lacked
the vigorous helicase activity observed in the nuclease-deadE675A
variant. This observation suggests either that the helicase/ATPase
domain of the wild-type protein is compromised, or that the nu-
clease of Dna2 inhibits its own helicase activity. To differentiate
between these two possibilities, we compared the initial rates of
ATP hydrolysis between thewild-type and the nuclease-deadDna2
E675A proteins. We show that both polypeptides display similar
levels of ATPase activity (Fig. 5C), indicating that the ATPase/
helicase domain in the wild-type protein is active and therefore
likely properly folded. This result suggested that the nuclease of
wild-type Dna2 limits the engagement of its helicase. We next set
out to study this phenomenon in more detail.
Because the nuclease activity of Dna2 preferentially degrades
5′ ssDNA overhangs, and these overhangs are required for DNA
unwinding by theDna2 E675A variant (Fig. 1E), we asked whether
the nuclease of wild-type Dna2 might cleave the 5′ ssDNA tails
before they can be accessed by the helicase. This activity could
explain the apparent lack of DNA unwinding activity of wild-type
Dna2. To this point, we set out to compare enzyme concentrations
required for the unwinding and/or the nucleolytic degradation of
oligonucleotide-based DNA substrates. Speciﬁcally, we compared
the nuclease activity of Dna2 wild type and Dna2 K1080E with the
helicase activity of Dna2 E675A. All these enzyme variants were
prepared using an identical procedure, and we noted that in-
dependent preparations of the same enzyme variant led to con-
sistent levels of speciﬁc activity (Materials and Methods). We
observed that, ﬁrst, the nuclease activities of both wild-type and
helicase-dead K1080E enzymes were indistinguishable based on
substrate utilization (Fig. 5D). The lack of the helicase activity
therefore did not affect the initial 5′ end cleavage byDna2. Second,
the nuclease activity was ∼sixfold more frequent than the helicase
activity based on substrate utilization: although 50 pM wild-type
and helicase-dead K1080E Dna2 cleaved ∼50% of the 5′ tails
within 30 min, as much as 300 pM of nuclease-dead Dna2 E675A
was required to unwind 50%of theDNAsubstrate during the same
time period (Fig. 5D). These results show that the wild-type protein
Fig. 4. Dna2 E675A shows DNA-dependent ATPase activity that is stimu-
lated by RPA. (A) Rate of ATP hydrolysis and its dependence on the DNA
concentration. The reactions contained Dna2 E675A (4 nM), ATP (1 mM), RPA
where indicated (150 nM), and the indicated concentrations of poly(dT). (B)
Apparent ATP turnover number and its dependence on various DNA struc-
tures (1 μM nucleotides). The reactions contained Dna2 E675A (3 nM) and
ATP (1 mM). Error bars, SE, n = 2.
Fig. 5. The nuclease activity of Dna2 interferes with its helicase activity. (A)
A representative experiment comparing the activities of wild-type Dna2 and
nuclease-dead E675A variant on 5′-tailed 2.7-kbp dsDNA substrate 32P-la-
beled at the 3′ end (1 nM). Reactions were incubated in the presence of
S. cerevisiae RPA (0.4 μM). *, position of the 32P label. Heat, heat-denatured
substrate. (B) A representative experiment comparing the activities of wild-
type Dna2 and nuclease-dead E675A variant on 5′-tailed 2.7-kbp dsDNA
substrate (3.8 nM). Reactions were incubated for 30 min in the presence of
S. cerevisiae RPA (1.68 μM). A 1% agarose gel was stained with ethidium
bromide. Heat, heat-denatured substrate. (C) Comparison of apparent ATP
turnover numbers of Dna2 wild-type and Dna2 E675A variant. The reactions
contained the indicated DNA structures (1 μM nucleotides), Dna2 wild type
or E675A (3 nM) and ATP (1 mM). Error bars, SE, n = 2. (D) Comparison of
nuclease and/or helicase activities of Dna2 wild-type, K1080E, and E675A
variants, respectively, based on substrate utilization. All assays contained
RPA (22.5 nM). Error bars, SE, n = 2. (E) Dependence of Dna2 activities on the
length of the 5′ ssDNA overhang. Dna2 concentrations required for 50% of
maximal DNA cleavage (by Dna2 wild type or Dna2 K1080E) or 50% of
maximal DNA unwinding (by Dna2 E675A) were plotted against the length
of the 5′ ssDNA overhang. The data were obtained by analysis of the results
such as from Fig. S8.
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is more likely to degrade a 5′ ssDNA tail, rather than to use it to
initiate DNA unwinding.
We next wondered whether varying the length of the 5′ ssDNA
tail might differentially affect the nuclease or the helicase activ-
ities of Dna2. To this point, we analyzed wild-type Dna2, E675A,
and K1080E variants on duplex DNA substrates containing 5′
ssDNA tails of 0- to 30-nt in length. Both nuclease and helicase
activities preferred longer ssDNA tails (Fig. S8 A–C). However,
irrespectively of the length of the ssDNA tail, ∼four- to sixfold
higher enzyme concentration was required for DNA unwinding
by Dna2 E675A than for the nucleolytic cleavage by either wild
type or Dna2 K1080E (Fig. 5E). The nuclease activity was thus
clearly dominant in the wild-type protein. In summary, our data
show that the nuclease of Dna2 limits its unwinding capacity.
Nuclease Activity of Wild-Type Dna2 Interferes with Its Stable Binding
to DNA. Nuclease-dead Dna2 E675A efﬁciently binds 5′-tailed
DNA (Kd ∼5 nM) and binds dsDNA with ∼eightfold lower ef-
ﬁciency (Kd ∼40 nM, Fig. 6 A and C; see also Fig. 1F). In con-
trast, wild-type Dna2 rapidly cleaves the 5′ tail and binds the
resulting structure with afﬁnity comparable with dsDNA (Kd ∼40
nM, Fig. 6 B and C), showing that the nuclease activity interferes
with DNA binding. We have also used ssDNA blocked with
biotin-bound streptavidin on both ends as a substrate for elec-
trophoretic mobility shift assays. Blocked ends are known to
inhibit both the ssDNA-speciﬁc nuclease as well as the helicase
activity of Dna2 (21, 22). Using this uncleavable DNA, we show
that both wild-type Dna2 and the E675A variant bound this
structure with similar afﬁnity (Kd ∼8 nM), indicating that wild-
type Dna2 is capable of strong DNA binding (Fig. 6 D–F).
Finally, we observed that, whereas the rate of ATP hydrolysis
by Dna2 E675A was relatively constant in the presence of 5′-
tailed DNA as a cofactor, it rapidly decreased in case of wild-
type Dna2 (Fig. 6G). In agreement with the data presented in
Fig. 6 A–C, we believe that the nuclease activity of the wild-type
protein rapidly degrades the ssDNA tail during the course of the
reaction, producing duplex or nearly duplex DNA structures that
no longer stimulate its ATPase activity (Fig. 6H).
Taken together, these data explain why the nuclease activity of
Dna2 strongly inhibits its unwinding capacity. We show that the
nuclease degrades 5′ ssDNA tails, which in turn inhibits DNA
binding and thus the unwinding capacity of Dna2. Previously, it
was believed that the nuclease of Dna2 obscures the detection
of the products of its limited unwinding activity (22). The data
presented here suggest a different scenario, in which the nuclease
Fig. 6. The nuclease activity of Dna2 inhibits its binding to DNA. (A) Electrophoretic mobility shift assays were performed with a range of Dna2 E675A
concentrations and 32P-labeled 30-nt-long 5′-tailed DNA or fully dsDNA (both 1 nM). The panel shows representative 6% polyacrylamide gels. *, position of
the 32P label. (B) Electrophoretic mobility shift assay as in A, but with wild-type Dna2. (C) Quantitation of DNA binding assays such as from A and B. Error bars,
SE, n = 2. (D) Electrophoretic mobility shift assays were performed with a range of Dna2 E675A concentrations and 32P-labeled 70-nt-long ssDNA substrate
(1 nM). The DNA substrate contained biotin near both of its ends, which was bound to streptavidin where indicated. Shown is a representative 6% poly-
acrylamide gel. *, position of the 32P label; S, position of biotin-bound streptavidin. (E) Electrophoretic mobility shift assay as in D, but with wild-type Dna2. (F)
Quantitation of the assays such as from D and E. Error bars, SE, n = 2. (G) Kinetics of ATP hydrolysis by wild-type Dna2 and Dna2 E675A (both 4 nM). The
reactions contained 30-nt-long 5′ overhang substrate (1 μM nucleotides). Error bars, SE, n = 2. (H) Model explaining the kinetics of ATP hydrolysis by wild-type
Dna2 on a 5′-tailed substrate. Initially, the overhang substrate stimulates the ATPase activity of wild-type Dna2. The nuclease activity then degrades the ssDNA
tail, which results in a substrate that no longer efﬁciently stimulates the ATPase activity.
Levikova et al. PNAS | Published online May 13, 2013 | E1997
BI
O
CH
EM
IS
TR
Y
PN
A
S
PL
US
	  
	  37	  
	   RESULTS	   	  	   	  
activity prevents the helicase activity from engaging its respective
substrate.
Helicase Activity of Wild-Type Dna2 Promotes Its Capacity to Degrade
dsDNA. Up to this point, we demonstrated that the nuclease of
wild-type Dna2 inhibits its unwinding capacity. By cleaving
ssDNA tails that serve as entry points for the helicase, the nu-
clease impedes DNA binding and thus the initiation of dsDNA
unwinding. In subsequent experiments, we set out to ﬁnd con-
ditions to detect the unwinding capacity of the wild-type enzyme.
Using 5′-tailed dsDNA substrate 32P-labeled at the ssDNA tail,
the activity of wild-type Dna2 was indistinguishable from that of
the helicase-dead K1080E variant. The helicase activity did not
stimulate cleavage of the 5′-terminated ssDNA tail, and we could
detect no DNA unwinding intermediates (Fig. S9 A and B). Sim-
ilarly to experiments presented in Fig. 5 D and E, the helicase
activity thus had no apparent effect on the behavior of Dna2. We
reasoned that Dna2 binds and translocates on the tailed oligonu-
cleotide, which gets then preferentially cleaved, and this cleavage
may limit the detection of DNA unwinding intermediates. We next
labeled the bottom oligonucleotide that does not contain the
overhang (see diagram at the top of Fig. 7A), and analyzed the
activity of wild-type, helicase-dead K1080E, and nuclease-dead
Dna2 E675A variants. The nuclease of both wild type and K1080E
degraded the 5′-terminated DNA overhang, resulting in species
that comigrated with the tail-less dsDNA marker (Fig. 7 A and B).
Importantly, we could also clearly detect ssDNA in reactions with
wild-type Dna2 (Fig. 7A, lanes 3–6). In contrast, ssDNA was nearly
undetectable in reactions with the helicase-dead K1080E variant;
the minimal amount of ssDNA we observed was likely the result
of the nuclease acting on the top strand upon spontaneous
thermal melting of the DNA substrate in the presence of RPA
(Fig. 7B). The ssDNA was apparent at wild-type Dna2 concen-
trations as low as 16–32 pM (Fig. 7A), which was also the min-
imal protein concentration required to detect DNA unwinding
by the nuclease-dead Dna2 E675A variant (Fig. 7C). These
results, together with the ATPase assays (Fig. 5C), indicate that
wild-type Dna2 likely possesses the same level of helicase activity
as the nuclease dead Dna2 E675A variant.
The experiments in Fig. 7 A and B also showed that the
helicase activity of Dna2 promotes degradation of dsDNA. The
degradation of DNA by the helicase-deﬁcient Dna2 K1080E
variant was mostly limited to the 5′-terminated ssDNA over-
hang, as the species comigrating with tail-less DNA was the
dominant product across a wide range of enzyme concen-
trations (Fig. 7B). In contrast, wild-type Dna2 could more ef-
ﬁciently enter and degrade dsDNA as well, as witnessed by the
appearance of small-molecular-weight DNA species, denoted
as degraded DNA (Fig. 7A).
To further investigate the role of the Dna2 helicase in deg-
radation of dsDNA, we carried out additional experiments with
a 5′-tailed substrate that was 3′-labeled at the dsDNA end (see
diagram at the top of Fig. 8A). As above, the helicase activity of
wild-type Dna2 promoted degradation of dsDNA (Fig. 8 A and
B). We show that dsDNA degradation requires the presence of
the 5′-terminated ssDNA tail, as tail-less dsDNA was not cleaved
at similar enzyme concentrations (Fig. S10A). Furthermore, the
dsDNA degradation was dependent on RPA, as no signiﬁcant 3′
end cleavage product was observed in the absence of RPA, with
both wild-type Dna2 or the helicase-dead K1080E variant (Fig.
S10B). RPA therefore stimulates the degradation of dsDNA by
both wild-type and helicase-dead Dna2 K1080E, probably by
melting the dsDNA ends. The dsDNA degradative capacity is then
further enhanced by the helicase activity of Dna2 (Fig. 8 A and B).
Finally, we investigated the degradation of plasmid-sized tailed
DNA on agarose gels stained with ethidium bromide. Limited
degradation of DNA near its ends resulted in change of mobility
(Fig. 8C). In the absence of ATP, a condition favored by the Dna2
nuclease (4), both wild-type and helicase-dead Dna2 K1080E
variant degraded DNA to a similar extent. Upon supplementing
the reaction with ATP, which lowered the free magnesium con-
centration required by the nuclease and activated the helicase,
DNA degradation by the wild-type enzyme was promoted whereas
DNA degradation by the K1080E variant was inhibited. Thus, in
the presence of ATP, the helicase of Dna2 clearly promotes deg-
radation of dsDNA. The extent of DNA degradation is, however,
limited in comparison with the extent of DNA unwound by the
equivalent concentration of the nuclease-dead Dna2 E675A mu-
tant (Fig. 5 A and B).
In summary, our data reveal an unusual interplay of the nu-
clease and helicase activities of Dna2. The nuclease activity
strongly reduces the ability of Dna2 to unwind DNA. However,
the inhibition of the DNA unwinding capacity is not total, and we
show that the helicase activity may promote nucleolytic degra-
dation of dsDNA. The ssDNA-speciﬁc nuclease activity thus
controls the unwinding capacity and the ability of the enzyme to
process and degrade dsDNA.We propose that modulation of the
interplay between the nuclease and helicase activities in vivo
might represent a regulatory mechanism for Dna2 to ﬁne-tune its
behavior to carry out speciﬁc cellular functions. Conditions that
promote the nuclease activity would result in Dna2 degradation
limited to ssDNA tails whereas inhibition of the nuclease ac-
tivity would allow the enzyme to process also dsDNA (Fig. 9 and
Discussion).
Discussion
The Dna2 nuclease-helicase functions in multiple fundamental
cellular processes ranging from lagging-strand DNA synthesis,
Fig. 7. Wild-type Dna2 possesses DNA helicase activity. (A) Processing of 5′-tailed DNA by wild-type Dna2. The bottom oligonucleotide was 32P-labeled at the 5′ end.
The reactions contained RPA (22.5 nM). Heat, heat-denatured DNA substrate. *, position of the 32P label. The panel shows a representative 10% polyacrylamide gel.
(B) Experiment as in panel A, but with helicase-dead Dna2 K1080E variant. (C) Experiment as in panel A, but with nuclease-dead Dna2 E675A variant.
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replication fork stability, and dsDNA break repair, to the repair
of damaged DNA (6, 18, 29, 39). Recombinant Dna2 possesses
a potent nuclease activity that appears to be essential for all
Dna2 functions, but the 5′–3′ DNA helicase activity of the en-
zyme was described as weak. The observed limited unwinding
capacity led to the speculation that the motor function of Dna2
might act as an ssDNA translocase that removes secondary
structures from ssDNA rather than to unwind dsDNA (23). We
noticed that recombinant Dna2 was very unstable and sensitive
to the omission of reducing agents during puriﬁcation. Because
Dna2 was recently shown to contain an iron–sulfur cluster (30, 31),
we speculated that it might be prone to inactivation by oxidation.
Indeed, our current puriﬁcation protocol yielded a highly
active enzyme with strong nuclease and helicase activities.
Unexpectedly, biochemical characterization of the wild-type,
nuclease-dead, and helicase-dead enzyme variants generated in
the course of this study revealed that Dna2 possesses a vigorous
but cryptic helicase activity. Mutational inactivation of the Dna2
nuclease unleashes this helicase activity. Nuclease-dead Dna2
E675A variant is capable of catalytic unwinding of oligonucleo-
tide-based DNA substrates at subnanomolar enzyme concen-
trations (Fig. 1). Furthermore, it shows functional interaction
with RPA, which allows it to unwind tens of kilobases of dsDNA
in length at low nanomolar enzyme concentrations (Fig. 2). The
helicase and ATPase activities of Dna2 E675A compare favor-
ably with the RecQ family Sgs1 helicase (Figs. 2 and 4), which is
possibly the most vigorous eukaryotic helicase characterized to
date (32). Single molecule experiments revealed that DNA un-
winding by Dna2 E675A is highly processive (Fig. 3).
The Dna2 nuclease inhibits this vigorous unwinding capacity;
although the ATPase activity of wild-type Dna2 is comparable with
that of the nuclease-dead Dna2 E675A variant, the former protein
is inefﬁcient in dsDNA unwinding (Fig. 5). The Dna2 helicase
requires a free 5′ terminus to load onto to initiate DNA un-
winding. We show that the nuclease activity of wild-type Dna2 is
more likely to degrade such structures rather than use them for
DNA unwinding (Figs. 5 and 6). Dna2 thus represents a remark-
able example of an enzyme in which one biochemical property
(nuclease) negatively regulates the other (helicase) by competing
for the same substrate (5′-tailed DNA).
The nuclease-mediated inhibition of the unwinding capacity
was not total, and we were able to observe a fraction of un-
wound DNA in reactions with wild-type Dna2 as well (Fig. 7).
As a result, the helicase activity of wild-type Dna2 promoted the
degradation of dsDNA to a limited extent (Figs. 7 and 8). We
therefore speculate that modulation of the nuclease activity
might regulate the global activity of Dna2. In this scenario,
moderate inhibition of the nuclease activity might promote
dsDNA unwinding and, consequently, also degradation of dsDNA.
Conversely, stimulation of the nuclease would inhibit the helicase,
which would restrict the nucleolytic activity of the enzyme to
ssDNA (Fig. 9). The regulatory mechanism proposed here might
therefore restrict the unwinding capacity only to situations when it
is required. It is of interest that overexpression of nuclease-dead
Dna2 proteins had a dominant negative effect in dna2-1 mutants
with impaired both helicase and nuclease functions of Dna2 under
certain growth conditions (20). Similarly, overexpression of
nuclease-dead human DNA2 was more detrimental than over-
expression of both nuclease and helicase-dead construct (40). This
result, together with our data showing that the nuclease activity
limits the helicase function, implies that hyperactive and un-
regulated Dna2 helicase is toxic, and highlights the importance
of restricting the helicase activity of Dna2 in vivo.
How could the activity of Dna2 be regulated in vivo? Ob-
vious candidates for potential regulators are interactors and/
or posttranslational modiﬁcations. During DNA replication,
Dna2 forms a complex with Rad27 whereas, during dsDNA
break repair, it interacts with Sgs1 (5, 12). It is thus possible that
these two proteins affect the balance between the helicase and
nuclease activities. Furthermore, the activity of human DNA2 was
found to be stimulated by acetylation (41). The effect of acetyla-
tion on the relative activities of the helicase and nuclease functions
is unknown. Similarly, Dna2 is also phosphorylated in vivo, which
regulates its recruitment to DNA and controls its function on
stalled replication forks (18, 42). It will be of interest to investigate
how these modiﬁcations affect the biochemical behavior of Dna2.
The Dna2 polypeptide contains a large (∼405-amino acid)
N-terminal domain, which mediates the interaction with RPA,
but which was also found to interact with a region of Dna2
located between the helicase and nuclease domains (43). Based
on this intramolecular interaction, it has been proposed that
the N-terminal domain might have a regulatory role, in that its
Fig. 8. The helicase activity of wild-type Dna2 moderately promotes its
capacity to degrade dsDNA. (A) A representative polyacrylamide gel (10%)
showing the activity of wild-type Dna2 and K1080E variant on 3′-labeled 5′-
ssDNA tailed substrate (1 nM). *, position of the 32P label. All reactions
contained RPA (22.5 nM). (B) Quantitation of data such as from panel A.
Error bars, SE, n = 2. (C). Degradation of 2.7-kbp dsDNA with 4-nt-long 5′
ssDNA overhangs by wild-type Dna2 and helicase dead Dna2 K1080E variant
in the presence of various ATP concentrations, as indicated. The reactions
contained 3.8 nM DNA and were supplemented with RPA (1.68 μM). The
reaction products were separated on 1% agarose gel and stained with
ethidium bromide. Panel shows a representative experiment.
Fig. 9. Model of the interplay of helicase and nuclease activities of Dna2. In
the presence of vigorous nuclease activity, the helicase capacity is inhibited
and the DNA degradation is limited to ssDNA (Left). Moderate inhibition of
the nuclease activity might allow the enzyme to degrade dsDNA (Center).
Complete inactivation of nuclease activity, such as in nuclease-dead Dna2
E675A variant, turns the enzyme into a vigorous DNA helicase (Right). See
text for details.
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position might affect the biochemical activities of Dna2 (43).
Finally, it is also possible that the interplay between the
nuclease and helicase activities of Dna2 might be controlled via
the redox states of its iron–sulfur cluster (30, 31).
Dna2 physically and functionally interacts with the Sgs1 helicase
in DNA end resection to initiate homologous recombination (12).
The Sgs1–Dna2 heterodimer is functionally similar to the re-
section machinery of E. coli, the RecBCD factor. Both complexes
possess two helicases and a single nuclease activity, and bothmust
load on free DNA ends, yet degrade DNA endonucleolytically
(12). Similarly, the Sgs1–Dna2 complex could be a bipolar heli-
case, with each subunit translocating on opposite strands but in
the same overall direction (12). The unwinding capacity of the
heterodimer cannot be inhibited by 5′ cleavage, as Sgs1 is likely
the lead helicase that translocates with a 3′ to 5′ polarity. A vig-
orous motor activity of Dna2 would be important here, as only
rapidly moving Dna2 could “keep up” with the Sgs1 helicase. We
also point out that the motor activity of Dna2 was reported dis-
pensable for DNA end resection in an earlier study (9). In com-
plementation experiments, the expression of wild-type and Dna2
variants was driven from a plasmid in the latter work, and higher
than physiological Dna2 levels may have masked the involvement
of the Dna2 helicase. Nevertheless, the role of the Dna2 helicase
in DNA end resection remains unclear and deserves further
attention.
In RecBCD, both RecB and RecD motors precede the RecB
nuclease domain to feed ssDNA into the RecB nuclease site in
a highly coordinated manner (44). The RecC subunit, however,
contains a defunct nuclease domain, which is interestingly situ-
ated ahead of the RecD motor (44–46). Our biochemical data
presented here might imply that the Dna2 nuclease is similarly
placed ahead of the Dna2 helicase although detailed structural
analysis will be required to test this hypothesis. In Bacillus
subtilis, the processing of dsDNA ends is catalyzed by the
AddAB complex, which in contrast contains one helicase motor
and two nuclease domains (47). The AddB subunit is however
clearly related to Dna2, and both proteins contain an iron–sulfur
cluster (30, 31). Data presented here together with previous
work (12, 47, 48) demonstrate that the interplay of helicase and
nuclease activities regulates dsDNA end processing in eukar-
yotes as well.
Materials and Methods
DNA Substrates. The oligonucleotides used for the preparation of the Y-
structure, dsDNA, ssDNA, 19-nt 5′-tailed and 19-nt 3′-tailed ssDNA substrates
have been described previously (32). The oligonucleotide used to prepare
the 30-nt 5′-tailed ssDNA substrate was PC 92, GGTACTCAAGTGACGTCA-
TAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATCGC. The oligonu-
cletides were 32P-labeled either at the 5′terminus with [γ-32P]ATP and T4
polynucletide kinase (New England Biolabs), or at the 3′ end with [α-32P]
cordycepin-5′-triphosphate and terminal transferase (New England Biolabs)
according to the manufacturer’s instructions. Unincorporated nucleotides
were removed using MicroSpin G25 columns (GE Healthcare). pUC19 dsDNA
and bacteriophage λ dsDNA were digested with HindIII and puriﬁed by
phenol-chloroform extraction and ethanol precipitation. The linearized
dsDNA was then 3′-labeled with [α-32P]dATP and Klenow fragment of DNA
polymerase I (New England Biolabs). Unincorporated nucleotides were re-
moved using MicroSpin G25 columns (GE Healthcare). Streptavidin-blocked
oligonucleotide was prepared by incubating streptavidin (15 nM) with the
DNA substrate in reaction buffer for 15 min before addition of other
recombinant proteins and initiation of the reaction.
Recombinant Proteins. Sgs1 and RPA proteins were expressed and puriﬁed as
described (32, 49). SSB was a gift from S. Kowalczykowski (University of
California, Davis) and human RPA from Stephanie Bregenhorn (University of
Zurich). Wild-type Dna2 as well as Dna2 E675A and K1080E variants were
expressed from a modiﬁed pGAL:DNA2 (20) vector that contained amino
(N)-terminal Flag and HA tags and a C-terminal His6 tag, in the S. cerevisiae
strain WDH668 (50). Yeast cells (4L) were grown to approximately OD ∼0.6 in
a standard synthetic medium, lacking uracil, and supplemented with glycerol
(3% vol/vol) and lactic acid (2% vol/vol) as carbon sources. Expression of
Dna2 was induced with galactose, the cells were lysed, and Dna2 was bound
to Ni2+-NTA agarose (Qiagen) as described previously (12). Dna2 was eluted
with 250 mM imidazole. The fractions containing proteins were pooled,
diluted 1:8 with de-gassed dilution buffer (25 mM Tris·HCl (pH 7.5), 150 mM
NaCl, 10% (vol/vol) glycerol, 0.5 mM β-mercaptoethanol, 10 μg·ml−1 leu-
peptin, 1 mM phenylmethylsulphonyl ﬂuoride and protease-inhibitor mix-
ture (Sigma, P8340, diluted 1:1,000)) and incubated batch-wise with M2 anti-
FLAG afﬁnity resin (0.5 mL; Sigma) for 45 min. The resin was then washed
with degassed wash buffer (25 mM Tris·HCl (pH 7.5), 150 mM NaCl, 10% (vol/vol)
glycerol, 1 mM β-mercaptoethanol), and Dna2 was eluted with wash buffer
supplemented with 4xFLAG Peptide (200 μg·ml−1; Sigma). Fractions containing
protein were pooled, and small aliquots were frozen in liquid nitrogen and
stored at −80 °C. The ﬁnal protein concentration was estimated by densi-
tometry by comparison with dilution series of broad range protein marker
(BioRad) on 10% (wt/vol) polyacrylamide gel stained with Coomassie blue. The
protein yields were ∼150–250 μg and concentration ∼100–400 nM for Dna2
wild-type, K1080E, and E675A variants. The speciﬁc activities of independent
enzyme preparations varied by about ±15% with respect to a mean value.
Helicase and Nuclease Assays. The experiments were performed in a 15-μl
volume in 25 mM Tris-acetate (pH 7.5), 2 mMmagnesium acetate, 1 mM ATP,
1 mM DTT, 0.1 mg/mL BSA (New England Biolabs), 1 mM phosphoenolpyr-
uvate, 16 U/mL pyruvate kinase, DNA substrate, and recombinant proteins,
as indicated. Unless indicated otherwise, the reactions were incubated for
30 min at 30 °C and carried out and analyzed as described previously (32).
We noted that recombinant Dna2 was unusually sensitive to protein di-
lution, and supplementing the reactions with BSA was often required to
observe enzymatic activity.
Magnetic Tweezers Assay. The DNA construct was prepared by digesting
plasmid pNLrep with BamHI, BsrGI, and Nt.BbvCI, ﬁlling part of the the gap
created by the nicking enzymewith an DNA oligomer (oliomer sequence: 5′-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCAGCTAGCCTCAGCCTACAAT-
CACC) and ligating the biotin (BsrGI digested) and digoxigenin-modiﬁed
(BamHI digested) tails as described (53, 52). Magnetic tweezers experiments
were carried out as described before (33). Helicase experiments were done
at room temperature using the same buffer as the bulk helicase assays (but
lacking the ATP recycling system) using 1 nM Dna2 E675A and 22 nM RPA.
RPA itself at this concentration was found to slowly unwind dsDNA (4 bp·s−1)
by polymerizing on ssDNA at forces of 35 pN. Experiments were therefore
always performed at lower forces where this behavior was not observed. To
convert DNA length changes during unwinding at a given force into a cor-
responding number of unwound bp, force-extension measurements on the
bare DNA construct and on the unwound RPA-coated construct were used.
ATPase and Electrophoretic Mobility Shift Assays. These experiments were
performed as described previously (32, 37, 38).
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Fig. S1. (A) A schematic representation of the nuclease-helicase Dna2 puriﬁcation process. SeeMaterials and Methods for details. (B) Puriﬁcation of wild-type
Dna2 and its variants. Panels show representative 10% SDS/PAGE gels stained with Coomassie Brilliant Blue.
Fig. S2. Representative polyacrylamide gels (10%) showing DNA helicase activity of Dna2 E675A on various 32P-labeled DNA substrates (1 nM), as indicated.
The length of the ssDNA tails was 19 nt. Reactions were supplemented with Saccharomyces cerevisiae replication protein A [RPA, 22 nM, except lane 9 (RPA
omitted) and lane 10 (RPA replaced with Esherichia coli single-strand DNA binding protein). The second image (Y-structure) is identical to the top image from
Fig. 1C.
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Fig. S3. (A) Electrophoretic mobility shift assays were performed with a range of Dna2 E675A concentrations with various DNA substrates (1 nM), as indicated.
Shown are representative 6% polyacrylamide gels. *, position of the 32P label. (B) Quantitation of electrophoretic mobility shift assays carried out in the
presence of a dsDNA competitor (50 ng pUC19 dsDNA). The reactions were performed with a range of Dna2 E675A concentrations with various DNA substrates
(1 nM), as indicated, and analyzed on 6% polyacrylamide gels. *, position of the 32P label. Data represent the average of at least two independent experiments.
Error bars, SE.
Fig. S4. A representative experiment showing the kinetics of unwinding of 5′-tailed 2.7-kbp-long dsDNA (1 nM) by either Dna2 E675A (1 nM) or Sgs1 (1 nM) in
the presence of RPA (0.4 μM).
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Fig. S5. Unwinding of long lengths of dsDNA by Dna2 E675A. λ phage DNA was digested with HindIII to produce dsDNA fragments ranging from 125 bp to 23
kbp in length, and 32P-labeled with Klenow fragment of DNA polymerase I. The resulting DNA fragments had 5′ ssDNA tails of 3 nt in length at their ends. The
15 nM Dna2 E675A was incubated with the restricted DNA (2.4 nM of DNA ends) in the absence or presence of yeast RPA (1.08 μM) or human RPA (hRNA) (1.08
μM), where indicated. ATP was omitted from the reaction in lane 5. Heat, heat-denatured substrate. Sizes of dsDNA substrates are indicated on the left. The
panel shows a representative agarose gel (1%).
Fig. S6. Single molecule analysis of DNA unwinding by Dna2 E675A. (A) Magniﬁed views of stalling events in the black and light green trajectories from Fig.
3C. (B) DNA unwinding by Dna2 E675A at various forces, as indicated by the legend. Two different DNA molecules (left and right traces at the given color) are
shown. For each molecule, different forces were applied during a single unwinding run to ensure that the same helicase molecule was studied. Mean un-
winding rates were 6 ± 2, 11 ± 4, and 30 ± 9 bp·s−1 (SE) at 10, 20, and 30 pN of applied force, respectively.
Fig. S7. Rate of ATP hydrolysis and its dependence on ATP concentration. The reactions contained Dna2 E675A (3 nM), Y-structure DNA substrate (1 μM
nucleotides), RPA where indicated (22.5 nM), and varying concentrations of ATP. The kinetic parameters for ATP hydrolysis were obtained by ﬁtting the data
into a Michaelis–Menten equation.
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Fig. S8. Comparison of nuclease and/or helicase activities of Dna2 wild-type, K1080E, and E675A variants. (A) Quantitation of DNA cleavage by wild-type
Dna2. 32P-labeled DNA substrates with 5′ ssDNA tails of different lengths, as indicated, were used in reactions supplemented with RPA (22.5 nM) and sub-
sequently analyzed on 10% polyacrylamide gels. The data represent the average of at least two independent experiments. Error bars, SE. (B) Quantitation of
DNA cleavage by Dna2 K1080E variant. Reactions were carried out and analyzed as in A. The data represent the average of at least two independent ex-
periments. Error bars, SE. See panel A for legend. (C) Quantitation of DNA unwinding by Dna2 E675A. Reactions were carried out and analyzed as in A. The
data represent the average of at least two independent experiments. Error bars, SE. See panel A for legend.
Fig. S9. Processing of 5′-tailed DNA by wild-type and helicase-dead Dna2 K1080E variant. (A) DNA degradation by wild-type Dna2. The 5′-labeled 5′ ssDNA
tailed DNA substrate (1 nM) was used in a kinetic assay with 240 pM Dna2 in the presence of RPA (22.5 nM). Heat, heat-denatured DNA substrate. *, position of
the 32P label. The panel shows a representative 10% polyacrylamide gel. (B) Same assay as in A, but with Dna2 K1080E variant.
Fig. S10. Degradation of dsDNA by wild-type Dna2 requires 5′ overhang and RPA. (A) A representative polyacrylamide gel (10%) showing the activity of wild-
type Dna2 on tail-less dsDNA substrate (1 nM). *, position of the 32P label. All reactions contained RPA (9.6 nM). (B) A representative polyacrylamide gel (10%)
showing the activity of wild-type and K1080E Dna2 on tailed dsDNA substrate (1 nM) in the absence of RPA. *, position of the 32P label.
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!
!
!
Abstract!
Dna2! is! an! essential! nucleaseVhelicase! and! a! key! player! in! several! DNA!metabolic!
pathways!including!DNA!replication!and!repair.!To!execute!all!its!functions!Dna2!has!
to!be!precisely!regulated!at!multiple!levels.!Here!we!show!that!sumoylation!is!one!of!
the!mechanisms!controlling!S.#cerevisiae#Dna2!activity!and!stability.!We!report!that!
Dna2!is!sumoylated!in#vitro!and!in#vivo,!and!sumoylation!as!well!as!protein!levels!of!
Dna2!are!cell!cycle!dependent.!We!map!the!sites!of!sumoylation!to!the!NVterminal!
regulatory! domain.! Further,!we! demonstrate! that! sumoylation! of! Dna2! impairs! its!
nuclease!but!not!its!helicase!activity.!Taken!together,!these!findings!strongly!suggest!
that!Dna2!sumoylation!regulates!its!activity!in#vivo.!!
!
!
! !
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Introduction!
!
Posttranslational! modifications! (PTMs)! modulate! protein! properties! and! regulate!
their! functions.! Covalent! attachment! of! small! ubiquitinVlike! modifier! (SUMO)! proV
teins!to!target!substrates!is!an!established!PTM!with!an!emerging!role!in!DNA!damV
age! response! (DDR)! (1V5).! SUMO! is! a! 76! amino! acid! containing! protein! that! is! atV
tached!to!the!lysine!of!the!target!substrate!via!its!CVterminal!glycine!residue!by!enV
zymatic!reactions!carried!out!by!E1,!E2!and!E3!ligases,!similarly!to!the!ubiquitin!sysV
tem.!While!vertebrate!cells!posses!three!SUMO!proteins!(SUMO1,!and!almost!identiV
cal!SUMO2!and!SUMO3),!budding!yeast!contain!only!a!single!SUMO!protein!named!
Smt3!(2,6).!!
Sumoylation!can!have!a!variety!of!effects!on!the!target!protein.!As!it!targets!the!lyV
sines!of!its!substrate!it!may!compete!with!other!PTMs!like!acetylation!and!ubiquitiV
nation!(7,8).!For!IκBα!and!Rad52!it!was!shown!that!sumoylation!prevents!proteosoV
mal! degradation! of! these! proteins! by! blocking! ubiquitination! (7,9).! Next,! sumoyV
lation!can!inhibit!proteinVprotein!interactions,!as!it!was!shown!for!yeast!proliferating!
cell!nuclear!antigen!(PCNA)!and!PCNAVinteracting!proteinVbox!(PIPVbox)! factor!Eco1!
(10).! Finally,! sumoylation! can! also! promote! proteinVprotein! interactions! (3).! The!
stimulatory!effect!is!based!on!the!property!of!the!SUMO!proteins!to!bind!to!SUMOV
interacting!motifs,!SIMs!(11).!Remarkably,!the!SUMOVSIM!interaction!can!be!not!only!
intermolecular!(called!SUMO!glue),!but!also!intramolecular,!as!most!of!the!proteins!
targeted!by!sumoylation!also!bear!SIMs!(3,4,12).!A!wellVstudied!example!for!intramoV
lecular!SUMOVSIM!interaction!is!the!thymine!DNA!glycosylase!(TDG)!that!functions!in!
the!base!excision!pathway.!Sumoylation!of!TDG!results! in!a!conformational!change!
of!the!enzyme!involving!its!NVterminal!domain!(13).!!
Many! proteins! acting! in! DNA!metabolism! are! regulated! by! sumoylation,! although!
typically!only!a!minor! fraction!of!a!protein! is!modified! (4).!Proteins! involved! in! the!
homologous!recombination!(HR)!pathway!and!DNA!damage!checkpoint!were!shown!
to!be!subjects!of!a!collective!sumoylation!wave!triggered!by!DNA!end!resection!upon!
DNA!damage! (12,14).!Also!human! flap!endonuclease!1! (FEN1),!a!protein! that! is! inV
volved! in! lagging!strand!replication!as!well!as! in!several!DNA!repair!pathways,!was!
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shown! to!be! regulated!by! sumoylation.! Specifically,! sumoylation!of! FEN1! led! to! its!
degradation! via! the! ubiquitinVproteasome! system! after! the! completion! of! the! SV
phase!(15).!!
Dna2!is!an!essential!nucleaseVhelicase!involved!in!several!key!processes!of!DNA!meV
tabolism,! including!DNA!replication,!homologous!recombination!and!checkpoint!acV
tivation!(16V21).!The!nuclease!activity!was!shown!to!be!vigorous!and!essential!for!the!
replication!function!of!Dna2!(22V24).!Recently,!Dna2!was!additionally!found!to!be!a!
strong!helicase,!although!the!helicase!activity!is!masked!by!its!nuclease!(25).!!!!
Here!we!report!that!S.#cerevisiae!Dna2!is!sumoylated!in#vitro!and!in#vivo.!SumoyV
lation!attenuates!the!nuclease!activity!of!Dna2,!while!the!helicase!activity!is!not!afV
fected.!In#vivo,!sumoylation!appears!to!be!protective!against!MMSV!and!bleomycinV
induced!decrease!in!Dna2!protein!levels.!Furthermore,!sumoylation!as!well!as!proV
tein!levels!of!Dna2!are!regulated!in!a!cellVcycle!dependent!manner,!suggesting!that!
Dna2!presence!and!activity!is!tightly!regulated!during!DNA!replication!and!cell!diviV
sion.!!
!
Results!
!
S.+cerevisiae!Dna2!is!sumoylated!in+vitro!and!in+vivo!
To!test!whether!Dna2!as!many!other!proteins!involved!in!DNA!metabolism!is!sumoyV
lated!(4),!we!first!performed!an!in#vitro#sumoylation!assay!with!recombinant!proteins!
from!S.#cerevisiae!(Fig.!1A).!Indeed,!when!Smt3!was!included!in!the!sumoylation!reV
action,!wild!type!Dna2!as!well!as!Dna2!variants!migrated!higher!in!the!silverVstained!
gel! than!the!mockVtreated!proteins! (Fig.!1A).!This! led!us! to!a!conclusion!that!yeast!
Dna2!can!be!sumoylated! in#vitro.#Next,!we!set!out!to!test!whether!the!sumoylation!
of!S.#cerevisiae#Dna2!is!also!occurring!in#vivo#(Fig.!1B,!C).!To!detect!modified!Dna2!we!
overexpressed! HisVtagged! Smt3! and! performed! NiVNTA! affinity! pulldowns! of! HisV
Smt3Vprotein!conjugates!under!denaturing!conditions,!as!described!previously!(26).!
We!were!able!to!detect!slower!migrating!Dna2VmycVform!in!the!pulldown!samples,!
while! this! band! was! missing! when! the! pulldown! was! performed! with! cells! transV
formed!with!the!empty!parental!vector!control!(Figure!1B,!compare!lanes!7!and!11),!
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or!when!Dna2!was!not!endogenously!mycVtagged!(Fig.!1B,!compare!lanes!7!and!9).!
We!suggest!that!this!Dna2!variant!represents!a!sumoylated!form!of!Dna2.! InterestV
ingly,!upon!treatment!of!cells!with!MMS,!an!alkylating!agent,!the!sumoylation!level!
of!Dna2!decreased!by!≈60%!(Fig.!1B,!compare! lanes!7!and!8,!Fig.!1C).!We!also!obV
served!an!overall!decrease!of!Dna2!protein!in!the!cell!extracts!upon!treatment!with!
MMS!(Fig.!1B,!compare!lanes!1!and!2,!or!5!and!6).!Same!effect!was!visible!when!cells!
were! treated!with!bleomycin! (radiomimetic!drug)! and!etoposide! (topoisomerase! II!
inhibitor)!(Supplementary!Fig.!1,!compare!lanes!1,!3!and!4).!However,!topoisomerase!
inhibition!did!not!lead!to!decrease!in!Dna2!sumoylation!(Supplementary!Fig.!1,!lane!
9),!while!MMS!and!bleomycin!treatments!seemed!to!have!two!effects:!the!amount!
of!Dna2VmycVSmt3!species!was!somewhat!reduced,!while!at!the!same!time!presumV
ably! unmodified! Dna2Vmyc! (lower! band)! disappeared! completely! (Supplementary!
Fig.!1,!lanes!7!and!8).!Proteasomal!degradation!of!Dna2!upon!genotoxic!treatments!
was!just!recently!reported!for!yeast!cells!treated!with!caffeine,!independently!of!its!
checkpoint!inhibition!effect!(27).!Our!data!infer!that!budding!yeast!Dna2!is!modified!
by!sumoylation!and!the!sumoylated! form!appears! to!be!partially! resistant! to!MMS!
and!bleomycinVinduced!decrease!in!Dna2!protein!levels.!!
!
CellAcycle!dependent!regulation!of!Dna2!sumoylation!!
Cell!cycle! is!a!highly!regulated!process! involving!a! large!amount!of!various!proteins!
that! are! fineVtuned! by! PTMs.! Sumoylation! of! human! FEN1,! a! nuclease! involved! in!
Okazaki!fragment!processing,!was!shown!to!peak!in!late!S!and!precedes!its!ubiquitinV
mediated!proteasomal!degradation!(15).!In!yeast,!Dna2!was!also!implied!to!function!
together!with!Fen1!in!the!processing!of!flaps!arising!during!lagging!strand!DNA!synV
thesis!(16,28).!We!set!out!to!test!whether!Dna2,!similarly!to!Fen1,!is!regulated!during!
cell!cycle!progression.!For!this!purpose!we!synchronized!the!S.#cerevisiae!cells!in!the!
G1!phase!by!addition!of!αVfactor!and!monitored!Dna2!protein!as!well!as!sumoylation!
levels! after! the! release! in! S! phase! (Fig.! 2A,! B).! Surprisingly,! the! amounts! of! Dna2!
were!low!in!G1!and!S!phases,!while!they!substantially!increased!in!late!S!and!G2/M!
phases!(Fig.!2B,!left!part).!This!variation!of!Dna2!protein!levels!contrasts!to!that!deV
scribed!for!FEN1,!as!FEN1! levels!were!highest! in!G1!and!S!and! largely!decreased! in!
G2/M!(15).!When!checking!Dna2!sumoylation,!we!observed!the!highest!levels!in!late!
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S/G2!phase!(Fig.!2B,!lane!9).!Unlike!it!was!shown!for!FEN1!(15),!Dna2!protein!levels!
did! not! decrease! after! its!modification! by! SUMO! (Fig.! 2B,! lane! 4,!G2/M),! inferring!
that!sumoylation!of!Dna2!does!not!likely!promote!its!degradation.!Additionally,!cells!
treated!with!MMS!displayed! an! accumulation! in! SVphase! (Fig.! 2C),! suggesting! that!
the!MMSVinduced!decrease!in!sumoylation!in!Figure!1C!might!be!attributable!to!cell!
cycle!arrest.!Taken!together,!these!findings!demonstrate!that!Dna2!is!regulated!durV
ing!the!cell!cycle!not!only!at!protein!level,!but!also!likely!by!postVtranslational!modifiV
cations!such!as!sumoylation.!!
!
In+vitro!sumoylation!of!Dna2!impairs!its!nuclease!activity!!
Next,!we!decided!to!evaluate!the!impact!of!sumoylation!on!the!biochemical!activities!
of! S.# cerevisiae#Dna2.! Specifically,!we!wanted! to! test!whether! sumoylation! affects!
the!balance!between! the!nuclease!and!helicase!activities!within! the!Dna2!enzyme,!
thus!changing! the!conditions!compared! to!unmodified!protein!where! the!nuclease!
masks!the!helicase!(25).!In!Figure!3!we!analyzed!the!nuclease!and!helicase!activities!
of! in# vitro! sumoylated!Dna2! in! comparison! to!mockVtreated!proteins!on!a!5'Vtailed!
substrate.!Sumoylated!wild!type!Dna2!was!≈3Vfold!less!efficient!in!substrate!cleavage!
than! its! nonVsumoylated! counterpart! (Fig.! 3A,! B).! The! length! distribution! of! DNA!
fragments!produced!by!modified! compared! to!unmodified!Dna2!was!not! changed,!
when!we!tested!for!ssDNA!degradation!(Supplementary!Fig.!2A,!B),!suggesting!that!
sumoylated!Dna2!was! still! able! to! efficiently! translocate! on! ssDNA.! This! is! further!
supported!by!the!fact!that!ATPase!activity,!which!powers!the!ssDNA!translocase,!of!
sumoylated!Dna2!wt! did! not! differ! from! that! of! the!mockVtreated!protein! and! exV
cludes!the!possibility!that!the!in#vitro!sumoylation!reaction!compromises!the!whole!
protein!(Supplementary!Fig.!2C).!Moreover,!helicaseVdead!Dna2!K1080E!variant!disV
played! the! same! decrease! in! DNA! cleavage! activity! upon! sumoylation! as! the!wild!
type!protein!(Fig.!3C,!D).!However,!nucleaseVdead!Dna2!E675A!did!not!show!any!deV
fect! in!DNA!unwinding!upon!sumoylation!(Fig.!3E,!F).!This! is! in!agreement!with!the!
results! indicating! that! ssDNA! translocase! and! ATPase! activities! of! wild! type! Dna2!
were!not!affected!by!sumoylation.!Also,!in!an!assay!using!a!5'!tailed!substrate!where!
the!bottom!oligonucleotide!is!radioactively!labeled!at!the!5'!end,!which!can!be!used!
to!see!unwinding!by!Dna2!wt!as!described!in!(25),!no!difference!in!accumulation!of!
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tailed!DNA!(means!unwound!substrate!detected!by!the!presence!of!bottom!oligonuV
cleotide)!was!observed!between!sumoylated!and!unmodified!Dna2!wt!(SupplemenV
tary!Fig.!2D).!Collectively,!this!data!show!that!sumoylation!of!Dna2!selectively!attenV
uates!its!nuclease!activity!without!impairing!the!helicase,!thus!changing!the!balance!
of!the!two!key!biochemical!activities!within!Dna2.!!!
!
Sumoylation!of!Dna2!6KA!is!abolished!in+vitro!
Eventually,!the!question!remained!which!lysines!within!the!Dna2!protein!are!modiV
fied!by!sumoylation.!To!address!this!issue!we!performed!mass!spectrometry!analysis!
of! in#vitro! sumoylated!Dna2! that!determined!six!potential! lysine! residues! (Fig.!4A).!
All!of!these!lysines!are!part!of!the!unstructured!NVterminal!domain!of!Dna2!that!was!
shown!to!mediate!the!checkpoint!activation,!to!promote!binding!to!secondary!strucV
ture!DNA,!as!well!as!to!be!involved!in!the!interaction!with!RPA!(19,29V31).!First,!we!
purified!Dna2!variants!lacking!the!NVterminal!405!amino!acids!and!tested!them!in!an!
in# vitro! sumoylation!assay! (Figure!4B,!C).! The! sumoylation!of!Dna2!Δ405N!variants!
was!largely!abrogated!compared!to!the!fullVlength!protein!(Fig.!4C,!compare!lanes!3,!
5! and!8! to! lane! 11).!Next,!we! substituted! all! the! six! lysines! to! alanines!within! the!
Dna2!enzyme! (Dna2!6KA),!purified! the!protein!and! tested!again!whether! it! can!be!
sumoylated! in# vitro! (Fig.! 4D,! E).! As! anticipated,! the! sumoylation! of! Dna2! 6KA!was!
highly! inefficient! in! comparison! to! the!wild! type!protein! (Fig.! 4E,! compare! lanes! 4!
and!6).!Thus,!the!six!lysine!residues!identified!by!mass!spectrometry!are!most!likely!
to!be!modified!by!SUMO!protein!in#vitro.!!
!
Discussion!
!
Dna2!is!an!essential!protein!that!is!carrying!out!a!multitude!of!functions!in!DNA!metV
abolic!pathways!(21).!It!is!obvious!that!Dna2!has!to!be!carefully!regulated!to!be!able!
to! exert! all! its! tasks.! Cdk1Vdependent!phosphorylation!of!Dna2!at! Thr4,! Ser17! and!
Ser237! residues! was! already! shown! to! stimulate! its! recruitment! to! doubleVstrand!
breaks,! to! stimulate! resection!and!subsequent!checkpoint!activation! (30).!Here!we!
demonstrate! that! Dna2! is! also! regulated! by! sumoylation.! We! show! that! Dna2! is!
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sumoylated!in#vitro!and!in#vivo!(Fig.!1).!Sumoylation!of!Dna2!appears!to!be!protective!
from!MMS!and!bleomycinVinduced!decrease! in!Dna2!protein! levels!(Supplementary!
Fig.!1),!suggesting!an!involvement!in!regulation!of!homologous!recombination.!A!reV
cent!study!inferred!that!Dna2!is!subjected!to!proteasomal!degradation!upon!caffeine!
treatment,!independently!of!checkpoint!inhibition!(27).!Our!data!would!now!suggest!
that! sumoylated! Dna2! is! degradationVresistant.! Next,! we! reveal! that! protein! and!
sumoylation!levels!of!Dna2!also!vary!during!the!cell!cycle!exactly!in!the!way!opposite!
to!what!was!described!for!human!FEN1!(Fig.!2!and!(15)).!Having!in!mind!that!Dna2!
and!Fen1!were!shown!to!process! long!DNA! flaps!during!Okazaki! fragment!maturaV
tion!(16,28)!and!Dna2!is!essential!for!replication!(17),!it!is!tempting!to!speculate!that!
Dna2!is!more!required!in!late!S!phase!to!process!DNA!flaps!that!escaped!from!Fen1!
cleavage.! Alternatively,! Dna2! could! be! also! recruited! to! DNA! flaps! arising! during!
postVreplicative!repair.!This!is!further!supported!by!data!that!suggested!a!role!for!S.#
cerevisiae!Dna2!in!late!S!phase,!as!dna2Δ!cells!arrested!in!G2/M!(32).!Furthermore,!
also!human!cells!depleted!from!DNA2!arrest!in!late!S/G2,!while!fen1Δ!yeast!cells!acV
cumulate!already!in!S,!again!supporting!the!notion!of!Fen1!and!Dna2!acting!in!differV
ent! time! frames! (33,34).! Additionally,! our! recent!work! demonstrated! that!Dna2! is!
able!to!process!long!DNA!flaps!without!the!need!of!Fen1,!thus!explaining!high!Dna2!
protein!levels!in!late!S/G2,!when!Fen1!is!most!likely!already!sequestered!by!the!proV
teasome! ((48)VLevikova! and! Cejka,! NAR! 2015,! in! press;! (15)).! It! is! possible,! that!
sumoylation!affects!Fen1!and!Dna2!in!two!distinct!manners:!for!Fen1,!it!mediates!its!
degradation! in! late!S! (15),!while!modification!of!Dna2! leads!to!protein!stabilization!
possibly! by! shielding! it! from! ubiquitinVmediated! proteasomal! degradation,! so! that!
Dna2!can! finalize! the!processing!of!DNA! flaps!and!complete!DNA! replication.! IntriV
guingly,!human!EXO1!was! just!recently!shown!to!be!targeted!by!SUMO!and!subseV
quently! degraded! by! ubiquitinVdependent! proteasome,! similarly! to! FEN1! (15,35).!
Given!the!fact!that!Exo1!functions!in!a!DNA!resection!pathway!that!is!redundant!to!
that!involving!Sgs1VTop3VRmi1!and!Dna2!(36),!differential!effects!of!sumoylation!on!
Exo1!and!Dna2!might!influence!the!DNA!resection!pathway!choice.!
Moreover,!we!showed!that!sumoylation!impairs!the!nuclease!activity!of!Dna2!withV
out!affecting!its!helicase!(Fig.!3),!suggesting!that!sumoylation!of!Dna2!might!occur!in!
	  
	  54	  
	   RESULTS	   	  	   	  
 
cases!when!its!helicase!activity!is!required,!possibly!after!MMS!treatment.!In!accord,!
it!was!shown!that!helicaseVdead#dna2!mutants!are!sensitive!to!MMS!(24).!FurtherV
more,!we!were!able! to! identify! six! lysine! residues!of!Dna2! that! all! locate! to! its!NV
terminal! domain.! Substitution! of! those! lysines! to! alanines! abolished! Dna2! sumoyV
lation! in#vitro!(Fig.!4).!By!using!the! in#silico#SIM!prediction!tool!(37,38)!we!obtained!
four!possible!SIMs!within!Dna2:!at!the!amino!acid!positions!470V474,!638V642,!671V
675,!1183V1187.!Interestingly,!the!first!three!SIMs!cluster!in!the!nuclease!domain!of!
Dna2.!This!led!us!to!the!hypothesis!that!sumoylated!NVterminus!of!Dna2!might!bind!
to! the!SIMs!within! the!nuclease!domain! intramolecularly,! similarly! to!nonVcovalent!
contacts!within!sumoylated!TDG!shown!previously! (13,39,40),! thus!attenuating! the!
nuclease!activity!of!Dna2!as!observed!in!our!assays.!!
Taken!together,!our!results!suggest!that!Dna2!is!regulated!by!sumoylation!in!multiV
ple!ways:!sumoylated!Dna2!appears!to!be!resistant!to!proteasomal!degradation! inV
duced! by! genotoxic! treatments! and! exhibits! impaired! nuclease! activity;!moreover,!
sumoylation!levels!of!Dna2!vary!throughout!the!cell!cycle!being!highest!in!late!S/G2!
when!Dna2!is!most!likely!executing!its!essential!replication!function.!
!
Materials!and!Methods!
!
Recombinant!proteins!
Wild!type!Dna2!as!well!Dna2!E675A!and!Dna2!K1080E!variants!were!expressed!from!
a!modified!pGAL:DNA2!vector!(23).!Dna2!Δ405N!proteins!(wt,!E675A!and!K1080E)!as!
well!as!Dna2!6KA!were!expressed!from!a!pYes2!vector.!All!Dna2!proteins!were!puriV
fied! as! described! previously! (25).! RPA! protein! was! expressed! and! purified! as! deV
scribed!(41).!
Expression!and!purification!of!S.#cerevisiae!SUMO!machinery!proteins,!including!GSTV
Aos1/Uba1,! HisVUbc9,! HisVFlagVSmt3,! HisVSiz1! (1V465)! and! HisVSiz2! was! described!
previously! (42,43).!HisVFlagVSmt3VKR! (all! lysines! substituted! by! arginines)!was! puriV
fied!the!same!way!as!wild!type!Smt3.!
!
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In+vitro!sumoylation!assays!and!mass!spectrometry!analysis!
In# vitro! sumoylation! assays!were! performed! as! described! previously! (44).! Proteins!
were! then! separated! by! SDSVPAGE! and! stained! by! silver! staining.! The!mass! specV
trometry! analysis! of! sumoylated! Dna2!was! carried! out! by! Dorothea! Anrather! and!
Gustav!Ammerer!in!Max.!F.!Perutz!Laboratories,!Vienna,!Austria.!!
DNA!substrates!
The!oligonucleotides!X12V3!and!X12V4SC!were!used!for!the!preparation!of!the!19!ntV
5'Vtailed!ssDNA!substrate,!and!292!and!X12V4SC!for!30!ntV5'Vtailed!ssDNA!substrate,!
as!described!previously!(25,45).!The!oligonucleotides!used!for!nuclease!and!helicase!
assays!were!32PVlabeled!at!the!5'!terminus!with![gammaV32P]!ATP!and!T4!polynucleoV
tide!kinase!(New!England!Biolabs)!according!to!manufacturer! instructions.!UnincorV
porated! nucleotides! were! removed! using!MicroSpin! G25! columns! (GE! Healthcare)!
before!annealing!of!the!substrates.!The!randomly!labeled!2200!ntVlong!substrate!was!
prepared!by!amplification!of!the!yeast!DNA!Ligase!I!gene!by!PCR!from!yeast!genomic!
DNA! using! the! following! primers:! forward:! 5'! ACGCATTAGCTAGCGGATCCCTGV
GAAGTTCTGTTCCAGGGGCCCATGCGCAGATTACTGACCGGTTG! 3';! reverse:! 5'! ACV
GCATTACTCGAGATTTTGCATGTGGGATTGGT! 3'.! In! addition! to! the! standard! dNTP!
concentration!in!the!PCR!reaction!(200!nM!each),![alphaV32P]!dATP!(60nM)!was!addV
ed.!The!PCR!reaction!was!purified!using!Chroma!Spin!TEV400!columns!(Clontech).!!
Nuclease,!helicase!and!ATPase!assays!
The!experiments!were!performed!in!a!15Vμl!volume!in!25!mM!TrisVacetate!(pH!7.5),!2!
mM!magnesium!acetate,!1!mM!ATP,!1!mM!dithiothreitol,!0.1!mg/ml!BSA!(New!EngV
land!Biolabs),!1!mM!phosphoenolpyruvate,!16!U/ml!pyruvate!kinase,!1!nM!DNA!subV
strate,!16.8!nM!RPA!for!5'Vtailed!oligonucleotideVbased!substrates,!350!nM!RPA!for!
2200!ntVlong!substrate,!and!Dna2!variants,!as!indicated.!The!reactions!with!oligonuV
cleotideVbased!substrates!were! incubated! for!30!min!at!30!°C,!and!carried!out!and!
analyzed! as! described! previously! (45).! Reactions! with! the! 2200! ntVlong! substrate!
were!incubated!at!30°C!and!aliquots!were!taken!at!indicated!time!points.!Reactions!
were!stopped!by!adding!equal!volume!of!the!formamide!dye!(95%!(v/v)!formamide,!
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20!mM!EDTA,!0.01%!bromophenol!blue),!samples!were!heated!at!95°C!for!4!min!and!
separated! on! 20!%! denaturing! polyacrylamide! gels! (ratio! acrylamide:bisacrylamide!
19:1,!Biorad).!After!fixing!in!a!solution!containing!40%!methanol,!10%!acetic!acid!and!
5%!glycerol!for!30!min,!the!gels!were!dried!on!DE81!chromatography!paper!(WhatV
man),!and!exposed!to!storage!phosphor!screens!(GE!Healthcare).!The!screens!were!
scanned! by! Typhoon! phosphor! imager! (GE! Healthcare).! ATPase! assays! were! perV
formed!as!described!previously!(45,46).!
Yeast!strains!and!plasmids!
All! experiments! were! performed! using! S.# cerevisiae# FF18733! strain! (MATa! his7V2!
leu2V3,112! lys1V1! trp1V289! ura3V52,! F.! Fabre).! Dna2! gene!was! CVterminally! tagged!
with!9VMYC!tag!using!pYM18!plasmid,!as!described!previously!(47).!Plasmids!used!for!
HisVSmt3!pulldown!experiments!were!YEp181VCUP1VHisVSMT3!and!the!parental!vecV
tor!YEplac181.!
Detection!of!Smt3ADna2!conjugates!
Yeast!strains!were!grown!exponentially!until!OD600=1!in!minimal!medium,!lysed!unV
der! denaturing! conditions,! proteins!were!precipitated! and!NiVNTA!affinity! chromaV
tography!was!performed!as!described!previously!(26).!Sumoylation!of!Dna2!was!anaV
lyzed! by! western! blotting! using! the! following! antibodies:! antiVcVMycVtag! mAb!
(A00704,! GenScript),! antiVSmt3! (ab14405,! Abcam),! antiVHisVtag! mAb! (A00186,!
GenScript).!Genotoxic!treatments!were!conducted!always!for!1.5!h!before!harvesting!
using!the!following!drug!amounts!(final!concentration):!MMS!0.03%!(SigmaVAldrich),!
Bleomycin!5!μg/mL!(Merck!Millipore),!Etoposide!295!μg/mL!(SigmaVAldrich).!
Cell!synchronization!and!flow!cytometry!
Cells! were! grown! until! OD600=0.3V0.4! and! synchronized! by! addition! of! αVfactor! (4!
μg/mL,!Primmbiotech)! in!YPD!medium!for!2!h.!Cells!were!released! into!SVphase!by!
treatment!with!Pronase!(20!mg/mL,!SigmaVAldrich).!Samples!were!taken!for!flow!cyV
tometry! and!NiVNTA! pulldowns! at! indicated! time! points.! For! flow! cytometry,! cells!
were!fixed!in!70%!ethanol!and!250!mM!TrisVHCl!pH!7.5!at!4°C!for!at!least!overnight,!
treated!with!RNase!A!(1!mg/mL,!Roche)!at!37°C!overnight,!washed,!and!resuspended!
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in!50!mM!TrisVHCl!pH!7.5,!200!mM!NaCl!and!80!mM!MgCl2!containing!propidium!ioV
dide!(50!μg/mL,!SigmaVAldrich).!!After!brief!sonication!in!50!mM!TrisVHCl!pH!7.5!the!
DNA! content!was!measured! using! CyAn! ADP! 9! flow! cytometer! (Beckman! Coulter)!
operated!with! Summit! software! and! the! data! was! analyzed!with! FlowJo! software!
(TreeStar).!!!
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Figure!Legends!
Figure!1:!Dna2! is!sumoylated! in+vitro!and! in+vivo.!(A)!SilverVstained!gel!showing! in#
vitro!sumoylated!(+)!and!mockVtreated!(−)!Dna2!proteins.!Sumoylated!Dna2!migrates!
higher! in! the!gel!and! is! indicated!on! the! right.!Dna2!K1080E! V!helicaseVdead,!Dna2!
E675A!V!nucleaseVdead!variant.!(B)!NiVNTA!pulldown!of!HisVSmt3!protein!conjugates!
from! S.# cerevisiae! cells! containing! epitopically! mycVtagged! Dna2! and! were! transV
formed!with!HisVSmt3!plasmid!or!an!empty!vector.!Input!and!pulldown!samples!were!
analyzed!by!western!blotting!using!antiVmyc,!antiVSmt3!and!antiVHis!antibodies.!Cells!
were! treated! with! 0.03%! MMS,! where! indicated.! Representative! western! blot! is!
shown.!(C)!Quantitation!of!Dna2!sumoylation! levels!such! in!(B).!*Relative! intensity:!
intensity!of!Dna2VSmt3!band!normalized!to!Dna2Vmyc! input;!untreated!sample!was!
set!as!100%.!Averages!shown,!n=3;!s.e.m.!
Figure!2:!Protein!levels!as!well!as!sumoylation!of!Dna2!are!regulated!during!the!cell!
cycle.! (A)!S.# cerevisiae! cells! containing! epitopically!mycVtagged!Dna2! and!HisVSmt3!
plasmid!were!synchronized!in!G1!by!the!αVfactor!and!released!into!S!phase.!Cell!cycle!
progression!was!monitored!by!flow!cytometry!(1N!and!2N!DNA!content! indicated).!
(B)! Sumoylation! of! Dna2! was!monitored! by! NiVNTA! pulldown! of! HisVSmt3! protein!
conjugates!in!course!of!the!cell!cycle.!Input!and!pulldown!samples!were!analyzed!by!
western! blotting! using! antiVmyc,! and! antiVHis! antibodies.! Representative! western!
blot! from! three! independent! experiments! is! shown.! Dna2! levels! are!markedly! deV
creased!in!G1!and!S,!while!sumoylation!of!Dna2!is!highest!in!late!S/G2!and!decreases!
in! G2/M.! (C).! Cell! cycle! profile! of! S.# cerevisiae# cells! containing! epitopically! mycV
tagged!Dna2! that!were! treated!with! 0.03%!MMS,! analyzed!by! flow! cytometry! (1N!
and!2N!DNA!content!indicated).!MMS!treatment!leads!to!cell!cycle!arrest!in!SVphase.!!!!
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Figure!3:!Sumoylation!of!Dna2!attenuates!its!nuclease!but!not!its!helicase!activity.!
(A)!Representative!native!PAA!gel!showing!the!degradation!of!5’!tailed!substrate!by!
sumoylated!and!mockVtreated!Dna2!wt.!The!top!oligonucleotide!was!32P! labeled!at!
the!5’!end.!The!reactions!contained!RPA!(22!nM)!and!various!Dna2!concentrations,!
as!indicated.!*,!position!of!32P!!label.!(B)!Quantitation!of!the!experiments!such!as!in!
(A).!Averages! shown,!n=2;!error!bars! s.e.m.! (C)! Experiment!as! in! (A),!but!with!helV
icaseVdead!Dna2!K1080E.!(D)!Quantitation!of!the!experiments!such!as!in!(C).!AveragV
es!shown,!n=2;!error!bars!s.e.m.!(E)!Representative!native!PAA!gel!showing!the!unV
winding!of!5’!tailed!substrate!by!sumoylated!and!mockVtreated!nucleaseVdead!Dna2!
E675A.! The! top! oligonucleotide! was! 32P! labeled! at! the! 5’! end.! The! reactions! conV
tained!RPA!(22!nM)!and!various!Dna2!concentrations,!as!indicated.!*,!position!of!32P!!
label.!Heat,!heatVdenatured!substrate.!(F)!Quantitation!of!the!experiments!such!as!in!
(E).!Averages!shown,!n=2;!error!bars!s.e.m.!
Figure!4:!Dna2!6KA!mutant!is!weakly!sumoylated! in+vitro.!(A)!Schematic!represenV
tation!of! the!domain! structure!of! the!Dna2!protein.! Lysine! residues! that!were!deV
termined!by!mass!spectrometry!of! in#vitro! sumoylated!protein!are!depicted! in!red.!
(B)!Coomassie!stained!gel!showing!purified!Dna2!wt,!E675A!and!K1080E!proteins,!all!
lacking! the! NVterminal! 405! amino! acids,! from! S.# cerevisiae.! (C)! SilverVstained! gel!
showing# in# vitro# sumoylated! (+)! and!mockVtreated! (−)! Δ405N! and! fullVlength!Dna2!
proteins.! Sumoylated! Dna2! migrates! higher! in! the! gel.! Dna2! Δ405N! proteins! are!
sumoylated!much!less!than!the!fullVlength!Dna2.!(D)!Coomassie!stained!gel!showing!
purified!Dna2!6KA! (K21A,!K33A,!K60A,!K93A,!K103A,!K247A)! from!S.# cerevisiae.! (E)!
SilverVstained!gel!showing!in#vitro!sumoylated!(+)!and!mockVtreated!(−)!wt!Dna2!and!
6KA!proteins.! Sumoylated!Dna2!migrates! higher! in! the! gel! and! is! indicated!on! the!
right.!Dna2!6KA!is!sumoylated!only!weakly.!!
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Figure 1: Dna2 is sumoylated in vitro and in vivo.  
(A) Silver-stained gel showing in vitro sumoylated (+) and mock-treated (−) Dna2 proteins. 
Sumoylated Dna2 migrates higher in the gel and is indicated on the right. Dna2 K1080E - helicase-
dead, Dna2 E675A - nuclease-dead variant. (B) Ni-NTA pulldown of His-Smt3 protein conjugates from 
S. cerevisiae cells containing epitopically myc-tagged Dna2 and were transformed with His-Smt3 
plasmid or an empty vector. Input and pulldown samples were analyzed by western blotting using 
anti-myc, anti-Smt3 and anti-His antibodies. Cells were treated with 0.03% MMS, where indicated. 
Representative Western blot is shown. (C) Quantitation of Dna2 sumoylation levels such in (B). 
*Relative intensity: intensity of Dna2-Smt3 band normalized to Dna2-myc input; untreated sample was 
set as 100%. Averages shown, n=3; s.e.m. 
	  
	  64	  
	   RESULTS	   	  	   	  
Figure 2 
A 
C 
2 1 
Ti
m
e 
af
te
r r
el
ea
se
 fr
om
 G
1 
ar
re
st
 (m
in
) 
G1 
15 
Early S 
45 
Late S/G2 
70 
G2/M 
100 
G1 
100 
Async 
B 
anti-myc 
G
1  
Input Ni-NTA pulldown 
 1      2      3     4      5       6        7      8     9    10   11    12 
E
ar
ly
 S
   
La
te
 S
/G
2   
G
2/
M
   
G
1 
  
A
sy
nc
  
Dna2-myc 
Dna2-myc-Smt3 
Ponceau 
G
1  
E
ar
ly
 S
   
La
te
 S
/G
2   
G
2/
M
   
G
1 
  
A
sy
nc
  
His-Smt3- 
conjugates 
anti-His 
His-Smt3 
+MMS 
−MMS 
1 2 
Figure 2: Protein levels as well as sumoylation of Dna2 are regulated during the cell cycle.  
(A) S. cerevisiae cells containing epitopically myc-tagged Dna2 and His-Smt3 plasmid were 
synchronized in G1 by the α-factor and released into S phase. Cell cycle progression was monitored 
by flow cytometry (1N and 2N DNA content indicated). (B) Sumoylation of Dna2 was monitored by Ni-
NTA pulldown of His-Smt3 protein conjugates in course of the cell cycle. Input and pulldown samples 
were analyzed by western blotting using anti-myc, and anti-His antibodies. Representative western 
blot from three independent experiments is shown. Dna2 levels are markedly decreased in G1 and S, 
while sumoylation of Dna2 is highest in late S/G2 and decreases in G2/M. (C). Cell cycle profile of S. 
cerevisiae cells containing epitopically myc-tagged Dna2 that were treated with 0.03% MMS, 
analyzed by flow cytometry (1N and 2N DNA content indicated). MMS treatment leads to cell cycle 
arrest in S-phase.    
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Figure 3: Sumoylation of Dna2 attenuates its nuclease but not its helicase activity 
(A) Representative native PAA gel showing the degradation of 5’ tailed substrate by sumoylated and 
mock-treated Dna2 wt. The top oligonucleotide was 32P labeled at the 5’ end. The reactions contained 
RPA (22 nM) and various Dna2 concentrations, as indicated. *, position of 32P  label. (B) Quantitation 
of the experiments such as in (A). Averages shown, n=2; error bars s.e.m. (C) Experiment as in (A), 
but with helicase-dead Dna2 K1080E. (D) Quantitation of the experiments such as in (C). Averages 
shown, n=2; error bars s.e.m. (E) Representative native PAA gel showing the unwinding of 5’ tailed 
substrate by sumoylated and mock-treated nuclease-dead Dna2 E675A. The top oligonucleotide was 
32P labeled at the 5’ end. The reactions contained RPA (22 nM) and various Dna2 concentrations, as 
indicated. *, position of 32P  label. Heat, heat-denatured substrate. (F) Quantitation of the experiments 
such as in (E). Averages shown, n=2; error bars s.e.m. 
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Figure 4: Dna2 6KA mutant is weakly sumoylated in vitro.  
(A) Schematic representation of the domain structure of the Dna2 protein. Lysine residues that were 
determined by mass spectrometry of in vitro sumoylated protein are depicted in red. (B) Coomassie 
stained gel showing purified Dna2 wt, E675A and K1080E proteins, all lacking the N-terminal 405 
amino acids, from S. cerevisiae. (C) Silver-stained gel showing in vitro sumoylated (+) and mock-
treated (−) Δ405N and full-length Dna2 proteins. Sumoylated Dna2 migrates higher in the gel. Dna2 
Δ405N proteins are SUMOylated much less than the full-length Dna2. (D) Coomassie stained gel 
showing purified Dna2 6KA (K21A, K33A, K60A, K93A, K103A, K247A) from S. cerevisiae. (E) Silver-
stained gel showing in vitro sumoylated (+) and mock-treated (−) wt Dna2 and 6KA proteins. 
Sumoylated Dna2 migrates higher in the gel and is indicated on the right. Dna2 6KA is sumoylated 
only weakly.  
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Supplementary Figure 1: Sumoylation of Dna2 is decreased after MMS and Bleomycin 
treatments in vivo. Ni-NTA pulldown of His-Smt3 protein conjugates from S. cerevisiae cells 
containing epitopically myc-tagged Dna2 and were transformed with His-Smt3 plasmid or an empty 
vector. Input and pulldown samples were analyzed by western blotting using anti-myc and anti-His 
antibodies. Cells were treated with either 0.03% MMS, or 5 µg/mL Bleomycin, or 295 µg/mL (0.5 mM) 
Etoposide, where indicated. Representative western blot from three independent experiments is 
shown. 
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Supplementary Figure 2: In vitro sumoylated Dna2 exhibits decreased nuclease activity, while 
helicase and ATPase remain untouched. (A). Representative denaturing 20% PAA gel showing the 
degradation kinetics of a uniformly labeled 2200 nt-long substrate by sumoylated Dna2 wt. (B) 
Experiment as in (A), but with mock-treated Dna2 wt. (C) Kinetics of ATP hydrolysis by sumoylated 
Dna2 wt compared to mock-treated control. The reactions contained 30 nt-long 5’ overhang substrate 
(1 µM in nucleotides). (D) Processing of 5’ tailed DNA substrate by sumoylated Dna2 wt. The bottom 
oligonucleotide was 32P labeled at the 5’ end. The reactions contained RPA (22.5 nM) and various 
Dna2 concentrations, as indicated. *, position of 32P  label.  
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!
ABSTRACT!!
!
During!DNA! replication,! synthesis! of! the! lagging! strand!occurs! in! stretches! termed!
Okazaki! fragments.!Before!adjacent! fragments!are! ligated,!any! flaps! resulting! from!
the!displacement!of!the!5'!DNA!end!of!the!Okazaki!fragment!must!be!cleaved.!Previ=
ously,!Dna2!was! implicated!to! function!upstream!of!Fen1! in! the!processing!of! long!
flaps!bound!by!the!replication!protein!A!(RPA).!Here!we!show!that!Dna2!efficiently!
cleaves! long!DNA!flaps!exactly!at!or!directly!adjacent!to!the!base.!A!fraction!of!the!
flaps!cleaved!by!Dna2!can!be!immediately!ligated.!When!coupled!with!DNA!replica=
tion,! the! flap! processing! activity! of!Dna2! leads! to! a! nearly! complete!Okazaki! frag=
ment!maturation!at!sub=nanomolar!Dna2!concentrations.!Our!results!indicate!that!a!
subsequent! nucleolytic! activity! of! Fen1! is! not! required! in! most! cases.! In! contrast!
Dna2! is! completely! incapable! to! cleave! short! flaps.!We! show! that! also! Dna2,! like!
Fen1,!interacts!with!PCNA.!We!propose!a!model!where!Dna2!alone!is!responsible!for!
cleaving!of!RPA=bound!long!flaps,!while!Fen1!or!Exo1!cleave!short!flaps.!Our!results!
argue!that!Dna2!can!function!in!a!separate,!rather!than!in!a!Fen1=dependent!path=
way.!
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INTRODUCTION!
!
All!cells!must!replicate!their!DNA!before!each!cell!division.!While!leading!strand!DNA!
synthesis!occurs!continuously!in!a!5'!to!3'!direction,!the!lagging!strand!is!synthesized!
in!short!stretches!termed!Okazaki!fragments!due!to!the!5'!to!3'!polarity!of!DNA!pol=
ymerases.!First,! the!DNA!polymerase!α=primase!complex! (pol!α)!synthesizes!a!~30=
nucleotide!RNA=DNA!primer.!The!replication! factor!C! (RFC)! then!binds! the! junction!
between!the!RNA=DNA!primer!and!the!parental!DNA!strand!and!initiates!the!loading!
of!proliferating!cell!nuclear!antigen!(PCNA).!Recruitment!of!PCNA!mediates!a!switch!
from!pol!α!to!pol!δ,!which!extends!the!newly!synthesized!DNA!strand!to!up!to!~200!
nucleotides!(nt)!(1,2).!RNAse!H1!is!primarily!responsible!for!the!removal!of!RNA!from!
DNA!(3=6).!PCNA!binds!pol!δ!(7,8)!and!enhances!its!processivity!(9),!and!also!serves!
as! a! binding! platform! for! further! replicative! factors! including! flap! endonuclease! 1!
(Fen1!or!Rad27)!and!DNA!ligase!I!(Lig1!or!Cdc9)!(8,10=14).!After!pol!δ!reaches!the!5'!
end!of!the!downstream!Okazaki!fragment!it!may!continue!DNA!synthesis!leading!to!
the!displacement!of!the!RNA=DNA!primer.!This!creates!5'=terminated!flaps!of!various!
lengths!that!must!be!cleaved!before! ligation!by!Lig1!can!occur.!This!process! is!also!
important!for!the!maintenance!of!genome!stability!as!it!contributes!to!the!removal!
of! RNA! as! well! as! DNA! from! the! initial! primer! synthesized! by! error=prone! pol! α!
(15,16).!
Dna2! is!an!essential!protein! that!was! found!to!be!necessary! for!DNA!replication! in#
vivo#(17=19).!While!it! is!not!necessary!for!bulk!DNA!synthesis!(20),!newly!replicated!
DNA!in!dna2)1!cells!contained!low!molecular!weight!fragments,!showing!that!Dna2!is!
required!for!sealing!nicks! in!newly!replicated!DNA,!reminiscent!of!cells! lacking!Lig1!
(18,21).!Dna2!has!both!DNA!nuclease!and!helicase!activities!(22=25).!While!a!loss!of!
its! nuclease! activity! is! lethal,! helicase=deficient! mutants! are! viable! under! some!
growth! conditions! (19,24).! This! suggested! that! specifically! the! nuclease! activity! of!
Dna2!is!essential!for!DNA!replication.!The!Pif1!helicase!was!shown!to!stimulate!the!
displacement!activity!of!pol!δ,!leading!thus!to!long!flap!formation!and!providing!re=
quirement!for!Dna2!(26=28).!In!accord,!pif1Δ!mutation!rescues!the!lethality!of!dna2Δ#
cells!(29).!Additional!deletion!of!pol32#(pol!δ!subunit!responsible!for!DNA!strand!dis=
placement! activity)! further! suppresses! the! growth! defects! of! pif1Δ# dna2Δ# cells!
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(29,30).!At!the!same!time,!the!lethality!of!dna2Δ#cells!can!be!also!rescued!by!a!muta=
tion!of!rad9,! leading!to! inactivation!of!DNA!damage!checkpoint! (31).!Nevertheless,!
these! data! collectively! suggest! that! Dna2! in# vivo! is! required! for! the! processing! of!
long!flaps!in!S.#cerevisiae!DNA!replication.!
Short! flaps! are! primarily! processed! by! the! flap! endonuclease! 1! (Fen1).! Fen1! is! a!
component!of!the!Okazaki!fragment!maturation!complex!composed!of!pol!δ,!PCNA!
and!Lig1! (7,8,10=14,32).! It!has!been!demonstrated!that!Fen1!becomes! incapable!of!
cleaving! flaps! that!are! long!enough! to!bind!RPA.!Thus,!RPA!mediates! the!nuclease!
switch!between!Fen1!and!Dna2!(33).!While!inhibiting!DNA!cleavage!by!Fen1!(26,33),!
RPA! promotes! the! nuclease! of! Dna2! (22,33,34).! However,! recombinant! Dna2!was!
shown!to!only!shorten!long!flaps!to!~5=8!nt,!even!when!used!at!very!high!concentra=
tions.!DNA!cleavage!at! these!positions!did!not!support! ligation!and!therefore!a!se=
cond! nuclease! activity!was! needed! (22,33,35).! As!Dna2!was! found! to! be! part! of! a!
complex!with!Fen1! in#vivo#(36),!it!was!proposed!that!Fen1!must!act!downstream!of!
Dna2!(32,33,35).!Indeed,!a!combination!of!recombinant!Dna2!and!Fen1!allowed!Oka=
zaki!fragment!processing!in#vitro,!leading!to!a!two=step!Okazaki!fragment!processing!
model!(33).!In!contrast!to!dna2Δ#cells,!rad27Δ#mutants!are!viable,!albeit!grow!slowly!
and! display! elevated! recombination! and! mutation! rates! (37,38).! The! viability! of!
rad27Δ! cells! seems! to!contradict! the!model!where!Fen1!acts!downstream!of!Dna2!
(32,33,35).! To! this!point,! Fen1!activity!was!proposed! to!be! redundant!with! that!of!
the!exonuclease!1!(Exo1)!(33).!Indeed,!overexpression!of!Exo1!could!suppress!some!
of! the!phenotypic!defects!of! rad27Δ! cells! and!exo1Δ! rad27Δ!mutant! is! lethal! (39).!
However,!there!is!no!evidence!to!date!suggesting!that!Dna2!physically!interacts!with!
Exo1,!nor!that!Exo1!acts!downstream!of!Dna2.!On!the!contrary,!Dna2!and!Exo1!nu=
cleases! function! in! strictly! separate! pathways! during!DNA! end! resection! (40).! Fur=
thermore,!the!direct!interaction!between!Dna2!and!Fen1!could!not!be!confirmed!in!a!
later!study!(41).!Also,!overexpression!of!Dna2!suppressed!the!growth!defects!associ=
ated!with!deletion!of!rad27,!while!overexpression!of!Fen1!suppressed!the!lethality!of!
dna2Δ#cells! (36).!Also! this! supports! the!notion! that!Dna2!and!Fen1!can! function! in!
separate!pathways.!Despite!that,!available!in#vitro!data!with!recombinant!Dna2!were!
in!contrast!with!such!an!explanation.!
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Here!we!show!that!Dna2!cleaves!DNA!flaps!near!their!base,!and!is!thus!able!to!sup=
port!complete!Okazaki!fragment!maturation!without!the!requirement!of!Fen1!during!
DNA!replication! in#vitro.!This! finding!provides!a!possible!explanation!of! the!diverse!
phenotypes!of!dna2Δ!and!rad27Δ#cells.!It!strongly!suggests!that!Dna2!can!function!as!
the! sole!nuclease! in! the!processing!of!at! least!a! fraction!of! long!DNA! flaps! in!DNA!
replication.!!
!
MATERIALS!AND!METHODS!
!
DNA!substrates!
The!oligonucleotides!used!to!prepare!the!flapped!substrates!were!as!follows:!"bot=
tom"!X12=4NC!and!"top"!Flap!19!X12=4C!were!annealed!with!a!variety!of!"top!flap"!
oligonucleotides!to!prepare!flapped!substrates!of!30!(oligonucleotide!292),!8!(293),!
and!4!nt!in!length!(294):!X12=4NC,!5'=GCGATAGTCTCTAGACAGCATGTCCTAGCAAGCC!
AGAATTCGGCAGGCTA=3';! Flap! 19! X12=4C,! 5'=TAGCCTGCCGAATTCTGGC=3';! 292,! 5'=
GGTACTCAAGTGACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATCGC=
3';!293,!5'=GGATTACATTGCTAGGACATGCTGTCTAGAGACTATCGC=3';!294,!5'=GACAT!
TGCTAGGACATGCTGTCTAGAGACTATCGC=3'.!For!8!nt!double!flap!substrate,!oligonu=
cleotides!X12=4NC,!Flap!20!X12=4C!and!293!were!annealed.!!The!sequence!of!Flap!20!
X12=4C!is:!5'=TAGCCTGCCGAATTCTGGCA=3'.!!
The!oligonucleotides!were! 32P=labeled!at! the!3'! end!with! [alpha=32P]! cordycepin=5'=
triphosphate! and! terminal#deoxynucleotidyl# transferase! (New! England! Biolabs)! ac=
cording! to! manufacturer! instructions.! Unincorporated! nucleotides! were! removed!
using!MicroSpin!G25!columns!(GE!Healthcare).!!
The!circular!3.197!kb=long!ssDNA!used!in!the!replication!assays!was!pGEM=3Zf(=)!that!
was! prepared! as! described! previously! (42).! This! DNA! was! annealed! with! either!
pR_T12flap! 5'=TTTTTTTTTTTTACCATCTGGCCCCAGTGCTGCAATG=3'! (primer!with! a! 12!
nt=flap),!pR_T30flap!5'=TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTACCATCTGGCCCCAGTGCT!
GCAATG=3'!!(primer!with!a!30!nt=flap),!or!pR_20!5'=GCGATCTGTCTATTTCGTTC=3'!(ful=
ly!complementary!primer!without!a!flap).!!
!
!
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Recombinant!proteins!
RPA! protein!was! prepared! as! described! (43).!Wild! type!Dna2! as!well! as! nuclease=
dead!E675A,!helicase=dead!K1080E!and!the!E675A/K1080E!double!mutant!were!ex=
pressed!and!purified!as!described!previously!(25).!We!note!that!care!must!be!taken!
during!cell!lysis!to!prevent!a!loss!of!activity.!Also,!Dna2!is!particularly!sensitive!to!ox=
idation,!so!reducing!agents!must!be!included!throughout!the!procedure.!Yeast!LIG1!
(CDC9)!gene!was!amplified!from!yeast!genomic!DNA!by!PCR!using!primers!Lig1_for!
5'=!ACGCATTAGCTAGCGGATCCCTGGAAGTTCTGTTCCAGGGGCCCATGCGCAGATTACT!
GACCGGTTG=3'! and! Lig1_rev! 5'=ACGCATTACTCGAGATTTTGCATGTGGGATTGGT=3'.!
The! PCR! product! was! digested! by! NheI! and! XhoI! restriction! endonucleases! (both!
New!England!Biolabs)!and!cloned!into!corresponding!sites!in!pFB=MBP=Sgs1=his!vec=
tor! (44),!creating!pFB=MBP=Lig1=his.!Lig1!was!expressed! in! insect!Sf9!cells!and!puri=
fied!by!affinity!chromatography!as!described!previously!for!Sgs1!(44).!
Yeast!FEN1! (RAD27)!was! amplified! from!yeast! genomic!DNA!by!PCR!using!primers!
Fen1_for:!5'=!ACGCATTAGCTAGCGAATTCCTGGAAGTTCTGTTCCAGGGGCCCATGGGTAT!
TAAAGGTTTGAATGC=3'!and!Fen1_rev:!5'=!ACGCATTACTCGAGTCTTCTTCCCTTTGTGAC!
TT=3'.! The! PCR! product! was! digested! by! NheI! and! XhoI! restriction! endonucleases!
(both!New!England!Biolabs)!and!cloned!into!corresponding!sites!in!pFB=MBP=Sgs1=his!
vector!(44),!creating!pFB=MBP=Fen1=his.!MBP!tag!was!excised!from!this!vector!by!di=
gestion!with!the!restriction!endonuclease!BamHI!(New!England!Biolabs)!followed!by!
self=ligation!of!pFB=Fen1=his.!Then,!a!fragment!coding!for!PP=MBP!(PP!is!PreScission!
protease!cleavage!site)!was!amplified!by!PCR!from!the!pFB=MBP=Sgs1=his!vector!(44)!
using!primers!XhoI_PP2G_MBP_for!5'=!ACGCATTACTCGAGCTGGAAGTTCTGTTCCAGG!
GGCCCGGTGGTATGAAAATCGAAGAAGGTAA=3'!and!MBP_XhoI_rev!5'ACGCATTACTCG!
AGCCCGAGGTTGTTGTTATTGT=3'.! The!PCR!product!was!digested!by!XhoI! restriction!
endonuclease! (New! England! Biolabs)! and! cloned! into! pFB=Fen1=His! directly! after!
Fen1,!creating!pFB=Fen1=MBP=his.!Fen1!was!expressed!in!insect!Sf9#cells.!Cells!were!
lysed!and!MBP=tagged!Fen1!was!first!incubated!with!amylose!resin!as!described!pre=
viously! for! Sgs1! (44).! Eluates! from! amylose! resin!were! applied! on!Ni=NTA! agarose!
column!and!extensively!washed!with!wash!buffer!(50!mM!Tris=HCl!pH!7.5,!2!mM!β=
mercaptoethanol,! 10%! glycerol,! 0.5! mM! phenylmethylsulfonyl! fluoride,! 1! M! NaCl!
and!20!mM!imidazole),!followed!by!a!wash!with!the!same!buffer,!but!containing!0.3!
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M!NaCl!and!60!mM!imidazole.!Protein!was!eluted!with!wash!buffer!containing!0.3!M!
NaCl!and!0.3!M! imidazole.!MBP!and!His! tags!were!cleaved!by!PreScission!protease!
and!the!eluate!was!incubated!with!glutathione!and!amylose!resins.!The!sample!was!
centrifuged! (2000!g,!5!min),!and!supernatant!containing!Fen1!was!dialyzed! into!50!
mM!Tris=HCl!pH!7.5,!5!mM!β=mercaptoethanol,!150!mM!NaCl,!10%!glycerol!and!fro=
zen!in!small!aliquots.!
Yeast!three!subunit!pol!δ!and!pol!δ!exonuclease=deficient!variant!(Pol3=D520V,!mu=
tation! introduced!by! site=directed!mutagenesis)!were!expressed! in! the!yeast! strain!
WDH668! as! described! previously! (45)! and! purified! according! to! existing! protocols!
(27).!PCNA!and!RFC!were!expressed!and!purified!from!E.#coli!by!minor!modifications!
of!previously!established!procedures!(46,47).!
!
Nuclease!assays!
Nuclease!assays!were!performed!in!a!15!μl!volume!in!25!mM!Tris=acetate!pH!7.5,!10!
mM! magnesium! acetate! (unless! indicated! otherwise),! 1! mM! ATP,! 1! mM! dithio=
threitol,!0.1!mg/ml!bovine!serum!albumin!(BSA,!New!England!Biolabs),!1!mM!phos=
phoenolpyruvate,!80!U/ml!pyruvate!kinase,!1!nM!DNA!substrate!(in!molecules)!and!
recombinant! proteins! as! indicated.! Where! indicated,! RPA! was! present! at! 27! nM,!
which! is! sufficient! to! fully! cover! the!entire!DNA! in! the! reactions!assuming!all!DNA!
was! single=stranded.! Samples! were! incubated! at! 30°C! for! 30! min,! reaction! was!
stopped! by! adding! an! equal! amount! of! formamide! dye! (95%! (v/v)! formamide,! 20!
mM!EDTA,!0.01%!bromophenol!blue),! samples!were!heated!at!95°C! for!4!min!and!
separated! on! 20!%! denaturing! polyacrylamide! gels! (ratio! acrylamide:bisacrylamide!
19:1,!Biorad).!After!fixing!in!a!solution!containing!40%!methanol,!10%!acetic!acid!and!
5%!glycerol!for!30!min,!the!gels!were!dried!on!DE81!chromatography!paper!(What=
man),!and!exposed!to!storage!phosphor!screens!(GE!Healthcare).!The!screens!were!
scanned!by!Typhoon!phosphor!imager!(GE!Healthcare).!!
!
Replication!assays!
Replication! assays! with! plasmid=based! substrates! were! performed! similarly! as! de=
scribed!previously!(32)!in!a!15!μl!volume!in!25!mM!Tris=acetate!pH!7.5,!10!mM!mag=
nesium!acetate,!125!mM!NaCl,!1!mM!ATP,!1!mM!dithiothreitol,!0.1!mg/ml!BSA!(New!
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England! Biolabs),! 1! mM! phosphoenolpyruvate,! 80! U/ml! pyruvate! kinase,! 100! μM!
dNTPs!(each)!and!6.4!nM!(molecules,!100!ng)!ssDNA!substrate.!PCNA!(20!nM),!RFC!
(20!nM)!and!RPA!(1!μM,!concentration!saturating!100%!of!DNA)!were!added!to!the!
reaction!and!preincubated!for!1!min!at!30!°C.!Pol!δ!(5!nM),!Dna2!and/or!yeast!Fen1!
(concentrations!as!indicated!in!figures!or!figure!legends)!and!Lig1!(20!nM)!were!then!
added!and!the!reactions!were! incubated,! if!not! indicated!otherwise,!at!30°C!for!60!
min.!!The!reactions!were!stopped!by!adding!5!μl!of!2%!stop!solution!(150!mM!EDTA,!
2%!SDS,!30%!glycerol,!bromophenol!blue)!and!1!μl!proteinase!K!(20.3!mg/ml,!Roche)!
for!10!min!at!30°C!and! separated!on!1%!agarose!gels! containing!GelRed! (1:10,000!
v/v,!Biotinum).!Gels!were!analyzed!by!an!AlphaImager!gel!imaging!system.!!
!
Pulldown!assays!
To!test!for!interactions!between!Dna2!and!RPA!or!PCNA,!2!μg!of!recombinant!Dna2!
was! diluted! in! Tris=buffered! saline! (TBS,! 50! mM! Tris=HCl,! pH! 7.5,! 150! mM! NaCl),!
bound!to!anti=HA!resin!(25!μl,!Pierce)!and!washed!with!TBS=T!(TBS!containing!0.05%!
Tween!20).!Then,!recombinant!RPA!(1.33!μg)!or!PCNA!(0.34!μg)!were!added!and!the!
resin!was!incubated!at!4°C!for!1!h.!The!resin!was!again!washed!with!TBS=T!and!pro=
teins!were!eluted!with!0.1!M!glycine,!pH!2.5,! according! to!manufacturer's! instruc=
tions.!The!proteins!in!the!eluate!were!analyzed!by!SDS=PAGE!stained!with!silver.!
!
RESULTS!
!
Dna2!cleaves!DNA!flaps!near!their!base!!
Previously,!we!were!able!to!purify!recombinant!S.#cerevisiae!Dna2!with!high!levels!of!
DNA!helicase!and!nuclease!activities! (25,34).!Here!we!tested! the!behavior!of!Dna2!
and!mutant! variants! (Supplementary!Figure!S1A)!on! flapped! substrates! that!mimic!
structures!arising!upon!displacement!synthesis!during!Okazaki! fragment!processing!
(Figure!1A).!We!first!used!a!substrate!with!a!30!nt=long!5'!ssDNA!flap,!and!examined!
the!exact!cleavage!position!by!S.#cerevisiae!Dna2!in!the!presence!of!RPA.!Cleavage!at!
exactly!the!base!of!the!flap!(position!0)!would!produce!a!fragment!of!32!nucleotides!
in! length.! It! is!known!that!Dna2!must! load!onto!the!5'! ssDNA!end,!and!translocate!
along!the!ssDNA!flap!before!cleavage!occurs!(23,35).!We!show!that!wild!type!Dna2!
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protein!efficiently!cleaved!the!flap!at!=1,!0!or!+1!positions!in!most!cases!(Figure!1B,!
cleavage!at! =1!position! leaves!behind!a! flap!of!1!nt! in! length,! cleavage!adjacent! to!
flap! base! within! dsDNA! corresponds! to! +1! position).! ! In! contrast,! nuclease=dead!
(E675A)! and! double=dead! (nuclease! and! helicase=dead,! E675A/K1080E)! Dna2! vari=
ants!did!not! show!any!activity,! demonstrating! that! the! cleavage! is! inherent! to! the!
nuclease! of!Dna2! and!not! a! product! of! a! contamination! (Figure! 1B).! These! results!
differ!from!those!published!previously!(33,35),!which!reported!that!Dna2!only!short=
ens!flaps!up!to!the!length!of!~5=8!nucleotides!in!a!vast!majority!of!cases.!The!position!
of! cleavage!was! unchanged! in!magnesium! concentrations! between! 2! and! 10!mM,!
indicating!that!DNA!melting!near!the!flap!base!cannot!explain!the!observed!position!
of! cleavage! (compare! Figure! 1B!with! Supplementary! Figure! S1C).! A! comparison! of!
DNA! flap!cleavage!by!Dna2!and!Fen1! is! shown! in!Supplementary!Figure!S1D;!Fen1!
cleaves!past!the!flap!just!within!the!dsDNA.!Furthermore,!Dna2!cleaved!the!long!flap!
sequentially,!with!the!first!cut!being!~5=10!nt!away!from!the!flap!end!(Supplemen=
tary! Figure! S1E).! This! is! in! agreement!with! previous! observations! that! Dna2!must!
load!on!a!free!flap!end!and!translocate!along!DNA!before!cleavage!occurs!(35).!RPA!
did!not!stimulate!the!overall!efficiency!of!DNA!cleavage!by!Dna2,!but!promoted!cut=
ting!at!positions!near!the!flap!base!(Figure!1C=E).!Without!RPA,!Dna2!often!cleaved!at!
=1! or! 0! positions,!while! no! cleavage! at! +1! position!was! observed! (Figure! 1C,! right!
part).!Furthermore,!without!RPA,!a!large!fraction!of!the!flap!was!only!cleaved!~20!nt!
away!from!the!flap!base!(Figure!1C,!right!part),! likely!due!to!secondary!structure!in!
the!flap!that!prevents!Dna2!translocation!along!the!ssDNA,!which!is!in!full!agreement!
with!previous!data!(48).!With!RPA,!Dna2!cleaved!majority!of!the!substrate!in!the!vi=
cinity!of!the!flap!base!(Figure!1C,!left!part,!Figure!1E).!We!also!show!that!Dna2!was!
able!to!cleave!an!8!nt=long!flap!in!the!same!manner!as!the!30!nt=long!flap,!but!could!
not!cleave!a!4!nt=long!flap!(Supplementary!Figure!S2A!and!B),!which!is!instead!as!ex=
pected!a!good! substrate! for! Fen1! (Supplementary!Figure!S2C=E).!RPA! inhibited! the!
cleavage!of!the!30!nt=long!flaps!by!Fen1,!while!it!had!no!effect!on!the!processing!of!
the! short! flaps! (Supplementary! Figure! S2C=G),! in! agreement! with! previous! data!
(33,35,49=54).! !The!helicase!activity!of!Dna2!did!not!significantly!affect!the!position!
of!cleavage!(Figure!1F!and!Supplementary!Figure!S3A!and!B).!In!summary,!these!data!
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suggest!that!Dna2!is!able!to!cleave!flaps!of!at!least!8!nt!in!length!at!or!very!near!their!
base.!
!
The!product!of!Dna2!can!be!directly!ligated!!
The! capacity! of! Dna2! to! cut! at! or! near! the! flap! base! prompted! us! to! investigate!
whether!a!fraction!of!the!cleaved!flaps!can!be!ligated!by!the!cognate!Lig1.!Previous=
ly,! it!was!shown!not!to!be!the!case!as!Dna2!was! leaving!a!~5=8!nt! flap!behind!that!
prevented! ligation! in! a! vast!majority! of! cases! (33).! This! gave! rise! to! the! two=step!
model!where!a!second!nucleolytic!activity!was!needed!(33).!We!show!in!Figure!2A=C!
that!~10=15%!of!the!cleaved!flap!structures!could!be!directly! ligated!by!Lig1,!which!
corresponded!to!the!flaps!cleaved!exactly!at!the!base!(position!"0"!in!Figure!2B).!RPA!
moderately!increased!ligation!efficiency!(Figure!2C,!primary!data!for!reactions!with=
out!RPA!not! shown),!while! the!helicase!of!Dna2!had!no!effect! (Figure!2D;! Supple=
mentary!Figure!S3C).!Furthermore,!~15=25%!of!8!nt=long!flap!structures!cleaved!by!
either!wild!type!or!helicase=dead!Dna2!were!ligated!by!Lig1!as!well!(Supplementary!
Figure! S4A=D,!primary!data! for! reactions!without!RPA!not! shown).! In! contrast,! the!
nuclease!activity!of!Fen1!resulted!in!almost!undetectable!ligation!efficiency!on!4!nt!
or! longer! flaps! (~1%!product,! Supplementary!Figure!S5A!and!B).!This! is!most! likely!
due! to! the! fact! that!Fen1!predominantly! cleaves!DNA!not!exactly!at! the! flap!base,!
but!just!inside!dsDNA!(+1!position,!Supplementary!Figure!S1D),!and!this!cleavage!po=
sition!does!not! produce! a! substrate! for! Lig1.! In! accord,! Fen1! is! known! to!prefer! a!
substrate!containing!an!additional!1!nt!3'!flap!(55).!Taken!together,!these!data!indi=
cate!that!a!fraction!of!flap!structures!cleaved!by!Dna2!exactly!at!their!base!(~15=20%)!
can!be!directly!ligated!by!Lig1.!The!nuclease!but!not!the!helicase!of!Dna2!is!essential!
for!this!process.!!
!
Dna2!is!highly!efficient!in!flap!processing!during!replication!
In!replication,!the!processing!of!flap!structures!occurs!coupled!with!DNA!synthesis!by!
pol! δ! (1).! It! was! shown! that! pol! δ! can! accommodate! for! inaccurate! cleavage!
(9,32,56,57).!Hence,!flap!cleavage!at!the!+1!position!(in!dsDNA),!can!be!coupled!with!
1!nt!synthesis!by!pol!δ,!which!creates!a!ligatable!substrate!(9).!Likewise,!cleavage!at!=
1!position!(leaving!behind!a!1!nt!flap)!can!be!accommodated!by!the!proofreading!3'!=!
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5'!exonuclease!activity!of!pol!δ.!By!going!1!nt!backwards,! the!exonuclease!of!pol!δ!
likewise! leads! to! a! ligatable! substrate! (57).!We! expressed! and! purified! the! three=
subunit!pol!δ,!PCNA!and!RFC!to!test!whether!Dna2!on!its!own!can!mediate!efficient!
flap!processing!in!the!context!of!ongoing!DNA!replication.!Previously,! it!was!shown!
that! Dna2!was! required! for! cleavage! of! exclusively! long! flaps! (e.g.! 30! nt)! that! are!
bound!by!RPA,!and!efficient!maturation!was!only!achieved!in!conjunction!with!Fen1!
(32,33).!We!used!a!plasmid!based!ssDNA!substrate!with!a!primer!containing!30!nt=
long!ssDNA!flap!(Figure!3A;!Figure!3B,!lane!2).!Pol!δ!in!conjunction!with!RFC,!PCNA,!
RPA! and! Lig1! efficiently! synthesized! DNA! (Figure! 3B,! lane! 3,! open! circular! DNA,!
ocDNA),!but!no!covalently! closed! supercoiled!DNA! (scDNA)!was!detected,! showing!
that!the!flap!structure!prevented!ligation.!As!shown!in!Figure!3B,!lanes!4=8,!supple=
menting! the! reactions! further!with!Dna2! resulted! in!nearly! complete!Okazaki! frag=
ment! maturation! already! at! sub=nanomolar! Dna2! concentrations! (see! also! Figure!
3C).!DNA!synthesis!was!fully!dependent!on!the!presence!of!pol!δ,!PCNA,!RFC!and!RPA!
but!did!not!require!Lig1,!while!generation!of!scDNA!required!additionally!both!Dna2!
and!Lig1!(Figure!3D).!The!same!results!were!obtained!when!we!used!a!substrate!with!
a!12!nt=long! flap! (Supplementary!Figure!S6A=D).!Nuclease=!and!helicase=dead!Dna2!
was!not!able!to!support!the!reactions!(Figure!3E,!Supplementary!Figure!S6E).!When!
using!a!substrate!without!a!flap,!the!maturation!was!fully!independent!of!Dna2!(Fig=
ure!3F),!as!expected,!but! still! required!all!other! components! (Figure!3G).!Next,!we!
tested!to!which!extent!the!Okazaki!fragment!maturation!activity!of!Dna2!is!depend=
ent!on!the!proofreading!exonuclease!of!pol!δ.!To!this!point,!we!substituted!wild!type!
pol!δ!with!3'!exo=!pol!δ!variant,!Pol3(D520V),! in! the! replication!assays! (Figure!4A).!
The!generation!of!scDNA!was!strongly! inhibited! in!the!absence!of!the!pol!δ!exonu=
clease!(Figure!4B,! lane!14!and!Figure!4C),!showing!that!the!proofreading!activity!of!
pol!δ!is!very!important!for!flap!processing!during!DNA!replication!in!conjunction!with!
Dna2,!in!accord!with!a!previous!study!(57).!
Fen1,!in!contrast,!was!unable!to!process!the!30!nt=long!flap!in!the!presence!of!RPA!
(Supplementary!Figure!S7A!and!B),!while! it!very!efficiently!supported!the!reactions!
with!a!4!nt=long!flapped!substrate!(Supplementary!Figure!S7C=E)!and!to!a!lesser!de=
gree!reactions!with!a!12!nt=long!flaps!(Supplementary!Fig.!S7F=H)!as!expected!(58).!!
Furthermore,!Fen1!was!fully!incapable!to!process!the!4!nt=long!flaps!without!the!3'!
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exonuclease!of!pol!δ!!(Supplementary!Figure!S7J=K),!most!likely!due!to!the!increased!
strand!displacement!activity!that!was!described!for!the!Pol3=DV!mutant!(57).!Genetic!
studies!showed!that!rad27Δ#pol3)DV!cells!grow!very!slowly!and!an!additional!dele=
tion!of!rad51!is!lethal!(56,57).!However,!the!lethality!of!the!rad27Δ#pol3)DV#rad51Δ#
triple!mutant!can!be!rescued!by!overexpression!of!Dna2,!suggesting!that!Dna2!can!
process!these!flaps!in!the!absence!of!Fen1!(57).!Our!experiments!demonstrate!that!
Dna2!in!concert!with!DNA!replication!is!highly!efficient!in!flap!processing!as!a!single!
nuclease,!thus!suggesting!that!Dna2!may!function!in!Okazaki!fragment!maturation!as!
the!sole!flap!processing!enzyme.!
!!
Dna2!does!not!function!with!Fen1!in!a!concerted!manner!
Our!data!so!far!indicated!that!the!Dna2!nuclease!was!remarkably!capable!of!promot=
ing!flap!processing!during!DNA!replication.!To!test!whether!Fen1!can!further!stimu=
late!the!ligation!efficiency!in!conjunction!with!Dna2,!we!combined!the!two!nucleases!
together!with!RPA!and!Lig1!on! the!30!nt=long! flap!oligonucleotide=based!substrate!
(Figure!5A).!As!shown!in!Figure!5B!and!C,!the!presence!of!Fen1!lowered!ligation!effi=
ciency!from!~15%!to!~5%!in!a!Fen1!concentration=dependent!manner,!in!accord!with!
the!observed!cleavage!position!of!Fen1!that!precludes! ligation!(Supplementary!Fig=
ure!1D).!!
We! next! analyzed! the! activity! of! Fen1! and! Dna2! in! replication=coupled! assays! on!
plasmid!based!DNA!substrates.!As!Fen1!was!incapable!to!process!the!30!nt!flapped!
substrates! (Supplementary!Figure!S7A!and!B),!we!tested!whether! it!could!promote!
the!production!of!covalently!closed!DNA! in!concert!with!Dna2.!Using!a! suboptimal!
Dna2!concentration!(0.13!nM),!we!show!in!kinetic!assays!that!an!equimolar!concen=
tration!of!Fen1!had!no!effect!on!the!ligation!efficiency!(Figure!5D,!E!and!G).!When!a!
10=fold!higher!Fen1!concentration!was!used,!a!moderate!stimulation!of!the!reaction!
was!observed!(Figure!5F!and!G).!Therefore,!Fen1!was!able!to!complete!the!flap!pro=
cessing!downstream!of!Dna2!in!some!cases.!We!showed!above!that!Dna2!cleaves!the!
flap!sequentially;!thus,!we!believe!that!Fen1!could!process!the!flaps!that!were!previ=
ously!shortened!by!Dna2.!The!fact!that!the!stimulation!occurred!at!Fen1!concentra=
tions! that! exceeded! those! of! Dna2! argues! against! the! notion! that! both! enzymes!
function!in!a!coordinated!manner.!However,!this!assumes!that!both!protein!prepara=
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tions!contain!an!identical!proportion!of!an!active!enzyme.!To!study!the!effect!of!Fen1!
on!flap!processing!by!Dna2!in!more!detail,!we!next!performed!experiments!with!an!
even! lower!Dna2! concentration! (32!pM),! and! titrated! Fen1! into! the! reactions.!We!
observed!that!Fen1!promoted!the!formation!of!covalently!closed!DNA!at!concentra=
tions!equal!or!higher!than!128!pM!(Supplementary!Figure!S8A=C).!However,!very!sim=
ilar!Fen1!concentrations!promoted!the!4!nt=long!flap!processing!without!Dna2!(Sup=
plementary!Figure!S7C=E).!In!case!of!a!concerted!reaction,!we!would!expect!Fen1!be=
ing!more!efficient!in!reactions!with!Dna2!rather!then!on!its!own,!which!was!not!the!
case.!We!conclude! that!Dna2! is! sufficient! for!Okazaki! fragment!processing! in!most!
cases!on!its!own!without!Fen1.!However,!we!do!not!exclude!that!Fen1!can!function!
downstream!of!Dna2!in!a!small!number!of!cases!when!either!Dna2!does!not!cleave!
near! the!base!of! the! flap,!or!when!pol!δ!displaces! the!annealed!5'!end!upon!Dna2!
cleavage! before! ligation! occurs.! In! accord,! we! observed! that! Fen1! but! not! Dna2!
could!promote!processing!of!a!substrate!without!a!flap!(Supplementary!Figure!S9A=
E).! These! results! collectively! argue! against! the! requirement! for! a! cooperation! be=
tween!Dna2!and!Fen1! in!flap!processing!and!rather!suggest!that!their!action! is!not!
concerted!in!most!cases.!
PCNA!has!a!central!function!in!lagging!strand!DNA!replication!as!it!interacts!with!RFC,!
pol!δ,!Lig1!and!Fen1!(7,8,10,11,13,14).!PCNA!also!stimulates!Fen1!activity!(54).!PCNA!
thus!not!only!promotes!DNA!synthesis!by!pol!δ!as!a!processivity!factor!(9),!but!also!
serves!as!a!docking!platform! for! factors! required! for!Okazaki! fragment!maturation!
(59).!We!show!in!Supplementary!Figure!10!that!Dna2!can!also!directly!interact!with!
PCNA! under! physiological! salt! concentrations.! In! addition,! as! demonstrated! previ=
ously!(60),!we!confirm!that!Dna2!interacts!with!RPA!(Supplementary!Figure!S10).!The!
observation!that!Dna2!binds!PCNA!is!in!accord!with!human!DNA2,!which!was!found!
to!be! in! complex!with! replication! component!And=1! in# vivo# (61).! Thus,!our!data! in!
conjunction!with!previous!work!suggest!a!model!(Figure!6)!where!Dna2!is!primarily!
responsible!for!the!processing!of!long!DNA!flaps!coated!with!RPA.!This!is!facilitated!
by! the!direct! interaction!between!Dna2!and!RPA,! and! the! capacity!of!Dna2! to!de=
grade!RPA=coated!ssDNA!more!rapidly!than!naked!DNA!(10,12,34,35,60,62).!Fen1!is!
primarily!responsible!for!short!flaps,!and!is!recruited!to!those!via!its!structure!specif=
ic!DNA=binding!capacity!(32,35,50).!The!polymerase!and!3'=5'!exonuclease!of!pol!δ!is!
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then! required! in!most! cases! downstream! of! both! Dna2! and! Fen1! before! adjacent!
fragments!can!be!sealed!by!Lig1!(9,57).!!
!
DISCUSSION!
!
Synthesis!of!the! lagging!DNA!strand!is!discontinuous!and!occurs! in!short!fragments!
of! ~200! nt! in! length.! In! order! to! complete! DNA! replication,! the! adjacent! Okazaki!
fragments!must!be!ligated!to!achieve!integrity!of!the!nascent!DNA.!Direct!ligation!is!
often!not!possible!due!the!displacement!synthesis!of!the!lagging!DNA!strand!pol!δ,!
which! leads! to! flap!structures!of!various! lengths! (1,2).! It!has!been!established! that!
Fen1! cleaves! short! flaps! that! are!not!bound!by!RPA! (33).! The! strand!displacement!
activity!of!pol!δ,! in!concert!with!the!Pif1!helicase,!can! lead!to! longer! flaps!that!be=
come! a! substrate! for! RPA! (26).! Binding! of! ssDNA! by! RPA! inhibits! the! cleavage! by!
Fen1!(33).!It!has!been!proposed!that!the!nuclease!of!Dna2!is!specifically!involved!in!
the!processing!of!these!RPA=bound!long!flaps!(32,33).! Importantly,! it!has!been!pre=
sented!that!Dna2!only!shortens!long!flaps!to!~5=8!nucleotides.!In!previous!prepara=
tions!of!Dna2,!only!a!very!small!proportion!of!flaps!was!cleaved!at!the!base,!which!
was!attributed!to!the!dsDNA!melting!capacity!of!RPA!at!low!magnesium!concentra=
tions,!which! creates! a! substrate! that!Dna2! can! cut! (63).! Therefore,! Fen1!was! pro=
posed!to!function!downstream!of!Dna2!(33,35).!This!hypothesis!was!however!in!con=
trast!with!the!viability!of!rad27Δ!but!lethality!of!dna2Δ#mutants!(19,36=38).!Previous=
ly,!we!characterized!recombinant!Dna2!that!exhibited!vigorous!nuclease!and!helicase!
activities!(25).!Here!we!show!that!recombinant!Dna2!cleaves!efficiently!DNA!directly!
at!or!on!either!side!of!the!flap!base!(Figure!1).!The!cleavage!of!DNA!by!Dna2!is!un=
changed! in!magnesium!concentrations!up!to!10!mM!and!requires!the!nuclease!but!
not!the!helicase!activity!of!Dna2.!A!fraction!of!flaps!that!are!cleaved!precisely!at!their!
base!can!be!directly! ligated!by!Lig1!(Figure!2).!When!coupled!with!DNA!replication,!
Dna2!was!remarkably!effective!in!flap!processing!by!allowing!a!nearly!complete!Oka=
zaki!fragment!maturation!at!sub=nanomolar!concentrations!(Figure!3),!supported!by!
the! polymerase! and! 3'=5'! exonuclease! activities! of! pol! δ! (Figure! 4)! (9,57).! This!
showed!that!in!most!cases!the!activity!of!Fen1!downstream!of!Dna2!is!not!required,!
arguing!against!the!two=nuclease!model.!We!showed!that!adding!Fen1!to!Dna2!reac=
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tions!only!led!to!an!increase!in!ligation!efficiency!when!Fen1!concentration!exceeded!
that!of!Dna2,!and!we!failed!to!obtain!evidence!for!cooperativity!between!Fen1!and!
Dna2!(Figure!5).!Our!results!thus!demonstrate!that!Fen1!does!not!promote!the!pro=
cessing!of!a!large!fraction!of!long!flaps!by!Dna2!and!suggest!that!Dna2!can!function!
in!Okazaki!fragment!processing!as!the!sole!nuclease.!However,!we!believe!that!Fen1!
can!still! function!downstream!of!Dna2! in!cases!when!Dna2!cleaves!the!flap! inaccu=
rately!or!when!5'!strand!displacement!occurs!again!upon!Dna2!cleavage!before!the!
fragments!are!ligated.!!
Dna2! in!multiple!organisms!was!proposed! to!be!part!of! the! replication!complex.! It!
has!been!shown!that!Xenopus#laevis!Dna2!is!forming!a!complex!with!Mcm10!(mini=
chromosome!maintenance!complex!component!10)!and!human!Dna2!was!found!to!
be! in! complex! with! And=1! during! G1/S! transition! (61,64).! Here! we! report! that! S.#
cerevisiae!Dna2! interacts!with!PCNA! (Supplementary! Figure! S10),! similarly! to! Fen1!
(10,12).!This,!together!with!previously!published!data,!might!suggest!that!Dna2!and!
Fen1!travel!with!the!DNA!replication!machinery!as!components!of!the!Okazaki!frag=
ment!maturation!complex.!Alternatively,!Dna2!can!be!recruited!to!gapped!DNA!near!
unprocessed!flaps!via! its! interaction!with!PCNA!post=replicatively.!This! is!supported!
by!our!observation!that!the!levels!of!Dna2!are!low!in!early!S!and!increase!significant=
ly!in!late!S/G2!phase!of!the!cell!cycle!(M.L.!and!P.C.,!unpublished).!This!contrasts!with!
the!expression!profile!of!human!FEN1!that!is!highly!expressed!in!the!G1!and!S!phases!
of!the!cell!cycle!and!gets!rapidly!degraded!in!late!S/G2!(65).!This!would!suggest!that!
Dna2! functions! rather! late! in!DNA!replication! to!cleave! flaps! that!are! refractory! to!
Fen1!and/or!Exo1.!In!accord,!yeast!dna2!mutants!are!proficient!in!bulk!DNA!synthe=
sis,!but!arrest!in!G2/M!phase!of!the!cell!cycle!(21).!Similarly,!replication!fork!progres=
sion! is!not!affected! in!human!cells!upon!DNA2!downregulation;!these!cells!also!ac=
cumulate! in! late! S/G2! (66).! In! contrast! fen1! cells! accumulate! in! S! phase! due! to! a!
block! in!DNA!replication!at!non=permissive!temperature!(67).!Collectively,!we!show!
that!Dna2!can!function!in!flap!processing!independently!of!Fen1.!These!results!are!in!
agreement!with! the! lethality! of!dna2Δ!mutation! (36),! viability! of! rad27Δ#or!exo1Δ!
cells!(37=39),!as!well!as!the!lethality!of!rad27Δ#exo1Δ#double!mutants!(39).!The!flap!
processing!activity!of!Dna2!described!here!may!also!play!a!role!in!other!processes!of!
DNA!metabolism!not!limited!to!DNA!replication.!!!
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FIGURE!LEGENDS!
!
Figure!1.!Dna2!cleaves!DNA!near!a!base!of!a!flap.!(A)!Nuclease!assay.!(B)!Wild!type!
(wt),!nuclease=dead!(E675A)!or!double=dead!(E675A/K1080E,!EA/KE)!Dna2!variants!
(all!2!nM)!were!incubated!with!a!DNA!substrate!containing!a!30!nt=long!flap,!(*,!radi=
oactive!label),!in!the!presence!of!RPA!in!a!buffer!containing!2!mM!magnesium!ace=
tate.!The!reaction!products!were!separated!on!20%!polyacrylamide!denaturing!urea!
gel.!Cleavage!at!the!base!of!the!flap!produces!a!fragment!of!32!nt!in!length!(position!
0).!(C)!Increasing!concentrations!of!Dna2!were!incubated!with!a!substrate!containing!
a!30!nt=long!flap!as!in!(B),!but!in!10!mM!magnesium!acetate!buffer,!with!or!without!
RPA,!as!indicated.!§,!substrate!cleaved!by!Dna2!in!the!absence!of!RPA.!(D)!Quantifi=
cation!of!experiments!such!as!in!(C).!Averages!shown,!n=2;!error!bars,!s.e.m.!(E)!
Quantitation!of!products!cleaved!within!5!nt!of!flap!base!from!(C).!Averages!shown,!
n=2;!error!bars,!s.e.m.!(F)!Experiment!as!in!(C),!but!with!helicase=dead!Dna2!K1080E!
variant!in!the!presence!of!RPA.!!!
!
Figure!2.!The!product!of!Dna2!can!be!directly!ligated.!(A)!Assay.!(B)!Increasing!con=
centrations!of!wild!type!Dna2!were!incubated!with!a!substrate!containing!a!30!nt=
long!flap!with!or!without!Lig1,!in!the!presence!of!RPA.!The!reaction!products!were!
separated!on!a!20%!polyacrylamide!denaturing!urea!gel.!Cleavage!at!the!base!of!the!
flap!produces!a!fragment!of!32!nt!in!length.!Ligation!of!the!cleaved!intermediate!re=
sults!in!a!final!product!of!51!nt!in!length.!(C)!Quantitation!of!data!such!as!in!(B),!with!
wild!type!or!mutants!of!Dna2!(nuclease=dead,!E675A;!helicase!and!nuclease=dead,!
EA/KE).!The!32P!label!was!placed!either!at!the!3'!terminus!of!the!flapped!oligonucleo=
tide!or!at!the!5'!terminus!of!the!upstream!primer.!Averages!shown,!n=2;!error!bars,!
s.e.m.!(D)!Quantitation!of!experiments!such!as!in!(B),!but!with!helicase=dead!Dna2!
K1080E.!The!32P!label!was!placed!either!at!the!3'!terminus!of!the!flapped!oligonucle=
otide!or!at!the!5'!terminus!of!the!upstream!primer.!Averages!shown,!n=2;!error!bars,!
s.e.m.!
!
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Figure!3.!Dna2!is!highly!efficient!in!flap!processing!during!replication.!(A)!Replication!
assay.!See!'Materials!and!Methods'!for!details.!(B)!Dna2!is!required!for!the!comple=
tion!of!replication!of!a!substrate!containing!a!5'!ssDNA!flap!of!30!nt!in!length.!Reac=
tions!contained!pol!δ,!PCNA,!RFC,!RPA,!Lig1!and!Dna2!as!indicated.!Positions!of!sub=
strate!ssDNA,!open!circular!intermediate!(ocDNA)!and!closed!circular!supercoiled!
final!product!(scDNA)!are!indicated.!Final!product!appears!in!a!Dna2!concentration!
dependent!manner.!(C)!Quantitation!of!data!such!as!in!(B).!Averages!shown,!n=3;!
error!bars,!s.e.m.!(D)!Pol!δ,!RFC,!PCNA!and!RPA!are!required!for!DNA!synthesis,!Dna2!
and!Lig1!for!the!formation!of!scDNA!product.!A!“complete”!reaction!contained!all!
components!as!described!in!(B)!without!Dna2.!Proteins!were!omitted!from!the!reac=
tions!as!indicated.!(E)!Nuclease!activity!of!Dna2!is!required!for!flap!processing.!Nu=
clease=!and!helicase=dead!Dna2!E675A/K1080E!variant!was!used!where!indicated.!(F)!
Same!assay!as!in!(E),!but!using!a!substrate!without!a!flap.!Dna2!was!not!required!for!
the!processing!of!the!flap=less!substrate.!A!“complete”!reaction!contained!all!com=
ponents!as!described!in!(B)!without!Dna2.!Marker,!a!sample!containing!DNA!species!
corresponding!to!scDNA,!linear!DNA!and!ocDNA.!(G)!Replication!assay!with!a!flap=
less!substrate.!Protein!components!were!omitted!from!the!reactions!where!indicat=
ed.!A!“complete”!reaction!contained!all!components!as!described!in!(B)!without!
Dna2.!
!
Figure!4.!Effect!of!pol!δ!exonuclease!activity!on!Okazaki!fragment!processing!by!
Dna2!and!Fen1.!(A)!Replication!assay!with!a!30!nt=long!flapped!primer.!(B)!Reactions!
contained!RFC,!PCNA,!RPA,!Lig1!and!Dna2,!where!indicated.!Pol!δ!wild!type!or!the!
exonuclease=deficient!mutant!(pol!δ!exo−)!were!titrated!into!the!reactions.!Positions!
of!substrate!ssDNA,!open!circular!intermediate!(ocDNA)!and!closed!circular!super=
coiled!final!product!(scDNA)!are!indicated.!In!the!presence!of!pol!δ!exo−,!Dna2!stimu=
lates!the!completion!of!replication!only!to!a!minor!extent.!(C)!Quantitation!of!data!
such!as!in!(B).!Averages!shown,!n=2;!error!bars,!s.e.m.!!
!
Figure!5.!Effect!of!Fen1!on!the!flap!processing!by!Dna2.!(A)!Assay.!(B)!Increasing!con=
centrations!of!Fen1!were!used!to!supplement!reactions!containing!RPA,!and!Dna2!or!
Lig1!as!indicated.!The!presence!of!Fen1!led!to!a!decrease!of!the!final!ligated!reaction!
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!
product.!(C)!Quantitation!of!data!such!as!in!(B).!Averages!shown,!n=2;!error!bars,!
s.e.m.!(D)!Replication!assay.!(E)!Kinetic!replication!reactions!contained!pol!δ,!PCNA,!
RFC,!RPA,!Lig1!and!either!0.13!nM!Dna2!(left!part),!or!0.13!nM!Dna2!and!0.13!nM!
Fen1!(right!part).!Positions!of!substrate!ssDNA,!open!circular!intermediate!(ocDNA)!
and!closed!circular!supercoiled!final!product!(scDNA)!are!indicated!on!the!right.!
Samples!were!terminated!at!various!time!points,!as!indicated.!(F)!Same!assay!as!in!
(E)!but!with!0.13!nM!Dna2!and!1.3!nM!Fen1.!(G)!Quantitation!of!experiments!such!as!
in!(E)!and!(F)!Averages!shown,!n=3;!error!bars,!s.e.m.!!!
!
Figure!6.!Model!of!Okazaki!fragment!processing!in!eukaryotes.!In!cases!when!flaps!
formed!upon!the!strand!displacement!activity!of!pol!δ!are!long!enough!to!bind!RPA,!
Dna2!alone!is!primarily!responsible!for!their!processing!in!most!cases!(left).!Short!
flaps!are!primarily!processed!by!Fen1,!Exo1!or!possibly!other!nucleases!(middle!and!
right).!See!text!for!details.!
!
!
!
!
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Supplementary Figure 1. Flap cleavage by Dna2 and Fen1. (A) Coomassie stained polyacrylamide 
gel showing purified wild type Dna2 (wt), Dna2 E675A (nuclease-dead variant), Dna2 K1080E 
(helicase-dead variant), Dna2 E675A/K1080E (EA/KE, helicase- and nuclease-dead variant) and 
RPA (Rfa1, Rfa2, Rfa3 subunits) used in this study. (B) Nuclease assay. (C) Experiment as in Figure 
1B, but in a buffer containing 10 mM magnesium acetate. (D) Experiment as in (C) showing a 
comparison of Dna2 and Fen1 nuclease activities. Lane 2, Dna2 (2 nM), with RPA. Lane 3, Fen1 (8 
nM), no RPA. (E) Experiment as in (C), but with a 30 nt flapped substrate where the 32P label was 
placed at the 5’ terminus of the downstream primer. Various concentrations of wt Dna2 in the 
absence or presence of RPA and ATP were used, as indicated.  
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Supplementary Figure 2. Cleavage of various flapped substrates by Dna2 and Fen1. (A) Experiment 
as in Figure 1C, but with a DNA substrate containing an 8 nt-long flap. Dna2 is able to cleave flaps of 8 
nt in length. (B) Experiment as in Figure 1C, but with a DNA substrate containing a 4 nt-long flap. Dna2 
is not able to cleave short flaps of 4 nt in length. (C) Various concentrations of Fen1 protein were 
incubated with a substrate containing either a 4 nt- or 8 nt-long flap, with or without RPA, as indicated. 
Cleavage at the base of the flap would produce a DNA fragment of 32 nt in length. Fen1 preferentially 
cleaves DNA beyond the flap base within the dsDNA region. (D) Quantitation of 4 nt-long flapped 
substrate degradation by Fen1 from experiments such as in (C). Averages shown, n=2; error bars, 
s.e.m. (E) Quantitation of 8 nt-long flapped substrate degradation by Fen1 from experiments such as in 
(C). Averages shown, n=2; error bars, s.e.m.  (F) Experiment as in (C), but with a 30 nt-long flapped 
substrate. (G) Quantitation of experiments such as in (F). Averages shown, n=2; error bars, s.e.m.   
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Supplementary Figure 3 
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Supplementary Figure 3. Cleavage and ligation of DNA flaps by helicase-dead Dna2. (A) 
Experiment as in Figure 1C, but with a helicase-dead Dna2 K1080E variant, without RPA. *, 
Substrate cleaved by Dna2 in the absence of RPA. The helicase activity of Dna2 does not affect 
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K1080E.  
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Supplementary Figure 4. Processing of 8 nt-long flaps by Dna2 and Lig1. (A) Experiment as in 
Figure 2B, but with a DNA substrate containing an 8 nt-long flap. (B) Quantitation of experiments 
such as in (A). Averages shown, n=2; error bars, s.e.m. (C) Experiment as in Figure 2B, but with 
a DNA substrate containing an 8 nt-long flap, and helicase-dead Dna2 K1080E. (D) Quantitation 
of experiments such as in (C). Averages shown, n=2; error bars, s.e.m.   
 
	  	  	  
	  104	  
	   RESULTS	   	  	   	  
Supplementary figure 5 
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Supplementary Figure 5. Cleavage of flapped substrates by Fen1 does not efficiently produce a 
substrate for Lig1. (A) Increasing concentrations of Fen1 were incubated with a substrate containing 
either a 4 nt- or 8 nt-long flap with or without Lig1 in the absence of RPA. Cleavage at the base of the 
flap would produce a fragment of 32 nt in length. Ligation of the cleaved intermediate would result in a 
final product of 51 nt in length. (B) Experiment as in (A), but with a 30 nt-long flapped substrate.  
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Supplementary Figure 6. Processing of 12 nt-long flaps by Dna2 during DNA replication. (A) Replication 
assay. (B) Experiment as in Figure 3B, but with a DNA substrate containing a 12 nt-long flap. (C) 
Quantitation of data such as in (B). Averages shown, n=2; error bars, s.e.m. (D) Pol δ, RFC, PCNA and 
RPA are required for DNA synthesis, Dna2 and Lig1 for the formation of scDNA product. A “complete” 
reaction contained all components as described in (B) without Dna2. Proteins were omitted from the 
reactions as indicated. (E) Nuclease activity of Dna2 is required for flap processing during replication. 
Nuclease- and helicase-dead Dna2 E675A/K1080E variant was used where indicated. 
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Supplementary Figure 7. Analysis of a flap endonuclease activity of Fen1 during DNA replication.  
(A) Replication assay with a 30 nt-long flapped primer. (B) Reactions contained pol δ, PCNA, RFC, RPA, 
Lig1 and Fen1 as indicated. Positions of substrate ssDNA, open circular intermediate (ocDNA) and closed 
circular supercoiled final product (scDNA) are indicated. Fen1 is unable to promote completion of replication. 
(C) Replication assay with a 4 nt-long flapped primer. (D) Same experiment as in (B), but with a 4 nt flapped 
primer. Final product appears in a Fen1 concentration-dependent manner. (E) Quantitation of experiments 
such as in (D). Averages shown, n=2; error bars, s.e.m. (F) Replication assay with a 12 nt-long flapped 
primer. (G) Same experiment as in (B), but with a 12 nt flapped primer. Final product appears in a Fen1 
concentration-dependent manner. (H) Quantitation of experiments such as in (G). Averages shown, n=2; 
error bars, s.e.m. (I) Replication assay with a 4 nt-long flapped primer. (J) Experiment as in Figure 4B, but 
with a 4 nt flapped primer substrate and Fen1 instead of Dna2. No scDNA product is detectable with pol δ 
exo− and Fen1. (K) Quantitation of data such as in (J). Averages shown, n=2; error bars, s.e.m.  
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Supplementary figure 8 
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Supplementary Figure 8. Fen1 moderately promotes flap processing activity of Dna2 in some cases. 
(A) Replication assay. (B) Replication reactions contained pol δ, PCNA, RFC, RPA, Lig1, Dna2 and 
Fen1 at indicated concentrations. Positions of substrate ssDNA, open circular intermediate (ocDNA) 
and expected closed circular supercoiled final product (scDNA) are indicated. Addition of at least 128 
nM Fen1 moderately stimulated the appearance of the scDNA product. (C) Quantitation of 
experiments such as in (B). Averages shown, n=2; error bars, s.e.m.     
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Supplementary figure 9 
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Supplementary Figure 9. Fen1 moderately promotes replication of a substrate containing a primer 
without a flap. (A) Replication assay. (B) Kinetic replication reactions contained pol δ, PCNA, RFC, 
RPA and Lig1. Positions of substrate ssDNA, open circular intermediate (ocDNA) and closed circular 
supercoiled final product (scDNA) are indicated on the right. Samples were terminated at various time 
points, as indicated. (C) Experiment as in (B), but also containing Dna2 (0.5 nM). Addition of Dna2 
had not effect on the kinetics of appearance of scDNA product. (D) Experiment as in (B), but also 
containing Fen1 (0.5 or 5 nM). Addition of 5 nM Fen1 moderately accelerated the appearance of 
scDNA product. (E) Quantitation of experiments such in (B), (C) and (D). Averages shown, n=2; error 
bars, s.e.m.     
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Supplementary figure 10 
Supplementary Figure 10. Dna2 directly interacts with PCNA. Purified recombinant HA-tagged Dna2 
was bound to anti-HA resin, and incubated (lanes 3 and 6) or not (lane 2) with recombinant RPA or 
PCNA, respectively. RPA and PCNA do not bind to anti-HA resin alone (lanes 4 and 7). Controls, 
recombinant RPA (80 ng, lane 5) and PCNA (20 ng, lane 8). *, degradation product of Dna2. Rfa1, Rfa2 
and Rfa3 are the three subunits of RPA. Shown is a silver-stained polyacrylamide gel representative of 
three independent experiments.  
	  
	  110	  
	   RESULTS	   	  	   	  	  
2.2.4	  The	  helicase	  activity	  of	  S.	  cerevisiae	  Dna2	  acts	  as	  a	  ssDNA	  translocase	  and	  
promotes	  ssDNA	  degradation	  	  
Maryna	  Levikova	  and	  Petr	  Cejka.	  	  
	  
	  
Manuscript.	  
	  
	  
I	  designed	  the	  research	  together	  with	  P.C.	  and	  performed	  the	  experiments	  with	  the	  help	  
of	  P.C.	  I	  analyzed	  the	  data	  together	  with	  P.C.	  and	  wrote	  the	  manuscript.	  	  
	  
	  
	  111	  
	   RESULTS	   	  	   	  
	  
!
!
The$helicase$activity$of!S.!cerevisiae$Dna2$acts$as$ssDNA$translocase$
and$promotes$ssDNA$degradation$
! !
Maryna$Levikova$and$Petr$Cejka!
!
Institute! of! Molecular! Cancer! Research,! University! of! Zurich,! Winterthurerstrasse!
190,!8057!Zurich,!Switzerland!
!
!
!
Key!words:!DNA!helicase!/!DNA!nuclease!/!Dna2!/!ssDNA!translocase!/!DNA!resection!!
!
!
!
!
!
!
Address!correspondence!to:!Petr!Cejka,!Institute!of!Molecular!Cancer!Research,!UniN
versity!of!Zurich,!Winterthurerstrasse!190,!Zurich,!8057.!Phone:!+41N44N635N4786;!EN
mail:!cejka@imcr.uzh.ch!
!
	  
	  112	  
	   RESULTS	   	  	   	  
 
$
Abstract$
$
Dna2! is! an! essential! nucleaseNhelicase! involved! in!multiple! processes! of! DNA!meN
tabolism.!During!the!initiation!step!of!homologous!recombination,!the!DNA!end!reN
section,! Dna2!was! shown! to! function! together!with! Sgs1! to! degrade! 5'Nteminated!
DNA!ends.!So!far,!the!helicase!activity!of!Dna2!was!reported!to!be!dispensable!for!all!
of!its!functions.!We!show!here!that!efficient!ssDNA!degradation!by!the!Dna2!enzyme!
is! stimulated! by! its!motor! activity! that! acts! as! a! ssDNA! translocase,! rather! than! a!
DNA! helicase.! Furthermore,! RPA! promotes! Dna2Nmediated! ssDNA! degradation! at!
multiple!levels.!Also,!in!reconstituted!DNA!resection!assays!with!Sgs1,!Dna2!helicase!
promotes!DNA!degradation.!Thus,!we!suggest!that!the!motor!activity!of!Dna2!funcN
tions!as!a! ssDNA! translocase! to!enhance! the!degradative!capability!of!Dna2!by!acN
tively!translocating!on!ssDNA!resulting!from!dsDNA!unwinding!by!Sgs1.!!
!
!
!
! !
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Introduction$
!
DNA! helicases! function! in! all! processes! of! DNA! metabolism! that! require! strandN
separation!of!duplex!DNA.!The!majority!of!these!enzymes!unwind!nucleic!acids!with!
either!3'!to!5'!or!5'!to!3'!polarity!by!coupling!ATP!hydrolysis!to!translocation!on!ssDN
NA!(1).!However,!it!is!not!yet!clear!whether!dsDNA!unwinding!by!helicases!is!only!a!
"byproduct"!of!their!translocation!on!ssDNA,!or!whether!it!is!an!additional!process.!
Furthermore,!structurally!similar!enzymes!were!described,!termed!DNA!translocases,!
that! employ! their! ATPase! activity! only! for! the!motion! along! DNA!without! the! unN
winding!reaction!(2).!Hence,!the!difference!between!DNA!helicases!and!ssDNA!transN
locases!is!not!completely!clarified.!!
Dna2!is!an!essential!enzyme!that!possesses!a!RecB!family!nuclease!domain!and!a!helN
icase!activity!provided!by!superfamily!II!helicase!domain!(3N5).!The!helicase!of!Dna2!
has!a!5'!to!3'!polarity!and!is!stimulated!by!replication!protein!A!(RPA),!while!the!nuN
clease!can!act! in!both!directions,!although! in!presence!of!RPA!DNA!degradation!by!
Dna2!is!inhibited!in!the!3'!to!5'!direction!(6,7),!so!Dna2!likely!degrades!DNA!5'!to!3'!
under!physiological!conditions.!However,!although!the!helicase!activity!of!Dna2!was!
recently!shown!to!be!very!strong!and!processive,!it!is!still!masked!by!the!nuclease!of!
the!wild! type!protein! (7).! The!nuclease!activity!of!Dna2! is! essential,!while! the!helN
icase!mutants!(dna2%2)!are!viable,!but!exhibit!growth!defects!and!sensitivity!to!alkylN
ating!agents!and!ionizing!radiation!(8,9).!!
S.( cerevisiae(Sgs1!contains!a! superfamily! II!helicase!domain!with!a!3'! to!5'!polarity!
and! is! a! RecQ! helicase! (10N12).! It! forms! a! complex! with! Top3! and! Rmi1! proteins!
(13,14).!Sgs1!was!shown!to!be!involved!in!homologous!recombination!(HR)!pathway!
at!different!steps:!during!initial!DNA!end!resection!and!later,!in!the!double!Holliday!
junction! dissolution! pathway! (6,15N18).! The! DNA! end! resection! is! carried! out! by!
Sgs1NTop3NRmi1!complex!in!conjunction!with!Dna2!and!RPA:!Sgs1!unwinds!the!DNA!
and!Dna2!degrades!the!5'Nterminated!strand,!thus!producing!RPANcovered!3'!singleN
stranded!overhangs!that!are!required!for!downstream!steps!of!HR!(6,18,19).!HowevN
er,!only!the!nuclease!activity!of!Dna2!was!shown!to!be!required!for!this!function! in(
vivo,!although!the!study!was!carried!out!by!ectopically!overexpressing!Dna2!helicaseN
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dead!variant,!thus!possibly!masking!potential!effects!(18).!Interestingly,!sgs1Δ(dna2%
2!double!mutants!were!more!sensitive!to!ionizing!radiation!than!the!single!mutants,!
indicating!that!Sgs1!activity!is!required!in!absence!of!Dna2!helicase!(8).!Moreover,!a!
recent!study!uncovered!that!Dna2!and!Sgs1!cooperate!in!another!DNA!repair!pathN
way,!namely!during!restart!of!reversed!DNA!replication!forks!by!most!likely!degradN
ing!the!reversed!arm.!Again,!the!helicase!of!Dna2!was!shown!to!be!dispensable!for!
this!activity!(20).!These!findings!raised!the!question!why!Dna2!evolved!such!a!potent!
helicase!activity,!which!is!comparable!to!that!of!Sgs1!(7),!without!any!implications!in(
vivo.!One!possible!hypothesis!originates! from!studies!of! the!nucleaseNhelicase!RecN
BCD!complex! in!bacteria.!RecB!has!a!3'!to!5'!helicase!and!a!nuclease!activity,!while!
the!faster!RecD!translocates!on!the!opposite!strand!with!5'!to!3'!polarity,!thus!coorN
dinating! two!helicase! and!one!nuclease! activity!within! a! functional! unit,! similar! to!
Sgs1NDna2.!Upon!encountering!the!Chi!(crossover!hotspot!instigator)!sequence!RecB!
becomes!the!lead!motor!and!degrades!preferentially!only!the!5'Nterminated!strand.!
The!helicase! activities!within! RecBCD!are! highly! coordinated:! the!RecBCD! complex!
can!clearly!carry!out!functions!that!exceed!the!sum!of!its!parts!(21).!So,!we!decided!
to!test!whether!there!is!any!similar!coordination!between!Sgs1!and!Dna2!activities!as!
well.!!
Here!we! report! that! the!motor! activity! within! the!wild! type! Dna2! protein! greatly!
stimulates!ssDNA!degradation!by!acting!as!a!ssDNA!translocase.!The!nucleolytic!degN
radation!capacity!of!Dna2!is!strongly!dependent!on!the!presence!of!RPA!and!ATP.!In!
in(vitro(reconstituted!resection!assays,!wild!type!Dna2!is!more!efficient!than!the!helN
icaseNdead!variant,!suggesting!that!the!helicase!activity!of!Dna2!promotes!DNA!end!
resection.!!
!
Results$
$
Helicase$activity$of$wild$type$Dna2$promotes$efficient$ssDNA$degradation$
Previously,!we!have!shown!that!our!Dna2!preparations!exhibit!strong!nuclease!and!
helicase! activities! (7).! In! Figure! 1A,! we! confirm! that! wild! type! and! helicaseNdead!
Dna2!efficiently!degrade!a!YNstructure!substrate,!while!nucleaseNdead!Dna2!unwinds!
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it.!In!agreement!with!previous!results!(7),!no!helicase!activity!of!wt!Dna2!is!detectaN
ble!when!using!this!substrate!with!5'!labeled!top!oligonucleotide!and!we!did!not!obN
serve!any!difference! in!DNA!cleavage!when!comparing!wt!Dna2!and!helicaseNdead!
variant! (Fig.! 1A,! left! and!middle!panel).!We!hypothesized! that! the!helicase!activity!
might!become!more!crucial!when!using! longer!ssDNA!substrates!mimicking! the!reN
section!situation!in(vivo,(when!multiple!thousands!of!nucleotides!are!resected.!Next,!
we! explored! the! degradation! of! ssDNA! fragments! of! various! lengths! (between! 0.1!
and!23!kb)!by!wt!Dna2!compared!to!helicaseNdead!Dna2!K1080E!variant!in!a!kinetic!
setup! (Fig.! 1B).! Surprisingly,! we! observed! that! wild! type! Dna2! was! multiple! folds!
faster! in! degradation! of! all! ssDNA! fragments! than! the! helicaseNdead!Dna2! K1080E!
(Fig.!2B!left!compared!to!right!part).!After!4!minutes!almost!all!fragments!were!deN
graded!by!wt!Dna2,!while!Dna2!K1080E!needed!16!minutes!(Fig.!1B,!compare!lanes!5!
and!16).! Taken! together,! these! results! let! us! conclude! that! the!helicase! activity!of!
Dna2!strongly!promotes!degradation!of!long!stretches!of!ssDNA.!!
!
Dna2$can$act$as$an$endonuclease$on$circular$plasmid$DNA$only$in$absence$of$RPA$
Next,!we!wondered!whether!the!fast!ssDNA!degradation!by!wild!type!Dna2!might!be!
achieved! through! its! endonucleolytic! activity,! as! e.g.! human! DNA2! was! shown! to!
cleave! telomeric!G4! quadruplex! structures! endonucleolytically! (22).!We! set! out! to!
test! this!by!using!circular!plasmid!ssDNA!and!dsDNA!substrates! (Figure!2).! In!presN
ence!of!RPA!no!endonuclease!activity!was!observed!on!circular!ssDNA!substrate!with!
wild! type! Dna2! and! its! variants! in! both,! magnesiumN! and! manganeseNcontaining!
buffer!(Figure!2AB).!However,!if!RPA!was!omitted!from!the!reactions,!wild!type!and!
helicaseNDna2!were! able! to! cleave! ssDNA!endonucleolytically,!while! nucleaseNdead!
Dna2!E675A!was!not,! showing! that! the!activity!was! specific! for!Dna2! (Figure!2AB).!
Finally,! Dna2!was! not! able! to! cleave! circular! dsDNA! (Figure! 2C).! Altogether,! these!
experiments!show!that!Dna2!cannot!cleave!DNA!endonucleolytically! in!presence!of!
RPA,!which! the! physiological! condition! in!most! cases.! Thus,! the! observed! efficient!
ssDNA!degradation!by!Dna2!was!not! stimulated!by! its!endonucleolytic!activity!and!
the!enzyme!had!to!initiate!the!cleavage!from!the!free!DNA!end,!as!described!previN
ously!(23).!!
!
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!
ssDNA$translocase$activity$of$Dna2$stimulates$degradation$of$long$DNA$
Next,!we!investigated!what! is!the!length!of!ssDNA!products!generated!by!Dna2.!To!
be!able!to!monitor!the!length!distribution!of!DNA!fragments!processed!by!Dna2!we!
generated!a!randomly!32P!labeled!2.2!kbpNlong!substrate!by!PCR!(see!Materials!and!
Methods! for!details).!This! substrate!was!heated! to!yield!2200!ntNlong!ssDNA,! incuN
bated!with!wt!Dna2!and!K1080E!variant!in!a!kinetic!experiment.!Products!were!sepaN
rated!on!an!agarose!gel! (Fig.!3A).!Wild! type!Dna2!was!again!more!efficient! in!DNA!
degradation! than! the! helicaseNdead! protein! (Fig.! 3A,! compare! 4!min! time! points).!
Moreover,!we!observed!an!additional!band!appearing!above!the!degradation!prodN
uct!"cloud"!produced!by!Dna2!wt,!but!not!by!Dna2!K1080E!(Fig.!3A,!lanes!3N6),!indiN
cating! that! the!product! lengths!might!be!different.!To!better! resolve! these!species!
the!same!reactions!were!separated!on!denaturing!20%!polyacrylamide!urea!gels!(Fig.!
3B).!The!cleavage!pattern!produced!by!Dna2!wt!contained!fragments!ranging!from!5!
to!100!nt!in!length,!appearing!as!a!smear!on!the!gel!(Fig.!3B,!left!panel).!In!contrast,!
Dna2!K1080E!was! less!efficient! in!DNA!degradation!and!yielded!fragments!only!beN
tween!5!and!12!nt!in!length!(Fig.!3B!and!D).!Image!analysis!of!fragment!distribution!
revealed!that!Dna2!wt!first!produces!an!80!ntNlong!DNA!product!that!is!subsequently!
degraded!to!5N12!ntNlong!pieces!(Fig.!3C!left!panel!and!Fig.!3E),!while!ssDNA!degradaN
tion!by!Dna2!K1080E!only!results!in!fragments!of!5N12!nt!in!length!(Fig.!3!right!panel!
and!Fig.!3E).!These!observations!suggested!that!the!ATPNdependent!Dna2!motor!acN
tivity!acts!as!a!ssDNA!translocase!to!promote!efficient!ssDNA!degradation.!This!hyN
pothesis!is!further!supported!by!the!fact!that!in!absence!of!ATP!the!cleavage!pattern!
produced!by!wt!Dna2!is!indistinguishable!from!that!of!Dna2!K1080E!(Fig.!3F).!!!!
!
!RPA$strongly$promotes$fast$ssDNA$degradation$by$Dna2$
RPA!was!shown!to!specifically!interact!with!Dna2!and!to!stimulate!both!its!nuclease!
and! helicase! activities,! especially!when! the! enzyme! acted! on! long!DNA! substrates!
(6,7,24).!To!test!the!contribution!of!RPA!to!ssDNA!degradation!by!wild!type!Dna2!we!
carried!out!experiments!using! the! randomly! labeled!PCRNbased!ssDNA!substrate! in!
the!presence!and!absence!of!RPA!(Fig.!4ANC).!Without!RPA,!the!degradation!of!DNA!
was!slower.!Furthermore,!both!wild!type!and!helicaseNdead!Dna2!were!comparable!
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in!their!capacity!to!degrade!ssDNA!(Fig.!3A!and!B).!Remarkably,!in!reactions!without!
RPA!(but!with!ATP)!wt!Dna2!degraded!DNA!in!a!way!reminiscent!of!the!Dna2!K1080E!
variant!(Fig.!4A!and!C).!This!means!that!RPA!stimulates!the!ssDNA!translocase!activiN
ty! of! Dna2,! which! is! in! agreement! with! previously! published! observations! of! RPA!
promoting!Dna2!helicase!and!ATPase!activities!(7).!!
Next,!as!we!knew!that!Dna2!has!to!start!DNA!degradation!from!the!free!end,!we!inN
vestigated!how!the!size!of!the!initially!cleaved!ssDNA!product!is!influenced!by!both!
RPA!and! the!helicase!activity!of!Dna2.!For! this!purpose!we!used!a!93!ntNlong!DNA!
substrate!labeled!at!the!5'!end!and!monitored!Dna2Nmediated!cleavage!by!separatN
ing!the!products!on!denaturing!urea!gels!(Fig.!4DNF).!Cleavage!by!wild!type!Dna2!in!
presence!of!RPA!led!to!the!appearance!of!two!species:!the!already!known!fragment!
between!5!and!12!nt!in!length!and!a!smaller!amount!of!longer!products!showing!as!a!
smear,! especially! at! earlier! time! points! (Fig.! 4D,! left! gel;! see! lanes! 2N5! for! longer!
products).!However,!without!RPA!the!DNA!degradation!was!very!inefficient!resulting!
only!in!a!small!amount!of!products!between!8!and!100!nt!at!later!time!points!(Fig.!4D!
and!F,!right!gels),!suggesting!that!RPA!additionally!promotes!efficient!recruitment!of!
Dna2! to! the! substrate,! in! agreement! with! previously! published! data! (24).! Finally,!
when!the!helicase!activity!of!Dna2!was!compromised!either!by!absence!of!ATP!(Fig.!
4E)!or!in!a!helicaseNdead!Dna2!variant!(Fig.!4F,!left!part),!only!5N12!ntNlong!fragments!
showed!on!the!gel,!but!not!the!longer!products!that!were!visible!with!the!wild!type!
protein,! supporting! the! notion! that! Dna2!motor! function! acts! as! a! translocase! to!
promote!degradation!of!ssDNA.!These!data!led!us!to!the!model!showed!in!Figure!3G.!
For!fast!ssDNA!degradation,!initiated!by!cuts!that!are!approximately!80!nt!apart!from!
each! other,! Dna2! requires! its! ATPNdependent! helicase/translocase! activity! and! the!
presence! of! RPA.! If! the!motor! activity! is! compromised! by!mutation! or! absence! of!
ATP,!or!RPA!is!omitted,!the!DNA!cleavage!is!slow!and!the!cuts!are!close!to!each!othN
er.!RPA!might!play!here!two!distinct!roles:!it!stimulates!Dna2!recruitment!to!the!subN
strate,!but! it!also!promotes!efficient!translocation!of!Dna2!on!ssDNA!and!substrate!
cleavage.!!
!
!
!
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Resection$by$Sgs1$and$Dna2$is$stimulated$by$Dna2$helicase$$
Dna2! was! shown! to! function! together! with! Sgs1! in! the! resection! of! DNA! breaks!
(6,18).!To!test!whether!the!helicase!activity!also!exhibits!its!stimulatory!effect!when!
Dna2!is!coupled!to!Sgs1!we!performed!an!in(vitro(resection!assay!with!a!2.7!kbpNlong!
substrate!(Fig.!5A!and!B).!Wild!type!Dna2!was!≈2Nfold!more!efficient! in!DNA!resecN
tion!with!Sgs1!than!the!helicaseNdead!Dna2!K1080E!(Fig.!5A!and!B).!We!then!wanted!
to!monitor!the!length!of!produced!DNA!products!by!using!the!randomly!labeled!PCRN
based!substrate!as!a!bluntNended!dsDNA!in!a!kinetic!resection!experiment!(Fig.!5C).!
Moreover,!in!this!assay!we!also!included!other!components!of!the!resection!machinN
ery:!Top3NRmi1!and!Mre11NRad50NXrs2!(6,10,14,18).!Although!no!difference!in!resecN
tion!speed!between!reactions!containing!Dna2!wt!and!K1080E!variant!were!detected!
(Fig.!4C),!we!observed!the!appearance!of!larger!DNA!fragments!with!Dna2!wild!type!
protein! inherent! to! its! translocase!activity! (Fig.!5C! left!gel),!despite!being! less!proN
nounced! than!previously! seen! in! Figure! 2B.! Those! results! can!be! explained!by! the!
fact!that!the!substrate!is!bluntNended!and!MRX!cannot!initiate!the!resection!properly!
without!the!stimulation!of! its!endonuclease!activity!by!Sae2!and!a!protein!block!at!
the!DNA!end,!as!it!was!shown!previously!(25).!Nevertheless,!collectively!these!obserN
vations!imply!that!the!helicase!activity!of!Dna2!also!contributes!to!more!efficient!reN
section!together!with!Sgs1.!
$
Discussion$
$
Dna2!is! involved!in!several!key!processes!of!DNA!metabolism,!including!DNA!repair!
by!homologous!recombination!and!DNA!replication!(6,20,26,27).!So!far,!primarily!the!
nuclease! activity! of!Dna2!was! implicated! to! be! important! to! carry! out! these! funcN
tions!((18,20)!and!(30)NLevikova!and!Cejka,!NAR!2015,!in!press).!However,!in!our!reN
cent!study!we!were!able!to!show!that!Dna2!is!a!very!strong!helicase!and!its!activity!is!
comparable!to!that!of!Sgs1!(7).!In!Figure!1!we!demonstrate!that!the!helicase!activity!
of! wild! type! Dna2! greatly! promotes! ssDNA! degradation.!We! show! then! that! DNA!
degradation!was!not!due!to!the!endonucleolase!activity!of!Dna2,!confirming!that!the!
enzyme!needs!a!free!end!to!engage!(Figure!2).!Furthermore,!we!show!that!efficient!
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nucleolytic!activity!of!Dna2!is!dependent!on!its!ATPNmediated!ssDNA!translocase!acN
tivity!and!the!presence!of!RPA!(Fig.!3!and!4).!RPA!appears!to!promote!ssDNA!degraN
dation! in! two! various!ways:! by! enhanced!Dna2! recruitment! and! by! stimulating! its!
translocase!activity!(Fig.!4).!Our!data!indicate!that!in!absence!of!RPA!Dna2!is! ineffiN
cient!in!DNA!degradation!and!translocation,!as!well!as!that!it! is!capable!of!endonuN
cleolytic! cleavage.! A! recent! study! reported! a! genomeNwide! DNA! replication! fork!
breakage!upon!RPA!exhaustion! in!ATRNdeficient! cells! (28).! Some!of! the!effects!deN
scribed!in!this!study!might!be!thus!attributable!to!altered!Dna2!activity!in!absence!of!
RPA.!Our!in(vitro!resection!assays!indicate!that!Dna2!helicase!activity!promotes!DNA!
end!degradation! in! conjunction!with! Sgs1! (Fig.! 5).! Considering! that!Dna2!and!Sgs1!
helicase!activities!are!comparably!strong!(7),!we!think!that!in!DNA!resection!pathway!
Sgs1!might!be!the!lead!helicase,!similar!to!RecB!in!bacteria,!unwinding!dsDNA,!while!
the!motor!activity!of!Dna2!acts!as!an!efficient!ssDNA!translocase,!rather!than!a!helN
icase,!thus!helping!to!keep!up!with!Sgs1.!In!contrast!to!RecBCD,!the!nuclease!activity!
is!associated!with!Dna2,!which!is!the!5'!to!3'!translocating!enzyme.!The!notion!that!
Dna2!helicase!activity!is!contributing!to!efficient!DNA!end!resection!is!in!agreement!
with!genetic!experiments!with!dna2%2!(helicaseNdead)!budding!yeast!strains!showing!
increased!sensitivity!to!alkylating!agents!and!ionizing!radiation,!treatments!that!also!
induce!DNA!doubleNstrand!breaks! (8,9).! Interestingly,!dna2%2! cells! show!a!slight! inN
crease!in!telomere!length!(9),!which!is!indicative!of!more!roles!for!Dna2!helicase!acN
tivity!in!DNA!metabolism!that!need!to!be!further!investigated.!!
$
Materials$and$Methods$
Recombinant$proteins$
Wild!type!Dna2!as!well!Dna2!E675A!and!Dna2!K1080E!variants!were!expressed!from!
a!modified!pGAL:DNA2!vector!(4)!and!were!purified!as!described!previously!(7).!Sgs1,!
Top3NRmi1!and!Mre11NTop3NRmi1!were!expressed!and!purified!as!described!previN
ously!(6,16,25).!RPA!protein!was!expressed!and!purified!as!described!(29).!
$
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DNA$substrates!
The! oligonucleotides! X12N3! and! X12N4NC!were! used! for! the! preparation! of! the! YN
structure! DNA! substrate! (7,16),! and! the! oligonucleotide! X12N3! TOPL! (20)! N! for! the!
preparation! of! 93! ntNlong! ssDNA.! The! oligonucleotides! were! 32PNlabeled! at! the! 5'!
terminus!with![gammaN32P]!ATP!and!T4!polynucleotide!kinase!(New!England!Biolabs)!
according!to!manufacturer! instructions.!Unincorporated!nucleotides!were!removed!
using!MicroSpin!G25!columns!(GE!Healthcare)!before!annealing!of!the!substrates.!!
pUC19!dsDNA!was!linearized!with!HindIII!and!purified!by!phenolNchloroform!extracN
tion!and!ethanol!precipitation.!Bacteriophage!λ!dsDNA!digested!by!HindIII!was!purN
chased! from!New!England!Biolabs.! The! linearized! dsDNA!was! then! 3'Nlabeled!with!
[alphaN32P]!dATP!and!Klenow!fragment!of!DNA!polymerase!I!(New!England!Biolabs).!
Unincorporated! nucleotides! were! removed! using! MicroSpin! G25! columns! (GE!
Healthcare).!Circular!singleNstranded!and!doubleNstranded!6.4!kbNlong!plasmid!DNA!
was!derived!from!bacteriophage!M13!and!purchase!from!New!England!Biolabs.!
The!randomly! labeled!2200!ntNlong!substrate!was!prepared!by!amplification!of! the!
yeast!DNA!Ligase!I!gene!by!PCR!from!yeast!genomic!DNA!using!the!following!primers:!
forward:! 5'! ACGCATTAGCTAGCGGATCCCTGGAAGTTCTGTTCCAGGGGCCCATGCGN
CAGATTACTGACCGGTTG! 3';! reverse:! 5'! ACGCATTACTCGAGATTTTGCATGTGGN
GATTGGT! 3'.! In! addition! to! the! standard! dNTP! concentration! in! the! PCR! reaction!
(200!nM!each),! [alphaN32P]!dATP!(60nM)!was!added.!The!PCR!reaction!was!purified!
using!Chroma!Spin!TEN400!columns!(Clontech).!!
Nuclease$and$helicase$assays$
The!experiments!were!performed!in!a!15Nμl!volume!in!25!mM!TrisNacetate!(pH!7.5),!2!
mM!magnesium!acetate!(if!not!indicated!otherwise),!1!mM!ATP,!1!mM!dithiothreitol,!
0.1! mg/ml! BSA! (New! England! Biolabs),! 1! mM! phosphoenolpyruvate,! 16! U/ml! pyN
ruvate!kinase!and!1!nM!DNA!substrate,!unless!indicated!otherwise.!RPA!was!includN
ed! into! the! reactions,!where! indicated,! at! a! concentration! saturating! all! ssDNA! to!
300%! for! oligonucleotideNbased! substrates! and! to! 150%! for! longer! substrates,! asN
suming!a!20!ntNlong!binding!site!for!RPA.!Recombinant!proteins!were!added!at!indiN
cated!concentrations.!The!reactions!were!incubated!at!30!°C!for!30!min,!if!not!indiN
cated!otherwise.!Reactions!were!either!stopped!by!adding!5!μl!2%!stop!solution!and!
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separated!on!an!agarose!gels,!as!described!previously!(16),!or!they!were!stopped!by!
adding!15!μl!formamide!dye!(95%!(v/v)!formamide,!20!mM!EDTA,!0.01%!bromopheN
nol!blue),! heated!at! 95°C! for!4!min!and! separated!on!20!%!denaturing!polyacrylaN
mide!gels!(ratio!acrylamide:bisacrylamide!19:1,!Biorad).!After!fixing!in!a!solution!conN
taining! 40%!methanol,! 10%! acetic! acid! and! 5%! glycerol! for! 30!min,! the! gels!were!
dried!on!DE81!chromatography!paper!(Whatman),!and!exposed!to!storage!phosphor!
screens! (GE! Healthcare).! The! screens!were! scanned! by! Typhoon! phosphor! imager!
(GE!Healthcare).!!
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$Figure$Legends$
Figure$1:$Helicase$activity$of$Dna2$promotes$ssDNA$degradation.$(A)!Processing!of!
YNstructure!DNA! substrate!by!wild! type!Dna2,!helicaseNdead!K1080E!and!nucleaseN
dead!Dna2!E675A!variants.! The! top!oligonucleotide!was! 32PNlabelled!at! the!5’! end.!
The!reactions!contained!RPA!(22.5!nM),!and!various!Dna2!concentrations,!as!indicatN
ed,!position!of!the!32P!label.!Heat,!heatNdenatured!substrate.!The!panel!shows!repreN
sentative!10%!polyacrylamide!gels.!(B)!Representative!agarose!gel!(1%)!showing!degN
radation!kinetics!of!radioactively! labeled!ssDNA!fragments!by!Dna2!wt!and!K1080E!
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(7.5!nM).!λ!phage!DNA!was!digested!with!HindIII!to!produce!dsDNA!fragments!rangN
ing!from!125!bp!to!23!kbp!in!length,!and!32PNlabeled!with!Klenow!fragment!of!DNA!
polymerase! I.! The! resulting!DNA! fragments! had! 5'! ssDNA! tails! of! 3! nt! in! length! at!
their!ends.!Dna2!wt!or!K1080E!were! incubated!for! indicated!time!periods!with!the!
heatNdenatured!restricted!DNA!(ssDNA!fragments)!in!the!presence!of!RPA!(1.08!μM).!
Heat,!heatNdenatured!substrate.!Sizes!of!dsDNA!substrates!are!indicated!on!the!left.!
Figure$2:$$Dna2$has$an$endonuclease$activity$on$circular$ssDNA$only$in$absence$of$
RPA.$(A)!A!representative!1%!agarose!gel,!showing!a!comparison!of!the!activities!of!
wild!type!Dna2,!helicaseNdead!K1080E!and!nucleaseNdead!E675A!variants!on!circular!
6.4!kbNlong! ssDNA!substrate! (1.6!nM).!Reactions!were! incubated! for!30!min! in! the!
presence!or!absence!of!RPA!(770!nM),!as!indicated.!Reaction!buffer!contained!2!mM!
manganese!acetate.!DNA!was!visualized!by!postNstaining!with!GelRed.!(B)!Same!exN
periment!as!in!(A),!but!in!2!mM!magnesium!acetate.!(C)!Same!experiment!as!in!(A),!
but!with!circular!6.4!kbpNlong!dsDNA! in!presence!or!absence!of!RPA! (1.54!μM),!as!
indicated.!Reaction!buffer!contained!2!mM!magnesium!acetate.!!
Figure$3:$Efficient$ssDNA$degradation$by$Dna2$ is$promoted$by$ its$ATPTdependent$
ssDNA$ translocase$ activity.$ (A)! Representative! agarose! gel! (1%)! showing!degradaN
tion!kinetics!of!randomly!radioactively!labeled!PCR!product!by!Dna2!wt!and!K1080E!
(3! nM).! PCR! reaction!was! conducted! in! presence! of! [alphaN32P]! dATP,! the! 2.2! kbp!
product!was!PCR!purified,!heatNdenatured!and!used!for!the!kinetic!experiment.!Dna2!
wt! or! K1080E!were! incubated! for! indicated! time! periods!with! the! heatNdenatured!
DNA!in!the!presence!of!RPA!(315!nM).!Heat,!heatNdenatured!substrate.!(B)!Same!as!
(A),!the!reactions!were!separated!on!20%!polyacrylamide!denaturing!urea!gel.!MarkN
er:! Low! molecular! weight! marker! (Affymetrix),! 10N100! nt,! 32PNlabeled! at! the!
5'terminus!with![gammaN32P]!ATP!and!T4!polynucleotide!kinase.!(C)!Histograms!of!an!
experiment!such!as!in!Figures!3A,!left!panel!only,!showing!the!optical!density!analyN
sis!of!the!gel!lanes!1N9.!Red!arrows!indicate!the!80!nt!peak.!(D),!(E),!Quantitation!of!
experiments!such!as!in!Figure!3A.!Averages!shown,!n=3;!error!bars,!s.e.m.!In!(E)!only!
the!quantitation!of!product!accumulation!with!1!nM!Dna2!is!shown.!!(F)!Degradation!
kinetics! of! randomly! radioactively! labeled!PCR!product! by!Dna2!wt! and!K1080E! (3!
nM)!in!absence!of!ATP.!Experiment!as!shown!in!(B).!$
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Figure$4:$RPA$stimulates$ ssDNA$degradation$by$Dna2.$ (A)!Experiment!as! in!Figure!
2B!showing!the!degradation!of!PCR!substrate!by!Dna2!wt!or!K1080E!in!presence!(left!
panel)!or!absence!of!RPA!(right!panel!as!indicated).!ssDNA!substrate!was!incubated!
with! increasing!amounts!of!Dna2! (1,!3,!10!nM)! for!10!min.! (B),! (C)!Quantitation!of!
experiments!such!as!in!(A).!The!data!with!RPA!are!the!same!as!in!Figure!1DE.!!AverN
ages!shown,!n=3;!error!bars,!s.e.m.!In!(C)!only!the!quantitation!of!product!accumulaN
tion!with!1!nM!Dna2!is!shown.!(D)!Degradation!kinetics!of!a!93!ntNlong!oligonucleoN
tide,!32P!labeled!at!the!5’!terminus.!Dna2!wt!was!added!in!presence!(left)!or!absence!
(right)!of!RPA.!The!size!of! first!cleavage!product!by!Dna2! in!presence!of!RPA! is!beN
tween!7N11!nt.!(E)!Same!assay!as!in!(D),!but!without!ATP.!(F)!Same!experiment!as!in!
(D),!but!with!helicaseNdead!Dna2!K1080E.!(G)!Model!of!ssDNA!degradation!by!Dna2!
wild!type!protein.!In!presence!of!the!helicase!activity!of!Dna2,!ATP!and!RPA!the!degN
radation! is! fast! and! long! DNA! fragments! are! generated! first.! In! absence! of! either!
RPA,!or!ATP,!or!the!helicase!activity!of!Dna2!the!ssDNA!degradation!is!slow!and!short!
fragments!are!produced.!!
Figure$5:$Helicase$activity$of$Dna2$wt$promotes$resection$of$dsDNA$together$with$
Sgs1.$ (A)!A!representative!1%!agarose!gel!showing!a!comparison!of!the!activities!of!
wild! type!Dna2!and!helicaseNdead!K1080E! variant! on!5'! tailed!2.7! kbp!dsDNA! subN
strate!(7.5!nM)!in!conjunction!with!1nM!Sgs1.!Reactions!were!incubated!for!30!min!
in!the!presence!of!RPA!(1.5!μM).!Reaction!buffer!contained!2!mM!ATP.!DNA!was!visN
ualized!by!staining!with!ethidium!bromide.!(B)!Quantitation!of!(A).!Averages!shown,!
n=2;!error!bars,!s.e.m.!(C)!Representative!20%!polyacrylamide!denaturing!urea!gels!
showing! the! resection! kinetics! of! uniformly! radioactively! labeled! PCR! product! by!
Dna2!wt!and!K1080E!(0.2!nM),!Sgs1!(0.3!nM),!Top3NRmi1!(10!nM)!and!Mre11NRad50N
Xrs2!(40!nM).!PCR!reaction!was!conducted! in!presence!of![alphaN32P]!dATP,!the!2.2!
kb!product!was!PCR!purified!and!used!for!the!kinetic!experiment.!Marker:!Low!moN
lecular! weight! marker! (Affymetrix),! 10N100! nt,! 32PNlabeled! at! the! 5'terminus! with!
[gammaN32P]!ATP!and!T4!polynucleotide!kinase.!$
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Figure 1:  Helicase activity of Dna2 promotes ssDNA degradation 
(A) Processing of Y-structure DNA substrate by wild type Dna2, helicase-dead K1080E and nuclease-dead 
Dna2 E675A variants. The top oligonucleotide was 32P-labelled at the 5’ end. The reactions contained RPA 
(22.5 nM), and various Dna2 concentrations, as indicated !, position of the 32P label. Heat, heat-denatured 
substrate. The panel shows representative 10% polyacrylamide gels. (B) Representative agarose gel (1%) 
showing degradation kinetics of radioactively labeled ssDNA fragments by Dna2 wt and K1080E (7.5 nM). λ 
phage DNA was digested with HindIII to produce dsDNA fragments ranging from 125 bp to 23 kbp in length, 
and 32P-labeled with Klenow fragment of DNA polymerase I. The resulting DNA fragments had 5' ssDNA tails 
of 3 nt in length at their ends. Dna2 wt or K1080E were incubated for indicated time periods with the heat-
denatured restricted DNA (ssDNA fragments) in the presence of RPA (1.08 µM). Heat, heat-denatured 
substrate. Sizes of dsDNA substrates are indicated on the left.  
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Figure 2:  Dna2 has an endonuclease activity on circular ssDNA only in absence of RPA.  
(A) A representative 1% agarose gel, showing a comparison of the activities of wild type Dna2, helicase-dead 
K1080E and nuclease-dead E675A variants on circular 6.4 kb-long ssDNA substrate (1.6 nM). Reactions 
were incubated for 30 min in the presence or absence of RPA (770 nM), as indicated. Reaction buffer 
contained 2 mM manganese acetate. DNA was visualized by post-staining with GelRed. (B) Same 
experiment as in (A), but in 2 mM magnesium acetate. (C) Same experiment as in (A), but with circular 6.4 
kbp-long dsDNA in presence or absence of RPA (1.54 µM), as indicated. Reaction buffer contained 2 mM 
magnesium acetate.  
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Figure 3:  Efficient ssDNA degradation by Dna2 is promoted by its ATP-dependent ssDNA translocase 
activity 
(A) Representative agarose gel (1%) showing degradation kinetics of randomly radioactively labeled PCR 
product by Dna2 wt and K1080E (3 nM). PCR reaction was conducted in presence of [alpha-32P] dATP, the 
2.2 kbp product was PCR purified, heat-denatured and used for the kinetic experiment. Dna2 wt or K1080E 
were incubated for indicated time periods with the heat-denatured DNA in the presence of RPA (315 nM). 
Heat, heat-denatured substrate. (B) Same as (A), the reactions were separated on 20% polyacrylamide 
denaturing urea gel. Marker: low molecular weight marker (Affymetrix), 10-100 nt, 32P-labeled at the 
5'terminus with [gamma-32P] ATP and T4 polynucleotide kinase. (C) Histograms of an experiment such as in 
Figures 3A, left panel only, showing the optical density analysis of the gel lanes 1-9. Red arrows indicate the 
80 nt peak. (D), (E), Quantitation of experiments such as in Figure 3A. Averages shown, n=3; error bars, 
s.e.m. In (E) only the quantitation of product accumulation with 1 nM Dna2 is shown.  (F) Degradation kinetics 
of randomly radioactively labeled PCR product by Dna2 wt and K1080E (3 nM) in absence of ATP. Experiment 
as shown in (B).  
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Figure 4:  RPA stimulates ssDNA degradation by Dna2  
(A) Experiment as in Figure 2B showing the degradation of PCR substrate by Dna2 wt or K1080E in 
presence (left panel) or absence of RPA (right panel as indicated). ssDNA substrate was incubated with 
increasing amounts of Dna2 (1, 3, 10 nM) for 10 min. (B), (C) Quantitation of experiments such as in (A). 
The data with RPA are the same as in Figure 1DE.  Averages shown, n=3; error bars, s.e.m. In (C) only the 
quantitation of product accumulation with 1 nM Dna2 is shown. (D) Degradation kinetics of a 93 nt-long 
oligonucleotide, 32P labeled at the 5’ terminus. Dna2 wt was added in presence (left) or absence (right) of 
RPA. The size of first cleavage product by Dna2 in presence of RPA is between 7-11 nt. (E) Same assay 
as in (D), but without ATP. (F) Same experiment as in (D), but with helicase-dead Dna2 K1080E. (G) Model 
of ssDNA degradation by Dna2 wild type protein. In presence of the helicase activity of Dna2, ATP and 
RPA the degradation is fast and long DNA fragments are generated first. In absence of either RPA, or ATP, 
or the helicase activity of Dna2 the ssDNA degradation is slow and short fragments are produced.  
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Figure 5:  Helicase activity of Dna2 wt promotes resection of dsDNA together with Sgs1. 
(A) A representative 1% agarose gel showing a comparison of the activities of wild type Dna2 and helicase-
dead K1080E variant on 5' tailed 2.7 kbp dsDNA substrate (7.5 nM) in conjunction with 1nM Sgs1. Reactions 
were incubated for 30 min in the presence of RPA (1.5 µM). Reaction buffer contained 2 mM ATP. DNA was 
visualized by staining with ethidium bromide. (B) Quantitation of (A). Averages shown, n=2; error bars, s.e.m.  
(C) Representative 20% polyacrylamide denaturing urea gels showing the resection kinetics of randomly 
radioactively labeled PCR product by Dna2 wt and K1080E (0.2 nM), Sgs1 (0.3 nM), Top3-Rmi1 (10 nM) and 
Mre11-Rad50-Xrs2 (40 nM). PCR reaction was conducted in presence of [alpha-32P] dATP, the 2.2 kbp 
product was PCR purified and used for the kinetic experiment. Marker: low molecular weight marker 
(Affymetrix), 10-100 nt, 32P-labeled at the 5'terminus with [gamma-32P] ATP and T4 polynucleotide kinase.  
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2.3	  Results	  from	  collaborations	  	  
2.3.1	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  drives	  processing	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  reversed	  replication	  forks	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  human	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Introduction
The accurate replication of our genome is an essential require-
ment for the high-!delity transmission of genetic information 
to daughter cells. DNA replication forks are constantly chal-
lenged and arrested by DNA lesions, induced by endogenous 
and exogenous agents, and by a diverse range of intrinsic repli-
cation fork obstacles, such as transcribing RNA polymerases, 
unusual DNA structures or tightly bound protein–DNA com-
plexes (Carr and Lambert, 2013). An emerging model of how 
stalled or damaged forks are processed is that replication forks 
can reverse to aid repair of the damage (Atkinson and McGlynn, 
2009; Ray Chaudhuri et al., 2012; Berti et al., 2013). This model 
implies signi!cant remodeling of replication fork structures into 
four-way junctions and the molecular determinants required for 
reversed fork processing and restart are just beginning to be 
elucidated. The !rst evidence that supports the physiological re-
levance of this DNA transaction during replication stress in 
human cells arose from studies with DNA topoisomerase I 
(TOP1) inhibitors (Ray Chaudhuri et al., 2012). Additional 
studies established that the human RECQ1 helicase promotes 
the restart of replication forks that have reversed upon TOP1 
inhibition by virtue of its ATPase and branch migration activi-
ties (Berti et al., 2013). These observations were recently ex-
tended to show that the RECQ1 mechanism of reversed fork 
restart is a more general response to a wide variety of replica-
tion challenges (Zellweger et al., 2015). Nonetheless, new lines 
of evidence point to alternative mechanisms and factors that 
might mediate either formation or processing of reversed repli-
cation forks (Bétous et al., 2012; Gari et al., 2008). These puta-
tive mechanisms likely include nucleases that are capable of 
processing stalled replication intermediates upon genotoxic 
stress (Cotta-Ramusino et al., 2005; Schlacher et al., 2011; 
Hu et al., 2012; Ying et al., 2012).
Here, we investigate the contribution of the human DNA2 
nuclease/helicase in reversed fork processing. DNA2 is a highly 
conserved nuclease/helicase initially identi!ed in Saccharomyces 
cerevisiae screening for mutants de!cient in DNA replication 
(Kuo et al., 1983; Budd and Campbell, 1995). Yeast Dna2 plays 
Accurate processing of stalled or damaged DNA replication forks is paramount to genomic integ-rity and recent work points to replication fork 
reversal and restart as a central mechanism to ensuring 
high-fidelity DNA replication. Here, we identify a novel 
DNA2- and WRN-dependent mechanism of reversed rep-
lication fork processing and restart after prolonged geno-
toxic stress. The human DNA2 nuclease and WRN ATPase 
activities functionally interact to degrade reversed replica-
tion forks with a 5?-to-3? polarity and promote replication 
restart, thus preventing aberrant processing of unresolved 
replication intermediates. Unexpectedly, EXO1, MRE11, 
and CtIP are not involved in the same mechanism of 
reversed fork processing, whereas human RECQ1 limits 
DNA2 activity by preventing extensive nascent strand 
degradation. RAD51 depletion antagonizes this mecha-
nism, presumably by preventing reversed fork formation. 
These studies define a new mechanism for maintaining 
genome integrity tightly controlled by specific nucleolytic 
activities and central homologous recombination factors.
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single-molecule DNA !ber replication assays. We pulse- 
labeled human osteosarcoma (U-2 OS) cells with the thymidine 
analogue CldU for 20 min, followed by a 60-min exposure to a 
selected genotoxic agent during the CldU labeling period, and 
by labeling with the second thymidine analogue, IdU, for an ad-
ditional 40 min after removal of the genotoxic drug. We found 
that DNA2 plays an important role in restarting replication 
forks after treatment with the ribonucleotide reductase inhibitor 
hydroxyurea (HU), the topoisomerase I inhibitor camptothecin 
(CPT), and the interstrand cross-linking agent mitomycin C 
(MMC) (Fig. 1 A). In addition, DNA2 depletion increased the 
percentage of origin !ring, but not of fork termination events 
(Fig. S1 A). Genetic knockdown–rescue experiments con!rmed 
that complementation in DNA2-depleted U-2 OS cells with 
siRNA-resistant WT DNA2 abrogated the effect of DNA2 de-
pletion on replication fork restart upon HU treatment. More-
over, expression of the nuclease-de!cient DNA2 mutant D294A 
in DNA2-depleted cells revealed that the nuclease activity 
of DNA2 was essential for its role in replication fork restart 
(Fig. 1 B and Fig. S1 B).
We next measured whether DNA2 uses its nuclease activ-
ity to process stalled replication intermediates by monitoring 
the integrity of the newly synthesized DNA after HU treatment. 
To this purpose, we changed the DNA labeling scheme. We !rst 
pulsed U-2 OS cells with IdU for 45 min, and then varied the 
exposure time to HU from 0 to 8 h. The mean length of the IdU 
tracts progressively decreased during HU treatment from 18.2 µm 
(0 h) to 12.0 µm (8 h; Fig. 1 C). However, shRNA-mediated 
DNA2 depletion largely prevented IdU tract shortening, con-
!rming that DNA2 is responsible for the observed nascent 
strand degradation (Fig. 1 D). Double-labeling experiments 
con!rmed that the observed nascent tract shortening is indeed 
caused by the DNA2-dependent processing of ongoing replica-
tion forks and that this degradation is important to mediate ef-
!cient replication fork restart upon prolonged HU treatment 
(Fig. 1 E). Clonogenic analysis of U-2 OS cells treated with the 
same HU concentration used for the DNA !ber experiments 
showed a signi!cantly reduced cell survival upon DNA2 deple-
tion, indicating that the DNA2-dependent processing of stalled 
replication intermediates is critical for recovery from replica-
tion fork blockage (Fig. 2 A). The results obtained with the 
shRNA DNA2-depleted U-2 OS cells were validated using a 
new conditional knockout human colorectal carcinoma cell line 
(HCT116) where addition of tamoxifen to the culture medium 
led to DNA2-null cells. Analysis of the mean tract lengths con-
!rmed that DNA2 knockout in HCT116 cells abrogates the 
prominent degradation observed upon HU treatment (Fig. 2 B). 
Collectively, these results indicate that human DNA2 degrades 
nascent strands at stalled replication forks to facilitate fork re-
start and promote viability after genotoxic stress induction.
RECQ1 regulates the fork processing 
activity of DNA2
On the basis of the recent discovery that RECQ1 is required to 
restart replication forks that have reversed upon genotoxic stress 
induction (Berti et al., 2013), we investigated whether RECQ1 
regulates the fork processing activity of DNA2. Nascent IdU 
an essential role in Okazaki fragment maturation during lagging 
strand DNA replication (Budd and Campbell, 1997; Bae et al., 
2001; Ayyagari et al., 2003). However, increasing evidence sug-
gests that DNA2 has important—albeit yet unde!ned—roles in 
DNA replication stress response and DNA repair, which go be-
yond its postulated role in Okazaki fragment processing (Duxin 
et al., 2012; Karanja et al., 2012; Peng et al., 2012). The notion 
that DNA2 is important for DNA replication is strengthened by 
the observation that DNA2 forms a complex with various repli-
cation core components, including the replisome protein And-1 
(Wawrousek et al., 2010; Duxin et al., 2012). Moreover, human 
DNA2 seems to play a partially redundant role with human exo-
nuclease I (EXO1) in replication-coupled repair (Karanja et al., 
2012), whereas a recent study in S. pombe suggested that the 
nuclease activity of DNA2 is required to prevent stalled forks 
from reversing upon HU treatment (Hu et al., 2012).
DNA2 also has an independent function in dsDNA break re-
pair. Two distinct pathways act redundantly to mediate processive 
DSB resection downstream from the MRE11-RAD50-NBS1 
(MRN) and CtIP factors in eukaryotic cells: one requires DNA2 
and the other EXO1 (Gravel et al., 2008; Mimitou and Symington, 
2008; Zhu et al., 2008; Nicolette et al., 2010). Speci!cally, DNA2 
and EXO1 resect the 5? ends of double-strand DNA breaks (DSBs) 
to generate 3? single-stranded overhangs, which are essential to 
initiate homologous recombination. In yeast, DNA2-dependent 
dsDNA-end resection reaction requires the Sgs1 helicase to un-
wind the DNA from the break (Zhu et al., 2008; Cejka et al., 2010; 
Niu et al., 2010). This mechanism appears to be largely conserved 
in mammalian cells where DNA2 cooperates with the human BLM 
helicase to resect dsDNA ends in vitro (Nimonkar et al., 2011). 
However, mammalian cells possess !ve human RecQ homologues 
(RECQ1, RECQ4, RECQ5, BLM, and WRN) and WRN can also 
assist DNA2-dependent end resection, suggesting that BLM might 
not be the sole RecQ homologue required for this process (Liao 
et al., 2008; Sturzenegger et al., 2014). The ability of DNA2 and 
EXO1 to process dsDNA ends might also be relevant in the con-
text of DNA replication to prevent the accumulation of replica-
tion-associated DSBs by promoting homologous recombination 
(HR) repair (Peng et al., 2012). Alternatively, these nucleases 
might be involved in the recovery of replication fork blockage 
by processing speci!c stalled replication fork structures.
This work uncovers a new DNA2- and WRN-dependent 
mechanism that mammalian cells use to process replication 
forks that have reversed as a result of replication inhibition. Im-
portantly, it also shows that this mechanism is tightly regulated 
by human RECQ1 and the HR factor RAD51. Our observations 
shed light on a novel pathway for the suppression of chromo-
somal instability in mammalian cells and provide important 
new insight into the mechanisms of replication stress response 
associated with chemotherapeutic drug damage.
Results
DNA2 is required for stalled fork 
processing and restart
To begin elucidating the role of human DNA2 during replication 
stress, we monitored replication perturbation by genome-wide 
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Figure 1. DNA2 is required for replication fork restart and stalled fork processing upon genotoxic stress. (A) Schematic of DNA fiber tract analysis. 
U-2 OS cells were transfected with control siRNA or DNA2 siRNA before CldU or IdU labeling. Red tracts, CldU; curved red tracts, CldU with genotoxic agents 
(HU or CPT or MMC); green tracts, IdU. (bottom) Representative DNA fiber image. (right) quantification of red-green contiguous tracts (restarting forks). 
Mean shown, n = 3. Error bars, standard error. ns, not significant; *, P < 0.05; **, P < 0.01 (paired t test). (B) Quantification of restarting forks in DNA2-
depleted cells expressing DNA-WT or DNA2-D294A. ns, not significant; *, P < 0.05 (paired Student’s t test). (C, top) Representative DNA fiber image. 
(bottom) Representative IdU tract length distributions in Luc-depleted cells during different exposure time to HU (out of 3 repeats; n ≥ 300 tracts scored 
for each dataset). Mean tract lengths are indicated in parentheses. (D) Top, DNA2 expression after shRNA knockdown. Bottom, representative IdU tracts 
in DNA2-depleted U-2 OS cells in the presence or absence of HU (out of 2 repeats; n ≥ 700 scored for each dataset). (E, left) Representative DNA fiber 
images. (middle) Quantification of red-green contiguous tracts (restarting forks) after 8 h of HU. Mean shown, n = 3. Error bars, standard error. **, P < 
0.01 (paired Student’s t test). (right) Statistical analysis of CldU tracts detected within contiguous red-green tracts. Whiskers the 10th and 90th percentiles. 
****, P < 0.0001 (Mann-Whitney test).
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Genetic knockdown–rescue experiments con!rmed that 
complementation in RECQ1-depleted U-2 OS cells with shRNA-
resistant WT RECQ1 abrogates the effect of RECQ1 depletion 
on replication fork processing upon HU treatment (Fig. 3 F). 
Interestingly, expression of the ATPase-de!cient RECQ1 mutant 
K119R in RECQ1-depleted cells also abrogated the effect of 
RECQ1 depletion indicating that the ATPase activity of RECQ1 
was not required for its role in protecting stalled forks from 
DNA2-dependent degradation (Fig. 3 F). These results point to 
an additional role of RECQ1 in protecting replication forks 
from extensive DNA2-dependent degradation, which is inde-
pendent of RECQ1 ATPase activity.
tracts were substantially shorter in RECQ1-depleted cells com-
pared with control when replication forks were stalled with HU 
(after 8 h of HU treatment, the mean tract lengths were 7.9 and 
12.0 µm, respectively; P < 0.0001; Fig. 3, A and B). In agree-
ment with results from luciferase-depleted cells, DNA2 was 
also responsible for the nascent strand degradation phenotype 
observed in RECQ1-de!cient U-2 OS cells (Fig. 3 C). Analo-
gous results were obtained using the conditional DNA2 knock-
out HCT116 cell line (Fig. 2 C). In addition, we con!rmed that 
the DNA2-dependent nascent strand degradation observed in 
the absence of RECQ1 is not limited to a speci!c replication in-
hibitor by replacing HU with CPT or MMC (Fig. 3, D and E).
Figure 2. DNA2 processes stalled replication forks. (A, top) DNA2 expression after siRNA knockdown. (bottom) Colony-forming assays in control and 
DNA2-depleted U-2 OS cells treated with 4 mM HU for the indicated time. (B) Representative IdU tracts in DNA2 conditional knockout HCT116 cells (out 
of two repeats). Tamoxifen was added to generate conditional knockout cells (see Materials and methods). (C, left) Expression of DNA2 and RECQ1 in 
tamoxifen-treated HCT116 cells. Right, representative IdU tracts in DNA2 conditional knockout HCT116 cells depleted for Luc or RECQ1 (out of three 
repeats). n ≥ 300 tracts scored for each dataset shown in B and C.
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Figure 3. RECQ1 regulates the DNA2-dependent degradation of stalled forks. (A) Representative IdU tracts in RECQ1-depleted U-2 OS cells during different 
exposure time to HU (out of 2 repeats; n ≥ 350 tracts scored for each dataset). (B) Bar graph represents the mean values of each time point from Figs. 1 C and 2 A. 
(top) RECQ1 expression after shRNA knockdown. (C, D, and E) Representative IdU tracts in RECQ1-, DNA2-, or RECQ1/DNA2-codepleted U-2 OS cells in the 
presence of HU (C), CPT (D), and MMC (E; out of 2 repeats; n ≥ 300 tracts scored for each dataset).(top) RECQ1 and DNA2 expression after shRNA or siRNA 
knockdown. (F) Representative IdU tracts in RECQ1-depleted U-2 OS cells complemented with shRNA-resistant WT RECQ1 (WT) or ATPase-deficient (K119R) 
RECQ1 (out of 2 repeats; n ≥ 325 tracts scored for each dataset). (top) Expression of Flag-tagged RECQ1-WT and RECQ1-K119R in RECQ1-depleted cells.
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part of the WRN:DNA2 complex. Collectively, these results 
suggest that DNA2 cooperates with WRN to promote nascent 
strand processing and fork restart after HU treatment.
The nuclease activity of DNA2  
and the ATPase activity of WRN are 
essential to process stalled replication forks
DNA2 is characterized by an N-terminal nuclease domain and 
by a C-terminal helicase domain, but the function of its helicase 
activity is still debated (Masuda-Sasa et al., 2006). To assess the 
roles of these two activities in stalled fork processing, we per-
formed genetic knockdown-rescue experiments where we de-
pleted DNA2 and then attempted to rescue fork processing by 
expressing a Flag-tagged siRNA resistant WT DNA2 control, 
nuclease-de!cient DNA2-D294A, or ATPase-de!cient DNA2-
K671E. All the experiments were performed in RECQ1-depleted 
cells, where the effect of DNA2 is more apparent. DNA !ber 
analysis showed that complementation with nuclease-de!cient 
DNA2 prevents fork processing, whereas complementation 
with WT or ATPase-de!cient DNA2 leads to the same fork pro-
cessing phenotype observed in DNA2-pro!cient cells (Fig. 5 D 
and Fig. S2 C). Therefore, the nuclease, but not the ATPase ac-
tivity of DNA2, is necessary for fork processing.
Next, we used a Werner Syndrome (WS) !broblast cell 
line (AG11395) expressing missense mutant forms of WRN, 
which inactivate either the exonuclease (WRN-E84A) or the 
ATPase (K577M) activity of WRN (Pirzio et al., 2008). The 
ATPase, but not the nuclease activity of WRN, was important 
for fork processing (Fig. 5 E and Fig. S2 D). These !ndings 
were validated by genetic knockdown-rescue experiments where 
we complemented WRN-depleted U-2 OS cells either with 
an shRNA resistant WT WRN control or the ATPase-de!cient 
WRN-K577M mutant and found that complementation with 
the ATPase-de!cient mutant prevented fork processing (Fig. S2, 
E and F). Collectively, these results show that human DNA2 
needs the support of the ATPase activity of WRN to promote 
degradation of the nascent DNA strands.
DNA2 processes reversed replication forks
To gain insight into the actual replication structures processed 
by DNA2, we inspected the !ne architecture of the replication 
intermediates using a combination of in vivo psoralen cross-
linking and EM (Neelsen et al., 2014). Our analysis showed 
a substantial fraction of reversed replication forks (?24% of 
molecules analyzed) in control U-2 OS cells treated with 4 mM 
HU. RECQ1-depletion, and to an even greater extent DNA2-
depletion, resulted in a higher frequency of fork reversal events 
(?30 and 40%, respectively) compared with HU-treated cells. 
Co-depletion of RECQ1 and DNA2 further increased the fre-
quency of reversed forks (?50%), suggesting that RECQ1 and 
DNA2 are involved into two distinct mechanisms of reversed 
fork processing. Interestingly, RECQ1 and/or DNA2 depletion 
also led to a signi!cant amount of fork reversal events in unper-
turbed U-2 OS cells (Fig. 6, A and B). WRN-depletion pheno-
copied DNA2-depletion in terms of reversed fork accumulation, 
both the presence and in the absence of HU. Moreover, DNA2/
DNA2 function in stalled fork processing  
is distinct from EXO1, Mre11, and CtIP
Next, we tested whether other nucleases share a function similar 
to DNA2 in stalled fork processing. To address this point, we 
depleted Mre11, EXO1, and CtIP in U-2 OS cells with siRNA-
mediated technologies. We found that none of these nucleases 
share the same phenotype of DNA2 in RECQ1-pro!cient cells 
(Fig. 4 A). Furthermore, depletion of these nucleases had only a 
marginal effect on the rescue of the prominent nascent strand 
degradation phenotype observed in the absence of RECQ1, indi-
cating that DNA2 has a unique function in reversed fork pro-
cessing that is not shared by these human nucleases (Fig. 4, B–D). 
MUS81 is another structure-speci!c nuclease that plays a critical 
role in replication fork rescue by converting stalled replication 
forks into DNA DSBs that can be processed by Homology Di-
rected Repair (HDR) (Hanada et al., 2007; Franchitto et al., 
2008). This raised the possibility that the DNA2-dependent 
degradation originated from the processing of MUS81-dependent 
DSBs. However, MUS81 depletion did not prevent nascent 
strand degradation, indicating that DNA2 is not processing 
stalled replication intermediates that are cleaved by MUS81 
(Fig. 4 E).
DNA2 and WRN act together to process 
stalled replication forks
DNA2-dependent dsDNA-end resection needs the support of 
a RecQ helicase to unwind the DNA from the break (Cejka 
et al., 2010; Niu et al., 2010; Nimonkar et al., 2011). To deter-
mine the identity of the helicase that acts in conjunction with 
DNA2 in stalled fork processing, we measured the extent of na-
scent strand degradation in BLM-, WRN-, and RECQ4-depleted 
U-2 OS cells. Our DNA !ber analysis showed that WRN deple-
tion mimicked the effect of DNA2-depletion, completely abro-
gating the prominent nascent strand degradation phenotype 
observed in RECQ1-depleted U-2 OS cells (Fig. 5 A). The same 
results were con!rmed using WRN and DNA2 codepleted cells, 
suggesting that DNA2 and WRN are epistatic in nucleolytic 
processing of stalled forks (Fig. S1 C). The partial nascent 
strand degradation observed in RECQ1-pro!cient U-2 OS cells 
was also abrogated by WRN depletion (Fig. S1 D). Conversely, 
BLM depletion had only a marginal effect on the nascent strand 
degradation phenotype observed in RECQ1-depleted cells, 
whereas RECQ4 depletion had no effect (Fig. S2, A and B). Thus, 
the WRN helicase plays a prominent role in assisting DNA2-
dependent degradation of stalled replication forks.
We next compared the percentage of restarting replication 
forks in DNA2-depleted, WRN-depleted, and DNA2/WRN-
codepleted cells. WRN depletion leads to a decrease in restart-
ing forks (69 to 50%; P = 0.0068). These results are almost 
identical to those obtained with the DNA2-depleted or DNA2/
WRN-codepleted cells, implying that WRN and DNA2 are 
epistatic also in the restart process (Fig. 5 B). The notion that 
DNA2 and WRN functionally interact to process stalled repli-
cation intermediates is further supported by our observation that 
the two proteins form a complex both in the presence and ab-
sence of replication stress (Fig. 5 C). Of note, RECQ1 is not 
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Figure 4. EXO1, MRE11, CtIP, and MUS81 depletion does not affect stalled fork processing. (A) Statistical analysis of IdU tracts from U-2 OS cells depleted 
for the indicated proteins in the presence of 4 mM HU. (B) Representative IdU tracts in control, RECQ1-, MRE11-, or RECQ1/MRE11-codepleted U-2 
OS cells (out of 2 repeats). (top) Expression of RECQ1 and MRE11 after siRNA knockdown. (C) Representative IdU tracts in control, RECQ1-, EXO1-, or 
RECQ1/EXO1-codepleted U-2 OS cells (out of 2 repeats). (top) Expression of RECQ1 and EXO1 after siRNA knockdown. (D) Representative IdU tracts in 
control, RECQ1-, CtIP-, or RECQ1/CtIP-codepleted U-2 OS cells (out of 2 repeats). (top) Expression of RECQ1 and CtIP after siRNA knockdown. 
(E) Representative IdU tracts in Luc-, RECQ1-, MUS81-, or RECQ1/MUS81-codepleted U-2 OS cells in the presence of HU (out of 2 repeats). (left) Expres-
sion of RECQ1 and MUS81 after shRNA knockdown. n ≥ 300 tracts scored for each dataset shown in A–E.
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Figure 5. DNA2 and WRN are epistatic in stalled fork processing and replication restart. (A) Representative IdU tracts in RECQ1-, WRN-, or RECQ1/
WRN-codepleted U-2 OS cells (out of 2 repeats; n ≥ 300 tracts scored for each dataset). (top) RECQ1 and WRN expression after shRNA knockdown. 
(B) Quantification of restarting forks in DNA2-, WRN-, or DNA2/WRN-codepleted cells. Mean shown, n = 3. Error bars, standard error. *, P < 0.05; 
**, P < 0.01 (paired t test). (top) Expression of WRN and DNA2 after shRNA knockdown. (C) Co-IP experiments in HEK293T cells transfected with empty vec-
tors, Flag-DNA2, or Strep-HA-WRN. Cells were treated with 4 mM HU (3 h) where indicated. Whole-cell extracts were analyzed before (input) and after IP. 
(D) Statistical analysis of IdU tracts from RECQ1/DNA2-codepleted U-2 OS cells complemented with WT, ATPase-deficient (K671E), or nuclease-deficient 
(D294A) DNA2, when indicated. (E) Statistical analysis of IdU tracts from RECQ1-depleted WS cells complemented with WT, ATPase-deficient (K577M), 
or nuclease-deficient (E84A) WRN. Whiskers in D and E indicate the 10th and 90th percentiles. ns, not significant; ****, P < 0.0001 (Mann-Whitney 
test). n ≥ 300 tracts scored for each dataset shown in D and E.
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Figure 6. DNA2 resects reversed replication 
forks. (A) Electron micrograph of a partially 
single-stranded (left) and entirely double-
stranded (right) reversed fork observed on 
genomic DNA upon HU-treatment. The black 
arrow points to the ssDNA region on the re-
versed arm. Inset, magnified four-way junction 
at the reversed replication fork. D, Daughter 
strand; P, Parental strand; R, Reversed arm. 
(B) Frequency of fork reversal and ssDNA 
composition of the reversed arms in RECQ1- 
or DNA2-depleted U-2 OS cells treated with 
HU (left) or in unperturbed conditions (right). 
The percentage values are indicated on the 
top of the bar. “# RI” indicates the number of 
analyzed replication intermediates. Data in B 
are reproduced with very similar results in at 
least one independent experiment.
WRN-codepletion did not cause a further increase in reversed 
fork frequency, thus supporting our conclusion that DNA2 and 
WRN work together in reversed fork processing (Fig. S3 A).
Next, we evaluated the single-strand composition of the 
regressed arms. To measure ssDNA, we carefully inspected 
the frequency and length of ssDNA regions on the regressed 
arms by detecting local difference in filament thickness. 
DNA2 depletion led to a higher frequency of reversed forks 
with a dsDNA arm—and a corresponding decrease of partially 
or entirely single-stranded reversed forks—in both RECQ1-
pro!cient and de!cient cells (Fig. 6). Thus, DNA2-mediated 
resection is directed to completely or partially digest one 
strand of the reversed arm leading to reversed forks that are 
either entirely single stranded or have a protruding ssDNA 
tail. However, prolonged stalling by HU was associated with 
accumulation of postreplicative ssDNA gaps on replicated 
duplexes, which was maximal in RECQ1-depleted cells and 
suppressed by DNA2 depletion (Fig. S3, B and C). Conse-
quently, ssDNA gaps may re"ect additional activity of the 
same nucleolytic apparatus along the postreplicated duplexes 
or restart of partially resected reversed forks.
As an alternative readout for DNA2-dependent resection, 
we examined the phosphorylation status of RPA and the check-
point kinase Chk1 (Zeman and Cimprich, 2014). DNA2 deple-
tion caused a reduction in RPA and Chk1 phosphorylation in both 
RECQ1-pro!cient and RECQ1-de!cient U-2 OS cells, suggest-
ing that the DNA2-dependent resection of nascent strands might 
also contribute to checkpoint activation (Fig. S3 D).
RAD51 promotes DNA2-dependent 
degradation of reversed replication forks
The central recombinase factor RAD51 is directly implicated in 
reversed fork formation upon genotoxic stress (Zellweger et al., 
2015). Thus, we investigated whether RAD51 depletion may 
affect the reversed fork processing activity of DNA2. We found 
that RAD51 knockdown largely prevents DNA2 nucleolytic 
processing both in RECQ1 pro!cient and RECQ1-de!cient 
cells (Fig. 7 A). Genetic knockdown–rescue experiments 
con!rmed that expression of exogenous RAD51 in RAD51- 
depleted U-2 OS cells restored the fork processing phenotype 
(Fig. 7 B). These results indicate that DNA2-dependent nucleolytic 
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Figure 7. RAD51 promotes DNA2-depedent 
degradation of reversed replication forks.  
(A) Representative IdU tracts in RECQ1-, RAD51-, 
or RECQ1/RAD51-codepleted U-2 OS cells 
(out of 2 repeats). Above, RECQ1 and RAD51 
expression after siRNA knockdown RAD51-
WT are U-2 OS cells stably expressing siRNA 
resistant exogenous RAD51. (B) Representa-
tive IdU tracts in U-2 OS cells expressing exog-
enous RAD51 (out of 2 repeats). n ≥ 300 tracts 
scored for each dataset shown in A and B.
processing is speci!cally targeted to reversed fork structures 
because it is not detected in a genetic background that prevents 
reversed fork formation—i.e., RAD51 knockdown.
DNA2 preferentially degrades reversed 
fork structures with a 5?-to-3? polarity
The notion that DNA2 end resection has a preferential polarity 
in vivo is consistent with biochemical studies showing that even 
though DNA2 has the intrinsic capacity to degrade both 5?- and 
3?-terminated ssDNA, RPA enforces a primarily 5?-to-3? end-
resection bias (Cejka et al., 2010; Niu et al., 2010; Nimonkar et al., 
2011). Thus, we set up new biochemical assays to test whether 
human DNA2 prefers four-way junction substrates—i.e., re-
versed replication forks—versus linear DNA duplexes and 
whether it degrades these substrates with a 5?-to-3? polarity in 
the presence of RPA (Fig. 8, A and B). The sequences of the 
four arms of the four-way junction substrates are mutually 
heterologous to prevent four-way junction branch migration. 
DNA2-degraded four-way junction substrates more ef!ciently 
than linear dsDNA duplexes, with 20 nM DNA2 required to de-
grade ?60% of the four-way junction substrates versus only 
?30% of the linear duplex (Fig. 8 C). Importantly, supplement-
ing the reaction with RPA greatly stimulated the degradation 
activity of human DNA2 (Fig. 8 D and Fig. S4 A). Additional 
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Figure 8. Human DNA2 preferentially degrades branched 
DNA in a 5?-3? direction in reactions stimulated by WRN. 
(A) Degradation of a four-way junction by human DNA2 
(hDNA2) in the presence of hRPA (native 6% polyacryl-
amide gel) (B) Experiment as in A, but with dsDNA. 
(C) Quantitation of data from A and B. Averages shown ± 
SEM; n = 2. (D) DNA degradation is stimulated by 
hRPA. The data points from +hRPA condition are the 
same as in C. Averages shown ± SEM; n = 2. (E) Quan-
titation of degradation of a 3? or 5? ssDNA-tailed three-
way junction by hDNA2. The reactions were performed in 
3 mM magnesium acetate and 22.3 nM hRPA. Averages 
shown ± SEM; n = 2. (F) Kinetics of degradation of a four-
way junction by hDNA2 (9 nM) in the presence of hRPA 
(denaturing 20% polyacrylamide gel). The substrate was 
labeled at the 5? end (*). D294A, nuclease-dead variant 
of hDNA2. (G) Experiment as in F, but using a four-way 
junction labeled at the 3? end. (H) Quantitation of DNA 
cleavage near (less than 15 nt) a 5? or 3? DNA end from 
experiments of F and G. Averages shown ± SEM; n = 2. 
(I) WRN and hDNA2 degrade four-way junction DNA in a 
synergistic manner. Reactions with indicated hDNA2 
and/or WRN concentrations and 65 nM hRPA were ana-
lyzed on a 6% native polyacrylamide gel. Heat, partially 
heated DNA substrate indicating the positions of DNA 
unwinding intermediates. (J) Quantitation of four-way junc-
tion and dsDNA degradation by human EXO1 (hEXO1). 
Averages shown ± SEM; n = 2.
experiments using either 5?-end or 3?-end 32P-labeled four-way 
junctions con!rmed that human DNA2 had a strong 5?-to-3? 
bias in end resection in the presence of RPA (Fig. 8, E–H; and 
Fig. S4, B and C). Catalytically dead DNA2 D294A had no 
capacity to degrade DNA, showing that the nuclease activity 
is inherent to WT DNA2 (Fig. 8 F). The same results were 
recapitulated using puri!ed yeast DNA2 (Fig. S5, A–F). Inter-
estingly, addition of the ATPase-de!cient RECQ1 mutant 
(RECQ1-K119R) to the reaction mix signi!cantly inhibited 
the four-way junction degradation activity of human DNA2 
(Fig. S4, D and E). These results suggest that the binding of 
RECQ1 to stalled replication forks limits the fork processing 
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DNA2 function during DNA replication is vital for main-
tenance of genome stability (this study; Duxin et al., 2012; 
Karanja et al., 2012). These !ndings indicate that the controlled 
DNA2-dependent degradation of reversed replication forks is a 
physiologically relevant mechanism to provide resistance to 
prolonged genotoxic treatments. This mechanism is distinct 
from the pathological MRE11-dependent degradation of stalled 
replication intermediates detected in the absence of crucial 
Fanconi Anemia (FA)/HR factors (Schlacher et al., 2011, 2012; 
Hashimoto et al., 2012; Ying et al., 2012).
We !nd that depletion of the central recombinase factor 
RAD51 prevents nascent strand degradation. This !nding, coupled 
with the recent observation that RAD51 is directly implicated in 
reversed fork formation (Zellweger et al., 2015), reinforce our con-
clusion that the DNA2-dependent pathway starts from the reversed 
arm of stalled replication forks and acts downstream of the 
RAD51-mediated replication fork reversal. Given that RAD51 is 
required for reversed fork formation (Zellweger et al., 2015), we 
speculate that the MRE11-dependent pathway is only uncovered in 
the absence of fork reversal—i.e., via a perturbation in RAD51 
function—and likely attacks unprotected and nonreversed forks 
upon prolonged stalling. A crucial challenge for future studies will 
be to investigate why we do not observe a contribution of the 
MRE11 pathway in nascent strand degradation upon RAD51 
depletion. It is tempting to speculate that RAD51 depletion might 
interfere with MRE11-dependent fork processing, in addition to 
preventing fork reversal. Conversely, perturbation of RAD51 
function—e.g., via BRCA2 depletion (Schlacher et al., 2011)—
might be suf!cient to prevent fork reversal—hence DNA2- 
dependent degradation—but still allow residual RAD51 loading 
to promote MRE11-dependent degradation.
Our DNA !ber analysis suggests that DNA2 degrades 
stalled replication intermediates beyond the maximum length 
of the reversed arms measured by EM (up to several kilobases). 
A possible interpretation of these results is that after the initial 
DNA2/WRN-mediated regressed arm degradation is complete, 
other nucleolytic activities or DNA2 itself may codegrade both 
sides of the replication fork, thus leading to extensive degra-
dation events detectable by DNA !bers. In this scenario, our 
EM images likely represent snapshots of the “slow steps” of 
this reaction—i.e., the DNA2/WRN-mediated degradation of 
the regressed arms—resulting in the drastic increase in reversed 
fork frequency observed in the absence of DNA2. Once the 
regressed arm has been resolved, the nucleolytic degradation 
might quickly proceed to degrade nascent strands behind the 
junction—as suggested by the DNA2-dependent increase in 
ssDNA gaps behind the observed forks—!nally leading to re-
annealing of the parental strands and backtracking of the fork 
(Fig. S3 E). A new reversal event may occur when this extensive 
degradation leads to asymmetric ssDNA accumulation at the fork 
(Zellweger et al., 2015), resetting the backtracked fork to the slow 
step of the process. However, fork backtracking is only one possi-
ble model to explain the extensive degradation detected by DNA 
!bers and further work would be required to uncover additional 
nucleolytic activities that might be involved in this process.
Biochemical studies suggested that Schizosaccharomyces 
pombe Dna2 cleaves the leading and lagging reversed strands of 
activity of DNA2, as inferred by our cellular studies. However, 
we cannot rule out the possibility that the inhibitory effect ob-
served in the biochemical assays is simply associated with com-
petition for substrate recognition between the two proteins. In 
agreement with our in vivo data, we show that WRN promoted 
the degradative capacity of DNA2 on nicked, gapped, or four-
way junction substrates (Fig. 8 I and Fig. S4, F and G); similar 
behavior was observed when yeast Dna2 was coupled with the 
Sgs1 helicase (Fig. S5, G and H). DNA was degraded by WRN 
and DNA2 in a remarkably synergistic manner: 5 nM concen-
tration of either WRN or DNA2 alone led only to a minor DNA 
unwinding/degradation (Fig. 8 I, lanes 2 and 8). When com-
bined, both enzymes completely degraded the four-way junc-
tion DNA (Fig. 8 I, lane 5). In contrast, no such synergy was 
observed when human DNA2 was combined with the noncog-
nate yeast meiotic Mer3 helicase (Fig. S4 H), suggesting that 
the species-speci!c interaction between DNA2 and WRN re-
sults in a vigorous DNA degradation. Similarly, WT RECQ1 
did not promote DNA degradation by DNA2 (Fig. S4 I).
On the basis of our results that DNA2 does not share the 
same function of EXO1 in reversed fork processing, we decided to 
compare the end-resection activities of human DNA2 and human 
EXO1 using the four-way junction substrates. EXO1—unlike 
DNA2—degraded both four-way junction substrates and linear 
duplexes with equal ef!ciency (Fig. 8 J and Fig. S4, J and K). The 
use of yeast variants of Dna2 and Exo1 yielded analogous results 
(Fig. S5, I–K). Collectively, these studies further implicate DNA2, 
and its nuclease activity, in reversed replication fork degradation—
that is speci!cally stimulated by WRN—and point to an important 
difference in substrate preference between DNA2 and EXO1. 
Moreover, the polarity of reversed fork degradation by DNA2 
measured in the presence of RPA displays the same bias antici-
pated from the EM analysis of the replication intermediates.
Discussion
The present work uncovers a new mechanism for reversed fork 
processing and restart that requires the coordinated activities of 
the human DNA2 nuclease and WRN helicase (Fig. 9). The 
DNA2-dependent end resection leads to partially single-stranded 
reversed forks and is required for ef!cient replication fork re-
start under conditions of persistent replication blockage. WRN 
interacts with DNA2 and its ATPase activity is needed for 
DNA2-dependent degradation, presumably to transiently open 
the dsDNA arm of the reversed replication forks.
To date, we have identi!ed two mechanisms of reversed 
replication fork resolution, one dependent on RECQ1 ATPase 
and branch migration activity (Berti et al., 2013) and the other on 
DNA2 nuclease and WRN ATPase activity. Moreover, the DNA2/
WRN mechanism is tightly regulated by an ATPase-independent 
function of RECQ1 that might limit DNA2 activity by binding to 
reversed forks. Of note, our EM experiments show that reversed 
replication forks accumulate in RECQ1- and DNA2-depleted 
cells also in unperturbed conditions suggesting that fork reversal 
is remarkably frequent when DNA replication faces intrinsic rep-
lication fork obstacles, and that RECQ1 and DNA2 have a con-
served role in restarting reversed forks in unperturbed S-phase.
	  
	  144	  
	   RESULTS	   	  	   	  
557DNA2 drives reversed replication fork restart • Thangavel et al.
depletion is consistent with observations that the deregulation 
of checkpoint activity leads to a large increase in the number of 
newly initiated origins (Couch et al., 2013). However, the extent 
of ATR activation does not necessarily re!ect the amount of 
ssDNA detected at replication forks, whether at the junction, at 
ssDNA gaps, or at regressed arms (Zellweger et al., 2015). In 
light of these "ndings, we rather suggest that DNA2-dependent 
ATR activation may re!ect DNA2 recruitment to the stalled 
forks per se, or subtle changes of fork architecture that are asso-
ciated with its recruitment but possibly escape our EM analysis. 
This interpretation is supported by the recent discovery that 
yeast Dna2 has a direct role in Mec1 activation (the ortholog of 
human ATR), independent from its nuclease or helicase activity 
(Kumar and Burgers, 2013). Of note, the increased origin "ring 
frequency observed upon DNA2 depletion is not associated to a 
parallel increase in the frequency of termination events (Fig. S1 A) 
possibly because the defects in replication fork restart associated 
a model replication fork with similar ef"ciency in the absence of 
replication protein A (Hu et al., 2012). However, it is likely that 
only the 5?-to-3? directionality is important in vivo, because RPA 
is known to stimulate the 5?-to-3? and inhibit the 3?-to-5? nuclease 
activity of yeast DNA2 (Cejka et al., 2010; Niu et al., 2010). In 
agreement with this conclusion, our biochemical data show that 
DNA2-dependent end resection proceeds with a 5? to 3? polarity 
in the presence of RPA. Moreover, our EM experiments clearly 
show that DNA2 depletion affects the frequency of reversed forks 
that are either entirely or partially single-stranded supporting the 
notion that DNA2-dependent degradation of reversed forks oc-
curs with a preferential polarity in vivo.
The resection activity of human DNA2 was postulated to 
activate the ATR/Chk1 checkpoint under conditions of replica-
tion stress (Karanja et al., 2012). Indeed, we "nd that DNA2 de-
pletion prevents ATR checkpoint activation after HU treatment. 
Moreover, the increased origin "ring observed upon DNA2 
Figure 9. Schematic model for the combined 
roles of DNA2 and WRN in reversed fork pro-
cessing. DNA2 and WRN functionally interact 
to process reversed forks. DNA2 degrades 
reversed forks with a 5?-to-3? polarity. WRN 
ATPase activity assists DNA2 degradation pos-
sibly by promoting the opening of the reversed 
arm of the fork. RECQ1 limits DNA2 activity 
by an ATPase-independent function. Branch 
migration factors specifically recognize the 
partially resected reversed forks to promote 
fork restart. Alternatively, the newly formed 3?  
overhang of the reversed fork invades the 
duplex ahead of the fork, resulting in Holliday 
junction structures that can be resolved by spe-
cific resolvases or dissolvases to promote fork 
restart. Gray box, RECQ1 can independently 
restart reversed forks by virtue of its ATPase 
and branch migration activity.
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speci!c genetic backgrounds. For example, MRE11 degrades 
stalled replication intermediates only in a BRCA2-de!cent back-
ground, as already discussed (Schlacher et al., 2011). Moreover, 
the cleavage of unresolved replicative intermediates by the 
structure-speci!c MUS81 endonuclease is a late response to 
replicative stress, which becomes activated only when other 
attempts to overcome stalled replication have been exhausted 
(Hanada et al., 2007; Franchitto et al., 2008). Thus, MUS81 
might still resolve reversed replication forks as a back-up sys-
tem to unlink sister chromatids and facilitate mitotic segregation 
in the absence of DNA2 or WRN.
Collectively, these studies highlight a new important 
mechanism for the recovery from replication blockage. This 
mechanism relies on the DNA2-dependent processing of re-
versed forks—leading to ssDNA stretches on the regressed 
arms—which appear to promote ef!cient fork restart. A possi-
ble explanation for the need of partially single-stranded DNA 
structures to promote fork restart is that they represent a key in-
termediate to activate an HDR-like mechanism of reversed fork 
restart, as recently proposed in S. pombe (Carr and Lambert, 
2013). In particular, the newly formed 3? overhang of the re-
versed fork might invade the duplex ahead of the fork resulting 
in Holliday junction structures that can be resolved by speci!c 
resolvases or dissolved by the combined action of the BLM 
helicase (Sgs1 in yeast) and the type I topoisomerase TOP3 
(Fig. 9). Alternatively, resumption of DNA replication might be 
obtained by reverse branch migration, where the partially re-
sected reversed fork structures might be speci!cally recognized 
by a motor protein—e.g., SMARCAL1 (Béous et al., 2013) or a 
human RecQ helicase—to promote the branch migration-assisted 
reestablishment of a functional replication fork.
Materials and methods
Cell lines, culture conditions, and reagents
U-2 OS, HEK 293, and Werner Syndrome fibroblast (AG11395) cells were 
grown in DMEM supplemented with 10% FBS at 37°C in 5% CO2. HCT116 
cells were grown in McCoy’s 5A medium supplemented with 10% FBS. 
CldU, IdU, BrdU, hydroxyurea, mitomycin C, camptothecin, tamoxifen, pu-
romycin, and hygromycin were obtained from Sigma-Aldrich.
DNA2 conditional knockout HCT116 cells
To examine the response of cells to the complete absence of DNA2, we used 
a DNA2 conditional knockout cell line where exon 2 of the DNA2 gene is 
deleted (Karanja et al., 2014). The colorectal carcinoma HCT116 cell line 
carries 3 copies of DNA2 due to a duplication on chromosome 10. Two 
chromosomal copies were disrupted using rAAV-mediated gene targeting 
technology and exon 2 of the third allele was replaced with a conditional 
exon where the exon was flanked by loxP sites (DNA2flox/?/?). To create 
a conditional cell line these cells were stably transduced with a tamoxifen 
(4-OHT)-inducible Cre recombinase. Thus, the cell line is viable and can be 
propagated. The addition of tamoxifen to the culture media leads to excision 
of the endogenous DNA2 and the generation of a true DNA2-null cell. Com-
plete loss of DNA2 occurs after 72 h of tamoxifen treatment. However, the 
DNA fiber experiments were performed after 40 h of tamoxifen treatment to 
have enough S-phase cells for DNA labeling.
Antibodies
Anti-DNA2 rabbit polyclonal (ab96488; 1:1,000), anti-MUS81 mouse 
monoclonal (ab14387; 1:1,000), and anti-CldU/BrdU rat monoclonal 
(ab6326; 1:6) antibodies (all from Abcam); anti-CtIP rabbit polyclonal 
(A300-488A; 1:1,000), anti-EXO1 rabbit polyclonal (A302-639A; 
1:1,000), anti-pRPA32 (S4/S8) rabbit polyclonal (A300-245A; 1:1,000), 
and anti-pRPA32 (S33) rabbit polyclonal (300-246A; 1:2,000; all from 
with DNA2 depletion limit the number of termination events 
even under conditions of increased origin !ring.
WRN plays an important—albeit mechanistically ill- 
de!ned—role in the recovery from replication blockage, and 
mutations in the WRN gene are linked to the cancer predisposi-
tion disorder Werner Syndrome (Sidorova et al., 2008; Murfuni 
et al., 2012). Our studies infer that the high genomic instability 
of WRN-de!cient cells may result from aberrant processing of 
reversed replication intermediates. In particular, given the con-
solidated role of WRN at dif!cult-to-replicate regions—e.g., 
telomeres and fragile sites (Crabbe et al., 2004; Murfuni et al., 
2012)—we speculate that WRN, in conjunction with DNA2, is 
required to process reversed forks arising spontaneously at 
these genomic loci. Biochemical studies pointed to a putative 
role of WRN in fork reversal and/or restart by showing that 
WRN ef!ciently promotes both the formation and restoration 
of oligonucleotide-based reversed fork substrates (Machwe 
et al., 2011). We show that WRN ATPase activity is needed for 
the DNA2-dependent degradation of reversed replication forks. 
Our interpretation for the role of WRN ATPase activity is that 
it facilitates DNA2-dependent degradation of the reversed forks 
by transiently opening the dsDNA arm of the reversed fork. 
This mechanism is reminiscent to the DNA2-dependent mecha-
nism of DSB resection where the yeast Sgs1 helicase is required 
to transiently open the DNA duplex to generate a 5? ssDNA tail 
that is in turn degraded by DNA2 (Zhu et al., 2008; Cejka et al., 
2010; Niu et al., 2010). We suggest that WRN is the functional 
homologue of Sgs1 in mammalian cells, at least in the context 
of DNA2-dependent reversed replication fork processing. How-
ever, BLM was also shown to interact and cooperate with DNA2 
to resect dsDNA ends in vitro opening the possibility that other 
human RecQ helicases might substitute for WRN, depending 
on the nature of the DNA lesion being processed or the particu-
lar cellular context (Nimonkar et al., 2011; Sturzenegger et al., 
2014). This mechanism seems to be well-conserved throughout 
evolution because it is highly reminiscent of the stalled fork 
processing pathway described in E. coli where the RecJ nucle-
ase cooperates with bacterial RecQ to process blocked replication 
intermediates (Courcelle et al., 2003). In addition, the prokary-
otic RecBCD helicase-nuclease plays an important role in re-
secting replication forks after reversal (Seigneur et al., 1998) 
and DNA2 is of the same family of nucleases as RecB. Whether 
the DNA2/WRN-mediated resection activity can degrade addi-
tional stalled replication intermediates other than reversed forks 
is worth future investigation.
EXO1, MRE11, and CtIP play central roles in DNA repair 
and are also implicated in the recovery from replication fork 
blockage (Cotta-Ramusino et al., 2005; Schlacher et al., 2011; 
Yeo et al., 2014). None of these nucleases, however, partici-
pates in the DNA2-dependent processing of reversed replica-
tion forks pointing to a speci!c role of DNA2 that, unlike 
its function in DSB resection, is not shared by other nucleases. 
A possible interpretation of these results is that the reversed 
forks are characterized by a particular structure of the terminal 
end that does not require the trimming activity of other nucle-
ases to promote DNA2-dependent resection. However, some of 
these nucleases might still be able to access stalled forks under 
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were kind gifts from Dr. Pietro Pichierri (Insituto Superiore di Sanità, Rome, 
Italy). All transfections were done with Lipofectamine 2000 (Life technolo-
gies Catalog no: 11668027). An shRNA targeting luciferase (5?-ACGCT-
GAGTACTTCGAAATGT-3?) was used for control shRNA experiments. The 
silencer select negative control (Life technologies, Catalog no. 4390843) or 
an siRNA targeting luciferase (5?-CGUACGCGGAAUACUUCGA-3?) were 
used for control siRNA experiments, as indicated. Lentiviral mediated shRNA 
depletions were achieved using the following sequences cloned into the 
pLKO.1 lentiviral shRNA expression vector: BLM (5?-CGAAGGAAGTTGTAT-
GCACTA-3?), WRN (5?-GCTGGCAATTACCAGAACAAT-3?), and MUS81 
(5?-CACGCGCTTCGTATTTCAGAA-3?). The procedure for lentiviral genera-
tion and transduction has been described (Berti et al., 2013). Transduced U-2 
OS cells were selected with 6 µg/ml puromycin. siRNA-mediated depletions 
were achieved using the following siRNAs from Invitrogen: DNA2 (5?-AUA-
GCCAGUAGUAUUCGAU-3?), CtIP (5?-CGAAUCUUAGAUGCACAAA-3?), 
EXO1 (Invitrogen-HSS113557), and RAD51 (Invitrogen-1299001). In brief, 
siRNAs were transfected using Lipofectamine RNAiMAX (Life Technologies) 
following the manufacturer’s protocol. MRE11 (5?-GAAAGGCUCUAUC-
GAAUGU-3?) and RECQ4 (SMART pool) siRNAs were from Dharmacon 
and were transfected as previously described (Thangavel et al., 2010).
Microfluidic-assisted DNA fiber stretching
For DNA replication fork restart analysis, asynchronous cells were pulse-
labeled with 50 µM CldU for 20–30 min. 2 mM HU, 300 nM MMC, or 
150 nM CPT was added to the CldU containing media and incubated for the 
indicated times. Cells were washed three times with medium and released 
with 50 µM IdU for 40 min. For nascent strand degradation analysis, asyn-
chronous cells were pulse-labeled with 50 µM IdU for 45 min, washed 
three times with medium, incubated with 4 mM HU, 100 nM CPT, 200 nM 
MMC, or medium for times indicated. The pulse-labeled cells were trypsin 
collected and lysed in agarose plugs to prevent any mechanical breakage 
of replication tracts. Microfluidic platform for stretching the high-molecular 
weight DNA, coverslips, immunostaining and image acquisition of replica-
tion tracts were performed as described (Sidorova et al., 2009; Berti et al., 
2013). In brief, polydimethylsiloxane (PDMS) stamps with microchannels 
were Oxygen plasma treated and reversibly sealed to the silanized cover-
slips. High-molecular weight DNA was loaded and stretched by capillary 
force into the microchannels. PDMS stamps were peeled-off and coverslips 
were left drying overnight. For immunostaining, DNA-stretched coverslips 
were denatured (2.5N HCL for 45 min), neutralized (0.1 M sodium borate 
and 3 washes with PBS), blocked (5% BSA and 0.5% Tween 20 in PBS for 
30 min), incubated with primary antibodies (Anti-IdU/BrdU or both anti-
IdU/BrdU and anti-CldU/BrdU for 30 min), washed (1% BSA and 0.1% 
Tween 20 in PBS, 3 times 5 min each) and incubated with secondary anti-
bodies (anti–mouse Alexa Fluor 488-conjugated, or both anti–mouse Alexa 
Fluor 488–conjugated and anti–rat Alexa Fluor 594–conjugated for 1 h). 
Washed slides were mounted in prolong gold anti-fade reagent (Life Tech-
nologies) and images were sequentially acquired (for double-label) with 
LAS AF software using TCS SP5 confocal microscope (Leica). A 63×/1.4 
oil immersion objective was used. Images were captured at room tempera-
ture. n ≥ 300 fiber tracts scored for each dataset. The DNA tract lengths 
were measured using ImageJ and the pixel length values were converted 
into micrometers using the scale bars created by the microscope. Statistical 
analysis was done using GraphPad Prism.
Clonogenic survival assay
Colony-forming assays were performed as previously described (Franken 
et al., 2006). In brief, 1,000 cells were plated per well and treated on the 
next day with 4 mM HU for 3, 6, and 8 h or 100 nM CPT for 6 h. Colonies 
were fixed, stained, and quantified 10 d after release from genotoxic stress. 
The plating efficiency and survival fraction were calculated as previously 
described (Franken et al., 2006). In brief, colonies were counted using an 
inverted stereomicroscope and the plating efficiency was calculated using 
the following formula: Plating Efficiency (PE) = (no. of colonies formed/no. of 
cells seeded) × 100%. From the plating efficiency, the surviving fraction (SF) 
was calculated as: SF = (no. of colonies formed after treatment/no. of cells 
seeded) × PE. The experiments were performed in triplicate and the statistical 
analysis was performed using GraphPad Prism.
Western blotting
Cells were washed with PBS and lysed either in standard RIPA buffer (PBS, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 µg/ml aprotinin, 
10 µg/ml PMSF, 1 mM Na3VO4, and 1 mM NaF) or MCL buffer (50 mM 
Tris, pH 8.0, 5 mM EDTA, 0.5% NP-40, 100 mM NaCl, 2 mM DTT, and 
freshly added protease and phosphatase inhibitors from Roche (1 tablet/10 ml 
of buffer). Cell lysates were resolved by SDS-PAGE and transferred to 
Bethyl); anti-WRN rabbit polyclonal (NB100-471; 1:1,000); and anti-
MRE11 rabbit polyclonal (NB100-142; 1:2,000; Novus); anti-RAD51 (H-92) 
rabbit polyclonal (sc-8349; 1:1,000) and anti-RECQ1 rabbit polyclonal 
(sc-25547; 1:2,000) from Santa Cruz; anti-rat Alexa (594-A11007; 
1:1,000); and anti–mouse Alexa Flour (488-A11001; 1:1,000; Invitro-
gen); anti-rabbit (31460; 1:10,000; Thermo Fisher Scientific); anti-tubulin 
mouse monoclonal (T5168; 1:5,000; Sigma-Aldrich); anti-IdU/BrdU 
mouse monoclonal (347580; 1:6) from BD; anti-Chk1 mouse monoclonal 
(sc-8408; 1:1,000; Santa Cruz Biotechnology, Inc.); anti-p-Chk1 (S345) 
rabbit monoclonal (2348; 1:1,000; Cell Signaling Technology); anti-RPA32 
mouse monoclonal (NA19L; 1:1,000) from EMD Millipore; anti-RECQ1 
rabbit polyclonal, raised against residues 634–649 of human RECQ1, is 
custom made (Mendoza-Maldonado et al., 2011); anti-BLM rabbit poly-
clonal, raised against residues 1–449 of human BLM (Wu and Hickson, 
2003), was a gift from I. Hickson (University of Copenhagen, Copenha-
gen, Denmark); and anti-RECQ4 rabbit polyclonal, raised against residues 
60–111 of human RECQ4 (Yin et al., 2004), was a gift from W. Wang 
(National Institute on Aging, Baltimore, MD).
Recombinant proteins
Yeast Dna2 was expressed in yeast WDH668 strain from pGAL:DNA2 
vector (Budd et al., 2000) and purified as previously described (Levikova 
et al., 2013). In brief, the cells were lysed and Dna2 was purified by 
affinity chromatography on Ni-NTA agarose (QIAGEN) and anti-Flag M2 
affinity gel (Sigma-Aldrich). Yeast RPA was expressed in yeast BJ5464 
strain containing three plasmids coding for Rfa1, Rfa2, and Rfa3 and 
purified as previously described (Kantake et al., 2003). In brief, the cells 
were lysed and yeast RPA was purified by affinity on ssDNA cellulose 
column (USB corporation) and by ion exchange chromatography using 
HiTrap Q column (GE Healthcare). Human DNA2 was expressed in Sf9 
cells from a pFastBac:hDNA2 vector (polyhedrin promoter) provided by 
J. Campbell (Masuda-Sasa et al., 2006). The soluble extracts were obtained 
by salt extraction as previously described for Sgs1 (Cejka and Kowalc-
zykowski, 2010). The subsequent purification of hDNA2 was performed 
as previously described for yeast Dna2 (Levikova et al., 2013) by affinity 
chromatography using Ni-NTA agarose (QIAGEN) and Anti-Flag M2 
affinity gel (Sigma-Aldrich). Human RPA was expressed from p11d-tRPA 
vector (Henricksen et al., 1994) in BL21 E. coli cells and purified as 
described (Henricksen et al., 1994). In brief, hRPA was first bound to 
HiTrap Blue column (GE healthcare) and then to HiTrap Q column. The 
sequence coding for yeast Mer3 helicase was amplified from yeast genomic 
DNA (SK1 strain) using primers Mer3FO (5?-GCGCGCGGGCCCATGAAAA-
CAAAGTTTGATCGCCTCGGTACAGGAAAAAGAAGTAGACCCTCTC-
CAAATAATATTGACTTTAACGACCAG-3?) and Mer3RE (5?-CGCGCGCTC-
GAGTTCAAACTCTATATCGGAAC-3?). The PCR product was digested 
with ApaI and XhoI restriction endonucleases (both from New England 
Biolabs) and cloned into corresponding sites in pFB-MBP-Sgs1-his after the 
polyhedrin promoter, creating pFB-MBP-Mer3-his vector. Mer3 was then 
expressed in Sf9 cells and purified using affinity chromatography as 
previously described for Sgs1 (Cejka and Kowalczykowski, 2010). In 
brief, MBP-tagged Mer3 was first bound to amylose resin (New England 
Biolabs), eluted and digested with PreScission protease to cleave the MBP 
tag. Mer3 was further purified by affinity on Ni-NTA agarose (QIAGEN) 
exploiting the 10x His-tag at its C-terminus. Sequence information is available 
on request.
Genetic knock-down-rescue experiments
RECQ1, DNA2, and RAD51 genetic knockdown-rescue experiments were 
performed using the procedure described (Berti et al., 2013; Yata et al., 
2012). In brief, RECQ1 is depleted using the pLKO.1-puro-shRECQ1 (5?-GAG-
CTTATGTTACCAGTTA-3?) construct and rescue experiments are performed 
using the shRNA resistant pIRES-RECQ1-WT or K119R (ATPase dead) con-
structs as described (Berti et al., 2013). DNA2 is depleted using an siRNA 
targeting the 3?UTR of DNA2 (5?-CAGUAUCUCCUCUAGCUAG-3?). At 
least one isoform of DNA2 is not targeted by this sequence. DNA2 rescue 
experiments are performed using the pBabe-hygro-3xFLAG-DNA2 WT, 
D294A (Nuclease dead), or K671E (helicase dead) constructs. RAD51 
is depleted using siRNAs targeting the 3?UTR (5?-GACUGCCAGGAU-
AAAGCUU-3? and 5?-GUGCUGCAGCCUAAUGAGA-3?) in U-2 OS stable 
cell lines expressing WT RAD51 as described (Yata et al., 2012). WRN 
depletions were achieved using pRS-puro-shWRN (5?-AGGCAGGTGTAG-
GAATTGAAGGAGATCAG-3?; sequence ID: TI333414) and exogenous 
expression is done with the shRNA resistant Flag-pCMVTag2B-WRN WT 
or K577M (helicase dead) constructs. Constructs for WRN depletion and 
overexpression of WT WRN and ATPase-deficient WRN (WRN-K577M) 
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pyruvate kinase, 1 nM DNA substrate (molecules), and recombinant pro-
teins, as indicated. The reactions were assembled on ice and incubated 
for 30 min at 30°C for yeast proteins and at 37°C for human proteins. Un-
less indicated otherwise, RPA was present in the reactions at saturating 
concentrations corresponding to a threefold excess over DNA, assuming 
all DNA was single-stranded and a DNA-binding site size of 25 nt for 
hRPA and of 20 nt for yRPA. The reactions were terminated by adding 5 µl 
Stop buffer (150 mM EDTA, 2% SDS, 30% glycerol, and 0.01% bromo-
phenol blue), incubated for 30 min at room temperature and separated on 
polyacrylamide gels in TBE buffer under native conditions. Alternatively, 
for denaturing conditions, the reaction were terminated by adding 15 µl 
Formamide stop buffer (95% (vol/vol) formamide, 20 mM EDTA, 0.01% 
bromophenol blue), denatured by heating at 95°C for 5 min and sepa-
rated on 20% denaturing polyacrylamide gels in TBE buffer. Gels were 
fixed, dried, exposed to a storage phosphor screen, and analyzed on 
Typhoon phosphor imager (GE Healthcare).
Online supplemental material
Fig. S1 shows quantification of stalled forks, new origins, and termination 
events in DNA2-depleted cells upon genotoxic stress induction, as well as 
the statistical analysis of IdU tracts from RECQ1-, DNA2-, WRN-, RECQ1/
DNA2-, RECQ1/WRN-, WRN/DNA2-, and RECQ1/WRN/DNA2-depleted 
U-2 OS cells. Fig. S2 shows the IdU tract length distribution in BLM- and 
RECQ4-depleted cells, respectively, as well as statistical analysis of IdU 
tracts from RECQ1/WRN-codepleted cells complemented with WT WRN 
or with ATPase-deficient WRN. Fig. S3 shows additional EM analysis, as 
well as the Western blot analysis of ATR-checkpoint activation in RECQ1- 
and/or DNA2-depleted U-2 OS cells. Fig. S4 shows additional biochemi-
cal analysis of substrate specificity of human DNA2 and human EXO1. 
TFig. S5 shows biochemical assays of substrate specificity of yeast Dna2 
and yeast Exo1. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201406100/DC1.
We are grateful to Pietro Pichierri (Istituto Superiore di Sanità, Rome) for provid-
ing the WS cells and WRN constructs, Damian Dalcher for his help with the 
EM analysis, Stephanie Felscher (University of Zurich) for kindly providing 
human EXO1 protein, Marc Wold (University of Iowa) for human RPA expres-
sion construct, Lepakshi Ranjha (University of Zurich) for Mer3 protein, Fumiko 
Esashi (University of Oxford) for the Rad51 siRNAs and the U-2 OS cells stably 
expressing exogenous RAD51, and Judith Campbell (California Institute of 
Technology) for human and yeast DNA2/Dna2 expression constructs. We 
thank the Research Microscopy Core Facility of Saint Louis University for techni-
cal support.
This work was supported by National Institutes of Health grant 
R01GM108648 to A. Vindigni, by startup funding from the Doisy Department 
of Biochemistry and Molecular Biology and from the Saint Louis University 
Cancer Center to A. Vindigni, by grants from the President’s Research Fund of 
Saint Louis University and by the GLIOMA-Interreg (Slovenian-Italian Coopera-
tion 2007-2013) project to A. Vindigni, by the Swiss National Science Foun-
dation grants 31003A_146924 to M. Levikova and PP00P3 133636 to 
P. Cejka, by National Institutes of Health grant GM0088351 and CA15446 to 
E.A. Hendrickson, and by a research contract from Horizon Discovery, Ltd 
to E.A. Hendrickson. M. Berti was supported by an EMBO short-term fellowship 
to perform EM experiments in M. Levikova laboratory.
The authors declare no competing financial interests.
Submitted: 24 June 2014
Accepted: 14 January 2015
References
Atkinson, J., and P. McGlynn. 2009. Replication fork reversal and the main-
tenance of genome stability. Nucleic Acids Res. 37:3475–3492. http://
dx.doi.org/10.1093/nar/gkp244
Ayyagari, R., X.V. Gomes, D.A. Gordenin, and P.M. Burgers. 2003. Okazaki 
fragment maturation in yeast. I. Distribution of functions between FEN1 
AND DNA2. J. Biol. Chem. 278:1618–1625. http://dx.doi.org/10.1074/
jbc.M209801200
Bae, S.H., K.H. Bae, J.A. Kim, and Y.S. Seo. 2001. RPA governs endonuclease 
switching during processing of Okazaki fragments in eukaryotes. Nature. 
412:456–461. http://dx.doi.org/10.1038/35086609
Berti, M., A. Ray Chaudhuri, S. Thangavel, S. Gomathinayagam, S. Kenig, M. 
Vujanovic, F. Odreman, T. Glatter, S. Graziano, R. Mendoza-Maldonado, 
et al. 2013. Human RECQ1 promotes restart of replication forks reversed 
by DNA topoisomerase I inhibition. Nat. Struct. Mol. Biol. 20:347–354. 
http://dx.doi.org/10.1038/nsmb.2501
PVDF membrane (GE Healthcare). Incubation with antibodies was per-
formed overnight at 4°C. Proteins were visualized using ECL (Thermo 
Fisher Scientific) according to the manufacturer’s instructions.
Co-immunoprecipitation experiments
HEK293T cells were transfected with empty vectors, FLAG-DNA2, and Strep-
HA-WRN by calcium phosphate. 48 h after transfection, cells were treated 
with 4 mM HU for 3 h, lysed in benzonase lysis buffer (50 mM Tris-HCl, 
pH 7.5, 75 mM KCl, 2 mM MgCl2, 20 mM NaF, 10 mM ?-glycerophosphate, 
0.2 mM Na3VO4, and 0.2% Triton X-100) supplemented with protease in-
hibitors (EDTA-free tablet; Sigma-Aldrich) by passing 10 times through a 
26-G syringe needle and incubated 1 h at 4°C with 2 U/µl Benzonase 
(Sigma-Aldrich) to digest genomic DNA. KCl and EDTA concentrations were 
adjusted to 120 and 3 mM, respectively, and lysates were centrifuged at 
14,000 rpm for 30 min. Immunoprecipitations of clarified lysates were per-
formed with FLAG M2 or HA affinity agarose resin (Sigma-Aldrich) overnight 
at 4°C. Beads were washed 5 times with wash buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM KCl, 3 mM EDTA, 2 mM MgCl2, 20 mM NaF, 10 mM 
?-glycerophosphate, 0.2 mM Na3VO4, and 0.2% Triton X-100) and bound 
proteins were eluted by boiling in SDS-PAGE sample buffer.
EM analysis of genomic DNA in mammalian cells
EM analysis of replication intermediates has been described in detail (Ray 
Chaudhuri et al., 2012; Neelsen et al., 2014), including a description of the 
important parameters to consider specifically for the identification and the 
scoring of reversed forks (Neelsen et al., 2014). In brief, 5–10 × 106 U-2 
OS cells were harvested and genomic DNA was cross-linked by two rounds 
of incubation in 10 µg/ml 4,5?,8-trimethylpsoralen (Sigma-Aldrich) and 
3 min of irradiation with 366 nm UV light on a precooled metal block. Cells 
were lysed and genomic DNA was isolated from the nuclei by proteinase K 
(Roche) digestion and phenol-chloroform extraction. DNA was purified by 
isopropanol precipitation, digested with PvuII HF in the proper buffer for 3–5 h 
at 37°C, and replication intermediates were enriched on a benzoylated 
naphthoylated DEAE–cellulose (Sigma-Aldrich) column. EM samples were 
prepared by spreading the DNA on carbon-coated grids in the presence of 
benzyl-dimethyl-alkylammonium chloride and visualized by platinum rotary 
shadowing. Images were acquired on a transmission electron microscope 
(JOEL 1200 EX) with side-mounted camera (AMTXR41 supported by AMT 
software v601) and analyzed with ImageJ (National Institutes of Health).
Preparation of oligonucleotide-based DNA substrates
DNA oligonucleotides were purchased from Microsynth and 32P-labeled 
either at the 5? terminus with [?-32P] ATP and T4 polynucleotide kinase (New 
England Biolabs), or at the 3? end with [?-32P] cordycepin-5?-triphosphate 
and terminal transferase (New England Biolabs) according to manufacturer’s 
instructions. Unincorporated nucleotides were removed using MicroSpin 
G25 columns (GE Healthcare). The substrates were prepared by heating the 
respective oligonucleotides at 95°C and gradually cooling to room temperature. 
The following oligonucleotides were used for the preparation of the four- 
way junction (X12-3 TOP L, HJ 1, HJ 2, and HJ 3), three-way junction with 
3? tail (X12-3 TOP L, HJ 1, HJ 2Sb, and HJ 3), three-way junction with 5? ssDNA 
tail (X12-3 TOP L, HJ 1S, HJ 2, and HJ 3), nicked four-way junction (X12-3 
TOP L, HJ 1, HJ 2Sa, HJ 2Sb, and HJ 3), replication fork (X12-3 TOP L, HJ 
1S, HJ 2Sb, and HJ 3), and dsDNA (X12-3 TOP L and Bottom LC), respec-
tively. The sequences of the oligonucleotides were: X12-3 TOP L (93 nt), 
5?-GACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATC-
GCGACTTACGTTCCATCGCTAGGTTATTTTTTTTTTTTTTTTTTT-3? X12-3 HJ 1 
(93 nt), 5?-AAAAAAAAAAAAAAAAAAATAACCTAGCGATGGAACGTA-
AGTCGCGATGGGCTTAACTAGGATGCTACTGGCCCCGAATCAACCGT-
ACTTGGG-3? X12-3 HJ 1S (48 nt), 5?-AAAAAAAAAAAAAAAAAAAT-
AACCTAGCGATGGAACGTAAGTCGCGAT-3? X12-3 HJ 2 (93 nt), 
5?-CCCAAGTACGGTTGATTCGGGGCCAGTAGCATCCTAGTT AAGCCCA-
TTACGATTCGTTACCCATTCACTGTCAGAAGGCACCAGATAGATCTC-3? 
X12-3 HJ 2Sa (45 nt), 5?-CCCAAGTACGGTTGATTCGGGGCCAGTAGCA-
TCCTAGTTAAGCCC-3? X12-3 HJ 2Sb (48 nt), 5?-ATTACGATTCGTTACCC-
ATTCACTGTCAGAAGGCACCAGATAGATCTC-3? X12-3 HJ 3 (93 nt), 
5?-GAGATCTATCTGGTGCCTTCTGACAGTGAATGGGTAACGAATCGT-
AATAGTCTCTAGACAGCATGTCCTAGCAATGTAATCGTCTATGACGTC-3? 
X12-3 BOTTOM LC, 5?-AAAAAAAAAAAAAAAAAAATAACCTAGCGAT-
GGAACGTAAGTCGCGATAGTCTCTAGACAGCATGTCCTAGCAATGTA-
ATCGTCTATGACGTC-3?.
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 Figure S1.  DNA2 and WRN function in stalled fork processing. (A, left) Schematic of DNA fi ber tract analysis. (right) Quantifi cation of red tracts (stalled 
forks), green tracts (new origins), and contiguous red–green–red tracts (termination events). Proper quantifi cation of stalled forks is complicated by the fact 
that termination events might also lead to red tracts if termination occurs before the addition of the second label. Mean shown,  n = 3. Error bars, standard 
error. ns, not signifi cant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (paired Student’s  t test). (B, left) Expression of Flag-tagged WT (DNA2-WT) or nuclease-
dead (DNA2-D294A) DNA2 in DNA2-depleted U-2 OS cells. (right) Quantifi cation of stalled forks in DNA2-depleted cells expressing DNA-WT or DNA2-
D294A. Mean shown,  n = 3. Error bars, standard error. ns, not signifi cant; *, P < 0.05 (paired  t test). (C, top) Expression of RECQ1, WRN, DNA2, and 
tubulin in U-2 OS cells transfected with the indicated shRNA or siRNA. (middle) Statistical analysis of IdU tracts from U-2 OS cells depleted for the indicated 
proteins in the presence of 4 mM HU. (bottom) Statistical analysis of IdU tracts from U-2 OS cells depleted for the indicated proteins in the absence of drug 
treatment. Whiskers indicate the 10th and 90th percentiles. ns, not signifi cant (Mann-Whitney test).  n ≥ 300 scored for each dataset. (D, top) Expression 
of WRN after WRN knockdown and representative fi ber tract images in Luc- and WRN-depleted U-2 OS cells. Bar, 15 µm. Representative IdU tracts in 
WRN-depleted U-2 OS cells in the presence or absence of HU (out of 2 repeats;  n ≥ 700 scored for each dataset). 
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 Figure S2.  BLM or RECQ4 depletion does not have a signifi cant effect on stalled fork processing. (A) Representative IdU tracts in Luc-, RECQ1-, BLM-, or 
RECQ1/BLM-codepleted U-2 OS cells in the presence of HU (out of 2 repeats;  n ≥ 300 scored for each dataset). (top) Expression of RECQ1, BLM and tubu-
lin in U-2 OS cells transfected with indicated shRNA. (B) Representative IdU tracts in control, RECQ1-, RECQ4-, or RECQ1/RECQ4-codepleted U-2 OS cells 
in the presence of HU (out of 2 repeats;  n ≥ 350 scored for each dataset). (top) Expression of RECQ1, RECQ4 and tubulin in U-2 OS cells transfected with 
indicated shRNA. (C) Expression of RECQ1, DNA2-WT, DNA2-K671E, and DNA2-D294A in U-2 OS cells transfected with the indicated shRNA or siRNA. 
(D) Expression of RECQ1, WRN-WT, WRN-K577M, and WRN-E84A in WS cells. (E) Statistical analysis of IdU tracts from RECQ1-, WRN-, or RECQ1/
WRN-codepleted U-2 OS cells. The RECQ1/WRN-codepleted cells were complemented with WT or ATPase-defi cient (K577M) WRN, where indicated. 
Whiskers indicate the 10th and 90th percentiles. ns, not signifi cant; ****, P < 0.0001 (Mann-Whitney test). (F) Expression of RECQ1, WRN-WT, and 
WRN-K577M in U-2 OS cells transfected with the indicated shRNA. 
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 Figure S3.  DNA2 promotes ssDNA gap accumulation on replicated duplexes and the ATR-mediated checkpoint activation. (A) Frequency of fork reversal 
and ssDNA composition of the reversed arms in WRN- and/or DNA2-depleted U-2 OS cells in the presence and absence of HU. The percentage values 
are indicated on the top of the bar. “# RI” indicates the number of analyzed replication intermediates. (B) Representative electron micrographs of replication 
forks displaying ssDNA gaps on the replicated duplexes or at the replication fork junction observed on genomic DNA in shRECQ1 U-2 OS cells upon HU-
treatment. The black arrows point to ssDNA gaps. D, Daughter strand; P, Parental strand. (C) Statistical distribution of ssDNA gaps on newly replicated du-
plexes in RECQ1- and/or DNA2-depleted U-2 OS cells treated with HU (top) or in unperturbed conditions (bottom). “# RI” is the number of analyzed 
replication intermediates. (D) Western blot analysis of ATR-checkpoint activation (pChk1 and pRPA) in RECQ1- and/or DNA2-depleted U-2 OS cells with 
or without HU treatment. Total Chk1 and RPA level are displayed and used as loading control. (E) Schematic of the different structures detected by EM and 
DNA fi bers. EM is a static method, which enriches for snapshots of the “slow steps” of a reaction (i.e., partially resected reversed forks). After fork restart, 
the nucleolytic degradation quickly proceeds to degrade nascent strands behind the junction. Reannealing of the parental strands leads to “backtracking” 
of the fork. A new reversal event arises as a consequence of asymmetric degradation, and thus ssDNA accumulation in proximity to the fork. Backtracking 
is easily detected by DNA fi ber, but not by EM because a reversed fork formed after degradation and backtracking is indistinguishable from the original re-
versed fork present before initial degradation. 	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 Figure S4.  Human DNA2 but not EXO1 preferentially degrades branched DNA. (A) Degradation of a four-way junction by hDNA2 without human RPA 
(hRPA). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. (B) Degradation of a three-way junction with 
a 5 ! ssDNA tail by hDNA2 in the presence of hRPA (22.3 nM). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the 
 32 P label. (C) Same experiment as in B, but with a junction containing a 3 ! ssDNA tail. (D) RECQ1 K119R (ATPase-dead) inhibits four-way junction degrada-
tion by hDNA2. Increasing concentrations of RECQ1 (K119R) were preincubated with the substrate, and then hDNA2 (20 nM) was added to the reaction 
mixture. All reactions contained hRPA (65 nM). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. 
(E) Quantitation of data from D. Averages shown ± SEM,  n = 2. (F) Synergistic action of hDNA2 and WRN on a nicked plasmid based DNA substrate. 
The reactions contained 614 nM hRPA and were incubated at 37°C for 60 min. Products were separated on a 1% agarose gel and stained with GelRed. 
WRN helicase promotes degradation of nicked DNA by hDNA2. (G) Same experiment as in F, but with a gapped DNA substrate. (H) Degradation of a 
four-way junction by hDNA2 and  S. cerevisiae Mer3. hDNA2 only degrades ssDNA unwound by Mer3, no synergy in DNA degradation was observed. 
All reactions contained hRPA, and were analyzed on a native polyacrylamide gel (6%). (I) Degradation of four-way junction by hDNA2 is not stimulated 
by WT hRECQ1. All reactions contained hRPA (65 nM). Reaction products were separated on a native polyacrylamide gel (6%). (J) Degradation of a four-
way junction by hEXO1. Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. (K) Same experiment as in J, 
but with dsDNA. 
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 Figure S5.  Yeast Dna2 but not Exo1 preferentially degrades branched DNA. (A) Degradation of a four-way junction by yDna2 in presence (left) or absence (right) 
of yeast RPA (yRPA). Reactions were separated on a native polyacrylamide gel (6%), *, position of the  32 P label. (B) Experiment as in A, but with dsDNA and yRPA. 
(C) Yeast Dna2 preferentially degrades four-way junctions in the presence of yRPA. Quantitation of data from A and B. Averages shown ± SEM;  n = 2. (D) yRPA 
promotes DNA degradation by yDna2. Quantitation of data from A. The data points representing the degradation of a four-way junction in the presence of yRPA 
are identical to those from C. Mean shown ± SEM,  n = 2. (E) Yeast Dna2 preferentially degrades branched structures over dsDNA. Quantitation of degradation 
of various DNA substrates as indicated (cartoons on the right) by yDna2 WT in presence of yRPA. Averages shown ± SEM;  n = 2. (F) Denaturing 20% polyacryl-
amide gel showing that nuclease-dead yDna2 E675A variant does not degrade the four-way junction substrate. (G) Synergistic action of yDna2 and Sgs1 helicase 
on a nicked dsDNA plasmid based substrates. The reactions contained 770 nM yRPA and were incubated at 30°C for 60 min before being separated on a 1% 
agarose gel containing GelRed. (H) Experiment as in G, but with gapped DNA substrate. (I) Degradation of a four-way junction by yExo1 in the presence (right) 
or absence (left) of yRPA. (J) Same experiment as in I, but with dsDNA. (K) Quantitation of data from I and J. Averages shown ± SEM,  n = 2. 	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Abstract	  
Transmission	   of	   a	   stable	   genome	   from	   mother	   cell	   to	   daughter	   cell	   requires	   each	  
chromosome	   to	   be	   fully	   replicated.	   To	   avoid	   underreplication,	   cells	   have	   evolved	  
mechanisms	   to	   protect,	   restart,	   and	   repair	   perturbed	   replication	   forks.	   Using	   budding	  
yeast	  as	  a	  model,	  we	   find	   that	   the	  helicase	  activity	  of	   the	  conserved	  nuclease-­‐helicase	  
Dna2	   is	   required	   for	   the	   completion	   of	   DNA	   replication.	   Dna2	   helicase-­‐defective	   cells	  
accumulate	   post-­‐replicative	   inter-­‐sister	   chromatid	   DNA	   links.	   Yen1,	   but	   not	   the	   other	  
Holliday	   junction	   (HJ)	   resolvases	   Slx1-­‐Slx4	   and	   Mus81-­‐Mms4,	   targets	   these	   DNA	  
structures	   to	   safeguard	   chromosome	   segregation	   along	   a	   pathway	   distinct	   from	  
canonical	   HJ	   resolution.	   Because	   Yen1	   activation	   requires	   entry	   into	   mitosis,	   Dna2	  
helicase-­‐defective	  cells	  are	  susceptible	  to	  terminal	  DNA	  damage	  checkpoint	  arrest	  at	  the	  
G2/M	   transition.	   These	   findings	   explain	   the	   exquisite	   sensitivity	   of	   Dna2	   helicase-­‐
defective	   cells	   to	   replication	   stress	   and	   suggest	   molecular	   mechanisms	   of	   genome	  
instability	   and	   cell	   death	   that	  may	   underlie	   human	   pathologies	   associated	  with	  DNA2	  
such	  as	  cancer	  and	  Seckel	  syndrome.	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2.3.3	  DNA2	  cooperates	  with	  WRN	  and	  BLM	  RecQ	  helicases	  to	  mediate	  long-­‐
range	  DNA	  end	  resection	  in	  human	  cells	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DNA2 Cooperates with theWRN and BLM RecQ Helicases to
Mediate Long-range DNA End Resection in Human Cells*
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Background: DNA end resection is a critical step in the homology-directed repair of DNA double strand breaks (DSBs).
Results: Human WRN helicase stimulates the DNA2-catalyzed resection of DNA ends and acts in concert with DNA2 to
promote DSB repair by single strand annealing.
Conclusion: DNA2 cooperates with WRN or BLM to mediate the resection of DSBs in mammalian cells.
Significance:Defects in DNA end resectionmight, in part, account for the genomic instability phenotype ofWerner syndrome.
The 5!-3! resection of DNA ends is a prerequisite for the
repair of DNAdouble strand breaks by homologous recombina-
tion, microhomology-mediated end joining, and single strand
annealing. Recent studies in yeast have shown that, following
initial DNA end processing by the Mre11-Rad50-Xrs2 complex
and Sae2, the extension of resection tracts is mediated either by
exonuclease 1 or by combined activities of theRecQ familyDNA
helicase Sgs1 and the helicase/endonuclease Dna2. Although
human DNA2 has been shown to cooperate with the BLM heli-
case to catalyze the resectionofDNAends, it remains amatter of
debate whether another human RecQ helicase, WRN, can sub-
stitute for BLM in DNA2-catalyzed resection. Here we present
evidence that WRN and BLM act epistatically with DNA2 to
promote the long-range resectionof double strandbreak ends in
human cells. Our biochemical experiments show thatWRN and
DNA2 interact physically and coordinate their enzymatic activ-
ities to mediate 5!-3! DNA end resection in a reaction depen-
dent on RPA. In addition, we present in vitro and in vivo data
suggesting that BLMpromotesDNA end resection as part of the
BLM-TOPOIII!-RMI1-RMI2 complex.Our studyprovidesnew
mechanistic insights into the process of DNA end resection in
mammalian cells.
DNA double strand breaks (DSBs)4 are a very dangerous
formofDNAdamage because they can cause cell death or chro-
mosomal rearrangements, a hallmark of cancer (1). DSBs can
occur accidentally during normal cellular metabolism or upon
exposure of cells to exogenous agents such as ionizing radiation
and radiomimetic drugs (2). There are also programmed DSBs
that drive recombination events essential for physiological pro-
cesses, such as meiosis and lymphocyte development (3, 4). In
eukaryotic cells, DSBs are repaired by one of two major path-
ways: non-homologous end joining (NHEJ) and homologous
recombination (HR). NHEJ involves religation of the broken
DNA ends and is frequently associated with a short deletion or
insertion of DNA at the break site (5). In contrast, HR restores
the DNA integrity accurately because it uses sister chromatids
or homologous chromosomes as a template for repair (6, 7). HR
is initiated by resection of the broken DNA ends to generate 3!
single-stranded (ss) DNA tails that are utilized by the RAD51
recombinase for a homology search on the donor DNA mole-
cule (6, 7). Genetic and biochemical studies in budding yeast
have shown that broken DNA ends are resected in a two-step
process (8–10). DNA end resection in yeast is initiated by the
Mre11-Rad50-Xrs2 complex in conjunction with Sae2 (8, 9,
11). These proteinsmay initiate resection of the 5! strand of the
brokenDNA to remove a stretch of about 100–200 nucleotides
from the DNA end (8, 9, 11). The Mre11-Rad50-Xrs2 complex
also recruits the components of the long-range resection path-
ways Exo1 or Dna2-Sgs1 (8–10, 12, 13). Exo1 is a dsDNA-de-
pendent 5!-3! exonuclease that preferentially degrades DNA
substrates with a 3! ssDNA tail in a reaction stimulated by the
ssDNA-binding protein RPA (13). Dna2 is a ssDNA-specific
nuclease and aDNAhelicase that functions in conjunctionwith
the RecQ family DNA helicase Sgs1 and RPA to catalyze long-
range DNA end resection (10, 14). In this reaction, RPA stimu-
lates DNA unwinding by Sgs1 and promotes degradation of the
5!-terminated strand by Dna2 while protecting the growing 3!
ssDNA tail (10). DNAend resection is also the initial step in two
other DSB repair pathways, single strand annealing (SSA) and
microhomology-mediated end joining (8, 15).
The molecular machinery of DNA end resection appears to
be largely conserved between yeast andman (15–19). However,
it remains a matter of debate which DNA helicase mediates
DNA2-catalyzed resection in mammalian cells. Mammals pos-
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sess five RecQ homologues: RECQ1, BLM, WRN, RECQ4, and
RECQ5 (20). Biochemical studies have shown that human
DNA2 can act in conjunction with the BLM helicase and RPA
to mediate 5!-3! resection of DNA ends in vitro (17). In agree-
ment with these findings, it has been observed that cells
depleted of both BLM and EXO1 show a reduction in the for-
mation of RPA foci in response to DSBs and are defective in
DSB repair by HR (16, 19). However, studies usingXenopus egg
extracts and purified proteins have shown that Dna2 mediates
DNA end resection together with WRN rather than BLM (21–
23). This discrepancy prompted us to investigate the role of
WRN in DNA end resection in human cells. Here we demon-
strate that WRN helicase is capable of acting in concert with
DNA2 and RPA to resect 5!-recessed DNA ends in vitro with a
catalytic efficiency even higher than that of BLM. Moreover,
our results show that human cells may employ either BLM or
WRN to assist DNA2 in long-rangeDNAend resection. Finally,
we present data suggesting that BLMacts inDNAend resection
as part of the BLM-TOPOIII!-RMI1-RMI2 (BTRR) complex.
EXPERIMENTAL PROCEDURES
Antibodies and siRNA—Primary antibodies used for immu-
noblotting were as follows: mouse monoclonal anti-WRN (BD
Biosciences, catalog no. 611169), rabbit polyclonal anti-DNA2
(Abcam, catalog no. ab96488), rabbit polyclonal anti-BLM
(Abcam, catalog no. ab476), rabbit polyclonal anti-TFIIH
(Santa Cruz Biotechnology, catalog no. sc293), mouse mono-
clonal anti-FLAG (Sigma, catalog no. F1804), and rabbit poly-
clonal anti-RMI1 (Proteintech, catalog no. 14630-1-AP).
Anti-FLAG M2 magnetic beads (Sigma) were used for immu-
noprecipitation. Primary antibodies used for immunofluores-
cence staining were as follows: mouse monoclonal anti-RPA2
(Abcam, catalog no. ab2175) and rabbit monoclonal anti-"-
H2AX (Cell Signaling Technology, catalog no. 9718S). Rabbit
polyclonal anti-WRN antibody used for immunoprecipitation
has been described previously (24).
All siRNA oligoduplexes used in this study were purchased
from Microsynth. The sequences of the sense strands of these
duplexes were as follows: siLuc, 5!-CGUACGCGGAAUAC-
UUCGAdTdT-3!; siWRN, 5!-UAGAGGGAAACUUGGCAA-
AdTdT-3!; siBLM, 5!-CCGAAUCUCAAUGUACAUAGAd-
TdT-3!; siDNA2, 5!-UACCGCUUAAAUCUAAGUCAAdTdT-
3!; siEXO1, 5!-CAGCCAUUCUUACUACGCUAAdTdT-3!;
siMRE11, 5!-GAGCAUAACUCCAUAAGUAdTdT-3! (25);
siCtIP, 5!-UCCACAACAUAAUCCUAAUdTdT-3! (26); and
siRMI1, 5!-AGCCUUCACGAAUGUUGAUdTdT-3! (27).
Plasmid Constructions—The human DNA2 (hDNA2) ORF
was amplified by PCRwithout the initiation and stop codons to
generate a fragment including ggatcc-hDNA2-ctcgag. After
digestion with BamHI and XhoI, the hDNA2 fragment was
cloned into pFLAG-CMV2 (Sigma) digested with BglII/SalI
(pFLAG-CMV2-hDNA2). The humanWRN(hWRN)ORFwas
inserted into pcDNA3.1/Hygro(") (Invitrogen) via the NheI
and DraI sites (pcDNA3.1-hWRN). The siRNA-resistant form
of this construct was generated by changing four nucleotides in
the siWRN-targeting region (T270C, A273G, G276C, and
A279G) using the QuikChange site-directed mutagenesis kit
(Stratagene).
Protein Purifications—Wild-type andmutant forms ofWRN,
BLM, EXO1, and RPAwere produced and purified as described
previously (28–31). The TOPOIII!-RMI1-RMI2 (TRR) com-
plex was a gift from Drs. Kata Sarlos and Ian Hickson (Univer-
sity of Copenhagen, Denmark). DNA2was produced as a fusion
with aHis6 tag (N terminus) and a FLAG tag (C terminus) in Sf9
cells using theBac-to-Bac baculovirus expression system (Invit-
rogen). The transfer vector for bacmid preparation was a gift
from Dr. Judith L. Campbell (32). The transfer vectors for
nuclease-deficient (D227A) and helicase-deficient (K654R)
mutants of DNA2 were generated using the QuikChange site-
directed mutagenesis kit (Stratagene). Sf9 cells expressing
DNA2 fusion proteins were harvested 52 h after infection (typ-
ically a 800-ml culture) and washed with PBS. All subsequent
steps were carried out at 4 °C. Pelleted cells were resuspended
in lysis buffer (25 mM Tris-HCl (pH 7.5), 2 mM #-mercaptoeth-
anol, 1# complete EDTA-free protease inhibitor (Roche), 1mM
phenylmethylsulfonyl fluoride, 30 $g/ml leupeptin, and 15 mM
imidazole) and incubated for 20min under continuous stirring.
Subsequently, glycerol and 5 M NaCl were added slowly to final
concentrations of 15% (v/v) and 300 mM, respectively, while
mixing the sample. The cell suspension was then incubated for
an additional 30 min under continuous stirring. The cell lysate
was centrifuged at 55,000 # g for 30 min to obtain soluble
extract, which was then incubated with 5 ml of nickel-nitrilo-
triacetic acid-agarose beads (Qiagen) for 1 h batchwise. The
resin was washed extensively with lysis buffer containing 10%
(v/v) glycerol and 1 M NaCl. The protein was eluted with lysis
buffer supplementedwith 10% (v/v) glycerol, 100mMNaCl, and
250 mM imidazole. Fractions containing detectable amounts of
protein, as measured by Bradford assay, were pooled, diluted
1:1 with TBS buffer (50 mM Tris-HCl (pH 7.5) and 150 mM
NaCl) and incubated batchwise with 1 ml of anti-FLAG M2
affinity resin (Sigma) for 30min. The resin was then transferred
to a gravity flow column and washed with TBS-PI buffer (TBS
buffer containing 1 mM #-mercaptoethanol and 5 $g/ml leu-
peptin). Elution of the protein was achieved by adding TBS-PI
buffer supplemented with 200 $g/ml 3# FLAG peptide
(Sigma). Fractions containing DNA2 were pooled, diluted with
0.5 volumes of water and 1 volume of AQ buffer (25 mM Tris-
HCl (pH 7.5), 100 mM NaCl, 10% (v/v) glycerol, and 5 mM
#-mercaptoethanol) and loaded onto a 1-ml HiTrap Q column
(GE Healthcare) pre-equilibrated with AQ buffer. The column
was washedwith AQbuffer andDNA2was eluted byAQbuffer
supplemented with 600 mM NaCl. Fractions containing DNA2
were identified by SDS-PAGE, pooled, and stored at "80 °C.
The activity of purified recombinant DNA2 proteins was tested
using a Y structure oligonucleotide duplexwith single-stranded
arms (10). In agreementwith previous reports, wild-typeDNA2
was found to be capable of degrading both ssDNA arms of this
structure (data not shown) (10, 17). In the presence of RPA, the
cleavage of the 3! ssDNA arm by DNA2 was inhibited, and
DNA2 degraded preferentially the 5! ssDNA arm (data not
shown) (10, 17). TheDNA2-D227Amutant did not contain any
nuclease activity, which indicated that the nuclease activity of
our wild-type DNA2 preparation was inherent to DNA2 (data
not shown).
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Nuclease andHelicase Assays—To test the activity of purified
DNA2, we used a 31-bp forked duplex with 19-nt ssDNA arms,
as described previously (10). The helicase activity of WRN and
BLM was tested using a 29-bp forked duplex generated by
annealing of the following oligonucleotides: f-9 (5!-ACTAT-
CATTC AGTCATGTAA CCTAGTCAAT CTGCGAGCTC
GAATTCACTG GAGTGACCT-3!) and f-10 (5!-GAGGT-
CACTC CAGTGAATTC GAGCTCGCAG TCAATGTCGA
CATACCTAGT ACTTTACTCC-3!). Both DNA substrates
were radiolabeled at the end of the 5! ssDNA arm.
Nuclease and helicase assays were performed in buffer con-
taining 25mMTris acetate (pH 7.5), 2mMmagnesium acetate, 1
mM dithiothreitol, 0.1 mg/ml BSA, 10.7 mM phosphocreatine,
and 0.02mg/ml creatine phosphokinase. Reactions (15!l) con-
tained 1nM 32P-labeled forkedDNAsubstrate and the indicated
concentrations of DNA2 orWRN/BLM.Where indicated, RPA
was present at a concentration of 6 nM. Reactions were assem-
bled on ice and started by addition of ATP to a concentration of
1 mM. Reactions were incubated for 30 min at 37 °C. Termina-
tion of the reactions was achieved by adding 1/3 volume of stop
solution (150 mM EDTA, 2% (w/v) SDS, 30% (v/v) glycerol, and
0.1% (w/v) bromphenol blue) and 1/15 volume of Proteinase K
(10 mg/ml), followed by incubation at 37 °C for 15 min. The
reaction products were separated by electrophoresis in a 10%
Tris borate-EDTA polyacrylamide gel. Gels were dried on
WhatmanMM3paper and analyzed by phosphorimaging using
a Typhoon 9400 scanner (GE Healthcare). Images were quan-
tified using ImageQuantTL software.
Construction of DNA Substrates for Resection Assays—The
DNA substrates used in resection assays were derived from the
plasmid pUC19 (2686 bp). The self-complementary oligonu-
cleotide, 5!-AGCT GCTGAGG GCTGAGG GCTGAGG
GCTGAGG AGGCCT CCTCAGC CCTCAGC CCTCAGC
CCTCAGC-3!, was annealed to form a duplex that was cloned
into the HindIII site of pUC19. This destroyed the HindIII site
and inserted a single recognition sequence for StuI (AGGCCT)
flanked on each side by four recognition sequences for the nick-
ase Nt.BbvCI (CC*TCAGC; the cleavage position is indicated
by the asterisk) that are oriented as an inverted repeat with
respect to the StuI site. The resulting pOH-S plasmid allowed
us to prepare a linear DNA substrate with 3! overhangs of 26
nucleotides (nt) in length. A blunt-ended substrate was gener-
ated by digestion of pOH-S with StuI (New England Biolabs),
followed by DNA purification using a Macherey Nagel Nucle-
oSpin! gel and PCR cleanup kit. The substrate with 26-nt 3!
overhangs was generated as follows. After digestion of pOH-S
with StuI and its heat inactivation, Nt.BbvCI (New England
Biolabs) was added, and the reaction was incubated further for
2 h at 37 °C. Subsequently, the reaction mixture was diluted six
times with water and incubated at 85 °C for 15 min. DNA puri-
ficationwas performed as described above. DNAconcentration
was determined using a NanoDrop ND-1000 spectrophotome-
ter (Witec AG).
DNA End Resection Assays—DNA end resection reactions
were carried out in a buffer containing 25 mM Tris acetate (pH
7.5), 2 mM magnesium acetate, 1 mM dithiothreitol, 0.1 mg/ml
BSA, 10.7 mM phosphocreatine, 0.02 mg/ml creatine phospho-
kinase, and 1 mM ATP. Reactions contained 2 nM DNA sub-
strate (molecules), 8 nMDNA2, 350 nMRPA (100%DNA strand
coverage, assuming all DNA was single-stranded), and various
concentrations of WRN or BLM as indicated. EXO1 was pres-
ent at a concentration of 20 nM. The reactions were assembled
on ice and initiated by the addition of ATP. Reaction mixtures
(15!l) were incubated at 37 °C for 60min in the case of protein
titration experiments. In time course experiments, 15-!l reac-
tion aliquots were withdrawn at defined time points as indi-
cated. Reactions were terminated as described for the helicase
assays. The samples were subjected to electrophoresis in a 1%
agarose gel run in 1" TAE buffer. Gels were post-stained with
SYBR Gold (Invitrogen) and analyzed using MultiImage Light
Cabinet (Alpha Innotech). To monitor resection by hybridiza-
tion of radiolabeled oligonucleotide probes, terminated reac-
tions (21!l) were divided equally into two tubes. 5! end-labeled
oligonucleotide probes were then added to a final concentra-
tion of 5 nM. This mixture was heated in an oven to 75 °C for 5
min and then slowly cooled down to room temperature over
2.5 h. Reaction products were separated by electrophoresis in a
1% agarose gel. Gels were dried on DE81 anion exchange paper
(Whatman) and subjected to phosphorimaging analysis using a
Typhoon 9400 scanner (GE Healthcare). Images were quanti-
fied using ImageQuantTL software. The relative concentration
of the resection products generated in WRN-DNA2 or BLM-
DNA2 reactions was calculated as a percentage of the product
generated in a reaction containing 20 nM EXO1 at the 2-min
time point, which led to 100% resection within the region
probed with radiolabeled oligonucleotides. Usually, the EXO1
reaction was loaded on each gel in triplicates. The following
oligonucleotides were used for the preparation of the hybrid-
ization probes: oligo#224, 5!-GGCCGTCGTTTTACAA-
CGTCGT-3! (it anneals to the 3!-terminated strand; annea-
ling position, 112–133 nt upstream of the StuI cleavage site; the
complementary sequence is underlined); oligo#227, 5!-GGCA-
TAGTTAAGCCAGCCCCGA-3! (it anneals to the 3!-termin-
ated strand; annealing position, 353–374 nt upstream of the
StuI cleavage site); and oligo#237, 5!-GGTCGGGGCTGGCT-
TAACTATG-3! (it anneals to the 5!-terminated strand; anne-
aling position, 122–133 nt upstream of the StuI cleavage site).
Oligonucleotides were 5! end-labeled using ["-32P]ATP andT4
polynucleotide kinase (New England Biolabs). The two non-
complementary dG residues at the 5! end of the oligonucleot-
ides were added to ensure equal labeling efficiency.
Cell Culture and Transfection—U2OS and HEK293 cells
were grown in DMEM (Sigma) supplemented with 10% fetal
calf serum (Invitrogen) and streptomycin/penicillin (100 units/
ml). Plasmid DNA was transfected using standard linear poly-
ethyleneiminemethod. Lipofectamine RNAiMAX (Invitrogen)
was used for siRNA transfection. To generate HEK293 clones
stably expressing FLAG-DNA2, cells were cotransfected with
pFLAG-CMV2-hDNA2 and pBABE-puro (Addgene) and sub-
jected to puromycin 1 (!g/ml) selection. Puromycin-resistant
clones were tested for expression of FLAG-DNA2 by Western
blotting.
Immunoprecipitation—HEK293 cells were transfected with
the pcDNA3.1-hWRN and/or pFLAG-CMV2-hDNA2 vectors.
Cells were harvested to lysis buffer (50 mM Tris-HCl (pH 8.0),
120 mM NaCl, 20 mM NaF, 15 mM sodium pyrophosphate, and
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0.5% (v/v) Nonidet P-40) supplemented before use with prote-
ase (Complete EDTA-free, Roche) and phosphatase (PhosS-
TOP, Roche) inhibitors, 2 mMMgCl2 and benzonase (50 units/
ml). Cells were sonicated briefly, and lysates were clarified by
centrifugation at 16,000 ! g for 30 min. Cell extracts (1 mg of
protein) were subjected to immunoprecipitation using anti-
FLAG M2 magnetic beads (10 !l) or Protein A/G Plus
UltraLink Resin (10 !l, Thermo Scientific) coated with rabbit
polyclonal anti-WRN antibody (10 !g), which was carried out
overnight at 4 °C. Immunoprecipitates were washed four times
with lysis buffer. Bound proteins were eluted by Laemmli sam-
ple buffer and analyzed by SDS-PAGE and Western blotting.
To test the interaction between purifiedWRN and DNA2 pro-
teins, 500 ng of each protein was mixed in 200 !l of NET-N100
buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 100 mM NaCl,
and 0.5% (v/v) Nonidet P-40) and incubated at 4 °C for 4 h. As a
control, DNA2was incubated in the absence ofWRN. The pro-
tein mixtures were subsequently subjected to immunoprecipi-
tation using anti-WRN antibody (4 !g), which was carried out
at 4 °C for 2 h. Immunoprecipitates were washed four times
with NET-N100 buffer. Bound proteins were eluted by Laem-
mli sample buffer and analyzed by SDS-PAGE and Western
blotting.
GST Pulldown Assay—GST-tagged fragments of WRN were
produced in the Escherichia coli BL21-CodonPlus(DE3)-RIL
strain (Stratagene) and bound to GSH Sepharose 4B (GE
Healthcare) as described previously (24). As a control, beads
were coated with GST protein only. The beads were incubated
with 500 ng of purified His6-DNA2-FLAG protein in 400 !l of
NET-N100 buffer at 4 °C for 2 h. After extensive washing with
NET-N100 buffer, proteins bound to the beads were analyzed
byWestern blotting. Blots were first stained in Ponceau S solu-
tion (0.1% (w/v) Ponceau S and 5% (v/v) acetic acid) to visualize
WRN fragments and subsequently probed with anti-FLAG
antibody.
Reverse Transcription and Quantitative Real-time PCR—
Total RNA was isolated from cells using the RNeasy mini kit
(Qiagen). 200 ng of RNA was used for cDNA synthesis using a
high-capacity cDNA reverse transcription kit (Applied Biosys-
tems). The target gene expression level was determined by
quantitative real-time PCR that was performed on a ABI Prism
7300 (Applied Biosystems) using SYBR Select Master Mix
(Applied Biosystems). The following primer pairs were used
to determine EXO1 mRNA levels: 5"-ACCTCTAAGG
AACAAGGTTC-3" (forward) and 5"-AGGAGGAAGCTTTTC-
AGAATC-3" (reverse). The housekeeping gene RPLPO, used as
a control, was amplified with the following primers: 5"-CCAG-
TCTGGA GAAACTGCTG-3" (forward) and 5"-CAGCAG-
CTGGCACCTTATTGG-3" (reverse). The Pfaffl equation was
used for normalization and calculation of relative EXO1 ex-
pression levels in comparison with the control gene (33).
SA-GFP Reporter Assay—SA-GFP reporter assays were per-
formed as described previously (34, 35). HEK293/SA-GFP cells
were seeded in poly-L-lysine-coated 6-well plates at a density of
0.5 million cells/well. U2OS/SA-GFP cells were seeded in
6-well plates at a density of 0.25 million cells/well. The next
day, cells were transfected with appropriate siRNA (40 nM)
using Lipofectamine RNAiMAX (Invitrogen). After 24 h,
siRNA-transfected cells were transferred into a 12-well plate,
with 200,000 cells/well for HEK293/SA-GFP and 100,000 cells/
well for U2OS/SA-GFP. 44 h after siRNA transfection, cells
were transfected with 0.6 !g of the I-SceI expression vector
pCBASce (36) using linear polyethyleneimine and, 6 h later,
with appropriate siRNA (20 nM) using the standard calcium
phosphate method. 52 h after I-SceI transfection, cells were
harvested and subjected to flow cytometry analysis using LSRII
(BD Biosciences) and FlowJo software to determine the per-
centage of GFP-positive cells. The mean values obtained with
control siRNA (siLuc) samples were 0.9% for HEK293/SA-GFP
cells and 2.0% for U2OS/SA-GFP cells. To test the effect of
ectopic expression of WRN on SSA repair efficiency of WRN-
depleted HEK293/SA-GFP cells, the mutant form of the
pcDNA3.1-hWRN construct harboring silent mutations in the
siWRN-targeting region (0.6 !g) was cotransfected with
pCBASce (0.6 !g). The plasmid pcDNA3.1 was used as a con-
trol vector in these experiments. Cells were subjected to flow
cytometry analysis at 52 h after plasmid transfection.
Immunofluorescence Assays—U2OS cells transfected with
the indicated siRNAs were cultured on glass coverslips. 48 h
after siRNA transfection, cells were treated with 1 !M camp-
tothecin (CPT) for 1 h. After pre-extraction for 5 min on ice in
25 mM HEPES (pH 7.4) buffer containing 0.5% (v/v) Triton
X-100, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl2 and 0.3 M
sucrose, cells were fixed with 4% (v/v) formaldehyde for 15min
at room temperature. Subsequently, cells were permeabilized
by soaking in 0.2% (v/v) Triton X-100 for 5 min at room tem-
perature.After blocking inPBS containing 10mg/mlBSA for 30
min at room temperature, fixed cells were incubated for 2 h at
room temperature with the indicated primary antibodies. The
slides were washed with PBS and incubated for 1 h at room
temperature with secondary antibodies diluted in blocking
solution (Alexa Fluor 568-conjugated goat anti-rabbit IgG and
Alexa Fluor 488-conjugated goat anti-mouse IgG (Invitrogen)).
After washing with PBS, coverslips were mounted using
Vectashield containing DAPI (Vector Laboratories). Auto-
mated image acquisition was performed using an Olympus
IX70 microscope equipped with the ScanˆR imaging platform.
A!40/1.3 numerical aperture objective was used. 10 z stacks at
a spacing of 0.3 !m were taken, and 100 images were acquired
for each sample. Analysis was performed using ScanˆR analysis
software. Nuclei were identified on the basis of theDAPI signal,
and RPA foci were identified on the basis of edge-based subob-
ject counts. At least 1000 cellswere analyzed for each condition.
RESULTS
DNA2 CanMediate DNA End Resection in Conjunction with
WRNHelicase—To test whether the humanWRN helicase can
mediate resection of broken DNA ends in concert with DNA2,
we purified these proteins to homogeneity and analyzed their
activities in vitro (Fig. 1A). WRN and BLM unwind DNA in the
3"-5" direction and require a 3" ssDNA tail for loading onto the
DNA substrate (37, 38). Therefore, we generated a derivative of
the pUC19 plasmid inwhich a StuI site was flanked on each side
by four recognition sites for the nicking endonuclease Nt.
BbvCI. Cleavage of this pUC19 derivative with StuI andNt.BbvCI
resulted in a 2.7-kb-long linear DNA molecule ending with 3"
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overhangs of 26 nt in length, whereas its cleavage by StuI alone
gave rise to a linear DNAmolecule with blunt ends. Processing
of the DNA substrates was monitored by agarose gel electro-
phoresis followed by SYBR gold staining (Fig. 1B). In addition,
32P-labeled synthetic oligonucleotides complementary to the
3!-terminated strand were used as hybridization probes to
detect ssDNA generated by resection at specific positions (Fig.
1B) (10). We found that WRN, together with DNA2 and RPA,
could catalyze efficient 5! end resection on the 3!-tailed sub-
strate but not the blunt-ended substrate (Fig. 1C). As expected,
no reaction products were detected with an oligonucleotide
probe complementary to the 5!-terminated strand, indicating
that the observed DNA resection activity is limited to the 5!
strand (Fig. 1D). Of note, the end product of the resection reac-
tion on the 3!-tailedDNA substrate appeared as a discrete band
onSYBRgold-stained gel thatwas clearly shiftedwith respect to
the unprocessed dsDNA substrate, indicating extensive resec-
tion (Fig. 1C, top panel, compare lanes 2 and 7). In contrast, no
gradual shift in the electrophoretic mobility of the resection
product was apparent after annealing of the radioactive probes.
This ismost likely due to the fact thatDNA2nuclease generates
short oligonucleotides that can reanneal to the resected DNA
along with the radioactive probe, leading to a DNA molecule
with an electrophoretic mobility similar to that of the DNA
substrate. Together, these results clearly demonstrate that
DNA2, in conjunction withWRN and RPA, can catalyze exten-
sive 5! end resection, providing that the DNA substrate con-
tains a 3! ssDNA overhang.
To further characterize the DNA end resection reaction
mediated by WRN-DNA2, reactions with the 3!-tailed sub-
strate were carried out at various WRN concentrations,
whereas DNA2 was kept at a concentration of 8 nM. We
observed that the amount of resection product increased grad-
ually with WRN concentration, reaching a plateau at about 10
nM (Fig. 1E, lanes 2–7, and Fig. 1F). Quantitative analysis of gel
images revealed that about 35% of the DNA substrate was
resected to the position of 133 nt from the 3! end and that about
15% of the DNA substrate was resected to the position of 374 nt
FIGURE 1.DNAend resection byDNA2 andWRN. A, SDS-PAGE analysis of purifiedWRN (0.7!g) andDNA2 (0.4!g) proteins. Gel was stainedwith Coomassie
Brilliant Blue R-250. Themolecular weights of protein standards are indicated on the left. B, schematic of the DNA end resection assay. The resection products
were either left untreated or hybridizedwith synthetic 32P-labeled oligonucleotides complementary to the 3!-terminated strand. DNA specieswere separated
by electrophoresis in a 1% agarose gel and visualized by SYBR gold staining and phosphorimaging, respectively. Probes complementary to the regions
spanning nt positions 112–133 and 353–374 (relative to the 3! end) were used in this study. Only a part of the DNA substrate is shown. C, time course of
resection of 3!-tailed (26 nt) and blunt-ended DNA substrates by DNA2 andWRN. Reactions were carried out at 37 °C and contained 2 nMDNA, 350 nM RPA, 10
nMWRN, and 8nMDNA2. Reaction products at the indicated timepointswere analyzed as outlined in B. The 112- to 133-nt probewas used in this analysis. Lane
1, heat-denatured substrate; lane 14, 3!-tailed substrate incubated with 20 nM EXO1 and 350 nM RPA for 2 min (R1); lane 15, blunt-ended substrate incubated
with 20 nM EXO1 and 350 nM RPA for 2 min (R2). D, directionality of DNA end resection by WRN-DNA2. Reactions were carried out at 37 °C for 60 min and
contained 2 nM 3!-tailedDNA substrate, 350 nM RPA, 8 nMDNA2, and 10 nMWRN. Resection productswere annealedwith radiolabeled oligonucleotide probes
complementary to either 3!-terminated (position 353–374 nt relative to the 3! end) or 5!-terminated (position 353–374 nt relative to 3! end) strand and
analyzed as in C. E, 5! end resection of 3!-tailedDNA substrate byWRN-DNA2 is dependent onWRN concentration and the presence of ATP and RPA. Reactions
were carried out at 37 °C for 60 min and contained, as indicated, 2 nM DNA, 350 nM RPA, 1 mM ATP, 8 nM DNA2, and different WRN concentrations. Resection
productsweredetectedusing the112–133-nt probe. F, dependenceofWRN-DNA2-catalyzed resectionof 3!-tailed substrate onWRNconcentration. Resection
at the positions of 112–133 nt and 353–374 nt from the 3! end of the DNA substrate wasmonitored. Reactions were carried out as in E. Relative concentration
of the resection product generated by WRN-DNA2 at each WRN concentration was calculated as a percentage of the product generated by 20 nM EXO1 after
2 min. Data are mean" S.D. (n# 3).
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within 1 h of incubation (Fig. 1F). Interestingly, a small amount
of resected product (1–2%) could also be detected in the
absence of WRN, suggesting that DNA2 itself could slowly
resect dsDNA ends, likely following RPA-mediated stabiliza-
tion of ssDNA ends generated by thermal fraying (Fig. 1E, lane
2). In the absence of DNA2, WRN was only capable of DNA
unwinding, as evident from the appearance of a fast-migrating
band (Fig. 1E, lane 8). The resection process catalyzed byWRN
and DNA2 was found to be dependent on the presence of ATP
and RPA, as expected for a helicase-driven reaction (Fig. 1E,
compare lanes 9–12).
WRN acts not only as a 3!-5! DNA helicase, but it also pos-
sesses a dsDNA-dependent 3!-5! exonuclease activity residing
in a separate domain located in the N-terminal portion of the
protein (39, 40). DNA2 functions as a 5!-3! helicase and a
ssDNA-specific endonuclease (32, 41). To define the functions
of the enzymatic activities of WRN and DNA2 in DNA end
resection, we carried out a set of resection reactions with the
3!-tailed pUC19 substrate where either WRN or DNA2 were
substituted with catalytically inactive mutants. We found that
the helicase-deficient mutant of WRN (K567M) failed to stim-
ulate DNA resection by DNA2, whereas the nuclease-deficient
mutant of WRN (E84A) behaved similarly as the wild-type
WRN in this reaction (Fig. 2, lanes 2–4). Substitution of DNA2
with its nuclease-deficient mutant (D277A) completely abol-
ished resection and stimulated unwinding of the plasmid sub-
strate (Fig. 2, lane 6). In contrast, the helicase-deficient mutant
of DNA2 (K654E) could resect the DNA substrate to the same
degree as the wild-type protein (Fig. 2, compare lanes 3 and 7).
These results indicate that DNA end resection mediated by
DNA2, WRN, and RPA is dependent on the helicase activity of
WRN and the endonuclease activity of DNA2.
DNA2 and WRN Interact Physically—Yeast Dna2 has been
shown to interact physically with Sgs1 (10). Likewise, BLM
forms a complex with human DNA2 (17). Therefore, we inves-
tigated whether human DNA2 interacts physically with WRN.
To this end, HEK293 cells were transfected with plasmids
expressing WRN and FLAG-tagged DNA2, respectively, and
complex formation between these proteins was tested by
immunoprecipitation using beads conjugated with anti-FLAG
M2antibody.We found thatWRNcoimmunoprecipitatedwith
FLAG-DNA2, indicating that these proteins form a complex in
vivo (Fig. 3A, lane 3). This interactionwas specific because anti-
FLAG beads did not immunoprecipitate WRN from an extract
lacking FLAG-DNA2 (Fig. 3A, lane 1). To further investigate
complex formation between WRN and DNA2, we generated a
stable HEK293 cell line expressing FLAG-DNA2. By immuno-
precipitation using anti-FLAG M2 beads or anti-WRN anti-
body, we found that FLAG-DNA2 formed a complex with
endogenousWRN in these cells (Fig. 3, B and C). Western blot
analysis indicated that the level of FLAG-DNA2 in these cells
was only slightly higher than that of endogenous DNA2, sug-
gesting thatWRN andDNA2 form a complex under physiolog-
ical conditions (Fig. 3B, top panel). Interaction between FLAG-
DNA2 and endogenous BLM was also detected as expected
(Fig. 3B) (17). The cellular concentration of these protein com-
plexes was not altered when cells were subjected to treatment
withCPT,which causes breakage ofDNA replication forks (Fig.
3B, lanes 2–5) (42). This suggests that the interaction of DNA2
with WRN and BLM in the cell is not dependent on DNA
damage.
To test whether WRN and DNA2 interact directly, purified
proteins were mixed and incubated at 4 °C for 4 h. Complex
formation between WRN and DNA2 was tested by immuno-
precipitation using anti-WRN antibody. We found that DNA2
coimmunoprecipitated with WRN. DNA2 was not present in
the immunoprecipitated material whether WRN was omitted,
confirming a direct protein-protein interaction (Fig. 3D). To
map the interaction site ofDNA2onWRN,we tested binding of
purified His6-DNA2-FLAG protein to variousWRN fragments
covering the entireWRNpolypeptide (Fig. 3E). TheWRN frag-
ments were produced in E. coli as fusions with a GST tag and
isolated on GSH-Sepharose beads. Using a GST pulldown
assay, we found that DNA2 bound specifically to a WRN frag-
ment including the core helicase domain (helicase/Zn2"-bind-
ing domains) and the winged helix domain (Fig. 3F, compare
lanes 1 and 4) a binding site of a number of other proteins
shown to interact withWRN (43, 44). DNA2 was also bound to
a fragment containing only the helicase core or to the C-termi-
nal portion of WRN starting at the beginning of the winged
helix domain (Fig. 3F, compare lanes 1, 3, 4, and 5). In contrast,
DNA2 did not bind theN-terminal portion ofWRN containing
the exonuclease domain (Fig. 3F, lane 2). Collectively, these
results suggest that there are at least two DNA2-interaction
sites on WRN: one located in the central helicase domain and
the other in the C-terminal region of WRN.
WRN-DNA2 Resects DNA Ends More Efficiently Than
BLM-DNA2—Next, we set out to compareWRNandBLMwith
respect to their abilities to resect DNA ends in concert with
DNA2 and RPA in vitro. Using a Y structure oligonucleotide
duplex (29 bp)with single-stranded arms (30 nt each), we found
that our preparations ofWRNandBLMexhibited similar levels
of specific helicase activity (Fig. 4A). For resection reactions, we
used the 3!-tailed DNA substrate that was readily processed by
FIGURE 2. 5! end resection of 3!-tailed DNA substrate by WRN-DNA2
depends on the helicase activity of WRN and the nuclease activity of
DNA2. Reactions were carried out at 37 °C for 60 min and contained 2 nM
DNA, 350 nM RPA, 1mM ATP, 8 nM DNA2, and 10 nMWRN. Resection products
weredetectedusing the112–133ntprobe.WRNHD, helicase-deficientmutant
of WRN (K567M);WRNND, nuclease-deficient mutant of WRN (E84A); DNA2HD,
helicase-deficient mutant of DNA2 (K654R); DNA2ND, nuclease-deficient
mutant of DNA2 (D277A).
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WRN-DNA2 in the presence of RPA (Fig. 1C). The extent of
DNA resection at various reaction time points was monitored
by annealing of radiolabeled oligonucleotide probes. These
experiments clearly showed that WRN-DNA2 resected the
DNA substrate at a much higher rate compared with BLM-
DNA2 (Fig. 4,B andC). Notably,WRN-DNA2-catalyzed resec-
tion to the position of 374 nt away from the 3! end was faster
than BLM-DNA2-catalyzed resection to the position of 133 nt
(Fig. 4, B and C). We also compared the activities of WRN-
DNA2 and BLM-DNA2 on blunt-ended DNA substrate in the
presence of RPA.We found that this DNA substrate was largely
refractory not only to processing by WRN-DNA2 but also to
processing by BLM-DNA2 (Fig. 4D, compare lanes 4 and 5 to
lanes 10 and 11). Taken together, we show that WRN-DNA2
resects DNA ends more efficiently than BLM-DNA2 in vitro.
Dissection of Pathways Involved in DNA End Resection in
HumanCells—To assesswhetherWRN is involved inDNAend
resection in vivo, we investigated the effect of its depletion on
the efficiency of SSA-mediated repair of endonuclease-induced
DSBs in cells that were either proficient or deficient for EXO1
and DNA2, respectively. For this epistasis analysis, we initially
used the human embryonic kidney cell line HEK293 stably
transfectedwith the SA-GFP reporter cassette consisting of two
truncated GFP gene alleles (5!GFP and Sce3!GFP) that form a
direct sequence repeat (280 bp) separated by a region of about
2.4 kb (Fig. 5A) (34, 45). SSA-mediated recombination between
these homologous sequences triggered by a DSB generated in
the distal GFP allele by the I-SceI endonuclease results in the
formation of a functional GFP gene (Fig. 5A). This requires
extensive DNA end resection to expose the complementary
ssDNA regions for annealing. The proteins of interest were
depleted from HEK293/SA-GFP cells by RNA interference.
Cells were subsequently transfected with an I-SceI expression
vector to create a DSB in the reporter cassette, and the percent-
age of GFP positive cells arising upon SSA-mediated repair was
determined by flow cytometry 2 days after plasmid transfec-
tion. We found that cells depleted of either EXO1, WRN, or
DNA2 exhibited a marked reduction in the frequency of SSA
repair events (55, 65, and 75%, respectively) compared with
mock-depleted cells (Fig. 5,B andC). In contrast, knockdownof
FIGURE 3. Physical interaction between DNA2 andWRN in vitro and in vivo. A, coimmunoprecipitation of WRNwith DNA2 from human cells. HEK293 cells
were transfectedwith vectors expressing FLAG-DNA2 andWRN as indicated. Cell extractswere immunoprecipitated (IP) with anti-FLAG antibody as described
under “Experimental Procedures.” Blotswereprobedwith the indicated antibodies. 5%of inputmaterialwas loaded.B, effect ofDNAdamageon the formation
of DNA2-WRN and DNA2-BLM complexes in human cells. HEK293 cells stably transfected with the FLAG-DNA2 construct (HEK293-D) were treated with 1 !M
CPT. At the indicated time points, complex formation between FLAG-DNA2 and endogenousWRN and BLM, respectively, was tested by immunoprecipitation
using anti-FLAG antibody. C, coimmunoprecipitation of DNA2 with WRN from human cells. Extracts from HEK293-D cells were subjected to immunoprecipi-
tationwith anti-WRNantibody or control IgG. The immunoprecipitateswere tested for the presence of FLAG-DNA2 andWRNbyWestern blotting. As a control,
a WRN immunoprecipitate from HEK293 cells was also analyzed (lane 3). D, coimmunoprecipitation of DNA2 with WRN from a mixture of purified proteins.
DNA2 (500 ng) was incubated with or without WRN (500 ng) at 4 °C for 4 h. The mixtures were subjected to immunoprecipitation with anti-WRN antibody. E,
domain organization of WRN. Exo, exonuclease domain; Zn, zinc-binding domain;WH, winged-helix domain; HRDC, helicase and RNaseD C-terminal domain.
Black lines indicateWRN fragments used for mapping the DNA2-interaction site onWRN. F, GST pulldown assay. Glutathione beads coated with the indicated
GST-tagged fragments ofWRNwere incubatedwith purifiedHis6-DNA2-FLAGprotein at 4 °C for 2 h, and boundproteinswere analyzed byWestern blotting as
described under “Experimental Procedures.” 1% of input was loaded in B and C, whereas 10% of input was loaded in D and F.
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BLM was found to be associated with a significant increase in
SSA repair efficiency (140%) comparedwith control cells (Fig. 5,B
andC).Ofnote, theSSArepairdefectofWRN-depletedcells could
be rescued by ectopic expression of the siRNA-resistant form of
WRN, excluding an off-target effect of theWRN siRNA used in
this study (Fig. 5D). Combined depletion of EXO1 andWRNor
EXO1 and DNA2 further decreased the repair efficiency com-
pared with the respective single depletions, whereas codeple-
tion of DNA2 and WRN did not (Fig. 5, B and C). In addition,
combined depletion of EXO1 and BLM had nearly the same
effect on the SSA repair efficiency as EXO1 depletion (Fig. 5, B
and C). Therefore, these findings suggest that HEK293 cells
have at least two pathways for long-range resection of DSB
ends: one mediated by EXO1 and the other dependent upon
DNA2 and WRN.
To substantiate these findings, we performed a similar set of
experiments using U2OS/SA-GFP cells (35). This analysis indi-
cated that combined depletion of EXO1 and DNA2 almost
completely abolished (reduced by 91%) SSA-mediated DSB
repair in U2OS/SA-GFP cells, as did depletion of MRE11 (by
89%) or CtIP (by 82%), suggesting that long-range DNA end
resection in U2OS cells is largely dependent on EXO1 and
DNA2 (Fig. 5, E–G). However, in contrast to the results
obtained with HEK293/SA-GFP cells, we observed a significant
reduction in SSA repair efficiency not only after depletion of
WRN (by 57%) but also after depletion of BLM (by 59%) (Fig. 5,
E and F). Codepletion of BLM andWRN further decreased the
repair efficiency to a level comparable with that in DNA2-de-
pleted (by 73%) cells (Fig. 5, E and F). Moreover, combined
depletion of DNA2 with either BLM or WRN had nearly the
FIGURE 4. Comparison of DNA end resection activities of WRN-DNA2 and BLM-DNA2. A, comparison of helicase activities of WRN and BLM. Reactions
contained 1 nM 32P-labeled forked DNA duplex (inset) and different concentrations ofWRN or BLM. Reactions were incubated at 37 °C for 30min, and reaction
products were quantified as described under “Experimental Procedures.” Data are mean! S.D. (n" 3). B, time course of resection of 3#-tailed DNA substrate
catalyzed by WRN-DNA2 and BLM-DNA2, respectively. Reactions contained 2 nM DNA, 350 nM RPA, 8 nM DNA2, and 10 nM WRN/BLM. Reaction aliquots
withdrawn at the indicated time points were subjected to electrophoresis on a 1% agarose gel after hybridization of radiolabeled probes complementary to
3#-terminated strand at the indicatedpositions. RadiolabeledDNA specieswere visualizedbyphosphorimaging.C, quantification of the reactions in B. Relative
concentration of resectionproducts generated at each timepointwas calculated as a percentageof theproduct generatedby 20nMEXO1after 2min. Data are
mean! S.D. (n" 3).D, processing of 3#-tailed (26 nt) and blunt-ended DNA substrates in reactions with indicated composition. Reactions were carried out at
37 °C for 60min and contained 2nMDNA, 350 nMRPA, and,where indicated, 8 nMDNA2, 20 nMWRN, and 20nMBLM. Reaction productswere analyzed as in Fig.
1C. Lane 1, heat-denatured substrate; lane 14, 3#-tailed substrate incubated with 20 nM EXO1 for 2 min (R1); lane 15, blunt-ended substrate incubated with 20
nM EXO1 for 2 min (R2).
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same inhibitory effect on SSA repair as DNA2 depletion (Fig. 5,
E and F). On the contrary, codepletion of EXO1 with either
WRN or BLM caused a much higher reduction in repair effi-
ciency than depletion of DNA2 alone, and triple depletion of
EXO1, BLM, and WRN brought repair efficiency down to the
level measured in cells depleted of EXO1 and DNA2 (Fig. 5, E
and F). Collectively, these data suggest that, in U2OS cells, both
WRNandBLMassist DNA2 tomediate long-range resection of
broken DNA ends.
To bolster our conclusion that DNA2, WRN, and BLM have
an epistatic relationship in DSB end resection, we extended our
analysis to measurement of RPA focus formation in U2OS cells
treated with CPT. As expected, 1 h after addition of CPT, RPA
formed numerous foci in !-H2AX-positive cells, which were
dependent on the presence of CtIP (Fig. 6). Depletion of DNA2
resulted in a marked reduction in the number of RPA foci per
cell compared with mock-depleted cells (Fig. 6). Cells depleted
of BLM or WRN displayed a mild decrease in RPA focus fre-
quency comparedwithmock-depleted cells (Fig. 6). In contrast,
combined depletion of BLM and WRN caused approximately
the same reduction in RPA focus frequency as depletion of
DNA2 alone. Moreover, cells depleted of DNA2 and BLM or
DNA2 andWRN displayed an RPA foci frequency comparable
with that of DNA2-depleted cells (Fig. 6). These data further
support the conclusion that DNA2,WRN, and BLM operate in
the same DNA end resection pathway.
Role of the BLM-TOPOIII"-RMI1-RMI2 Complex in DNA
End Resection—In human cells, BLM exists in a complex with
TOPOIII", RMI1, and RMI2, which is known to catalyze dou-
ble Holliday junction dissolution during HR (46–49). Studies
in yeast have shown that Top3" and Rmi1 are also required for
DNA-end resection in vivo and stimulateDNAend resection by
FIGURE 5.WRN and BLM interact epistatically with DNA2 to promote DSB repair by SSA in human cells. A, schematic of the SA-GFP reporter cassette.
SSA-mediated repair of a DSB at the I-SceI-cutting site results in the formation of a functional GFP allele. B, efficiency of SSA-mediated repair of I-SceI-induced
DSB in HEK293/SA-GFP cells treated with the indicated siRNAs. Cells were transfected with the appropriate siRNAs (40 nM) 2 days prior to transfection of the
I-SceI-expressing plasmid. The percentage of GFP-positive cells in each sample was measured by flow cytometry 2 days after I-SceI plasmid transfection and
taken as ameasure of DSB repair efficiency. The plotted values represent the relative repair efficiency calculated as a percentage of repair efficiencymeasured
in cells transfected with control siRNA (siLuc, 100%). Data are mean! S.D. (n# 3). C, Western blot analysis of extracts from HEK293/SA-GFP cells transfected
with indicated siRNAs under the same conditions as for SA-GFP reporter assays. Blots were probed with the indicated antibodies. D, rescue of the SSA-repair
defect of WRN-depleted HEK293/SA-GFP cells by expression of the siRNA-resistant variant of WRN. An SA-GFP reporter assay was performed as in B. TheWRN
plasmid (WRN) or empty vector (EV) were cotransfectedwith the I-SceI plasmid. E, efficiency of SSA-mediated repair of I-SceI-inducedDSB inU2OS/SA-GFP cells
treated with the indicated siRNAs. Experiments were performed as in B. F, Western blot analysis of extracts from U2OS/SA-GFP cells transfected with the
indicated siRNAs. Blots were probed with the indicated antibodies. G, quantitative real-time PCR showing that EXO1 mRNA levels are down-regulated by
specific siRNA. Data are mean! S.D. (n" 3).
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Sgs1-Dna2 in vitro by promoting the helicase activity of Sgs1 (9,
10, 14). Our study revealed that BLM-DNA2 resects DNA ends
less efficiently than WRN-DNA2 in vitro, whereas in vivo, at
least in U2OS cells, BLM and WRN appeared to contribute
equally to promote DNA end resection (Fig. 5E). Therefore, we
investigated whether BLM requires TOPOIII!, RMI1, and
RMI2 (TRR) to efficiently support DNA end resection by
DNA2. To this end, we first investigated the effect of a purified
TRR complex on DNA end resection by BLM-DNA2 in vitro
(Fig. 7A). We found that TRR enhanced resection of the
3!-tailed pUC19 substrate by BLM-DNA2 (Fig. 7,B andC, lanes
3–6). On the contrary, the TRR complex had no effect on DNA
end resection by WRN-DNA2 (data not shown). Moreover, it
could not enhance DNA end resection by DNA2 in the absence
of BLM (Fig. 7, B and C, compare lanes 2 and 7).
Next we tested the effect of depletion of RMI1 on the effi-
ciency of SSA-mediated repair of I-SceI-induced DSBs in
U2OS/SA-GFP cells. We found that RMI1 depletion reduced
the repair efficiency to the level displayed by BLM- or DNA2-
depleted cells (Fig. 7, D and E). Importantly, codepletion of
RMI1 with BLM or DNA2 did not further reduce the repair
efficiency compared with single depletions of these proteins,
suggesting that RMI1, BLM, andDNA2act in the samepathway
(Fig. 7, D and E). Collectively, these results suggest that, in
human cells, BLM promotes long-range DNA end resection as
part of the BTRR complex.
DISCUSSION
Here we present evidence suggesting that humanDNA2 acts
in conjunctionwith eitherWRNor BLM tomediate long-range
resection of broken DNA ends in vivo. Moreover, we show that
WRN helicase can cooperate with DNA2 and RPA to catalyze
resection of DNA ends in vitro, generating long 3!-terminated
ssDNA tails. Our study also reveals that bothWRN-DNA2 and
BLM-DNA2 require a 3! ssDNA overhang to efficiently initiate
DNA end resection in vitro, which is in agreement with the
“two-step” resectionmodel in which the initial 5! end trimming
is carried out by the MRE11-RAD50-NBS1/Xrs2 complex in
conjunction with CtIP/Sae2 (8, 9, 11, 19). In addition, we pres-
ent evidence that BLM and DNA2 interact epistatically with
RMI1 to mediate DNA end resection in vivo. Moreover, we
show that the TRR complex stimulates DNA end resection by
BLM-DNA2 in vitro. These data suggest that, in cells, BLM
mediates DNA end resection as part of the BTRR complex.
Our discovery of the involvement ofWRN inDNAend resec-
tion is consistent with the findings that WRN interacts physi-
cally with the MRN complex and accumulates at sites of DSBs
in human cells (50, 51). Moreover, it has been demonstrated
that WRN depletion leads to a marked reduction in the fre-
quency of RPA and BrdU/ssDNA foci formed in response to
ionizing radiation, indicative of a resection defect (52). A simi-
lar phenotype has been observed in DNA2-depleted cells (18).
Although the previous studies did not address the relationship
between WRN and DNA2, they demonstrated that these
enzymes act synergistically with EXO1 to promote DNA end
resection in human cells (18, 52). A role for WRN as a critical
DNA end resection factor is also consistent with the cellular
phenotype of Werner syndrome, a severe premature aging dis-
order caused by inherited mutations in the WRN gene (53).
Cells derived from Werner syndrome patients are character-
ized by non-homologous chromosome exchanges, termed var-
iegated translocation mosaicism, and large chromosomal dele-
tions that may result from aberrant DSB repair by NHEJ as a
consequence of a defect inDNA end resection (54–56). Indeed,
it is becoming clear that NHEJ accounts formost chromosomal
translocations in humans (57). Moreover, a role for DNA end
resection as the critical determinant of DSB repair pathway
choice is well established (58). Accumulating evidence suggests
that defects in homology-directed repair pathways, which are
dependent onDNAend resection, result in overuse ofNHEJ for
repair, leading to accumulation of chromosomal rearrange-
ments (57). However, it should be noted that WRN is also
known to promote DSB repair by the classical Ku-dependent
NHEJ (C-NHEJ) pathway to suppress microhomology-medi-
ated end joining (59, 60). This alternative end joining pathway is
capable of producing chromosomal translocations, particularly
when Ku-dependent NHEJ is deficient (57). Moreover, WRN
has been shown to be involved in the resolution HR intermedi-
ates (61, 62). Therefore, it seems that the genomic instability in
Werner syndrome is a consequence of multiple defects in DNA
repair pathways.
Our finding that the TRR complex stimulates DNA end
resection by BLM-DNA2 in vitro is consistent with previous
reports showing that the association of BLM with TOPOIII!
and RMI1 enhances its DNA unwinding activity, which drives
the BLM-DNA2-catalyzed resection reaction (17, 63). Simi-
larly, RMI1 and RMI2 have been shown to enhance the effi-
ciency of the BLM-TOPOIII!-mediated double Holliday junc-
tion dissolution reaction (48, 49, 64). It has also been shown that
RMI1 forms a complex with RPA and that this interaction is
essential for the stimulatory effect of RPA on double Holliday
junction dissolution by the BTRR complex (65). Therefore, it is
possible that a physical interaction between RMI1 and RPA
FIGURE 6. DNA2, WRN, and BLM act in the same pathway of DSB end
resection. A, frequency of camptothecin-induced RPA foci in nuclei of U2OS
cells depleted of the indicated proteins. Cells were transfectedwith appropri-
ate siRNAs and, 48 h later, treated with 1"M camptothecin for 1 h. Cells were
then detergent-extracted and fixed with formaldehyde. RPA and #-H2AX (a
marker of DNA damage) were visualized by indirect immunofluorescence.
DAPI was used to stain nuclei. The average number of RPA foci per #-H2AX-
positive cell was determined for each sample using an Olympus ScanˆR
screening station. The data points are mean " S.D. (n # 3). B, Western blot
analysis of extracts from U2OS cells transfected with indicated siRNAs. Blots
were probed with the antibodies indicated on the right.
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loaded on the 3!-terminated DNA strand during DNA2-cata-
lyzed resection might enhance the DNA unwinding processiv-
ity of the BTRR complex and, hence, increase the efficiency of
the resection reaction. However, it should be noted that the
stimulatory effect of the TRR complex on DNA end resection
by BLM-DNA2 in vitro was rather modest under our experi-
mental conditions. On the contrary, RMI1 depletion in U2OS/
SA-GFP cells reduced the efficiency of SSA-mediated DSB
repair to levels displayed byBLM-orDNA2-deficient cells, sug-
gesting that BLM requires RMI1 to promote DNA end resec-
tion in vivo. Of note, it has been shown that silencing of RMI1 or
RMI2 expression by RNA interference destabilizes both BLM
andTOPOIII! (47, 49). Therefore, it is evident that, in addition
to being important for the functional attributes of the BTRR
complex, RMI1 and RMI2 are indispensable for the structural
integrity of its components in vivo.
Although BLM depletion compromised SSA-mediated DSB
repair in U2OS/SA-GFP cells, it had an opposite effect on SSA
in HEK293/SA-GFP cells. Similarly, the efficiency of SSA-me-
diatedDSB repair inHEK293/SA-GFP cells was elevated signif-
icantly upon depletion of RMI1 (data not shown). These find-
ings suggest that, inHEK293 cells, the BTRR complexmight act
as an SSA suppressor, most likely through unwinding of the
annealed intermediate formed following DNA end resection.
Strikingly, we found that BLM concentration in HEK293 cells
was much higher than in U2OS cells (data not shown). There-
fore, it appears that the BTRR complex exerts an inhibitory
effect on SSAwhen its concentration in the cell exceeds certain
threshold.
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ABSTRACT
Replication protein A (RPA) is a single-stranded DNA
binding protein, involved in most aspects of eukaryotic DNA
metabolism. The strong binding of RPA to single-stranded
DNA is well established. However, at boundaries between
single- and double-stranded DNA (ssDNA and dsDNA)
the binding and release of RPA must be carefully tuned
such that the DNA can be made accessible to the DNA
processing machinery without interfering with its function.
Here we study the dynamics of RPA for such a situation
using a replication fork mimic that is subjected to force by
magnetic tweezers. We show that both yeast and human
RPA can open the forked DNA in a step-wise manner
when su cient tension is applied. In contrast, when the
force is reduced, RPA becomes rapidly displaced by the
rehybridization of the progressively closing DNA fork. A
simple theoretical model can explain the observed dynamics
of DNA opening and closing, which is driven by passive
binding of RPA to the ssDNA fork arms rather than active
DNA duplex destabilization. Rate limiting step for both
processes is only the binding or the release of a few bp-long
RPA microdomain (toehold). This provides an extremely
rapid exchange dynamics of RPA at the fork. Fork rezipping
rates reach up to hundreds of base pairs per second, being
orders of magnitudes faster than RPA dissociation from
ssDNA alone. Additionally, we show that RPA undergoes
di↵usive motion on ssDNA, such that it can be pushed over
long distances by a rezipping fork. Generally the behavior
of both RPA types is generally very similar. However, the
dissociation of human RPA from ssDNA is greatly reduced
at low Mg2+ concentrations, such that it can melt DNA in
absence of force. In contrast the behavior of yeast RPA is
rather invariant against changes of the Mg2+ level.
⇤To whom correspondence should be addressed. Tel: +49 341 97 32501; Fax: +49 341 97 32599; Email: ralf.seidel@physik.uni-leipzig.de
INTRODUCTION
Replication protein A (RPA) is a highly ubiquitous (1),
heterotrimeric (2), protein essential in virtually all aspects of
eukaryotic DNA processing involving single-stranded DNA
(ssDNA) intermediates (3). Due to the strong binding of RPA
to ssDNA (2, 4, 5, 6) RPA was originally thought to solely
prevent the formation of secondary structures and confer
protection from nucleolytic degradation. However, strong
evidence for direct interactions with specific protein partners
has been reported (7, 8, 9, 10), and a new paradigm emerged.
In there RPA additionally acts as a scaffold for the recruitment
of other DNA processing enzymes on ssDNA intermediates,
in order to channel the processing along specific pathways
(11, 12). Of particular interest are hereby boundaries between
ssDNA and double-stranded DNA (dsDNA), where many
DNA processing factors are acting. There, in particular in
the cellular context, the binding and release of RPA must be
highly dynamic, and organized in such a way that the DNA
can be rapidly made accessible to the subsequent processing
machinery.
The importance of ssDNA-dsDNA boundaries is also high-
lighted by the fact, that despite the low affinity towards dsDNA
(13), RPA binds appreciably to damaged dsDNA (14, 15),
is able to disrupt partially double-stranded DNA structures
such as triplexes (16), tetraplexes (17, 18), and suppresses
formation of secondary structures such as hairpins (11).
Under certain circumstances, the ATP-independent melting of
dsDNA by RPA has also been shown, (19, 20, 21) where it was
proposed that the observed duplex destabilization proceeds by
trapping fluctuations of the helix (21).
Several recent studies have advanced our understanding of
the molecular mechanisms that may control the coordination
of RPA by employing single-molecule analysis techniques:
(i) Using single-molecule DNA supercoiling experiments in
magnetic tweezers it was shown that RPA can bind to transien-
tly forming bubbles in the DNA duplex in a torque-dependent
manner (22). (ii) Single-molecule imaging of fluorescent RPA
has shown that RPA bound ssDNA may undergo more rapid
exchange in presence of free RPA in solution (23). (iii) Using
c  2015 The Author(s)
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a combination of single-molecule fluorescence techniques it
was found that under certain conditions RPAmay diffuse/slide
along ssDNA (24), transpiring the intriguing possibility that
this way it provides access of other enzymes to the DNA.
Recently Chen and Wold (12) pointed out that, central to
all of these single-molecule studies is the emerging view
that RPA binding is highly dynamic and that microscopic
rearrangements of the RPA DNA binding domains (DBDs)
are underlying the observed dynamics. However, it was also
emphasized that more work is required to fully understand the
rich dynamics RPA in compex with various DNA structures.
Here, we investigate in detail the dynamics of RPA at
the boundary of ssDNA and dsDNA such as arising at
a replication fork. For this we utilize magnetic tweezers
that allow precise manipulation and length determination
of immobilized DNA substrates via an attached magnetic
microsphere (25). At the single-molecule level they support
the study of fast dynamic processes while preserving intrinsic
molecular variation with spatial resolution on the scale of one
base-pair (25).
By these means, we have characterized the force-dependent
binding dynamics of RPA from human and budding yeast
(Saccharomyces cerevisiae) on a DNA fork down to single
protein association events. The interplay between RPA, fork
and force tightly regulates the opening and closing of the fork.
Our results indicate that RPA uses a ’toehold’-like mechanism
to trap small transient openings of the DNA helix with a
microdomain that then get expanded by binding of the full
protein. Similarly RPA displacement by the rezipping fork
first occurs through an initial rate-limiting displacement of
a toehold. This gives rise to a very rapid helix rezipping
upon which RPA dissociates much faster then on ssDNA.
Thus, while RPA protects ssDNA rather firmly and statically,
it is extremely dynamic at DNA processing sites. This is
additionally supported by the observation that a DNA fork can
slide/push RPA upon rezipping.
MATERIALS AND METHODS
DNA and proteins
The hairpin substrate containing a 488 bp long hairpin was
prepared as described (26). The 5’ end the of the hairpin
carried a single biotin modification, while the 3’ end was
linked through a 40 nt ssDNA spacer to a ⇠600 bp ds DNA
spacer folled by a ⇠600 bp digoxigenin-modified attachment
handle.
The nicked dsDNA substrate was prepared as described
(27). Central part is a 6.1 kbp unmodified dsDNA with a nick
being located at 700 bp from its proximal DNA end. ⇠600 bp
attachment handles carrying multiple digoxigenins and biotins
were attached to the 6.1 kbp fragment at its nick-proximal and
distal ends, respectively.
yRPA (28) and hRPA were recombinantly expressed and
purified as described.
Magnetic tweezers experiments
For the single molecule experiments a home-built magnetic
tweezers setup was applied (25, 29). Magnetic tweezers expe-
riments were conducted at room temperature using flow cells
assembled from two coverslips that were separated by a layer
of Parafilm into which a sample chamber was cut out. The
bottom coverslip was coated with polystyrene. 3 µm carboxyl-
modified latex beads (Invitrogen) that served as reference
were attached to the bottom slide of the mounted flow cell
by incubation in 1 M NaCl for 1 h. Subsequently, anti-
digoxigenin (Roche) was allowed to unspecifically bind to the
coated surface of the flow cell, by incubation with 50 µg/mL
for 1 h at room temperature. Subsequently, the flow cell was
passivated by over-night incubation with 10 mg/mL bovine
serum albumin (BSA) (NEB). DNA constructs were bound
to streptavidin-coated M280 magnetic beads (Invitrogen) and
then flushed into the flow cell. After allowing them to bind
for approximately 5 min, excess beads were washed out with
PBS rendering the sample chamber ready for experiments. The
positions of reference and DNA-attached beads were tracked
in all three dimensions at 300 Hz using videomicroscopy
and real-time GPU-accelerated image analysis (25). Typically
multiple beads were evaluated in parallel. Forces were calibra-
ted using a recent methodology that supports the usage of short
molecules and high forces (30). Experiments were conducted
in 50 mM Tris acetate pH 7.5 supplemented with magnesium
acetate in concentrations as described in the results. Data were
analyzed in Labview (National Instruments), Origin 9.1 (Ori-
ginLab) and Matlab (MathWorks). Length changes measured
in nm for opening of the hairpin or melting of the nicked DNA
construct were converted into the number of opened base pairs
as detailed in Supplementary Methods.
RESULTS
RPA association and dissociation at a DNA fork
We measured the association and dissociation of RPA on a
488 bp long DNA hairpin substrate using magnetic tweezers.
One end of the hairpin is immobilized via a dsDNA spacer at
the bottom surface of a fluidic-cell. The other end is tethered
to a 2.8µm magnetic bead (Figure 1a). A set of permanent
magnets is mounted on a movable stage above the fluidic-
cell, such that the magnetic force acting on the bead can be
controlled by lowering or raising the magnets (see Materials
& Methods for details).
The DNA hairpin substrate can be opened mechanically by
applying sufficient force on the bead. At forces above a critical
force, further called unzipping curve, a series of sudden, well-
defined transitions in DNA extension occurs, amounting to
about 475 nm from the fully-closed to the fully-open state over
the course of about 1 s (see Supplementary Figure S1).
In contrast, when adding 20 nM yRPA a gradual opening
of the hairpin at forces well below the unzipping force was
observed. Also the opening process extended over a much
longer time-scale and continued until the hairpin was extended
to the fully opened state (Figure 1b). Upon force reduction , a
gradual reversion to the closed state took place. We interpret
these gradual transitions as the result of RPA binding to the
fork of the hairpin. The sequential association of more RPA
opened the hairpin and generated RPA-covered ssDNA. Upon
lowering the force, RPA is displaced by the rezipping DNA
(Figure 1a). The slopes of both association and dissociation
are approximately constant throughout the complete hairpin
opening or closing process, irrespective of the amount of
double stranded substrate remaining, suggesting that binding
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Figure 1. Force-controlled association and dissociation of RPA on a DNA
fork substrate. (a) Schematic of the experiment: A 488 base-pair long DNA
hairpin substrate (red), is immobilized onto a glass-surface and tethered to a
magnetic bead. When sufficient force is applied to the bead, RPA (yellow)
can bind to the ssDNA/dsDNA interface at the fork. As a result, the hairpin
is opened to accommodate the entire RPA heterotrimer. Further association
proceeds by the contiguous binding of RPA to the fork until the hairpin is fully
opened. Upon lowering the magnetic force the DNA helix refolds reversibly
and RPA dissociates from the ssDNA. (b) Example time-trace of force-
controlled RPA association and dissociation in presence of 3 mM Mg2+. At
a force of 13.2 pN, sequential binding of RPA opens the hairpin with a rate of
4.7 bp/s, until it is fully opened and completely covered with RPA. Lowering
the force to 4.5 pN causes dissociation of RPA evident in rapid refolding of
the hairpin with a rate of 107 bp/s.
occurs only at the fork in a contiguous manner with respect the
previously bound RPA. We emphasize that the process is fully
reversible and the same molecule can be opened and closed
multiple times without systematic alteration of the resulting
curves.
Force-dependence of RPA binding at the fork
Next, we investigated the influence of the applied force on
the association and dissociation rates of RPA on the DNA
hairpin substrate. These rates showed a strong dependence on
the applied force. Above 11 pNwe observed a gradual opening
of the hairpin and the rate of opening increased with stronger
force (Figure 2a). When the force acting on such an RPA
covered, open hairpin, was reduced below 11 pN, we observed
a gradual closing of the hairpin and the rate of closing was the
faster, the lower the applied force was (Figure 2b).
Plotting the rates of hairpin opening and closing against the
applied force, it became apparent, that both the association and
dissociation rates varied exponentially with force as shown
in Figure 2c. We devised a model in which the net rate of
RPA binding to the DNA is the rate difference between force-
dependent RPA association and RPA dissociation at the fork.
Each rate is is expressed by an exponential Arrhenius terms
as obtained from transition-state theory in which the applied
force F effects the height of the transition barrier:
vnet=kon ·exp
✓
Fc zon
kBT
◆
 ko↵ ·exp
✓ Fc zo↵
kBT
◆
(1)
Hereby the pre-exponential factors kon and ko↵ describe
the expected rates for association and dissociation at zero
force. The second pair of fit parameters ( zon and  zoff )
corresponds to the distance of the initial state (before asso-
ciation/dissoctiation of a new RPA) from the transition state
along the relevant reaction coordinate, in this case the number
of base-pairs along the DNA hairpin. For association ( zon)
it is thus the number of base pairs that need to spontaneously
open to allow a sufficiently long part of an RPA complex to
bind to allow full complex binding. For dissociation  zoff
it is the number of base pairs that need to rezip and displace
part of the RPA complex to allow full complex dissociation.
The factor c converts the number of base-pairs into a DNA
extension change, i.e. a length. c is itself a function of the
force and was determined as described in the Supplementary
Information. The model well describes the force-dependent
rates, as evident in a fit to the data (Figure 2c). This provided
at 20 nM yRPA and 3 mM Mg2+ a hairpin closure rate at
zero force of ko↵ =308.9 bp s 1. Furthermore, zon=3.5 bp
and  zo↵ =2.5 bp was obtained, i.e. that spontaneous helix
opening or partial RPA displacement amounting to only few
base pairs is required to overcome the transitions state for RPA
association or dissociation, respectively. This is reminiscent
to the toehold mechanism in DNA nanotechnology, where an
association of a small protein microdomain (toehold) is the
rate limiting step for full protein binding and further helix
opening. Vice versa disengagement of a terminal microdomain
is rate limiting for helix rezipping. The fit also provides the
hairpin opening rate at zero force of kon=9.8 ⇥ 10 4 bp s 1
(see Table 1 for full set of fit parameters). This implies that in
the absence of force, dissociation dominates and equilibrium
favors the unbound state. The equilibrium force at which the
two processes balance out resulting in a net rate of zero is
11.2 pN.
For the distance of the initial reactant state from the
transition state we find values of  zon=3.5 bp for the
association reaction and zo↵ =2.5 bp for dissociation.
RPA binding on a nicked DNA duplex substrate
Next, we probed whether the observed RPA binding behavior
is unique to the DNA hairpin geometry, or if it could
be observed on a nicked DNA duplex as well. The DNA
substrate utilized in this case consists of a 6.1 kbp stretch of
dsDNA with a nicked strand (see Materials and Methods), as
illustrated in Figure 3a. This DNA construct undergoes a rapid
disruption of the base-pairing in the dsDNA when the applied
force exceeds 65 pN, as indicated by a marked increase in
the DNA length. This corresponds to the DNA overstretching
transition (31, 32).
In the presence of 20 nM of yRPA, again a gradual
increase in DNA length for forces well below the overstre-
tching transition can be observed, which proceeds for several
thousand base-pairs, see Figure 3b. This is in agreement
with the association of RPA at the junction of ssDNA and
dsDNA of the substrate, generating RPA-coated ssDNA as
illustrated in Figure 3a. As observed previously for the DNA
hairpin geometry, the process is again fully reversible. Upon
reduction of the applied force the DNA extension gradually
decreases until the duplex is fully restored, corresponding to
the sequential refolding of the helix when RPA dissociates.
Examining the association and dissociation rates as function
of the applied force, again an exponential dependence is
revealed. Applying our previous model yields an excellent
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Figure 2. Force dependence of the RPA association/dissociation kinetics at the fork in presence of 3 mM Mg2+. (a) Example time-traces of RPA association
on the DNA hairpin at different forces. The DNA hairpin sequentially opened due to successive association events of RPA. With increasing forces the overall
association rate becomes faster, ranging from 2.8 bp s 1 at 12.4 pN (blue) to 36.6 bp s 1 at 15.7 pN (red). (b) RPA dissociation time-traces for varying force.
Following a complete coverage of RPA on the DNA hairpin substrate, the force was lowered to the indicated values causing the hairpin to close and RPA to
dissociate. The rate of dissociation is much faster than association and ranges from 107 bp s 1 at 2.8 pN (blue) to 16.2 bp s 1 at 6.3 pN (red). (c) Association
and dissociation rates as function of force obtained by tracking multiple DNA substrates with magnetic beads in parallel (open circles). A fit to the data with
Equation 1 (red line) zero-force rates of 9.8⇥10 4 bp s 1 for association and 308.9 bp s 1 for dissociation.
fit to the data (Figure 3c). The zero force association and
dissociation rate parameters from the fit are comparable with
the hairpin geometry, with kon=5.9⇥10 3 bp/s and ko↵ =
564.0 bp/s. Because of the altered geometry of this DNA
substrate, an elevated force of 43 pN is required to bring
these competing processes to equilibrium. The distances to the
transition state, zon=2.9 bp and zo↵ =1.6 bp, are also in
good agreement to the values obtained for the DNA hairpin
geometry (see Table 1).
Magnesium dependence of RPA binding
The ionic strength in general and magnesium in particular are
of vital importance for DNA-protein interactions due to both
a general screening of charges and also the specific mediation
of important contacts byMg2+(33, 34). Our bulk experiments,
confirm earlier work reporting that hRPA is capable of melting
dsDNA even in the absence of force under conditions of low
magnesium concentration (19, 20, 21), see Supplementary
Figure S2. Therefore, we probed RPA-mediated opening /
closing of DNA hairpins as a function of the magnesium
concentration also at the single-molecule level.
To this end, the behavior of hRPA binding to the DNA
hairpin under comparable conditions as for yRPA was inve-
stigated. Generally speaking, hRPA behaves comparably to
yRPA. Again the force dependent opening and closing of
the DNA hairpin is observed, which can be attributed to the
association and dissociation of hRPA on the DNA at the
fork (data not shown). Also in terms of the absolute force-
dependent rates the two paralogs are comparable as shown in
Figure 4a. Our model (Equation 1) also fits the hRPA data
well, yielding fit parameters that closely resemble those of
yRPA as summarized in Table 1.
Varying the concentration of Mg2+ in the range of
1 to 10 mM shows no considerable effect for yRPA in
terms of the force-dependent kinetics, as shown in Figure 4a.
Within the margins of experimental uncertainty and stochastic
error, the fit parameters remain practically unchanged over
the examined concentration range as tabulated in Table 1.
For hRPA however, there is a pronounced effect on the
yRPA hRPA
1 mM Mg2+ 3 mM Mg2+ 10 mM Mg2+ 3 mM Mg2+ 5 mM Mg2+ 10 mM Mg2+
kon [bp/s] 3.6⇥10 7 9.8⇥10 5 3.3⇥10 3 9.2⇥10 5 1.2⇥10 2 1.4⇥10 2
ko↵ [bp/s] 310 300 400 40 120 200
dzon [bp] 5.3 3.5 2.5 3.2 2.1 2.5
dzo↵ [bp] 2.3 2.0 2.0 0.9 1.0 0.8
Table 1. Fit parameters for yRPA and hRPA association and dissociation kinetics. kon and koff are the apparent rates of association and dissociation at zero
force, dzon and dzoff are the transition state distances for binding or dissociation of an RPA heterotrimer in base-pairs. The parameters were obtained by fitting
the force-dependent association and dissociation rates of yRPA and hRPA on the 488 base-pair DNA hairpin, to a model comprised of two Arrhenius terms (see
Equation 1).
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Figure 3. Association and dissociation can be measured also on a DNA duplex substrate. (a) RPA also associates reversibly onto a 6.1 kbp long DNA duplex
with a 40 nt long 5’-end flap subject to force. (b) Example time-trace of RPA association and dissociation. The duplex is seen to open continuously over several
thousand base-pairs, caused by association of RPA. In this geometry, association proceeds at a rate of 63.8 bp/s, when a magnetic force of 48.7 pN is exerted.
Complete opening is avoided, to prevent detachment of the magnetic bead, by lowering the force. At 26.7 pN force, the helix refolds rapidly with a rate of 70 bp/s
as RPA dissociates. (c) Association and dissociation rates are plotted against the applied force (open circles). Again both the association and dissociation rates
vary exponentially with the applied force. A double exponential (see main text) fits the data well (red line), and reveals zero-force rates of 5.9⇥10 3 bp/s for
association and 564.0 bp/s for dissociation.
dissociation rates, which drop from 200 bp/s in 10 mMMg2+
down to 120 bp/s at 5 mMMg2+ and 40 bp/s at 3 mMMg2+.
Below 3 mMMg2+ dissociation is no longer measurable. This
is demonstrated by the exemplary time traces recorded at 2 pN
force shown in Figure 4b. The DNA hairpin remains open
under conditions where yRPA dissociates with the same rate
as at higher levels of Mg2+.
In fact, even in the absence of force the DNA hairpin is
completely opened after introducing hRPA in buffer contai-
ning<3 mMMg2+. This is in agreement to the melting of the
duplex DNA under similar conditions evident from our bulk
experiments (Supplementary Figure S2). Furthermore, extra-
polation of the dissociation rates from the single-molecule
assay shows that the rate is expected to reach zero below
2.5 mM Mg2+. This is consistent with the onset of melting
activity observed in bulk.
Finally, the measurement of the RPA binding kinetics were
repeated in the absence of salt, and find that the entire curve is
shifted towards lower forces while its shape is preserved, and
the shift is consistent with the shift of 2 pN that we see for the
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Figure 4. Comparison of human and yeast RPA association/dissociation on the DNA hairpin substrate, and the effect of varying the magnesium concentration.
(a) The association and dissociation behavior of yeast RPA (left panel) and human RPA (right panel) is generally quite similar. Individual association/dissociation
rates measured over a range of forces are indicated by markers, and are on the same order of magnitude for human and yeast RPA. For both paralogs the rates
exhibit exponential force dependence, which is well described by a double exponential model (solid lines, see main text). Force-dependent association and
dissociation rates of yRPA are not affected significantly by changing the concentration of Mg2+ in the range of 1 to 10 mM, our model fits the data well and
parameters obtained are comparable (see Table 1). For hRPA our model describes the force-dependence equally well, however, lowering the concentration of
Mg2+ results in significantly reduced dissociation rates in the range of 3 to 10 mM. (b) Example time-traces of dissociation are shown for both yRPA and hRPA at
forces close to 2 pN for different magnesium concentrations. For yRPA, changing Mg2+ concentration from 1 to 10 mM has no marked effect as indicated by the
hairpin opening distance decreasing with comparable slope in all cases. In contrast, the dissociation rate of hRPA becomes reduced at lower Mg2+ concentrations
until no dissociation is observable at all below 3 mM, as shown by the hairpin remaining fully open (right panel, blue curve).
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Figure 5. Concentration dependent association of yRPA on the DNA hairpin
substrate. (a) Example time-traces of association at a force of 12.7 pN are
shown. The rate of association is increased from 0.4 bp/s at 5 nM RPA (red
curve), to 16.2 bp/s at 50 nM (blue curve). (b) Observed association rates
(open-circles) vary linearly with the concentration of RPA as indicated by
the linear fit (red line). Points shown correspond to mean values of triplicate
measurements with error bars representing one standard deviation.
difference in unzipping force in salt-free buffer and containing
1 mM Mg2+ (see Supplementary Information).
Concentration effect on RPA association kinetics
We also examined the influence of the concentration of yRPA
on the rate of association on the DNA hairpin substrate. Time
traces recorded at concentrations ranging from 2 to 50 nM are
shown in Figure 5a for a given force. It can be seen that the rate
of association is increased from 0.6 bp/s at 5 nM to 16 bp/s at
50 nM, and as expected, the association rate follows a linear
dependence on the RPA concentration (Figure 5b).
Binding-site size determination
We carefully examined our data to investigate whether we
could identify consistently sized steps in the opening of
the DNA hairpin resulting from RPA binding. In conditions
favoring very slow association (moderate force and low RPA
concentration) steps become well resolved and discernible as
shown in Figure 6a.
Constructing dwell-state histograms reveals that the DNA
hairpin opening occurs via discrete well-populated states
which are separated by sharp transitions (steps). Examining
the separation of adjacent dwell states provides some estimate
of the step-size. The value of ⇠20 nt is consistent the binding-
site size of RPA reported in literature (24, 35).
We interpret these steps as the consequence of single
binding events, and thus analyzed our data using an in-
house developed step-finding algorithm (see Supplementary
Methods). Using this analysis, an average step-size of 24 for
yRPA and 26 for hRPA is most prominent, see Figure 6b. Steps
of this size are persistent throughout the length of the hairpin
opening and this step-size is independent of the applied force.
In conditions where dissociation occurs at appreciable rates,
backward steps of similar size were observed.
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Figure 6. Binding-site size of RPA. (a) Exemplary time trace for yRPA
association on the hairpin substrate showing clearly resolved steps. (a) Step-
size distribution for yRPA (from multiple traces collected under the same
conditions), calculated using a step-finding algorithm. The step-size of 25 bp
occurs most frequently in the data), co (c) The step-size distribution for hRPA
is similar, with the most common size being 28 bp.
Sliding of hRPA along ssDNA
Finally, it was investigated whether a single hRPA heterotri-
mer could be pushed along the ssDNA by the hairpin refolding
behind it. To achieve this, the hairpin was repetitively opened
and closed by alternating between forces above and below the
characteristic unzipping force (22.5 and 15.5 pN, respectively)
in about 0.5 s intervals. In the absence of hRPA the hairpin
reproducibly closes in a single fast transition. At very low
concentrations of hRPA (150 pM), the hairpin closing is
in some instances perturbed, such that a continuous slower
refolding takes place (Figure 7a). This slow closing takes place
only about once in 10 force cycles, and at a force for which our
previous experiments indicate that association is favored over
dissociation. Furthermore, the closing observed in this case
takes place in a smooth fashion, whereas dissociation data at
higher hRPA concentration (down to 5 nM) takes place in a
more discontinuous almost step-wise manner, as one hRPA
heterotrimer is sheared off after the other.
Therefore, we believe that the events observed here corre-
spond to the binding of a single hRPA to the ssDNA while the
hairpin is open, and a pushing of the refolding hairpin against
the friction of the single hRPA heterotrimer sliding along
the ssDNA (see Figure 7b). The fact that this sliding can be
interrupted by again increasing the force to open the hairpin,
and then resumes upon re-lowering the force (see Figure 7a,
second highlighted portion) substantiates this explanation.
Systematically varying the closing force (defined as the
difference between the applied force and the characteristic
unzipping force of 17.8 pN under these conditions), reveals
that the average velocity depends linearly on the force.
Figure 7c shows the mean velocities as function of the closing
force. A linear fit describes the observed trend well (R2=0.86),
with the intersection of the velocity axis at -18.23 nt/s for zero
force. Furthermore, the slope of this fit can be used to calculate
a friction coefficient, as the velocity is expected to vary with
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Figure 7. hRPA can slide along ssDNA. (a) Repetitively opening and closing
the hairpin by alternating the applied force between 22.5 and 15.5 pN (as
indicated in red) in conditions of very low (150 pM) hRPA concentration
reveals sliding of hRPA. For the majority of these cycles (gray background)
the closing of the hairpin is unperturbed, however approximately once in ten
cycles, a continuous slower closing is observed (pale yellow background).
(b) Cartoon illustrating the observed behavior. After opening the hairpin,
a single hRPA heterotrimer may bind to the exposed ssDNA. When the
force is reduced, the closing hairpin pushes the hRPA along the ssDNA.
(c) Estimation of the friction coefficient. The mean sliding velocity (black
markers, error bars indicate standard errors) is shown to vary linearly with
the closing force (defined as the difference between the applied force and
characteristic unzipping force). The slope of the linear fit to the data (shown
in red) provides an estimate for the friction coefficient, for which a value of
⇣=0.005 pN·nt 1·s.
the force as given by F =⇣ ·v, for which we find a value of
⇣=0.005 ± 0.0009 pN·nt 1·s.
DISCUSSION
We have shown that both human and yeast RPA destabilize
forked dsDNA. The fact that both yeast and human RPA
exhibit comparable behavior underlines the relevance of our
findings. In both the DNA hairpin and duplex geometries a
gradual opening is observed, at forces far below the chara-
cteristic forces for unzipping or the overstretching transition,
respectively. We attribute this gradual opening to the binding
of RPA to short stretches of single-stranded DNA exposed by
intermittent openings of the DNA helix. As a result of the
strong binding of RPA to ssDNA, these transient openings are
trapped and the hairpin is opened further to accommodate the
entire unit of RPA. The sequential opening of the dsDNA then
proceeds by successive binding events of RPA to the interface
of ssDNA and dsDNA.
This interpretation of our data is consistent with previous
work investigating the association and dissociation of yRPA
on super-coiled dsDNA (22), where RPA was found to bind
to transient bubbles that occur on the DNA, destabilized by
the applied torque. The forked geometry is of advantage
because it is more well-defined and much better resolved. On
super-coiled substrates bubbles that are trapped by RPA may
occur in multiple sites, as dsDNA overstretching experiments,
using fluorescently-modified RPA as probe for single-stranded
regions, show that melting initiates throughout the DNA
molecule by localized base-pair breaking, leading to melting
bubbles (36, 37). In our forked substrates the unzipping
most likely initiates only from the fork, albeit binding can
occur to either strand. Especially for the hairpin substrate, in
which the opening of a single base-pair causes an extension
of two nucleotides single-stranded DNA, our fork geometry
provides a much improved signal as compared to super-coiled
substrates. Consistently with these super-coiling experiments,
however, our measurement of the RPA dynamics on forked
DNA also suggests a passive mechanism for the observed
helix opening, as had already been proposed previously (21).
The strong force dependence of the kinetics of RPA
association supports this passive view, as the breathing of
the DNA helix required for initial RPA binding becomes
enhanced by stronger forces in both its length scale and
duration. Our model for this force-dependence consists of an
Arrhenius exponential. Using the association rate extrapolated
to zero force kon from this model, together with the linear
concentration dependence (that one may expect for simple
first-order binding kinetics), and the determined footprint of
yRPA, one can estimate the absolute rate (for 2 mM Mg2+)
as k on=
9.8⇥10 5 bp/s
20 nM · 25 bp =2⇥10 7 nM 1s 1. The rate of
association on a DNA fork is thus 7 orders of magnitude
slower than the association rate on pure single-stranded DNA
of 2 nM 1·s 1 (also at 2 mM Mg2+)(38), consistent with
view that binding to the fork is rate-limited by the fluctuations
of the DNA helix. Similarly, an absolute dissociation rate can
be estimated: ko↵ =
300 bp/s
25 bp =60 s
 1, which is 4 orders of
magnitude faster than the rate of 0.006 s 1 (measured in
5mM Mg2+) for dissociation from ssDNA (39). Again this is
consistent with the interpretation that the rapid rehybridization
of the helix is the driving force for dissociation on forked
DNA. This provides further support for the fact that a passive
helix destabilization mechanism underlies the opening and
closing of forked DNA mediated by RPA, and the dynamics
are governed by simple mechanics.
By comparison of equilibrium forces (at which the rates of
association and dissociation balance out to yield a net rate
of zero) with the force required to mechanically unzip the
DNA (the unzipping force or the overstretching force for the
two respective geometries), the energetic contribution of RPA
towards destabilization of the DNA helix can be calculated.
For yRPA and the DNA hairpin configuration, using the values
of 17.2 pN for mechanical unzipping in buffer containing
2 mM magnesium and the equilibrium force of 11.2 pN, this
corresponds to an energetic contribution of 35 %. Intriguingly,
the relative fraction is the same also for yRPA on the nicked
duplex DNA, for which we find 34% using 65 pN for the DNA
overstretching transition and an equilibrium force of 43 pN.
This implies that RPA supplies a contribution of one-third
of the total energy required to fully destabilize dsDNA in a
fork. Using these equilibrium force values together with the
size of the RPA binding site determined by our analysis, it is
furthermore possible to estimate the binding energy of RPA:
 Gbind=F
RPA
eq ·zRPA=138 pN·nm, which corresponds to
the binding energy of a single RPA heterotrimer to the stretch
of DNA corresponding to its binding site size and is equal to
a standard free-energy change of G bind=83 kJ mol
 1. This
energy, however, cannot be converted into a binding constant
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in a straightforward manner. RPA can bind on both strands of
the DNA duplex and additionally neighboring RPAs might be
bound with some gaps in between the individual heterotrimers.
However, our simple model (Equation 1) for the force-
dependent net rate, which sufficiently describes the observed
kinetics as the superposition of two Arrhenius exponentials
for the association and dissociation rate, respectively, allows
an estimation of an apparent dissociation constant. Comparing
the parameters kon and ko↵ , Kd⇡kon/ko↵ ⇡20 nM. It
becomes clear, that in the absence of force dissociation
strongly dominates and the RPA unbound state is favored.
This observation holds over a wide range of ionic strength
conditions, with the exception of hRPA dissociation (discus-
sed below), such that no considerable changes to the kinetics
are instigated in the range of 1 to 10 mMMg2+. We examined
how the unzipping force of our DNA hairpin construct varies
under the same conditions in the absence of RPA, and found
that these vary only slightly between 1 and 2.5 mM, and do
not vary at all in excess of 2.5 mM. The predominant effect
of increasing the ionic strength is the stabilization of the DNA
helix by screening the negative charges in the phosphodiester
backbone, however the largest part of this effect takes place
already below 1 mM Mg2+. Our data recorded in the absence
of salt indicates that yRPA - DNA interactions are unchanged
and the observed shift in the equilibrium point is caused
by the reduced helix stability under these conditions. The
fact that apart from DNA stabilization, the ionic strength has
insignificant effect on our measured kinetics, is in agreement
with our passive model of the destabilization of the helix
mediated by RPA.
The magnesium dependence of the dissociation rate we
observed is specific to hRPA, yRPA did not exhibit this
behavior. The ionic strength in general and magnesium in
particular are of vital importance for DNA-protein interacti-
ons. Beyond the effect of charge screening on the DNA, the
mutual approach of negatively charged RPA and the DNA is
also affected. Together these factors may account for a minute
increase we see in the apparent association rates. However,
the much more significant influence on the hRPA dissociation
rates seems to involve a highly specific effect of magnesium
on the binding of RPA to the DNA. It is conceivable that
yRPA may have conserved a salt-independence evolutionarily,
in order to allow for variable magnesium concentrations in
the cell. Yeast cells are expected to have greater variability
of their intracellular ion composition due to the diversity
of environments in which they grow. Indeed intracellular
magnesium concentrations strongly depend on the magnesium
concentration outside of the cell (40). Alternatively the
possibility exists that the hRPA binding equilibrium could be
regulated by cell-cycle dependent regulation of intra-nuclear
magnesium levels. Moderate magnesium concentrations are
essential for the activity of a whole host of DNA repair
proteins (41) and the distribution of intracellular magnesium
is both variable, (40, 42, 43), and tightly regulated throughout
the cell-cycle progression (41).
Our model describing the force-dependence of kinetics is
based on transition-state theory. In this view the parameters
 zon and zo↵ correspond to the distance between the initial
reactant state and the transition state along the relevant rea-
ction coordinate, in this case the number of base-pairs along
the DNA hairpin. An analogous formalism was previously
used, where the corresponding parameter descibes the step-
size for a helicase (44). The values we find for RPA are on the
order of only a few base-pairs throughout the experimental
conditions we examined (Table 1). Compared to the binding-
site size of RPA this is quite small, indicating that it is
sufficient for only a small portion of RPA to engage contact
with the DNA, in order for the rest of the RPA heterotrimer to
then wedge in, and open the DNA hairpin by length necessary
to accommodate the entire RPA heterotrimer. Similarly, in the
context of dissociation, where the corresponding parameter
is consistently slightly lower than for the reverse reaction,
this means that it is sufficient for the helix to refold by
only one-two base-pairs in order to destabilize the binding
of RPA sufficiently and shear it off. Such a toe-hold model
has been proposed previously, in order to explain the observed
binding properties of RPA (12, 22, 23). Furthermore, recent
studies suggest that these binding properties can be understood
in terms of the structural information available for RPA
binding to the DNA. RPA has multiple DNA binding domains
(DBDs) flexibly-linked together that interact with the DNA
in a defined orientation. Interestingly the toe-hold size we
observe for the association compares well with the length
of DNA that interacts with a single DBD as determined
crystallographically (45, 46).
Despite the strong binding reported for each of the DBD
subdomains (3), diffusion of hRPA on ssDNA as reported in
(24). We investigated this possibility in terms of single hRPA
heterotrimers sliding along the ssDNA, pushed by the closing
hairpin. Since the capability to diffuse is a prerequisite to
the sliding behavior, that we indeed observe, we can confirm
that hRPA is capable of diffusion on ssDNA. Furthermore,
from our data of the mean sliding velocities as function of
the closing force, a friction coefficient of ⇣=0.005 pN·nt 1·s
can be calculated. This can in turn be used to estimate
the diffusion coefficient via the Einstein relation: D= kBT⇣ .
From this data a one-dimensional diffusion coefficient of
D=960 ± 350nt2/s on ssDNA can be estimated, which
is surprisingly well comparable to the published value of
D=2800 ± 200 nt2/s (24), particularly given the high salt
concentration of 0.5 MNaCl used in that study. The possibility
of RPA to diffuse along allows for the possibility of bound
hRPA to rearrange itself on the ssDNA, in order to free-up
access to other processing factors.
To recapitulate, we find that RPA dynamics on forked
DNA are governed by a passive mechanism in which a RPA
binds to short stretches of ssDNA that are intermittently
exposed from the dsDNA helix, using a small toe-hold.
As the binding energy is only sufficient to overcome one-
third of the base-pairing energy of the DNA, and given the
predominance of the dissociation rate in the absence of force,
we conjecture that it is unlikely that RPA disrupts dsDNA on
its own in a cellular context. It seems more likely that RPA
strongly binds and protects ssDNA generated in other DNA
processing steps, such as DNA repair, stalled-replication, and
homologous recombination, and for the case of a DNA fork,
DNA processing helicases or other enzymes bound to the fork,
will prevent RPA from dissociation due to the refolding of the
helix. In such a context it could then provide a scaffold for
the recruitment of further DNA processing machinery, and the
capability to diffuse suggests a mechanism in which access to
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the DNA can be freed-up. Then, the possibility exists that the
degree of RPA binding could be controlled by small changes in
force or torque exerted by downstream enzymes. Remarkably
however, the refolding of the helix is sufficient to rapidly expel
RPA by shearing it off the ssDNA with speeds of several
hundred base-pairs per second corresponding to a removal
of tens of RPA heterotrimers per second. Thus RPA may not
be sufficient to maintain a stretch of DNA as single-stranded
by impeding the helix rehybridization, eg. once a helicase
uncouples its activity, as has recently been postulated for
SSBs in general (47), as the refolding helix could very rapidly
drive the removal of RPA. Furthermore, this also implies that
no further processing enzymes are absolutely necessary to
remove RPA, as could be expected and would be a plausible
role for helicases that preferentially rewind the helix (26) as
has also previously been speculated (48). Instead the helix
refolding can be sufficient to return the dsDNA to its native
RPA-unbound state, once processing has been completed and
the processing machinery has dissociated from the DNA.
CONCLUSION
We have shown that RPA destabilizes the double helix
protruding from a DNA fork by binding to intermittently
exposed stretches of ssDNA using a microscopic toe-hold.
These findings hold for both yRPA as well as hRPA. This
destabilization can be understood as passive trapping of
fluctuations on the helix, and with the aid of additional force,
it is sufficient to disrupt DNA double helix. Our results
indicate that RPA binding to forked DNA is highly dynamic,
as it is governed by competition with the hybridization of
the DNA helix. As the binding energy is only sufficient to
overcome one-third of the base-pairing energy of the DNA,
we conjecture that it is unlikely that RPA disrupts dsDNA on
its own in a cellular context. For yRPA, we found the process
to be independent of the magnesium concentration. For hRPA
in contrast, the dissociation of RPA from the single strand
is highly dependent on magnesium, such that under certain
circumstances, equilibrium may favor DNA melting in the
absence of force. Furthermore, we confirm a previous report
that revealed that hRPA is capable of diffusion on ssDNA,
and this capability may allow RPA to free-up access to the
ssDNA for other processing factors. In summary, our single-
molecule measurements characterize the binding kinetics of
RPA on forked DNA and provide insight into the underlying
molecular mechanisms. The mechanistic details we draw from
our results fit in well with the emerging view, RPA binding is
highly dynamic, and governed by microscopic domains, that
are compete for ssDNA with the hybridization of the helix.
Regarding its function in vivo, we believe that RPA does not
melt dsDNA on its own, but rather coats ssDNA intermediates
to protect them, while providing a scaffold for the recruitment
of further effector proteins. These may then dislodge RPA by
rearrangement of RPAs microscopic domains DNA binding
and furthermore RPA may slide along the ssDNA to permit
access. Ultimately, for the release of RPA from a fork after
DNA processing, we believe that rehybridization of the double
helix after removal of the processing machinery, is sufficient
as the driving force.
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3.	  DISCUSSION	  
	  
3.1	  Biochemical	  activities	  of	  Dna2	  and	  its	  regulation	  
	  
S.	   cerevisiae	   Dna2	   protein	   has	   a	   tripartite	   structure	   as	   it	   contains	   a	   C-­‐terminal	  
superfamily	   I	   helicase	   domain,	   a	   central	   RecB	   family	   nuclease	   domain	   and	   an	  
unstructured	  N-­‐terminal	  tail	  (35).	  The	  nuclease	  activity	  has	  a	  5'	  to	  3'	  polarity	   in	  the	  
presence	   of	   RPA	   and	   is	   essential	   for	   cell	   survival	   (25,27,28).	   The	   ATP-­‐dependent	  
helicase	   activity	   of	   Dna2	   has	   been	   considered	   as	   weak,	   although	   helicase-­‐dead	  
mutants	   exhibited	   increased	   sensitivity	   to	   alkylating	   agents	   and	   ionizing	   radiation	  
(17,30,31).	   The	  N-­‐terminal	   domain	   has	   been	  proposed	   to	  mediate	  DNA	  binding	   to	  
secondary	  structure	  DNA,	  to	  be	  involved	  in	  the	  interaction	  with	  RPA	  as	  well	  as	  to	  be	  
a	  Mec1	  activator	  (36,37,39).	  	  
We	  were	  able	  to	  show	  that	  Dna2	  has	  a	  vigorous,	  but	  cryptic	  helicase	  activity	  that	  is	  
comparable	   to	   that	  of	   Sgs1	   ((125);	   see	  2.2.1).	  However,	   in	   the	  wild	   type	  Dna2	   the	  
nuclease	   activity	   masks	   the	   helicase,	   so	   the	   question	   arised	   whether	   there	   is	   an	  
additional	   regulatory	   mechanism	   attenuating	   Dna2	   nuclease	   activity.	   Indeed,	   we	  
demonstrate	  that	  Dna2	  is	  sumoylated	  in	  vitro	  and	  in	  vivo	  (Levikova	  et	  al.,	  manuscript	  
in	   preparation,	   see	   2.2.2).	   In	   vitro,	  we	   show	   that	   six	   lysines	  within	   the	  N-­‐terminal	  
domain	  are	  modified	  by	  SUMO	  and	  that	  the	  sumoylation	  selectively	  attenuates	  the	  
nuclease	  activity	  of	  Dna2,	  without	  affecting	   its	  helicase	  or	  ATPase.	  We	  hypothesize	  
that	   the	   sumoylated	   N-­‐terminal	   tail	   of	   Dna2	   might	   interact	   with	   the	   SUMO-­‐
interaction	   motifs	   (SIMs)	   within	   the	   nuclease	   domain	   of	   Dna2,	   thus	   partially	  
inhibiting	  its	  activity.	   In	  vivo,	  we	  found	  Dna2	  to	  be	  sumoylated	  primarily	   in	  the	  late	  
S/G2	  phases	  of	   the	  cell	  cycle.	  Furthermore,	  sumoylation	  appeared	  to	  protect	  Dna2	  
from	   reduction	   of	   protein	   levels	   induced	   by	   the	   alkylating	   agent	   MMS	   and	  
radiomimetic	  drug	  Bleomycin.	  It	  appears	  that	  sumoylation	  is	  not	  only	  modulating	  the	  
balance	  between	   the	  nuclease	  and	  helicase	  within	  Dna2,	  but	  also	  has	  a	  protective	  
function.	  The	  attenuation	  of	  the	  nuclease	  induced	  by	  sumoylation	  brings	  possibly	  the	  
helicase	  into	  play,	  which	  seems	  to	  be	  important	  in	  late	  S/G2	  phases	  of	  the	  cell	  cycle	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and	   upon	   genotoxic	   stress.	   Interestingly,	   we	   detected	   sumoylated	   Dna2	   upon	  
treatment	   with	   alkylating	   and	   radiomimetic	   drugs;	   both	   treatments	   to	   which	  
helicase-­‐dead	  mutants	  displayed	  increased	  sensitivity	  (17,31).	  Taken	  together,	  these	  
results	  would	  infer	  that	  in	  late	  replication	  and	  upon	  genotoxic	  stress	  Dna2	  nuclease	  
is	  attenuated	  by	  sumoylation	  so	  the	  potent	  helicase	  can	  come	  into	  play	  and	  possibly	  
contribute	   to	  more	   efficient	   "screening"	   of	   DNA	   for	   specific	   structures/lesions	   like	  
flaps,	   DNA	   breaks	   and	   G4	   quadruplexes.	   Moreover,	   sumoylation	   hubs	   were	  
described	  to	  occur	  at	  sites	  of	  DNA	  damage	  as	  well	  as	  at	  telomeres	  (126),	  suggesting	  
that	  Dna2	  might	  be	  part	  of	  those	  events.	  	  	  
3.2	  Role	  of	  Dna2	  in	  replication	  and	  replication	  stress	  response	  	  
Dna2	  was	  described	  to	  be	  essential	  for	  replication	  (16).	  It	  has	  an	  established	  role	  in	  
Okazaki	   fragment	   processing	   where	   it	   acts	   together	   with	   Fen1	   to	   remove	   flaps	  
arising	  form	  strand	  displacement	  activity	  of	  pol	  δ	  that	  are	  refractory	  to	  subsequent	  
ligation	   (53,54).	   However,	   this	   sequential	   model	   was	   based	   on	   the	   biochemical	  
observation	  that	  Dna2	  can	  cleave	  the	  DNA	  flap	  structures	  only	  up	  to	  5-­‐8	  nucleotides	  
away	  from	  the	  base,	  thus	  providing	  the	  requirement	  for	  a	  second	  nuclease	  activity	  
(54).	  Moreover,	  dna2Δ	  mutation	   is	   lethal,	  while	   rad27Δ	  cells	   are	   viable	   (16,56,57),	  
which	  stands	  in	  contrast	  to	  the	  notion	  of	  Dna2	  acting	  upstream	  of	  Fen1.	  	  	  
We	   show	   that	   our	  Dna2	   protein	   preparation	   is	   able	   to	   cleave	   the	   flaps	   at	   or	   near	  
their	  base	  and	  the	  products	  can	  be	  ligated	  by	  DNA	  ligase	  I	  (Levikova	  and	  Cejka,	  NAR	  
2015,	  in	  press;	  see	  2.2.3).	  In	  conjunction	  with	  replication	  Dna2	  was	  highly	  efficient	  in	  
Okazaki	   fragment	   processing	   as	   a	   sole	   nuclease.	   Addition	   of	   Fen1	   had	   only	   a	   very	  
moderate	  additive	  effect	  on	  the	  overall	  processing	  efficiency,	  suggesting	  that	  Dna2	  is	  
able	  to	  process	  long	  RPA-­‐bound	  DNA	  flaps	  alone,	  which	  fits	  with	  genetic	  data.	  These	  
observations	   raise	   the	   question	   about	   the	   redundancy	   of	   the	   Okazaki	   fragment	  
processing	  pathways.	  We	  propose	  that	  Fen1	  and	  Dna2	  act	   in	  different	  time	  frames	  
during	  the	  cell	  cycle.	  Several	  lines	  of	  evidence	  suggest	  that	  Fen1	  is	  acting	  primarily	  in	  
the	  S	  phase	  of	  the	  cell	  cycle	  as	  human	  FEN1	  is	  degraded	  in	  late	  S/G2	  and	  fen1	  yeast	  
cells	  arrest	  already	  in	  S	  phase	  (127,128).	  In	  contrast,	  dna2	  mutants	  are	  proficient	  in	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DNA	  bulk	  synthesis,	  but	  arrest	  in	  G2/M	  (129).	  Also	  human	  cell	  depleted	  from	  DNA2	  
arrest	  in	  late	  S/G2	  (41).	  So,	  we	  think	  that	  Fen1	  is	  still	  responsible	  for	  the	  processing	  
of	  the	  majority	  of	  flaps	  in	  S	  phase,	  while	  Dna2	  takes	  care	  of	  those	  that	  became	  long	  
enough	   to	   bind	   RPA,	   which	   is	   refractory	   to	   Fen1	   cleavage.	   It	   is	   also	   possible	   that	  
Dna2	   is	   additionally	   involved	   in	   the	   cleavage	   of	   flaps	   that	   arised	   during	   post-­‐
replicative	  repair	  in	  late	  S/G2	  phases.	  Furthermore,	  Dna2	  might	  function	  in	  telomere	  
replication	   as	   well,	   as	   it	   was	   shown	   to	   localize	   to	   telomeres	   in	   late	   S/G2	   and	   to	  
cleave/unwind	  telomeric	  G4	  structures	  (109,110,113).	  	  
Additionally,	   we	   show	   that	   Dna2	   is	   also	   involved	   in	   replication	   under	   perturbed	  
conditions.	   In	   a	   collaborative	   work	   we	   demonstrate	   that	   Dna2	   is	   able	   to	   process	  
reversed	   forks,	   thus	   driving	   their	   restart	   ((130);	   see	   2.3.1).	   Furthermore,	   we	  
demonstrate	   that	   the	   helicase	   activity	   of	   Dna2	   is	   required	   for	   completion	   of	  
replication	   and	   helicase-­‐deficient	   cells	   depend	   on	   Yen1	   upon	   replication	   stress	  
(Ölmezer	   et	   al.,	   under	   revision	   in	   Nat.	   Com.,	   see	   2.3.2).	   Hence,	   these	   findings	  
support	  the	  idea	  of	  Dna2	  involvement	  in	  error-­‐free	  DNA	  damage	  tolerance	  pathway	  
at	  multiple	  levels.	  	  	  
Taken	   together,	   our	   results	   posit	   Dna2	   as	   a	   safeguard	   of	   replication	   and	   its	  
checkpoint	   function	   (37)	   stresses	   even	  more	   the	   importance	   of	   Dna2	   for	   genome	  
stability.	  	  	  
	  
3.3	  Dna2	  and	  DNA	  end	  resection	  
	  
Dna2	   has	   a	   well-­‐established	   role	   in	   long-­‐range	   DNA	   end	   resection	   where	   it	   acts	  
together	  with	   Sgs1	   (28,92,93).	   So	   far,	   the	   contribution	  of	  Dna2	  helicase	   activity	   to	  
this	  process	  was	  negligible	  (93).	  
Using	   biochemical	   assays	  we	   show	   now	   that	   the	  motor	   activity	   of	   Dna2	   acts	   as	   a	  
ssDNA	  translocase	  especially	   in	  presence	  of	  RPA	  and	  greatly	  promotes	  degradation	  
of	   long	   stretches	   of	   ssDNA	   (Levikova	   and	   Cejka,	   manuscript	   in	   preparation,	   see	  
2.2.4).	   RPA	   stimulates	   the	   recruitment	   of	   Dna2	   and	   its	   translocase	   as	   well	   as	   its	  
nuclease	  activities.	  We	  think	  that	  in	  resection	  Sgs1	  is	  the	  lead	  helicase,	  translocating	  
with	  3'	  to	  5'	  polarity,	  while	  Dna2	  translocase	  activity	  allows	  it	  to	  keep	  up	  with	  Sgs1	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on	   the	   5'-­‐terminated	   strand.	   These	   findings	   provide	   a	   further	   proof	   for	   analogy	  
between	  Dna2-­‐Sgs1	   and	   the	  RecBCD	   complex.	  Nevertheless,	   additional	   research	   is	  
needed	  to	  show	  the	  contribution	  of	  Dna2	  helicase	  activity	  to	  DNA	  end	  resection	   in	  
vivo.	  	  
Another	   collaborative	   work	   provided	   further	   evidence	   for	   human	   DNA2	   acting	   in	  
conjunction	  with	  BLM	  or	  WRN	   in	   long-­‐range	  DNA	   resection	   ((131);	   see	  2.3.3).	   This	  
work	   underlines	   the	   evolutionary	   conservation	   of	   DNA2	   enzymatic	   functions.	   It	  
would	   be	   interesting	   to	   know	   whether	   human	   DNA2	   helicase	   plays	   a	   similar	   role	  
here	  as	  in	  the	  yeast	  protein.	  	  
We	  and	  others	  demonstrated	   the	   importance	  of	  RPA	   in	  DNA	  end	   resection	  and	   its	  
stimulatory	   activity	   on	   Dna2	   (28,54,92,125).	   However,	   the	  molecular	   basis	   of	   RPA	  
polymerization	   on	   ssDNA	   and	   depolymerization	   was	   still	   outstanding.	   The	   single-­‐
molecule	   analysis	   of	   RPA	   behavior	   was	   conducted	   by	   the	   laboratory	   of	   Prof.	   Ralf	  
Seidel	   (Kemmerich	   et	   al.,	  manuscript	   in	   preparation,	   see	   2.2.4).	   Their	   results	   infer	  
that	   RPA	   is	   not	   capable	   of	   disrupting	   dsDNA	   on	   its	   own,	   but	   rather	   it	   binds	   and	  
protects	   ssDNA.	   This	   is	   in	   agreement	   with	   the	   role	   of	   RPA	   in	   resection	   where	   it	  
promotes	  Dna2-­‐mediated	  degradation	  of	  the	  5'-­‐terminated	  strand,	  while	  protecting	  
the	   3'-­‐terminated	   tail	   (28,92).	   Furthermore,	   the	   study	   confirms	   the	   previously	  
reported	   diffusion	   of	   human	   RPA	   along	   ssDNA	   (132),	   thus	   leading	   to	   "melting"	   of	  
dsDNA	  and	  possibly	  allowing	  access	  to	  ssDNA	  to	  other	  proteins.	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4.	  PERSPECTIVES	  
	  
This	   work	   underlines	   the	   multifunctionality	   of	   the	   essential	   Dna2	   enzyme	   and	   its	  
importance	   for	  maintaining	   genome	   integrity.	   It	   provides	  possible	  explanations	   for	  
the	   complex	   role	   of	   Dna2	   in	   cancer	   development	   where	   its	   involvement	   is	  
ambiguous.	  Dna2	   is	   a	   caretaker	   gene,	   thus	   loss	   of	   its	   activity	  might	   be	   one	  of	   the	  
initial	   events	   in	   cancer	   development	   and	   the	   driving	   force	   of	   genome	   instability,	  
while	  during	  cancer	  progression	  overexpression	  of	  Dna2	  provides	  cancer	  cells	  with	  
additional	  fitness	  and	  helps	  to	  survive	  higher	   levels	  of	  replication	  stress	   induced	  by	  
increased	   proliferation.	   Thus,	   targeting	   Dna2	   in	   cancer	   therapy	   is	   a	   considerable	  
option,	  especially	  in	  combination	  with	  other	  treatments.	  However,	  thorough	  analysis	  
of	   tumor	   genome	   and	   gene	   expression	   profile	   as	  well	   as	   proper	   staging	   is	   pivotal	  
before	   such	   treatment.	   In	   collaboration	   with	   the	   laboratory	   of	   Prof.	   Lumir	   Krejci	  
(Masaryk	   University,	   Brno,	   Czech	   Republic)	   we	   are	   currently	   conducting	   a	   high-­‐
throughput	   screening	   of	   a	   small	   molecule	   library	   in	   order	   to	   obtain	   a	   selective	  
inhibitor	  of	  both	  yeast	  and	  human	  Dna2.	  In	  case	  of	  success,	  first	  biochemical	  and	  cell	  
biological	   validation	   would	   be	   required,	   with	   a	   possible	   long-­‐term	   perspective	   of	  
testing	  it	  in	  mouse	  models.	  	  
Cancer	  is	  a	  very	  complex	  disease	  and	  we	  are	  now	  only	  starting	  to	  see	  the	  big	  picture.	  
The	  idea	  of	  finding	  THE	  cancer-­‐inducing	  mutation	  and	  targeting	  the	  mutated	  protein	  
turned	  out	  to	  be	  utopic,	  as	  cancers	  display	  a	  large	  variety	  of	  mutational	  landscapes	  
that	   even	   differ	   within	   one	   tumor	   entity	   (133).	   Further,	   the	   concept	   of	   oncogene	  
addiction	  and	  targeting	  the	  oncogene	  within	  the	  corresponding	  pathway	  appears	  to	  
be	   difficult	   (134),	   as	   cancers	   develop	   multiple	   escape	   mechanisms	   and	   drug	  
resistance.	   It	  appears	  that	  personalized	  combinational	   therapies,	   targeting	  multiple	  
hallmarks,	  are	  the	  future	  of	  cancer	  therapy.	  To	  develop	  these	  therapies	  we	  need	  to	  
collaborate	   on	   an	   interdisciplinary	   level	   and	   above	   all	   the	   teamwork	   between	  
clinicians	  and	  basic	  scientists	  is	  of	  an	  essential	  importance.	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